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Abstract	  
	  
Hirschsprung’s	  disease	  causes	  a	  life-­‐threatening	  bowel	  obstruction	  in	  children	  
shortly	  after	  birth,	  because	  the	  stem	  cells	  that	  will	  form	  the	  enteric	  nervous	  
system	  (ENS)	  have	  failed	  to	  colonise	  the	  entire	  length	  of	  the	  gut,	  creating	  an	  
absence	  of	  neuronal	  cell	  bodies	  –	  the	  aganglionic	  region.	  	  Although	  there	  are	  
numerous	  surgical	  techniques	  to	  deal	  with	  this	  problem,	  many	  children	  go	  on	  to	  
have	  severe	  problems	  with	  constipation	  and	  faecal	  incontinence,	  and	  some	  
require	  a	  permanent	  colostomy.	  
	  
It	  was	  hypothesised	  that	  clinical	  outcomes	  in	  children	  with	  Hirschsprung’s	  disease	  
could	  be	  improved	  by	  transplanting	  ENS	  stem	  cells,	  as	  previous	  studies	  had	  shown	  
it	  was	  possible	  to	  produce	  such	  stem	  cells	  from	  embryonic	  bowel.	  	  The	  aim	  of	  this	  
thesis	  was	  to	  develop	  a	  method	  of	  isolating	  such	  cells	  from	  the	  bowel	  of	  children	  
with	  and	  without	  Hirschsprung’s	  disease,	  characterise	  these	  cells	  and	  investigate	  
whether	  they	  could	  be	  successfully	  transplanted	  in	  an	  in	  vitro	  model.	  
	  
In	  the	  first	  part	  of	  this	  thesis,	  a	  method	  was	  developed	  to	  take	  samples	  of	  
postnatal	  bowel	  (both	  small	  and	  large)	  and	  dissociate	  it	  to	  produce	  a	  cell	  
suspension	  that	  allows	  ENS	  stem	  (or	  progenitor)	  cells	  to	  grow	  in	  the	  form	  of	  
neurospheres.	  	  These	  neurospheres	  are	  characterised	  in	  terms	  of	  growth	  and	  
composition,	  and	  it	  is	  shown	  that	  they	  contain	  reproducing	  cells	  that	  are	  capable	  
of	  forming	  neurons	  on	  subsequent	  differentiation.	  	  When	  the	  neurospheres	  are	  
transplanted	  into	  aganglionic	  embryonic	  mouse	  bowel	  grown	  in	  tissue	  culture,	  
neurons	  and	  glia	  from	  the	  neurosphere	  colonise	  the	  bowel	  wall.	  
	  
In	  the	  second	  part	  of	  this	  thesis,	  the	  neurospheres	  were	  further	  characterised	  in	  
terms	  of	  their	  response	  to	  the	  ENS	  growth	  factors	  glial	  cell	  derived	  neurotrophic	  
factor	  (GDNF)	  and	  endothelin	  3	  (EDN3)	  and	  this	  was	  compared	  to	  the	  response	  of	  
neurospheres	  derived	  from	  embryonic	  and	  neonatal	  mice.	  	  It	  was	  shown	  that	  
postnatal	  human	  ENS	  neurospheres	  require	  the	  addition	  of	  GDNF	  to	  produce	  
significant	  neurite	  outgrowth.	  	  Subsequent	  studies	  then	  demonstrated	  that	  the	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human	  neurospheres	  could	  be	  dissociated	  and	  regrown	  in	  culture,	  exponentially	  
increasing	  their	  numbers	  whilst	  retaining	  the	  ability	  to	  produce	  neurons	  and	  glia	  
on	  transplantation	  into	  aganglionic	  embryonic	  hindgut.	  
	  
In	  the	  final	  part	  of	  this	  thesis	  the	  functional	  effect	  of	  neurosphere	  transplantation	  
into	  aganglionic	  embryonic	  hindgut	  was	  investigated.	  	  Firstly	  it	  was	  shown	  that	  
the	  transplanted	  neurons	  integrate	  closely	  with	  the	  recipient	  smooth	  muscle	  and	  
gut	  pacemaker	  cells	  (the	  interstitial	  cells	  of	  Cajal).	  	  Secondly	  it	  was	  shown	  that	  
aganglionic	  embryonic	  mouse	  hindgut	  has	  a	  higher	  rate	  of	  contraction	  than	  
ganglionic	  bowel	  cultured	  in	  the	  same	  conditions,	  and	  that	  human	  and	  mouse	  ENS	  
neurosphere	  transplantation	  restores	  the	  contraction	  frequency	  of	  aganglionic	  
bowel	  to	  that	  of	  ganglionic	  bowel.	  
	  
Taken	  together	  the	  results	  presented	  in	  this	  thesis	  demonstrate	  that	  it	  is	  possible	  
to	  generate	  neurospheres	  from	  postnatal	  human	  bowel	  samples	  that	  contain	  ENS	  
stem	  cells	  that	  are	  capable	  of	  producing	  a	  restorative	  functional	  effect	  when	  
transplanted	  into	  an	  in	  vitro	  model	  of	  Hirschsprung’s	  disease.	  	  This	  is	  a	  step	  
toward	  the	  development	  of	  a	  successful	  stem	  cell	  treatment	  for	  this	  condition.	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ANOVA	  	   analysis	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CNTF	   	   ciliary	  neurotrophic	  factor	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  variation	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DCC	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DMEM	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  medium	  
DNA	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dpc	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E12.5,	  E21	   embryonic	  day	  12.5,	  embryonic	  day	  21	  
ECE-­‐1	   	   endothelin	  converting	  enzyme	  –1	  
ECM	   	   extracellular	  matrix	  
EDN1	   	   endothelin-­‐1	  gene	  
EDN2	   	   endothelin-­‐2	  gene	  
EDN3	   	   endothelin-­‐3	  gene	  
EDNRA	   	   endothelin-­‐A	  receptor	  gene	  or	  RNA	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   endothelin-­‐B	  receptor	  gene	  or	  RNA	  
ET-­‐1	   	   endothelin-­‐1	  peptide	  
ET-­‐2	   	   endothelin-­‐2	  peptide	  
ET-­‐3	   	   endothelin-­‐3	  peptide	  
EMNS	   	   embryonic	  mouse-­‐derived	  neurosphere	  
ENS	   	   enteric	  nervous	  system	  
ENSPC	   	   enteric	  nervous	  system	  progenitor	  cell	  
ENSC	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  nervous	  system	  stem	  cell	  
FACS	   	   fluorescent-­‐activated	  cell	  sorting	  
FITC	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  isothiocyanate	  
FGF	   	   fibroblast	  growth	  factor	  
GFP	   	   green	  fluorescent	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GDNF	   	   glial	  cell-­‐line	  derived	  neurotrophic	  factor	  
GIT	   	   gastro-­‐intestinal	  tract	  
GFAP	   	   glial	  fibrillary	  acidic	  protein	   	  
HEPES	   	   4-­‐(2-­‐hydroxyethyl)-­‐1-­‐piperazineethanesulfonic	  acid	  
HRNP	   	   human	  ribonucleoprotein	  
Hox	   	   Homeobox	  gene	  
HSCR	   	   Hirschsprung’s	  disease	  
IBS	   	   irritable	  bowel	  syndrome	  
ICC	  	   	   interstitial	  cells	  of	  Cajal	  
ICC-­‐SM	   	   interstitial	  cells	  of	  Cajal	  in	  the	  submucosal	  plexus	  
ICC-­‐DMP	   interstitial	  cells	  of	  Cajal	  in	  the	  deep	  muscular	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ICC-­‐IM	   	   interstitial	  cells	  of	  Cajal	  in	  the	  intramural	  region	  
ICC-­‐MY	  	   interstitial	  cells	  of	  Cajal	  within	  the	  myenteric	  plexus	  
IND	   	   intestinal	  neuronal	  dysplasia	  
IgG	   	   Immunoglobulin	  G	  
	   vii	  
LIF	   	   leukaemia	  inhibitory	  factor	  
Mash1	   	   mammalian	  achaete-­‐scute	  homologue-­‐1	  
MEN	   	   multiple	  endocrine	  neoplasia	  syndrome	  
MMC	   	   migrating	  motor	  complex	  
mRNA	   	   messenger	  ribonucleic	  acid	  
NC	   	   neural	  crest	  
NCAM-­‐1	   neural	  cell	  adhesion	  molecule-­‐1	  
NHNS	   	   neonatal/postnatal	  human-­‐derived	  neurosphere	  
NLB	   	   neurosphere-­‐like	  bodies	  
NMNS	   	   neonatal	  mouse-­‐derived	  neurosphere	  
NOS	   	   nitric	  oxide	  synthase	  
NPY	   	   neuropeptide	  Y	  
NT-­‐3	   	   neurotrophin-­‐3	  
NTN	   	   neurturin	  
P0	   	   postnatal	  day	  0	  
PDGF	   	   platelet-­‐derived	  growth	  factor	  (PDGF)	  
PBS	   	   phosphate	  buffered	  saline	  
PCR	   	   polymerase	  chain	  reaction	  
PGP9.5	   	   protein	  gene	  product	  9.5	  
PHH3	   	   phospho-­‐histone	  H3	  
PSP	   	   persephin	  
RET	   	   receptor	  tyrosine	  kinase	  gene	  (rearranged	  in	  transfection)	  
RNA	   	   ribonucleic	  acid	  
RT	   	   reverse	  transcription	  
RT-­‐PCR	   	   Reverse	  Transcriptase	  Polymerase	  Chain	  Reaction	  
S100B	   	   S100	  calcium	  binding	  protein	  B	  
SCF	   	   Stem	  Cell	  Factor	  
	   viii	  
SHH	   	   sonic	  hedgehog	  
SMA	   	   smooth	  muscle	  actin	  
SOX	   	   transcription	  factor	  containing	  an	  SRY-­‐related	  HMG-­‐box	  
SP	   	   substance	  P	  
SRY	   	   Sex	  determining	  region	  on	  the	  Y	  chromosome	  
STC	   	   slow	  transit	  constipation	  
TGFβ	   	   transforming	  growth	  factor	  β	  
TH	   	   tyrosine	  hydroxylase	  
TTX	   	   tetrodotoxin	  
	  
VIP	   	   vasoactive	  intestinal	  polypeptide	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Chapter	  1:	  	  Introduction	  
	  
1.1	  	  Preface	  
	  
“Is	  life	  worth	  living?	  	  This	  is	  a	  question	  for	  an	  embryo	  and	  not	  a	  man.”	  	  Samuel	  
Butler,	  1835-­‐1902,	  The	  Note-­‐Books	  of	  Samuel	  Butler,	  
www.gutenberg.org/dirs/etext04/nbsb10h.htm	  
	  
Samuel	  Butler’s	   father	  died	   in	   1886,	   the	   same	  year	   that	  Dr	  Harald	  Hirschsprung	  
described	   two	   children	   dying	   from	   bowel	   obstruction.	   	   Given	   that	   it	   would	   be	  
many	   years	   before	   the	   causes	   of	   Hirschsprung’s	   disease	   would	   be	   understood,	  
Butler’s	  remark	  was	  remarkably	  prescient:	   	  children	  with	  Hirschsprung’s	  disease,	  
and	   their	   parents,	   may	   well	   feel	   that	   life	   is	   not	   worth	   living,	   and	   it	   is	   a	  
developmental	  defect	  in	  embryonic	  life	  that	  is	  responsible.	  	  	  
	  
Hirschsprung’s	   disease	   (HSCR)	   is	   the	   commonest	   congenital	   disorder	   of	  
gastrointestinal	   motility,	   and	   is	   characterised	   by	   a	   lack	   of	   ganglion	   cells	   in	   the	  
myenteric	   plexus.	   	   This	   results	   in	   a	   life-­‐threatening	   bowel	   obstruction	   requiring	  
surgery	  in	  the	  neonatal	  period,	  but	  despite	  recent	  advances	  in	  surgical	  technique,	  
including	   minimally	   invasive	   surgery(Langer	   et	   al.,	   1999)	   and	   totally	   transanal	  
surgery(Albanese,	   1999),	   the	   overall	   outcome	   for	   this	   condition	   remains	   poor,	  
with	   up	   to	   10%	   of	   patients	   suffering	   from	   long	   term	   severe	   incontinence	   and	  
requiring	  a	   colostomy(Baillie	   et	   al.,	   1999).	   	   In	   addition,	  many	  other	   children	  will	  
experience	   incontinence	   and	   painful	   and	   potentially	   serious	   episodes	   of	  
enterocolitis	   requiring	   admission	   to	   hospital(Rintala	   and	   Pakarinen,	   2006).	   	   It	   is	  
not	  surprising	  that	  this	  significantly	  impacts	  on	  their	  quality	  of	   life:	   	  up	  to	  half	  of	  
all	  children	  with	  Hirschsprung’s	  disease	  feel	  that	  it	  significantly	  affects	  their	  social	  
and	  family	  life(Yanchar	  and	  Soucy,	  1999).	  
	  
Understanding	  the	  cause	  of	  Hirschsprung’s	  disease	   is	  key	  to	  the	  development	  of	  
novel	   treatment	   strategies	   that	   try	   to	   improve	   the	   outcome	   of	   existing	   surgical	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techniques.	   	   Knowledge	   of	   the	   development	   and	   function	   of	   the	   bowel,	   and	  
especially	  the	  enteric	  nervous	  system	  (ENS),	  forms	  the	  foundation	  of	  our	  current	  
theories	  of	  the	  pathogenesis	  of	  HSCR,	  which	  is	  ultimately	  the	  result	  of	  a	  failure	  in	  
the	  migration	  of	  ENS	  precursor	  cells.	  	  	  To	  know	  how	  this	  process	  fails	  in	  HSCR	  it	  is	  
also	   important	   to	   understand	   the	   interplay	   between	   the	   ENS	   and	   the	   other	  
functional	  components	  of	  the	  gastrointestinal	   tract	   (GIT),	  both	  to	  appreciate	  the	  
pathophysiology	  of	  HSCR	  and	  to	  envisage	  ways	  to	  correct	  it.	   	  This	  is	  essential	  for	  
the	   development	   of	   new	   treatments	   for	   not	   only	   this	   condition,	   but	   other	  
disorders	  of	  bowel	  motility	  also.	  	  	  
	  
This	  chapter	  will	  therefore	  begin	  with	  an	  overview	  of	  GIT	  structure	  and	  function,	  
before	  moving	  on	  to	  the	  function	  of	  the	  ENS	  and	  describing	  how	  the	  ENS	  interacts	  
with	  other	   gut	   structures	   to	  produce	  motility.	   	   It	  will	   then	   look	   in	  depth	   at	   ENS	  
development,	   concentrating	  on	  areas	   that	  have	  been	   shown	   to	  be	   significant	   in	  
the	  pathogenesis	  of	  HSCR.	  	  	  This	  is	  followed	  by	  an	  overview	  of	  the	  clinical	  aspects	  
of	  HSCR	  with	  further	  detail	  on	  the	  known	  molecular	  genetic	  mechanisms	  involved	  
in	  the	  development	  of	  clinical	  HSCR,	  the	  treatment	  strategies	  currently	  used	  and	  
the	   potential	   shortcomings	   of	   these	   strategies.	   	   Finally,	   it	  will	   conclude	  with	   an	  
exposition	   of	   the	   case	   for	   a	   potential	   stem	   cell	   treatment	   for	   Hirschsprung’s	  
disease,	  with	  a	  description	  of	  the	  work	  done	  prior	  to	  the	  commencement	  of	  the	  
research	  contained	  in	  this	  thesis.	  
	  
A	  note	  on	  stem	  cell	  terminology	  
	  
In	  this	  thesis,	  the	  following	  terms	  will	  be	  used:	  
	  
Stem	  cell	  (e.g.	  enteric	  nervous	  system	  stem	  cell):	  	  Cells	  that	  have	  both	  the	  capacity	  
to	   self-­‐renew	   (make	  more	   stem	   cells	   by	   cell	   division)	   as	  well	   as	   to	   differentiate	  
into	  mature,	   specialized	   cells.	   	   An	   ENS	   stem	   cell	   is	   capable	   of	   producing	   all	   cell	  
types	  within	  the	  ENS.	  
	  
Precursor	   cell	   (e.g.	  enteric	  nervous	   system	  precursor	   cell):	   	  A	  progenitor	   cell,	   an	  
early	  descendant	  of	  a	  stem	  cell	  that	  can	  differentiate	  in	  to	  a	  more	  limited	  range	  if	  
cell	  types,	  such	  as	  neurons	  or	  glia.	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1.2	  	  Bowel	  development,	  structure	  and	  function	  
	  
1.2.1	  	  Development	  of	  the	  GI	  Tract	  
	  
The	   bowel	   itself	   develops	   from	   endoderm	   and	   mesoderm,	   with	   the	   gut	   tube	  
formed	   by	   infolding	   of	   the	   endodermal	   layer	   and	   subsequent	   cranio-­‐caudal	  
patterning	   to	   differentiate	   the	   areas	   of	   foregut,	  midgut	   and	   hindgut,	  which	   are	  
defined	   in	   terms	   of	   their	   blood	   supply(Rubin,	   2007).	   	   Folding	   begins	   at	  
approximately	   E21	   in	   humans,	   with	   the	   tubular	   foregut	   and	   hindgut	   rapidly	  
becoming	  blind-­‐ending	  tubes	  while	  the	  midgut	  remains	  connected	  to	  the	  yolk	  sac	  
via	  the	  vitello-­‐intestinal	  duct.	  	  Mesodermal	  ingrowth	  contributes	  to	  the	  muscular	  
and	  peritoneal	  components	  of	  the	  developing	  bowel(Larsen,	  2001).	  	  Although	  the	  
bowel	  undergoes	  extensive	  growth	  and	   rotation	  during	   the	  embryonic	  and	   fetal	  
periods,	   the	   eventual	   “adult”	   patterning	   and	   structure	   are	   developed	   early	   and	  
can	  be	  seen	  by	  week	  12	  of	  development	  in	  humans(Fu	  et	  al.,	  2004b).	  
	  
1.2.2	  	  Structure	  of	  the	  GI	  tract	  
	  
The	  organisation	  of	  the	  structures	  that	  make	  up	  the	  gastrointestinal	  tract	  is	  shown	  
in	  Figure	  1.1.	  	  In	  general	  there	  is	  a	  specialised	  layer	  of	  lining	  mucosal	  epithelium,	  
with	   two-­‐	   three	   layers	  of	   smooth	  muscle,	   in	   longitudinal	   and	   circular	  directions.	  
Covering	   the	   wall	   of	   the	   bowel	   is	   the	   serosa	   –	   a	   single	   layer	   of	   columnar	  
epithelium,	   except	   for	   the	   oesophagus	   and	   rectum.	   	   The	   serosa	   continues	   onto	  
the	  mesentery,	  containing	  the	  nerves,	  blood	  vessels	  and	  lymphatics	  supplying	  the	  
gut.	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Figure	  1.1	  Diagrammatic	  cross-­‐section	  of	  small	  intestine	  demonstrating	  relevant	  
structures.	  	  





1.2.3	  	  Functions	  of	  the	  GI	  tract	  
	  
The	   principal	   function	   of	   the	   GIT	   is	   to	   digest	   food	   and	   absorb	   the	   released	  
nutrients	  and	  water,	  whilst	  expelling	  the	  waste	  products	  and	  protecting	  the	  rest	  
of	   the	   body	   from	   any	   pathogens	   present.	   There	   are	   additional	   functions	   of	   the	  
GIT,	   including	   hormonal	   and	   immune,	   but	   consideration	   of	   these	   is	   outside	   the	  
scope	   of	   this	   thesis,	   although	   it	   should	   be	   noted	   that	   immune	   function	  may	   be	  
altered	  in	  animal	  models	  and	  clinical	  examples	  of	  HSCR(Fujimoto,	  1988,	  Moore	  et	  
al.,	  2008).	  	  	  	  
	  
In	   order	   to	   function,	   subsections	   of	   the	   GIT	   are	   highly	   specialised	   in	   terms	   of	  
secretion,	   absorption	   and	  motility.	   	   In	   particular,	   various	  motility	   patterns	   have	  
been	   identified:	   	   the	   swallowing	   reflex	   and	  propulsion	   through	   the	  oesophagus,	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the	  mixing,	   emptying	   and	   emetic	   patterns	   of	   the	   stomach,	   the	   segmenting	   and	  
propulsive	  contractions	  of	   the	  small	  and	   large	  bowel	  and	   the	  expulsive	   reflex	  of	  
the	  rectum	  and	  anal	  sphincter.	  	  
	  
1.2.3.1	  An	  overview	  of	  bowel	  motility	  patterns	  
	  
There	   are	   various	   patterns	   of	   motility	   recognised	   in	   the	   human	   bowel,	   with	  
important	  differences	  between	  small	  and	  large	  bowel.	  	  
	  
In	  small	  bowel,	  contractions	  are	  divided	  into	  mixing	  and	  propulsive	  contractions,	  
although	   there	   is	   a	   functional	   overlap	   between	   the	   two(Christensen,	   1974).	  	  
Mixing,	   or	   segmentation	   contractions,	   occur	   when	   the	   bowel	   is	   distended	   by	  
intraluminal	   contents	   and	   divide	   the	   bowel	   into	   small	   segments	   (approximately	  
1cm	   long)	   with	   relaxation	   and	   contraction	   causing	   mixing	   of	   the	   chyme.	   	   The	  
frequency	   of	   these	   contractions	   is	   generally	   determined	   by	   the	   underlying	   ICC	  
slow	  wave	   activity,	   and	   the	   rate	   decreases	   from	  proximal	   to	   distal	   small	   bowel.	  	  
Propulsive	  contractions	  can	  be	  further	  subdivided	  into	  peristaltic	  contractions	  and	  
the	  migrating	  motor	  complex	  (or	  MMC).	  	  Peristaltic	  contractions	  usually	  progress	  
with	   a	   velocity	   of	   0.5-­‐2cm/sec	   but	   are	   usually	   weak	   and	   short	   lived,	   with	   a	  
maximum	  propagating	  length	  of	  10cm	  in	  the	  human	  small	  bowel.	  	  This	  situation	  is	  
altered	   after	   a	   meal	   when	   neuronal	   and	   hormonal	   (including	   gastrin	   and	   CCK,	  
insulin	   and	   serotonin)	   effects	   increase	   the	   activity	   of	   peristaltic	   waves.	   	   The	  
migrating	  motor	  complex	  only	  occurs	  in	  the	  fasting	  state	  and	  initiates	  a	  slow	  wave	  
of	  contraction	  which	  moves	  from	  the	  stomach	  to	  terminal	  ileum	  with	  a	  velocity	  of	  
6-­‐12cm/min(Kunze	  and	  Furness,	  1999).	  
	  
The	   large	   bowel	   features	   analogues	   of	   the	   contractions	   seen	   in	   the	   small,	   with	  
important	  differences.	  	  Mixing	  movements	  cause	  haustrations	  to	  occur	  and	  also	  a	  
slow	   but	   steady	   propulsion	   of	   luminal	   contents	   in	   the	   caecum	   and	   ascending	  
colon.	  	  Classical	  peristaltic	  waves	  are	  absent,	  but	  mass	  movements	  of	  contraction	  
do	  occur	  from	  the	  transverse	  colon	  onwards.	  	  In	  a	  mass	  movement,	  a	  contraction	  
ring	  appears	  in	  the	  colon	  and	  the	  distal	  bowel	  loses	  the	  normal	  haustrations	  and	  
instead	  contracts	  en	  masse,	  forcing	  the	  contents	  onwards.	   	  The	  contractions	  last	  
for	   approximately	   30	   seconds	   and	   recur	   every	   2-­‐3	   minutes	   during	   a	   cycle	   of	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activity	  that	  may	  last	  for	  30	  minutes.	  	  	  This	  movement	  pattern	  is	  initiated	  neurally	  
(via	  the	  gastrocolic	  reflex)	  and	  locally	  by	  distension	  and	  irritation(Guyton	  and	  Hall,	  
1996).	  	  	  
	  
Finally,	   the	   defecation	   reflex	   is	   a	   complex	   event	   involving	   parasympathetic	  
autonomic	   input	  to	  the	   large	  bowel,	  rectum	  and	   internal	  anal	  sphincter,	  skeletal	  
smooth	   muscle	   inputs	   to	   the	   external	   anal	   sphincter	   and	   higher	   neuronal	  
control(Rao	  et	  al.,	  1998).	  
	  
1.2.3.2	  Regulation	  of	  motility	  by	  the	  ENS	  
	  
The	  coordination	  and	  regulation	  of	  these	  phenomena	  is	  a	  formidable	  task,	  and	  the	  
organ	   responsible,	   the	   enteric	   nervous	   system,	   has	   been	   dubbed	   “the	   second	  
brain”	  in	  recognition	  of	  its	  size	  and	  complexity	  (Gershon,	  1998a).	  
	  
	  
1.2.4	  	  The	  ENS	  
	  
The	   ENS	   itself	   is	   part	   of	   the	   peripheral	   nervous	   system,	   and	   extends	   the	   entire	  
length	  of	  the	  gastrointestinal	  tract	  in	  which	  it	  regulates	  both	  gut	  motility,	  fluid	  and	  
electrolyte	   balance	   and	   immune	   function(Newgreen	   and	   Young,	   2002a,	   Wood,	  
2002).	   	   Neurons	   and	   glia	   of	   the	   ENS	   are	   clustered	   in	   ganglia	   located	   in	   the	  
myenteric	  (Auerbach’s)	  plexus	  and	  the	  submucosal	  (Meissner’s)	  plexus	  of	  the	  gut	  
wall.	   	   These	   enteric	   ganglia	   contain	   many	   types	   of	   neuron	   producing	   a	   wide	  
variety	   of	   excitatory	   and	   inhibitory	   neurotransmitters	   that	   regulate	   smooth	  
muscle	   contraction,	   alter	   secretions	   into	   the	   lumen	   of	   the	   gut,	   and	   receive	   or	  
transmit	  information	  to	  other	  parts	  of	  the	  nervous	  system.	  There	  are	  estimated	  to	  
be	   over	   100	   million	   neurons	   in	   the	   human	   gut(Grundy	   and	   Schemann,	   2005),	  
together	   with	   enteric	   glia	   that	   outnumber	   the	   neurons.	   The	   glia	   function	   as	   a	  
store	   for	   neurotransmitter	   precursors,	   uptake	   and	   degrade	   neurotransmitters,	  
express	   receptors	   for	   the	   neurotransmitters,	   and	   maintain	   the	   integrity	   of	   the	  
mucosal	  barrier	  of	  the	  gut(Ruhl	  et	  al.,	  2004).	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The	  ENS	  retains	  a	  high	  degree	  of	  autonomy	  but	  is	  also	  subject	  to	  extrinsic	  control	  
in	  the	  form	  of	  sympathetic	  and	  parasympathetic	  inputs,	  endocrine	  responses	  and	  
intraluminal	   factors(Johnson,	   2001).	   	   These	   combined	   inputs	   exert	   a	   profound	  
influence	   on	   all	   digestive	   processes:	   	   motility,	   ion	   transport	   associated	   with	  
secretion	   and	   absorption,	   and	   gastrointestinal	   blood	   flow,	   plus	   an	   influence	   on	  
immune	  function.	   	  However,	  the	  principal	  effect	  of	  the	  ENS,	  as	  evidenced	  by	  the	  
dramatic	   obstructive	   symptoms	   present	   in	   HSCR,	   is	   to	   regulate	   smooth	   muscle	  
activity	  within	  the	  GIT.	  	  
	  
1.2.5	  	  An	  overview	  of	  smooth	  muscle	  
	  
Smooth	   muscle	   is	   distinct	   from	   skeletal	   muscle	   in	   several	   key	   ways.	   	   Smooth	  
muscle	   cells	   are	   smaller	   than	   their	   striated	   counterparts,	   and	   are	  mononuclear.	  	  
Smooth	   muscle	   lacks	   the	   striated	   arrangement	   of	   actin	   and	   myosin	   found	   in	  
skeletal	  muscle	  and	   lacks	   troponin	  –	   the	  regulatory	  protein	  that	  couples	  calcium	  
influx	   to	   contraction(Prosser,	   1974).	   	   Mechanically	   they	   develop	   contractions	  
slower,	   cycle	   actin-­‐myosin	   cross	   bridges	   at	   a	   slower	   rate	   and	   functionally	   their	  
contractility	   can	  be	  altered	   in	   a	  multitude	  of	  ways(Guyton	  and	  Hall,	   1996).	   	   The	  
smooth	  muscle	  in	  the	  wall	  of	  the	  GIT	  is	  known	  as	  unitary	  smooth	  muscle	  because	  
of	  the	  gap	  junctions	  between	  cells	  and	  the	  numerous	  cell	  membrane	  attachments	  
that	  mean	  that	  the	  muscle	  contracts	  as	  a	  whole	  unit(Guyton	  and	  Hall,	  1996).	  	  	  
	  
Instead	  of	  troponin,	  contractions	  in	  smooth	  muscle	  are	  coupled	  to	  calcium	  influx	  
by	  the	  protein	  calmodulin(Marston	  et	  al.,	  1998).	  	  When	  calcium	  enters	  the	  cell,	  it	  
binds	   to	   calmodulin	   and	  activates	  myosin	   kinase,	  which	   can	   then	  phosphorylate	  
smooth	   muscle	   myosin	   and	   activate	   it,	   to	   allow	   actin-­‐myosin	   crossbridge	  
cycling(Chalovich,	  1992,	  Marston	  et	  al.,	  1998).	  	  	  
	  
Smooth	   muscle	   regulation	   in	   the	   ENS	   can	   happen	   in	   a	   number	   of	   different	  
ways(Brading,	  2006).	  	  Smooth	  muscle	  does	  not	  exhibit	  the	  classical	  neuromuscular	  
junction	   as	   found	   in	   skeletal	  muscle;	   the	   nerve	   fibres	   terminate	   in	   a	   number	   of	  
diffuse	   junctions	   in	   close	   proximity	   to	   the	   muscle	   cell.	   	   The	   nerve	   fibres	  
themselves	   have	  multiple	   varicosities	   along	   the	   length	   of	   the	   axon	   rather	   than	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specialised	  end	  plates.	  	  In	  addition,	  the	  number	  of	  neurotransmitter	  types	  is	  much	  
higher	   than	  simple	  acetylcholine(Burnstock,	  2006)	  and	  hormones	  can	  also	  affect	  
smooth	  muscle	  cells	  .	  	  	  	  
	  
A	  particular	  property	  of	  GIT	  smooth	  muscle	  is	  the	  slow	  wave	  cycling	  of	  the	  resting	  
membrane	  electrical	   potential.	   	   These	   slow	  waves	  do	  not	   generate	   contractions	  
themselves,	   but	   once	   a	   certain	   threshold	   (about	   -­‐35mV)	   is	   reached,	   voltage-­‐
dependent	   calcium	   channels	   open	   and	   a	   depolarising	   action	   potential	   will	  
occur(Duthie,	   1974).	   	   The	   interstitial	   cells	   of	   Cajal	   (ICC)	   (Sanders	   et	   al.,	   2006b)	  
generate	  slow	  waves.	  	  The	  importance	  of	  slow	  wave	  generation	  and	  its	  regulatory	  
effect	  are	  discussed	  in	  the	  following	  section.	  
	  
1.2.6	  	  Interstitial	  Cells	  of	  Cajal	  
	  
As	   mentioned	   above,	   ICC	   are	   responsible	   for	   slow	   wave	   activity	   in	   the	   smooth	  
muscle	  of	  the	  GIT.	   	  These	  cells	  reside	  within	  the	  gut	  wall	   in	  close	  relation	  to	  the	  
smooth	   muscle	   cells	   and	   yet	   they	   are	   functionally	   and	   histologically	  
distinct(Thuneberg,	  1999).	  	  The	  ICC	  were	  originally	  described	  as	  small	  fusiform	  or	  
stellate	  cells	  with	  prominent	  nuclei	  and	  varicose	  processes	  that	  formed	  networks	  
in	   the	  gut	  wall	  by	  Ramon	  y	  Cajal	   in	  1892	  and	  1893(Cajal,	  1892,	  Cajal,	  1893),	  but	  
Cajal	   was	   under	   the	   impression	   that	   the	   cells	   were	   neuronal	   in	   origin.	   	   Later	  
authors	  classified	  them	  as	  neurons,	  Schwann	  cells	  and	  fibroblasts	  (see	  Thuneberg	  
1999	  for	  a	  detailed	  review(Thuneberg,	  1999)).	   	   It	  was	  not	  until	  many	  years	   later	  
that	   the	   functional	   significance	   of	   these	   cells	   was	   appreciated,	   initially	   by	  
Ambache	   in	  1947(Ambache,	  1947)who	  thought	  that	  electrical	  slow	  wave	  activity	  
in	   the	   gut	   originated	   from	   Cajal’s	   interstitial	   cells	   and	   later	   by	   Thuneberg,	   who	  
suggested	   that	   they	  may	   have	   a	   pacemaker	   function	  within	   the	   gut(Thuneberg,	  
1982).	  	  
	  
There	   have	   been	   two	   recent	   developments	   that	   have	   confirmed	   Thuneberg’s	  
original	   hypothesis	   and	   stimulated	   further	   research	   into	   the	   structure	   and	  
function	  of	  ICC.	  	  The	  first	  was	  the	  realisation	  that	  antibodies	  directed	  against	  the	  
proto–oncogene	   c-­‐Kit	   (which	   is	   a	   receptor	   tyrosine	   kinase	   in	   the	   PDGF/CSF-­‐1	  
family	   (Qui	   et	   al.,	   1988))	   labelled	   cells	   within	   the	   gut	   wall,	   and	   that	   the	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distribution	   of	   kit	   immunoreactive	   cells	   was	   similar	   to	   that	   seen	   in	   previous	  
studies	  on	  ICC(Maeda	  et	  al.,	  1992).	  	  Administration	  of	  neutralising	  c-­‐Kit	  antibodies	  
to	  neonatal	  mice	   resulted	   in	   the	   loss	  of	   slow	  wave	  activity,	  disappearance	  of	  kit	  
immunoreactivity,	   and	   severe	   intestinal	   dysmotility	   of	   ICC	   (Maeda	   et	   al.,	   1992).	  	  
This	   finding	  not	  only	  gave	  support	   to	   the	  concept	   that	   the	   ICC	  were	   responsible	  
for	  mediating	   slow	  wave	  activity	  within	   the	   smooth	   intestine,	   it	   also	  provided	  a	  
convenient	  way	  to	  identify	  ICC	  and	  affect	  their	  development	  in	  in	  vitro	  conditions.	  	  
It	  also	  provides	  evidence	  that	  c-­‐kit	   immunoreactivity	  is	  an	  important	  indicator	  of	  
functional	  ability	  as	  well	  as	  an	  anatomical	  marker.	  
	  
The	  second	  development	  was	  the	  finding	  that	  the	  mouse	  dominant	  white	  spotting	  
(W)	   locus	   is	   allelic	   with	   c-­‐kit(Chabot	   et	   al.,	   1988).	   	   Although	   mouse	   W/W	  
homozygous	  mice	   die	   before	   birth	   due	   to	   severe	   anaemia,	   attenuated	  mutants	  
(such	  as	  W/Wv	  mice,	  where	  a	  point	  mutation	   reduces	  but	  does	  not	   abolish	   the	  
function	  of	  the	  tyrosine	  kinase)	  have	  proved	  valuable	  in	  studying	  the	  function	  of	  
the	  ICC	  in	  vivo(Sanders	  et	  al.,	  2002).	  
	  
As	  a	  result	  of	   these	  discoveries,	  significant	  advances	   in	  the	  understanding	  of	   ICC	  
development,	  structure,	  function	  and	  regulation	  have	  been	  made.	  
	  
1.2.6.1	  	  Development	  of	  the	  ICC	  
	  
Given	   that	   the	   nature	   of	   the	   ICC	   was	   questioned	   for	   many	   years,	   it	   is	   not	  
surprising	   that	   their	   embryological	   origin	   was	   also	   debated.	   	   Immature	   ICC	  
possess	   few	   of	   the	   ultrastructural	   features	   associated	   with	   mature	   ICC.	   	   The	  
numerous	   mitochondria,	   endoplasmic	   reticulum,	   caveolae,	   myofilaments,	   basal	  
lamina,	  and	  structural	  junctions	  with	  smooth	  muscle	  cells	  are	  not	  apparent	  during	  
development.(Faussone-­‐Pellegrini,	   1985,	   Ward	   and	   Sanders,	   2001).	  	  
Immunofluorescent	   and	   immunohistochemical	   techniques	  using	   antibodies	   to	   c-­‐
kit	   have	   subsequently	   shown	   that	   the	   ICC	   originate	   from	   bowel	   mesenchymal	  
tissue(Young	   et	   al.,	   1996,	   Lecoin	   et	   al.,	   1996)	   and	   not	   the	   neural	   crest.	  	  	  
Furthermore,	   primitive	   ICC	   will	   express	   markers	   of	   smooth	   muscle,	   such	   as	  
smooth	  muscle	   actin	   (SMA),	   and	   it	   has	   been	   hypothesized	   that	   ICC	   represent	   a	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specialised	  form	  on	  smooth	  muscle	  cell,	  which	  may	  be	  a	  direct	  consequence	  of	  c-­‐
kit	  expression	  and	  stimulation(Sanders	  et	  al.,	  1999).	  
	  
In	  support	  of	  the	  mesenchymal	  origin	  of	   ICC,	  experiments	  where	  ICC	  are	  treated	  
with	   the	   c-­‐kit	   blocking	   antibody	   ACK-­‐2	   showed	   a	   loss	   of	   c-­‐kit	   expression	   and	  
pacemaker	   activity	   with	   evidence	   of	   smooth	  muscle	   differentiation(Torihashi	   et	  
al.,	  1999).	  	  In	  addition,	  in	  experimental	  models	  of	  small	  bowel	  obstruction,	  there	  
is	   a	   loss	   of	   immunohistochemical,	   ultrastructural	   and	   pacemaker	   features	  
associated	  with	  the	  ICC	  and	  the	  appearance	  of	  a	  new	  cell	  population	  with	  features	  
more	  in	  keeping	  with	  smooth	  muscle	  and	  fibroblasts.	  	  After	  the	  removal	  of	  small	  
bowel	  obstruction,	  these	  cells	  appear	  to	  re-­‐differentiate	  into	  ICC,	  and	  re-­‐establish	  
pacemaker	   activity(Chang	  et	   al.,	   2001).	   	   This	   result	   indicates	   that	   ICC	  origin	   and	  
plasticity	  are	  important	  clinical	  concepts	  as	  well	  as	  theoretical	  ones.	  
	  	  
In	  the	  mouse,	  c-­‐Kit	   immunoreactivity	  and	  Kit	  mRNA	  can	  be	  detected	  by	  E12	  and	  
by	   E14	   a	   network	   of	   presumptive	   ICC	   (identified	   by	   c-­‐Kit	   labelling)	   is	   well	  
developed	  in	  a	  single	  layer	  encircling	  the	  bowel(Jun	  J.	  Wu,	  2000).	  	  This	  pattern	  is	  
not	  the	  pattern	  seen	  in	  adult	  mice	  however,	  and	  further	  development	  of	  the	  ICC	  
network	  must	  occur.	   	   In	   fact,	   in	   term	  mice	  neonates	   the	   ICC	  network	   is	   still	  not	  
fully	   developed,	   and	   the	   adult	   pattern	   is	   only	   established	   once	   weaning	   has	  
occurred(Faussone-­‐Pellegrini,	   1985).	   	   In	   humans,	   ICC	   development	   occurs	   after	  
smooth	   muscle	   differentiation	   of	   the	   mesenchyme.	   	   An	   initial	   study	   by	  
Kenny(Kenny	  et	  al.,	  1999)	  indicates	  that	  in	  the	  human	  developing	  ICC	  are	  present	  
by	   9	  weeks	   of	   gestation.	   	   Subsequently,	  Wallace	   and	   Burns(Wallace	   and	   Burns,	  
2005)	   showed	   that	   by	   week	   8,	   	   smooth	  muscle	   actin	   (SMA)	   staining	   is	   present	  
throughout	  the	  whole	  of	  the	  GIT	  but	  differentiation	  appears	  to	  start	  rostrally	  and	  
move	   caudally,	   so	   that	   the	   smooth	  muscle	   of	   the	   oesophagus	   is	  well	   organised	  
into	   layers	   by	   this	   time	   but	   in	   the	   large	   intestine	   no	   distinct	   muscle	   layers	   are	  
present.	   	   By	   week	   9,	   weak	   c-­‐kit	   immunoreactivity	   was	   observed	   within	   the	  
existing	   muscle	   layer,	   again	   implying	   that	   ICC	   are	   differentiating	   from	   smooth	  
muscle	  cells.	  	  In	  the	  human	  however,	  the	  ICC	  network	  is	  better	  developed	  at	  term	  
than	  in	  mice.	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1.2.6.2	  Arrangement	  of	  the	  ICC	  
	  
The	  arrangement	  of	  the	  ICC	  varies	  throughout	  the	  GIT.	  	  However,	  there	  is	  a	  typical	  
arrangement	  of	  which	  others	  represent	  variations.	   	  The	  ICC	  are	  usually	  classified	  
on	  an	  anatomical	  basis	  according	  to	  their	  arrangement	  in	  the	  gut.	  
	  
The	  densest	  arrangement	  of	   the	   ICC	  can	  be	   found	  around	  the	  myenteric	  plexus,	  
with	   networks	   forming	   between	   and	   around	   the	   ganglia(Streutker	   et	   al.,	   2007).	  	  
These	  ICC	  are	  usually	  referred	  to	  ICC-­‐MY.	  	  ICC	  are	  also	  present	  within	  the	  circular	  
and	   longitudinal	   layers	   of	   muscle	   between	   intramural	   neurons	   and	   smooth	  
muscle	  cells,	  both	  within	  the	  muscle	  and	  along	  fibrous	  septa:	   	  these	  are	  the	  ICC-­‐
IM	  .	  	  There	  are	  also	  ICC	  present	  along	  the	  inner	  portion	  of	  the	  circular	  layer;	  in	  the	  
small	  bowel	  they	  are	  separated	  from	  the	  submucosa	  by	  a	  very	  thin	  muscle	   layer	  
and	  are	   referred	   to	  as	   the	  deep	  muscular	  plexus	   ICC	   (ICC-­‐DMP)	  and	   in	   the	   large	  
intestine	   they	   are	   immediately	   adjacent	   to	   the	   submucosa	   and	   are	   associated	  
with	   the	  submucosal	  plexus	   (ICC-­‐SM)	   (Rumessen	  et	  al.,	  1993).	   	   	  The	   ICC-­‐DMP	  of	  
the	   small	   intestine	   often	   have	   little	   or	   no	   c-­‐kit	   staining	   and	   appear	   more	   like	  
smooth	  muscle	   cells	   than	   the	   ICC-­‐MY	   or	   ICC-­‐IM(Wang	   et	   al.,	   2003).	   	   Compared	  
with	   the	   small	   bowel,	   in	   the	   large	   bowel	   immunohistochemistry	   for	   C-­‐kit	   in	   the	  
ICC	  is	  less	  intense	  and	  the	  number	  of	  ICC	  is	  less(Streutker	  et	  al.,	  2007).	  	  However,	  
important	  variations	  also	  exist	  within	  the	  distribution	  of	  ICC	  in	  the	  large	  bowel,	  a	  
fact	   that	  may	  explain	   the	   conflicting	   reports	   regarding	   the	  distribution	  of	   ICC	   in	  
Hirschsprung’s	   disease(Ward	   et	   al.,	   2002).	   	   Specifically,	   this	   study	   found	   that	   in	  
mouse	  colon	  the	  density	  of	  ICC	  decreases	  from	  proximal	  to	  distal	  within	  the	  colon,	  





1.2.6.3	  	  Function	  of	  the	  ICC	  
	  
	  
ICC	  have	   several	   important	   functions	   in	   the	  GI	   tract.	   	   They	   generate	  pacemaker	  
electrical	   slow	  wave	   activity	   and	   propagate	   slow	  wave	   activity,	   and	   they	   act	   as	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signal	   transducing	   elements	   for	   neural	   inputs	   and	  mechanical	   stretch.	   	   As	   such,	  
they	  are	  essential	  for	  normal	  bowel	  peristalsis.	  
	  
1.2.6.3.1	  	  Pacemaker	  function	  of	  ICC	  
	  
The	   evidence	   for	   ICC	   pacemaker	   activity	   is	   now	   overwhelming,	   with	   examples	  
coming	   from	   the	   experiments	   of	   Thuneberg(Thuneberg,	   1982),	   the	   evidence	  
provided	   by	   W/Wv	   knockout	   mice(Ward	   et	   al.,	   1994,	   Ward	   et	   al.,	   1995)	   and	  
electrical	  studies	  on	  smooth	  muscle	  and	  ICC(Ward	  et	  al.,	  1991,	  Liu	  and	  Huizinga,	  
1993)	  (Ward	  et	  al.,	  1997).	  	  These	  studies	  are	  only	  examples	  of	  what	  is	  now	  a	  well-­‐
established	  field,	  and	  more	  detailed	  reviews	  are	  available(Horowitz	  et	  al.,	  1999a).	  
	  
How	   the	   ICC	   generate	   rhythmic	   electrical	   slow	   wave	   activity	   is	   less	   clear.	  	  
Sanders(Sanders	   et	   al.,	   2006b),	   on	   the	   basis	   of	   ultrastructural	   and	   chemical	  
blocking	  studies,	  has	  proposed	  that	  a	   functional	  unit	  exists	  consisting	  of	  smooth	  
endoplasmic	  reticulum,	  mitochondria	  and	  calcium	  channels	  in	  close	  proximity.	  	  It	  
is	  proposed	  that	  local	  entry	  of	  a	  small	  amount	  of	  extracellular	  calcium	  into	  the	  cell	  
mediated	   by	   inositol	   triphosphate	   causes	   a	   larger	   uptake	   of	   Ca++	   into	   the	  
mitochondria	   and	   subsequent	   triggering	   of	   non-­‐selective	   cation	   channels	   to	  
depolarise	   the	   cell.	   	   This	   activity	   can	   then	   spread	   to	   other	   cells	   in	   the	   vicinity.	  	  
There	   is	   now	   experimental	   data	   in	   human	   ICC	   to	   support	   this	  model(Lee	   et	   al.,	  
2007).	  	  
	  
Active	  propagation	  of	  slow	  waves	  occurs	  within	  the	  ICC	  network,	  at	  a	  speed	  of	  5-­‐
40mm	   per	   second,	   which	   implies	   that	   an	   electrical	   mechanism	   rather	   than	  
diffusion	  of	  calcium	  is	  responsible(Sanders	  et	  al.,	  2006b).	  	  Smooth	  muscles	  cannot	  
generate	   slow	   waves(Horowitz	   et	   al.,	   1999b)	   and	   therefore	   there	   must	   be	   a	  
method	  of	   coupling	   ICC	   slow	  wave	  activity	   to	   smooth	  muscles.	   	   This	   area	   is	   still	  
the	   subject	   of	   controversy;	   it	   has	   been	   assumed	   that	   gap	   junctions	   are	  
responsible,	  and	  there	  is	  evidence	  that	   inhibitors	  of	  gap	  junction	  function	  inhibit	  
slow	  wave	   transmission(Lee	  et	  al.,	   2007).	   	  However,	  ultrastructural	  evidence	   for	  
gap	  junctions	  coupling	  ICC	  to	  smooth	  muscle	   in	  the	  neonatal	  and	  adult	  mouse	  is	  
lacking(Faussone-­‐Pellegrini,	   1985,	   Daniel,	   2004b)	   and	   recent	   evidence	   has	  
suggested	   that	   gap	   junctions	   are	   not	   required	   for	   the	   transmission	   of	   ICC	   slow	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waves	   or	   the	   transduction	   of	   neuronal	   activity(Daniel	   et	   al.,	   2007b).	   	   This	  
conflicting	   data	  may	   however	   be	   explained	   by	   the	   close	   spatial	   arrangement	   of	  
ICC	   and	   smooth	   muscle	   cells,	   such	   that	   electrical	   charge	   and	   neurotransmitter	  
diffusion	  could	  couple	  the	  cells	  even	  though	  no	  direct	  contact	  exists.	  
	  
The	   effect	   of	   ICC	   pacemaker	   activity	   is	   to	   produce	   a	   slowly	   changing	   electrical	  
potential	  below	  the	  threshold	  for	  spontaneous	  depolarisation.	  	  This	  has	  an	  effect	  
on	   the	   smooth	   muscle	   cells	   by	   affecting	   the	   probability	   of	   voltage	   dependent	  
smooth	  muscle	   Ca++	   channels	   opening	   and	   therefore	   provides	   intrinsic	   rhythmic	  
peristalsis	  by	  greatly	  increasing	  the	  likelihood	  of	  smooth	  muscle	  depolarisation	  on	  
contraction	   at	   the	   peak	   of	   the	   wave(Tomita,	   1981).	   	   	   Given	   the	   mesenchymal	  
origin	   of	   the	   ICC,	   it	   is	   tempting	   to	   speculate	   that	   this	   may	   represent	   an	   early	  
primitive	  form	  of	  motility	  upon	  which	  more	  complex	  neuronal	   inputs	  developed.	  	  
It	   is	  also	   important	   to	  state	   that	   in	   the	  absence	  of	  neural	   crest	  colonisation	  and	  
the	   presence	   of	   aganglionosis,	   slow	   wave	   activity	   in	   the	   small	   bowel	   of	   GDNF	  
knockout	  mice	  is	  essentially	  normal(Ward	  et	  al.,	  1999).	  
	  
Classically,	  slow	  wave	  activity	  has	  been	  attributed	  to	  the	  ICC-­‐MY	  rather	  than	  ICC-­‐
DMP/ICC-­‐IM,	   but	   it	   has	   been	   shown	   that	   these	   other	   classes	   of	   ICC	   can	   act	   as	  
pacemakers	   in	   some	   conditions(Beckett	   et	   al.,	   2003).	   	   However,	   colon	   motor	  
patterns	   are	   more	   complex	   than	   simple	   rhythmic	   peristalsis	   and	   more	  
complicated	  neuronal	  mechanisms	  must	  intervene.	  	  	  
	  
	  
1.2.6.3.2	  	  Development	  of	  slow	  wave	  function	  
	  
Developmentally,	  slow	  wave	  activity	  has	  been	  shown	  to	  start	   in	   the	  small	  bowel	  
before	  birth	  in	  mice,	  but	  not	  in	  the	  colon	  (Ward	  et	  al.,	  1997,	  Torihashi	  et	  al.,	  1997,	  
Beckett	   et	   al.,	   2007).	   	   This	   is	   significant	   as	   colonic	   peristalsis	   has	   been	   seen	   to	  
occur	   in	   the	  mouse	   fetus(Anderson	   et	   al.,	   2004)	   and	   it	   would	   imply	   that	   other	  
mechanisms	  might	  be	   functioning.	   	   Further	   support	   to	   this	  hypothesis	  has	  been	  
added	  by	  the	  findings	  of	  Roberts	  et	  al(Roberts	  et	  al.,	  2007)	  who	  identified	  colonic	  
“ripples”	  using	  spatiotemporal	  mapping	  but	  did	  not	  see	  colonic	  migrating	  motor	  
complexes.	   	   These	   investigators	   noted	   the	   frequency	  of	   ripples	   to	   be	   five	   times	  
	   30	  
higher	   than	   those	  of	   slow	  waves,	   and	   saw	  very	   few	  slow	  waves	   in	  adult	   colonic	  
tissue.	  	  It	  should	  however	  be	  noted	  that	  the	  number	  of	  neonatal	  samples	  studied	  
(only	   3	   at	   P0)	   does	   leave	   a	   question	   over	   the	   reproducibility	   of	   these	   results.	  	  
Further	  work	  by	  the	  same	  group	  on	  the	  duodenum	  has	  again	  shown	  that	  “ripples”	  
are	   present	   early	   in	   embryonic	   development	   in	   mice	   and	   that	   they	   are	   again	  
independent	  of	   slow	  wave	  and	  c-­‐Kit	  positive	   ICC,	  before	  becoming	  entrained	  by	  
emergent	  slow	  waves	  prior	  to	  birth(Roberts	  et	  al.,	  2010).	  	  	  
	  
However,	   the	   techniques	   used	   in	   these	   two	   papers	   have	   also	   identified	   that	  
neurally	  mediated	  motility	   patterns	   do	   not	   develop	   in	  mice	   until	   P10,	   implying	  
that	   other	   mechanisms	   are	   responsible	   for	   colonic	   emptying.	   	   Given	   that	   Dom	  
mice	  have	  an	  established	  megacolon	  by	  day	  10	  of	  life,	  neural	  regulation	  must	  play	  
a	  key	  part	  in	  at	  least	  rectal	  emptying(Lane	  and	  Liu,	  1984).	  	  	  
	  
The	  relevance	  and	  development	  of	  ICC	  slow	  wave	  function	  in	  intestinal	  peristalsis	  
in	  human	  neonates	  is	  still	  unknown.	  
	  
1.2.6.3.3	  	  ICC	  signal	  transduction	  and	  regulation	  
	  
There	  is	  now	  extensive	  evidence	  that	  the	  ICC	  receive	  neural	  inputs	  in	  the	  stomach	  
and	   small	   intestine.	   	   Neuronal/ICC-­‐DMP	   synapses,	   in	   the	   form	   of	   varicosities	  
existing	   in	   close	   apposition,	   exist	   within	   the	   guinea	   pig	   ileum	  with	   inputs	   from	  
both	  excitatory	  and	  inhibitory	  nerves(Burns	  et	  al.,	  1996,	  Wang	  et	  al.,	  1999,	  Ward,	  
2000,	  Ward	  et	  al.,	  2000).	  	  These	  synapses	  provide	  a	  mechanism	  whereby	  ICC	  can	  
act	   as	   signal	   transducers	   inducing	   a	   change	   in	   slow	   wave	   activity,	   and	   hence	  
smooth	  muscle	  activity,	  in	  response	  to	  ENS	  signalling.	  	  It	  should	  be	  noted	  however	  
that	   in	   the	   mouse	   colon,	   nerve	   endings	   containing	   synaptic	   vesicles	   are	   not	  
present	  within	  the	  muscle	  wall	  and	  nerve	  endings	  at	  the	  myenteric	  plexus	  level	  do	  
not	  contact	  the	  presumptive	  ICC-­‐MY	  and	  "myenteric"	  side	  of	  the	  circular	  smooth	  
muscle	  cells(Faussone-­‐Pellegrini,	  1985,	  Faussone-­‐Pellegrini,	  1987).	   	  However,	  the	  
close	   spatial	   relationship	   of	   the	   neuronal	   endings	   and	   the	   ICC,	   especially	   in	   the	  
neonatal	  population,	  mean	  that	  a	  direct	  effect	  due	  to	  neurotransmitter	  release	  is	  
still	  possible.	  There	   is	  also	  evidence	  for	  other	  neurotransmitter	  receptors	  on	  the	  
ICC,	   including	   somatostatin(Sternini	   et	   al.,	   1997),	   substance	   P	   (Portbury	   et	   al.,	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1996,	  Sternini	  et	  al.,	  1995,	  Publicover	  et	  al.,	  1992),	  VIP(Publicover	  et	  al.,	  1992)	  and	  
acetylcholine(Ward	  et	  al.,	  2000).	  
	  	  	  
In	   addition,	   not	   only	   do	   ICC	   receive	   neuronal	   inputs,	   they	   also	   appear	   to	   be	  
capable	  of	  neurotransmitter	  synthesis	  and	  release.	  	  ICC-­‐DMP	  in	  the	  mouse	  colon	  
express	   eNOS	   and	   nNOS(Vannucchi	   et	   al.,	   2002).	   	   In	   ICC	   isolated	   from	   the	  
submucosal	   plexus	   of	   canine	   colon,	   NO	   donors	   increased	   their	   intracellular	  
calcium	  levels	  and	  caused	  a	  release	  of	  NO	  from	  the	  ICC	  themselves(Publicover	  et	  
al.,	   1993).	   	   This	   is	   significant	   as	   there	   is	   also	   evidence	   that	   ICC	   are	   sensitive	   to	  
mechanical	   inputs,	   such	  as	  stretch,	  and	   they	  are	   therefore	  capable	  of	   regulating	  
gut	   activity	   independently	   of	   higher	   neuronal	   inputs,	   although	   to	   date	   such	   a	  
function	  has	  only	  been	  identified	  in	  the	  ICC-­‐IM	  of	  the	  stomach(Won	  et	  al.,	  2005).	  
	  
Taken	   together,	   these	   results,	   and	   the	   close	   anatomical	   relationship	   between	  
neuronal	  synapses	  or	  nerve	  endings	  and	  the	  ICC	  have	  led	  to	  the	  	  concept	  that	  the	  
effectors	  of	  the	  ENS	  on	  intestinal	  motility	  are	  not	  the	  smooth	  muscle	  cells,	  but	  are	  
instead	   the	   ICC.	   	   This	   has	   important	   ramifications	   for	   the	   development	   of	   a	  
successful	   stem	   cell	   treatment	   for	   HSCR,	   as	   any	   new	   ENS	   neurones	   must	   be	  
capable	  of	  interacting	  with	  endogenous	  ICC.	  
	  
1.2.6.4	  	  Relevance	  in	  disease	  
	  
The	  status	  of	   ICC	  in	  HSCR	  and	  other	  bowel	  disorders	   is	  still	  not	  entirely	  clear.	   	   In	  
particular,	  there	  have	  been	  conflicting	  reports	  of	  the	  numbers	  and	  distribution	  of	  
ICC	   in	   mice	   and	   humans	   with	   HSCR	   or	   its	   equivalent.	   	   Several	   studies	   have	  
reported	   that	   ICC	   number	   and	   distribution	   are	   normal(Horisawa	   et	   al.,	   1998,	  
Newman	   et	   al.,	   2003,	   Ward	   et	   al.,	   2002).	   	   However,	   other	   investigators	   have	  
found	   reductions	   in	   ICC	   in	   the	   colon	   proximal	   to	   and	   within	   the	   HSCR	  
segment(Yamataka	  et	  al.,	  1995,	  Rolle	  et	  al.,	  2002,	  Taguchi	  et	  al.,	  2003,	  Sandgren	  
et	  al.,	  2002).	  	  The	  reasons	  for	  these	  discrepancies	  are	  not	  entirely	  clear.	  	  It	  may	  be	  
that	   the	   differences	   reflect	   part	   of	   the	   spectrum	   of	   HSCR,	   which	   is	   a	   polygenic	  
disorder	   and	   may	   well	   have	   a	   subset	   of	   cases	   where	   in	   addition	   to	   the	  
abnormalities	  of	  ENSC	  migration	  there	  are	  alterations	  in	  the	  distribution	  of	  ICC.	  	  	  It	  
seems	   unlikely	   that	   there	   would	   be	   such	   local	   clustering	   of	   cases	   however.	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Ward(Ward	   et	   al.,	   2002)	   has	   suggested	   that	   confusion	   may	   arise	   because	   the	  
density	  of	  ICC	  in	  the	  distal	  colon	  is	  naturally	  fewer	  than	  in	  the	  proximal	  colon,	  and	  
that	   unless	   normal	   controls	   are	   selected	   from	   a	   carefully	   selected	   anatomically	  
equivalent	   region,	   confusion	  may	  arise.	   	   In	   addition,	   there	   is	   now	  also	  evidence	  
that	  prolonged	  intestinal	  obstruction,	  such	  as	  that	  seen	  in	  HSCR,	  may	  cause	  a	  loss	  
of	   ICC	   c-­‐kit	   immunoreactivity(Chang	   et	   al.,	   2001).	   	   It	   is	   therefore	   possible	   that	  
where	   fewer	   ICC	  are	   identified,	   this	   is	   an	  effect	  of	  prolonged	  obstruction	   rather	  
than	   a	   cause.	   	   The	   age	   of	   patients	   seen	   in	   some	   of	   the	   studies	   (e.g.	   mean	   3	  
months	   in	   Yamataka	   et	   al(Yamataka	   et	   al.,	   1995))	   indicate	   this	   may	   be	   a	  
possibility.	   	   This	   is	   an	   area	   that	   deserves	   further	   study,	   but	   on	   the	   balance	   of	  
probabilities	   it	  would	   seem	   that	   the	   distribution	  of	   ICC	   in	   children	  with	  HSCR	   is	  
normal	  initially	  but	  may	  well	  become	  rapidly	  disordered	  if	  a	  functional	  obstruction	  
persists.	  
	  
Other	   studies	   have	   also	   identified	   variances	   in	   ICC	   distribution,	   in	   premature	  
infants	   with	   bowel	   dysfunction(Kenny	   et	   al.,	   1998b)	   and	   anorectal	  
malformations(Kenny	   et	   al.,	   1998a),	   although	   the	   same	   caveats	   as	   to	   the	   cause	  
and	  effect	  of	  bowel	  obstruction	  must	  apply.	  	  Disordered	  ICC	  distribution	  has	  also	  
been	  identified	  in	  an	  animal	  model	  of	  gastroschisis,	  which	  can	  also	  be	  associated	  
with	  a	  prolonged	  postnatal	  ileus(Midrio	  et	  al.,	  2004).	  	  	  
	  
It	  is	  clear	  that	  despite	  the	  recent	  advances	  in	  understanding	  the	  role	  of	  ICC	  in	  the	  
production	   and	   regulation	   of	   bowel	   motility,	   the	   importance	   of	   ICC	   and	   their	  
interactions	  with	  the	  ENS	  and	  smooth	  muscle	  cells	  in	  mediating	  disease	  processes	  
is	  just	  beginning	  to	  be	  understood.	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1.2.7	  	  Summary	  of	  GIT	  structure	  and	  function	  
	  
The	  preceding	  sections	  have	  shown	  how	  coordinated	  bowel	  motility	  is	  dependent	  
on	   the	   interaction	   between	   intestinal	   smooth	   muscle,	   the	   ICC	   and	   the	   ENS.	  	  
Although	   changes	   in	   smooth	   muscle	   and	   ICC	   distribution	   have	   been	   noted	   in	  
HSCR,	  the	  most	  striking	  defect	  is	  the	  absence	  of	  ganglion	  cells	  in	  affected	  bowel.	  	  
As	   mentioned	   in	   the	   introduction	   to	   this	   chapter,	   the	   key	   factor	   in	   the	  
pathogenesis	   of	   HSCR	   is	   a	   failure	   of	   normal	   ENS	   development.	   	   The	   following	  
section	  therefore	  describes	  the	  development	  of	  the	  ENS	  in	  detail.	  
	  
1.2.8	  	  Development	  of	  the	  enteric	  nervous	  system	  
	  
The	   ENS	   is	   derived	   from	  migrating	  neural	   crest	   cells.	   	   The	  neural	   crest	   (NC)	   is	   a	  
specialised	  transient	  embryonic	  tissue,	  the	  cells	  of	  which	  emerge	  from	  both	  sides	  
of	  the	  neural	  plate	  along	  the	  cranio-­‐caudal	  axis	  of	  the	  early	  embryo.	  The	  NC	  cells	  
then	  undergo	  extensive	  migration	  and	  differentiation	   to	   form	  various	   structures	  
throughout	  the	  body	  including	  the	  ENS,	  and	  also	  cranial	  ganglion	  cells,	  craniofacial	  
connective	   tissue,	   pigment	   cells	   and	   the	   peripheral	   and	   autonomic	   nervous	  
system(Newgreen	  and	  Young,	  2002b).	  	  	  
	  
1.2.8.1	  	  The	  vagal	  neural	  crest	  
	  
The	  NC	  cells	  that	  become	  the	  stem	  cells	  for	  the	  majority	  of	  the	  ENS	  originate	  from	  
the	  vagal	  region	  of	  the	  NC(corresponding	  with	  the	  level	  of	  somites	  1-­‐7)	  and	  enter	  
the	  gut	  in	  the	  pharyngeal	  region,	  before	  migrating	  along	  the	  whole	  length	  of	  the	  
gut	   in	   a	   rostrocaudal	   wave	   toward	   the	   anus(Yntema	   and	   Hammond,	   1954,	   Le	  
Douarin	  and	  Teillet,	  1973).	  	  A	  smaller	  contribution	  from	  the	  sacral	  neural	  crest	  is	  
considered	  at	  the	  end	  of	  this	  section.	  
	  
The	   first	  ENS	  stem	  cells	  arrive	   in	   the	   foregut	  on	  embryonic	  day	  9.5	   (E9.5)	   in	   the	  
mouse	  and	  approximately	  E26	  in	  humans	  (Wallace	  and	  Burns,	  2005,	  Young	  et	  al.,	  
1998).	   	   The	   leading	   edge	   of	   this	   rostrocaudal	   wave	   in	   the	   mouse	   enters	   the	  
midgut	  on	  E10.5,	   the	   caecum	  on	  E11.5	   and	  gut	   colonization	   is	   complete	  by	  day	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14.5(Young	  et	  al.,	  1998).	   	   In	  human	  embryos,	  the	  stem	  cells	  enter	  the	  foregut	  at	  
week	   4,	   and	   reach	   the	   terminal	   hindgut	   by	   week	   7(Wallace	   and	   Burns,	   2005).	  	  
Table	  1.1	  (adapted	  from	  (Newgreen	  and	  Young,	  2002b))	  illustrates	  these	  key	  time	  
points.	  	  	  
	  




	   Mouse	  	  
(embryonic	  day)	  
Human	  	  
(estimated	  embryonic	  day)	  
Vagal	  neural	  crest	  cells	   	   	  
Begin	  migration	   8.5	   22	  
Enter	  foregut	   9.5	   26	  
Enter	  midgut	   10.5	   30	  
Enter	  caecum	   11.5	   37	  
Enter	  hindgut	   11.5	   38	  
Complete	  migration	   14.5	   43	  
Sacral	  neural	  crest	  cells	   	   	  
Begin	  migration	   9.5	   27	  




The	   ENS	   stem	   cells	   migrate	   through	   the	   embryonic	   bowel	   in	   chains	   and	   the	  
leading	  cells	  in	  the	  migratory	  wave	  provide	  a	  scaffold	  which	  is	  then	  maintained	  for	  
several	   hours,	   creating	   the	   route	   that	   is	   followed	   by	   later	   cells,	   with	  migration	  
occurring	  in	  the	  outer	  layers	  of	  the	  developing	  gut	  (Young	  et	  al.,	  2004).	  	  The	  large	  
majority	   of	   cells	   in	   the	   migrating	   wavefront	   are	   undifferentiated,	   although	  
approximately	   10%	   are	   more	   differentiated	   neurons,	   half	   of	   which	   are	   still	  
capable	  of	   further	  migration(Hao	  et	  al.,	  2009a).	   	  There	   is	  now	  evidence	  that	   the	  
initial	  migratory	  scaffold	  formed	  by	  the	  migratory	  wave	  is	  follows	  a	  template	  laid	  
down	  by	  existing	  vascular	  channels(Nagy	  et	  al.,	  2009).	  
	  	  
Unlike	   the	   CNS,	   where	   cell	   death	   is	   the	   main	   mechanism	   of	   controlling	   cell	  
number,	  the	  driving	  force	  in	  populating	  the	  ENS	  is	  rapid	  cell	  proliferation	  (Gianino	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et	  al.,	  2003,	  Landman	  et	  al.,	  2007).	  	  How	  this	  translates	  into	  the	  mass	  migration	  of	  
the	  ENS	  stem	  cells	  along	  the	  length	  of	  the	  bowel	  has	  until	  recently	  been	  unclear.	  	  	  
The	   chemotactic	   influences	   of	   GDNF	   and	   EDN3	   (see	   below)	  would	   suggest	   that	  
chemotactic	   “pull”	   would	   be	   the	   most	   important	   factor,	   but	   there	   is	   now	  
convincing	  evidence	   that	  population	  pressure	   itself	   is	   at	   least	   equally	   important	  
(Simpson	  et	  al.,	  2006).	  	  This	  paper	  presents	  a	  detailed	  mathematical	  model,	  based	  
on	  vagal	  NC	  cell	  migration,	  which	  takes	  into	  account	  the	  above	  factors	  as	  well	  as	  
concomitant	   growth	   of	   the	   bowel	   during	   the	   migration	   period.	   	   It	   would	   now	  
appear	   that	  one	  of	   the	  main	  driving	   forces	  of	  ENSC	  migration	   is	   the	  pressure	   to	  
move	   into	   an	   area	  where	   there	   are	   no	   other	   ENSC,	   therefore	   driving	  migration	  
from	   proximal	   to	   distal.	   	   This	   may	   be	   explained	   by	   contact	   inhibition	   of	  
locomotion	  observed	  in	  neural	  crest	  cells(Carmona-­‐Fontaine	  et	  al.,	  2008).	  
	  
It	   has	   been	   shown	   that	   once	  NC	   cells	   have	   commenced	   the	   colonisation	   of	   the	  
caecum	  only	  a	  small	  number	  of	  stem	  cells	   from	  the	   leading	  edge	  of	  the	  wave	  of	  
migration	   are	   sufficient	   to	   colonise	   the	   entire	   colon(Sidebotham	  et	   al.,	   2002b)	   .	  	  
More	  recent	  evidence	  has	  also	  demonstrated	  that	  the	  migration	  of	  ENS	  stem	  cells	  
is	   inhibited	   by	   tetanus	   toxin,	   potentially	   indicating	   that	   neural	   signalling	   is	   also	  
important	  for	  distal	  gut	  colonisation(Hao	  et	  al.,	  2009b).	  
	  
1.2.8.2	  	  The	  sacral	  neural	  crest	  
	  
As	  alluded	  to	  previously,	  colonisation	  of	  the	  hindgut	  by	  the	  vagal	  ENS	  stem	  cells	  is	  
further	   complicated	   by	   the	   contribution	   from	   the	   sacral	   neural	   crest.	   	   This	  
contribution	   has	   been	   demonstrated	   in	   a	   quail/chick	   hybrid	   model	   and	  
demonstrates	   that	   in	   birds	   there	   is	   a	   contribution	   from	   the	   sacral	   level	   neural	  
crest	   (corresponding	   to	   somites	   24+	   in	   mice	   and	   humans),	   which	   colonise	   the	  
bowel	  in	  a	  retrograde	  manner	  to	  the	  umbilicus(Burns	  and	  Douarin,	  1998).	  	  It	  has	  
also	  been	   reported	   that	   although	   the	  migration	  of	   this	   sacral	  wave	  occurs	   after	  
the	   influx	   of	   vagal	   neural	   crest	   cells(Kapur,	   2000),	   it	   can	   still	   occur	   when	   the	  
migration	  of	  the	  vagal	  neural	  crest	  is	  prevented(Burns	  et	  al.,	  2000).	  	  Crucially,	  in	  a	  
RET	   mouse	   knockout	   model	   of	   HSCR,	   although	   there	   are	   a	   few	   sacral-­‐derived	  
neurons	   present	   within	   the	   most	   distal	   hindgut,	   the	   population	   of	   NOS	   +ve	  
neurons	  is	  dramatically	  reduced(Anderson	  et	  al.,	  2006),	  indicating	  that	  the	  sacral	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contribution	   is	   insufficient	   to	   rescue	   the	   ENS	   in	   the	   case	   of	   vagal	   neural	   crest	  
migratory	  failure.	  	  There	  is	  also	  evidence	  that	  the	  sacral	  neural	  crest	  contribution	  
itself	  may	  also	  be	  sensitive	  to	  deficiencies	  in	  RET/GDNF	  signalling(Anderson	  et	  al.,	  
2006).	  	  Overall,	  in	  mammals	  the	  contribution	  of	  the	  sacral	  neural	  crest	  to	  the	  ENS	  
is	  small	  in	  terms	  of	  the	  number	  of	  neurons	  produced,	  partially	  dependent	  on	  the	  
successful	   migration	   of	   the	   vagal	   neural	   crest	   and	   unable	   to	   rescue	   the	   distal	  
bowel	  from	  a	  HSCR	  phenotype.	  
	  
1.2.8.3	  	  Regulation	  of	  the	  development	  of	  the	  ENS	  
	  
The	  development	  of	  the	  ENS	  therefore	  comprises	  a	  complex	  sequence	  of	  events	  
that	  have	  important	  spatial,	  temporal	  and	  species-­‐specific	  regulatory	  differences.	  	  	  
It	  has	  recently	  become	  clear	  that	  initial	  specification	  of	  the	  neural	  crest	  stem	  cell	  
phenotype	   is	   controlled	   by	   selective	   expression	   of	   a	   number	   of	   transcription	  
factors	   including	   snail,	   Sox	   -­‐8,	   -­‐9	   and	   -­‐10,	   FoxD3	   and	   c-­‐Myc(Barembaum	   and	  
Bronner-­‐Fraser,	   2005).	   	   The	   events	   initiating	   expression	   of	   these	   transcription	  
factors	  are	  in	  turn	  regulated	  around	  the	  time	  of	  delamination	  of	  neural	  crest	  cells	  
from	   the	   neural	   plate	   by	   a	   series	   of	   extracellular	   signalling	  molecules	   including	  
bone	   morphogenic	   proteins	   (BMPs),	   Wnt	   and	   fibroblast	   growth	   factors	  
(FGFs)(Barembaum	  and	  Bronner-­‐Fraser,	  2005).	   	  These	  signalling	  molecules	  often	  
act	   during	   the	   subsequent	   development	   of	   NC	   cell	   progeny,	   but	   with	   different	  
developmental	   outcomes	   depending	   on	   context(Raible	   and	   Ragland,	   2005).	  
Additionally,	   many	   other	   factors	   and	   associated	   signalling	   pathways	   have	   been	  
identified	  as	  essential	  to	  this	  process.	  The	  majority	  of	  factors	  are	  detailed	  below	  in	  
the	   text,	   but	   in	   this	   burgeoning	   field	   there	   are	  many	  whose	   role	   is	   less	   clear	  or	  
which	  have	  not	  been	  fully	  elucidated,	  and	  these	  can	  be	  found	  in	  Table	  1.2.	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Table	  1.2:	  	  Other	  developmental	  factors	  involved	  in	  ENS	  development	  
Factor	   Class	   Comments	  and	  functions	   References	  






Neuregulin/erbB2	   Growth	   factor	  
+	  receptor	  
Maintains	  postnatal	  ENS	  





ZFHX1B/Sip-­‐1	   Transcription	  
factor	  
May	  regulate	  E-­‐cadherin	  
expression.	  Specific	  HSCR-­‐
mental	  retardation	  




de	  Putte	  et	  
al.,	  2003)	  
Indian	  hedgehog	   Differentiation	  
factor	  
Involved	  in	  later	  ENS	  
development.	  Knockout	  





Hoxb3	   Homeobox	  
gene	  
Specific	  to	  vagal	  neural	  
crest	  cells.	  Functional	  
effects	  not	  characterised.	  
(Tassabehji	  
et	  al.,	  1992)	  




(Fu	  et	  al.,	  
2003)	  
Hox11L1	   Homeobox	  
gene	  




Controversy	  exists	  over	  
functional	  effects.	  
(Shirasawa	  
et	  al.,	  1997,	  
Parisi	  et	  al.,	  
2003)	  
Hand2	   Transcription	  
factor	  
Expression	  of	  Hand2	  is	  
regulated	  by	  BMP2/4	  and	  
GDNF.	  Interacts	  with	  






Foxd3	   Transcription	  
factor	  
Involved	  in	  zebrafish	  ENS	  
development.	  Significance	  
in	  HSCR	  unknown.	  
(Lister	  et	  al.,	  
2006)	  
Trap	  100	   Receptor	  
complex	  
Involved	  in	  zebrafish	  
ENSC	  proliferation.	  
Significance	  in	  HSCR	  
unknown.	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1.2.8.4	  	  Signalling/Growth	  factors	  regulating	  development	  
	  
1.2.8.4.1	  	  GDNF	  
	  
Glial	  cell	  derived	  neurotrophic	  factor	  (GDNF)	  is	  important	  for	  the	  development	  of	  
subpopulations	   of	   both	   peripheral	   and	   central	   neurons.	   It	   is	   part	   of	   a	   family	   of	  
signalling	  molecules	  that	  also	  comprises	  artemin,	  neurturin	  and	  persephin,	  all	  of	  
which	   are	   distantly	   related	   to	   transforming	   growth	   factor	   β	   (TGFβ)(Massague,	  
1996).	   GDNF	   acts	   through	   the	   RET	   tyrosine	   kinase	   receptor	   via	   an	   accessory	  
molecule,	  GFRα1;	  the	  other	  members	  of	  the	  GFRα	  family	  providing	  specificity	  for	  
the	  binding	  of	  artemin,	  persephin	  and	  neurturin(Jing	  et	  al.,	  1996,	  Treanor	  et	  al.,	  
1996).	   Homozygous	   Ret	   knockout	   mice	   show	   complete	   intestinal	   aganglionosis	  
(with	  the	  exception	  of	  the	  oesophagus	  as	  this	  is	  derived	  from	  somatic,	  not	  vagal,	  
neural	  crest	  cells),	  as	  well	  as	  defects	  of	  the	  superior	  cervical	  sympathetic	  ganglia	  
and	   renal	   agenesis(Schuchardt	   et	   al.,	   1994).	   	   An	   identical	   phenotype	   in	  mice	   is	  
created	  in	  gdnf-­‐/-­‐	  mutants(Moore	  et	  al.,	  1996a,	  Pichel	  et	  al.,	  1996,	  Sanchez	  et	  al.,	  
1996).	  
	  
GDNF	  has	  been	  shown	  in	  a	  variety	  of	  culture	  systems	  to	  promote	  NC	  cell	  survival,	  
proliferation,	  differentiation	  and	  migration(Ebendal	  et	  al.,	  1995,	  Matheson	  et	  al.,	  
1997,	  Hearn	  et	  al.,	  1998,	  Young	  et	  al.,	  2001,	  Gianino	  et	  al.,	  2003).	   	  Migrating	  NC	  
stem	   cells	   are	   initially	   unresponsive	   to	   GDNF	   (Hearn	   et	   al.,	   1998,	   Young	   et	   al.,	  
2001),	   and	   it	   is	  only	  on	  entering	   the	   foregut	   that	   they	  begin	   to	  express	   the	  RET	  
receptor,	   and	   so	   become	   responsive	   to	  GDNF(H.M.	   Young,	   2001).	   Expression	   of	  
GDNF	  by	  mesenchymal	  tissues	  is	  not	  uniform	  throughout	  the	  developing	  gut,	  with	  
a	  slight	  delay	  in	  the	  appearance	  of	  a	  GDNF	  mRNA	  signal	  in	  the	  hindgut	  as	  opposed	  
to	  caecum	  and	  midgut(Young	  et	  al.,	  2001)	  .	  As	  caecal	  expression	  of	  GDNF	  occurs	  
just	  prior	  to	  arrival	  of	  NC	  cells	  at	  the	  caecum,	  this	  observation	  is	  consistent	  with	  
the	  idea	  that	  it	  plays	  a	  role	  in	  the	  directed	  caudal	  movement	  of	  the	  cells.	  
	  
The	  functions	  of	  the	  other	  members	  of	  the	  GDNF	  family	  (artemin,	  neurturin	  and	  
persephin)	   in	   the	   ENS	   are	   less	   well	   characterised.	   	   Murine	   models	   which	   are	  
neurturin-­‐	  or	  GFRα2-­‐	  deficient	  have	  a	  decreased	  number	  of	  neurons	   in	   the	  ENS;	  
the	  reasons	  for	  this	  remain	  unclear(Rossi	  et	  al.,	  1999,	  Heuckeroth	  et	  al.,	  1999).	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The	   descriptions	   of	   GDNF	   signalling	   effects	   detailed	   to	   date	   have	   been	   on	  
embryonic	  neural	   crest	   and	  ENS	   stem	  cells.	   	   Although	   there	  has	  been	  extensive	  
study	  of	   the	  effect	  of	  growth	   factors	  on	  embryonic	  ENSPC,	   there	  has	  been	   little	  
work	   on	   postnatally	   derived	   ENSPC	   and	   ENS	   neurospheres.	   	   	   	   Bondurand	   et	  
al(Bondurand	   et	   al.,	   2003)	   demonstrated	   that	   individual	   ENSPC	   isolated	   from	  
embryonic	  and	  neonatal	  mice	  showed	  an	   increase	   in	  mitotic	   rate	   in	   response	  to	  
GDNF	   and	   qualitatively	   the	   presence	   of	   GDNF	   appeared	   to	   increase	   neurite	  
branching	  and	  length.	  	  Barlow	  et	  al(Barlow	  et	  al.,	  2003)	  showed	  that	  in	  embryonic	  
isolated	  ENSPC	  this	  effect	  of	  GDNF	  on	  mitotic	  rate	  was	  enhanced	  by	  the	  action	  of	  
EDN3.	   	   Kruger	   et	   al(Kruger	   et	   al.,	   2002),	   also	   looking	   at	   individual	   ENSPC	  
responses,	  demonstrated	   that	  postnatal	   rat	  ENSPCs	  have	  a	   reduced	   response	   to	  
bone	   morphogenic	   protein	   4	   (BMP4).	   	   However,	   the	   environment	   within	   a	  
neurosphere	   is	   likely	   to	   be	   substantially	   different	   to	   that	   experienced	   by	  
individual	   cells	   or	   small	   colonies,	   and	   there	   is	   evidence	   that	   the	   unique	   niche	  
occupied	   by	   stem	   cells	   within	   it	   enhances	   their	   survival	   and	   may	   alter	   their	  
response	   to	   environmental	   signalling	   cues(Campos,	   2004).	   	   This	   is	   therefore	   an	  
area	  that	  is	  of	   interest	  in	  the	  development	  of	  stem	  cell	  treatments	  for	  HSCR	  and	  
one	  studied	  as	  part	  of	  this	  thesis.	  
	  
1.2.8.4.2	  	  EDN3	  
	  
Endothelin-­‐3	   (EDN3)	   is	   one	   of	   the	   three	   members	   of	   the	   endothelin	   family	   of	  
intercellular	   messenger	   molecules.	   	   Endothelin	   3	   is	   converted	   from	   an	   inactive	  
form	   to	   an	   active	   form	  by	   endothelin	   converting	   enzyme-­‐1	   (ECE-­‐1)(Heanue	   and	  
Pachnis,	   2007).	   	   Endothelins	   are	   ligands	   for	   cell	   surface	   endothelin	   receptors	   A	  
and	  B;	  in	  the	  gut	  EDN3	  acts	  principally	  via	  endothelin	  receptor	  B	  (EDNRB),	  which	  
begins	  to	  be	  expressed	  by	  NC	  cells	  under	  control	  of	  Sox10(Britsch	  et	  al.,	  2001)	  in	  
the	  neural	  folds	  prior	  to	  NC	  stem	  cell	  migration	  [(Nataf	  et	  al.,	  1998).	  
	  
In	   contrast	   to	   the	   total	   enteric	   aganglionosis	   seen	   in	   the	   intestine	   of	  mice	  with	  
GDNF/RET	  knockouts,	  EDN3	  or	  EDNRB	  knockout	  mice	  show	  a	   lack	  of	  ENS	  that	   is	  
restricted	  to	  the	  terminal	  colon	  and	  rectum,	  which	  is	  very	  similar	  in	  phenotype	  to	  
HSCR	   in	   humans	   (Hosoda	   et	   al.,	   1994).	   Prior	   to	   the	   arrival	   of	   NC	   cells	   in	   the	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embryonic	   caecum,	  EDN3	  has	  been	  shown	   to	  promote	  proliferation	  of	  avian	  NC	  
cells	   and	   improve	   survival	   of	   mammalian	   NC	   cells(Nagy	   and	   Goldstein,	   2006,	  
Hearn	  et	  al.,	  1998,	  Barlow	  et	  al.,	  2003).	  However,	  the	  most	  striking	  effect	  of	  EDN3,	  
very	   similar	   to	   the	   HSCR	   phenotype	   seen	   in	   EDN3	   knockouts,	   is	   related	   to	   its	  
action	  once	  NC	  cells	  have	  reached	  the	  caecum.	  At	   this	   time	  point,	  expression	  of	  
EDN3	   has	   been	   located	   in	   the	  mesenchyme	   of	   the	   caecum	   and	   proximal	   colon	  
(Leibl	  et	  al.,	  1999,	  Shin	  et	  al.,	  1999,	  Woodward	  et	  al.,	  2000),	  and	  EDN3	  signalling	  
via	  the	  EDNRB	  receptor	  has	  been	  demonstrated	  to	  be	  necessary	  for	  colonization	  
of	   the	   distal	   gut(Woodward	   et	   al.,	   2000,	   Shin	   et	   al.,	   1999,	   Sidebotham	   et	   al.,	  
2002b).	   	   Given	   the	   time-­‐dependent	   interaction	   between	   migrating	   EDNRB-­‐
expressing	   NC	   cells	   and	   caecal	   mesenchymal	   EDN3	   expression,	   it	   has	   been	  
proposed	  that	  EDN3	  is	  necessary	  to	  prevent	  the	  premature	  differentiation	  of	  ENS	  
stem	   cells	   prior	   to	   their	   colonising	   the	   distal	   part	   of	   the	   gut	   (Wu	   et	   al.,	   1999,	  
Hearn	  et	  al.,	  1998).	  	  	  
	  
More	  recent	  work	  has	  shed	  light	  on	  the	  interaction	  between	  the	  GDNF	  and	  EDN3	  
signalling	  systems;	  this	  is	  detailed	  below.	  
	  
1.2.8.4.3	  	  Other	  factors	  –	  BMP2	  and	  4,	  neurturin,	  CNTF,	  neuregulin	  and	  NT3	  
	  
Like	   GDNF,	   the	   bone	   morphogenic	   proteins	   2	   and	   4	   (BMP	   2	   and	   4)	   are	   also	  
members	   of	   the	   TGF-­‐β	   protein	   superfamily.	   	   Evidence	   has	   been	   presented	   that	  
BMP2	  and	  4	  limit	  the	  size	  of	  the	  ENS	  while	  promoting	  the	  development	  of	  specific	  
subsets	  of	  neurons(Chalazonitis	  et	  al.,	  2004)	  and	  ganglion	  formation(Goldstein	  et	  
al.,	   2005).	   These	   responses	   to	   BMP	   signalling	   are,	   at	   least	   in	   part,	   due	   to	   a	  
structural	   alteration	   of	   neural	   cell	   adhesion	   molecule	   (NCAM-­‐1)	   through	   the	  
addition	  of	  polysialic	   acid(Fu	  et	  al.,	   2006).	   	   The	  effect	  of	   these	   factors	   therefore	  
seems	  to	  be	  in	  modulating	  the	  final	  extent	  and	  pattern	  of	  the	  ENS.	  	  Interestingly,	  
in	  transgenic	  mice	  overexpressing	  the	  BMP4	  antagonist	  noggin,	  hyperganglionosis	  
reminiscent	  of	   the	   controversial	  pathological	   entity	   intestinal	  neuronal	  dysplasia	  
develops(Chalazonitis	  et	  al.,	  2004).	  
	  
Other	  growth	  factors	  have	  also	  been	  identified	  as	  having	  roles	  in	  the	  development	  
of	   the	   ENS,	   and	   this	   is	   a	   rapidly	   expanding	   field.	   	   As	   previously	   mentioned,	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neurturin	  is	  related	  to	  GDNF	  and	  	  also	  promotes	  neural	  crest	  and	  ENSPC	  survival,	  
proliferation	   and	   neurite	   outgrowth	   in	   vitro(Heuckeroth	   et	   al.,	   1998,	   H.	   Yan,	  
2003a).	   	   However,	   as	   with	   all	   the	   other	   growth	   factors	   aside	   from	   GDNF	   and	  
EDN3,	  neurturin	  is	  rarely	  implicated	  in	  clinical	  cases	  of	  HSCR(Brooks	  et	  al.,	  2005).	  	  	  
	  
Ciliary	  neurotrophic	   factor	   (CNTF)	  affects	   the	  differentiation	  and	  maintenance	  of	  
late-­‐developing	  enteric	  neurons(Chalazonitis	  et	  al.,	  1998b),	  although	  CTNF	  lacks	  a	  
signal	   sequence	   that	  would	   allow	   it	   to	   be	   excreted	   and	   it	  may	   be	   that	   it	   is	   the	  
CTNF	  receptor	  that	  is	  key,	  and	  this	  receptor	  is	  being	  activated	  by	  an	  unidentified	  
cytokine(Gershon,	  2002).	  	  
	  
Neuregulin	  signalling	  has	  been	  identified	  in	  the	  postnatal	  maintenance	  of	  enteric	  
neurons	  but	  it	  is	  as	  yet	  unknown	  if	  it	  has	  a	  developmental	  role(Crone	  et	  al.,	  2003).	  	  
Neurotrophin-­‐3	   (NT3)	   is	   the	   only	   member	   of	   the	   neurotrophin	   family	   that	   has	  
been	   shown	   to	   have	   a	   potential	   role	   in	   ENS	   development	   as	   it	   promotes	  
differentiation	   of	   ENS	   precursors	   in	   vitro,	   albeit	   at	   a	   later	   stage	   than	  
GDNF(Chalazonitis	   et	   al.,	   1998a),	   resulting	   in	   neurite	   outgrowth	   and	   neuronal	  
differentiation	  from	  ganglia	  in	  infant	  rats(Saffrey	  et	  al.,	  2000).	  Studies	  in	  knockout	  
mice	  lacking	  either	  NT3	  or	  its	  receptor	  have	  shown	  reduced	  numbers	  of	  myenteric	  
and	   submucosal	   neurons,	   whilst	   overexpression	   of	   NT3	   leads	   to	   increased	  
numbers	   of	   myenteric	   neurons	   only(Chalazonitis	   et	   al.,	   2001),	   lending	   further	  
weight	   to	   the	   concept	   that	   NT3	   affects	  more	   differentiated	   neuronal	   precursor	  
cells	  rather	  than	  multipotent	  ENSPC.	  
	  
	  
1.2.8.5	  	  Transcription	  factors	  regulating	  development	  of	  the	  ENS	  
	  
The	  link	  between	  directly-­‐acting	  growth	  factors	  on	  the	  developing	  cells	  of	  the	  ENS	  
and	  the	  genetic	  controls	  that	  regulate	  them	  is	  becoming	  clearer,	  and	  many	  of	  the	  
transcription	   factors	   now	   identified	   as	   functioning	   in	   ENS	   development	   directly	  
influence	  the	  growth	  factors/receptors	  mentioned	  above.	  	  	  	  
	  
The	   transcription	   factor	   Phox2b	   is	   expressed	   in	   all	   NC	   derived	   cells(Young	   and	  
Newgreen,	  2001,	  Young	  et	  al.,	  1999).	  It	  is	  known	  to	  regulate	  the	  expression	  of	  RET	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as	  well	  as	  enzymes	  necessary	  for	  the	  production	  of	  adrenergic	  neurotransmitters	  
(tyrosine	  hydroxylase	  and	  dopamine	  β	  hydroxylase).	  Phox2b	  knockout	  mice	  have	  
an	  identical	  phenotype	  to	  RET	  deficient	  mice,	  with	  no	  migration	  of	  NC	  stem	  cells	  
beyond	  the	  foregut(Pattyn	  et	  al.,	  1997).	   	  Also	  influencing	  RET	  activity,	  Sox10	  and	  
Pax3	  act	  synergistically	  to	  promote	  RET	  expression,	  binding	  adjacent	  sites	  within	  
an	  enhancer	  sequence(Lang	  et	  al.,	  2000).	   	  Consequently,	  defects	  of	   the	  sensory,	  
autonomic	   and	   the	   enteric	   nervous	   system	   have	   been	   noted	   in	   Sox10	   deficient	  
mice,	   in	  which	   failure	   to	  colonize	   the	  terminal	  gut	   results	   in	  dilatation	  similar	   to	  
that	   seen	  with	   incomplete	   loss	   of	   function	  mutations	   of	   RET(Southard-­‐Smith	   et	  
al.,	   1998,	   Kapur,	   1999,	   Britsch	   et	   al.,	   2001).	   	   In	   addition,	   recent	   work	   has	  
uncovered	  a	  link	  between	  SOX10	  and	  EDN3	  signalling,	  which	  is	  discussed	  below.	  
	  
In	   contrast	   to	   the	   effects	   of	   the	   Sox10,	   Pax3	   and	   Phox2b,	  mammalian	   achaete-­‐
scute	   homologue	   1	   (Mash1)	   is	   specifically	   required	   for	   the	   development	   of	   the	  
serotoninergic	   neuronal	   lineage	   from	   NC	   stem	   cells	   in	   the	   gut(Sommer	   et	   al.,	  
1995)	   and	   in	   particular	   appears	   to	   affect	   the	   ENS	   of	   the	   oesophagus,	   which	   is	  
absent	   in	   Mash1	   knockout	   mice	   despite	   the	   presence	   of	   more	   distal	  
neurones(Sang	  et	  al.,	  1999).	   	  This	  difference	  highlights	   the	  different	  neural	  crest	  
origin	  of	  the	  oesophageal	  ENS	  and	  may	  explain	  the	  presence	  of	  the	  oesophageal	  
ENS	  in	  RET	  knockout	  mice.	  	  	  
	  
Sonic	   hedgehog	   (SHH),	   part	   of	   the	   hedgehog	   family	   of	   transcription	   factors,	   is	  
initially	   expressed	   in	   the	   endoderm	  of	   the	  developing	   vertebrate	   gut(Roberts	   et	  
al.,	  1995,	  Ramalho-­‐Santos	  et	  al.,	  2000),	  and	  while	   the	  colonisation	  of	   the	  gut	  by	  
NC	  stem	  cells	  has	  been	  shown	  to	  be	  complete	  in	  SHH	  -­‐/-­‐	  mice,	  there	  is	  abnormal	  
neural	   plexus	   formation	   and	   placement	   (Ramalho-­‐Santos	   et	   al.,	   2000).	   SHH	   has	  
been	   shown	   to	   promote	   the	   proliferation	   and	   inhibit	   the	   differentiation	   and	  
migration	   of	  NC	   stem	   cells	   in	   response	   to	  GDNF(Fu	   et	   al.,	   2004a).	   These	   results	  
suggest	   a	   role	   for	   SHH	   in	   “fine	   tuning”	   the	   response	   of	   NC	   stem	   cells	   to	   the	  
RET/GDNF	  signalling	  system.	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1.2.8.6	  	  Cellular	  adhesion	  molecules	  
	  
Finally,	   as	  well	   as	   hormonal	   and	   transcriptional	   regulation	   of	   ENS	   development,	  
spatial	  cues	  and	  the	  extracellular	  environment	  are	  also	   important.	   	   	   Integrin	  cell	  
surface	   receptor	   expression	   is	   essential	   for	   gut	   colonisation	   and	   structured	  
ganglion	  formation	  by	  NC	  stem	  cells,	  although	  in	  its	  absence,	  migration	  along	  the	  
gut	   does	   occur	   to	   a	   limited	   extent(Breau	   et	   al.,	   2006).	   	   While	   the	   β1	   integrin	  
pathway	  has	  not	  yet	  been	  implicated	  in	  the	  pathogenesis	  of	  HSCR,	  much	  attention	  
has	  been	  focused	  on	  the	  extracellular	  matrix	   (ECM)	  molecules	  that	  are	  potential	  
integrin	   β1	   ligands	   as	   they	   have	   been	   shown	   to	   have	   profound	   effects	   on	   cell	  
migration	  in	  many	  other	  systems.	  
	  
The	   ECM	   protein	   laminin	   is	   encountered	   by	  migrating	   NC	   stem	   cells	   within	   the	  
developing	  gut	  and	  has	  been	  shown	  to	  affect	  neurite	  outgrowth	  and	  migration	  of	  
ENS	  neurons(Pomeranz	  et	  al.,	  1991,	  Miner	  and	  Yurchenco,	  2004).	  	  Although	  a	  100	  
kDa	  laminin	  binding	  protein	  (LBP110)	  was	  originally	  reported	  to	  be	  expressed	  by	  
stem	  cells	   and	  was	   suggested	   to	  be	   involved	   in	   their	   development(Pomeranz	   et	  
al.,	  1991),	  the	  identity	  of	  this	  protein	  and	  any	  functional	  role	  as	  a	  laminin	  receptor	  
has	  not	  subsequently	  been	  established.	  While	  abnormalities	  in	  laminin	  expression	  
have	  been	   found	   in	  patients	  with	  HSCR,	   it	   remains	  unclear	  whether	   these	  are	  a	  
cause	  or	  consequence	  of	  the	  disease(Parikh	  et	  al.,	  1992,	  Alpy	  et	  al.,	  2005).	  
	  
The	  laminin-­‐related	  netrins	  (1	  and	  3	  in	  mice)	  and	  their	  receptors	  (deleted	  in	  colon	  
cancer	  (DCC)	  and	  neogenin)	  have	  been	  detected	  in	  embryonic	  mouse	  gut(Jiang	  et	  
al.,	   2003).	   	   Significantly,	   NC	   stem	   cells	   express	   DCC	   and	  were	   found	   to	  migrate	  
radially	   inwards	   towards	   the	   netrins	   that	   are	   expressed	   on	  mucosal	   epithelium.	  	  
This	   study	  also	   found	   that	  netrins	  promote	   the	   survival	   and	  development	  of	  NC	  
stem	  cells.	  As	  the	  initial	  migrating	  wave	  of	  ENSC	  colonises	  the	  bowel	  in	  the	  outer	  
layer	   of	  mesenchyme,	   coupled	   with	   differential	   SHH	   expression	   the	   netrin/DCC	  
mechanism	  helps	  to	  explain	  how	  the	  radial	  patterning	  of	  the	  ENS	  forms	  with	  later	  
formation	  of	  the	  submucosal	  plexus.	  	  
	  
The	  findings	  described	  above	  are	  important	  when	  considering	  the	  generation	  and	  
clinical	  transplantation	  of	  NC	  stem	  cells	  because	  it	  is	  necessary	  to	  maintain	  multi-­‐
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potent,	   undifferentiated	   precursor	   cells	   in	   vitro	   and	   also	   to	   provide	   an	  
environment	   capable	   of	   producing	   functional,	   differentiated	   cells	   when	  
transplanted	   in	   vivo.	   	   An	   understanding	   of	   the	   interaction	   between	   these	  
mechanisms	  is	  therefore	  also	  necessary.	  
	  
1.2.8.7	  	  Integration	  of	  controlling	  systems	  
	  
As	   mentioned	   previously,	   there	   are	   now	   several	   areas	   where	   it	   is	   known	   that	  
RET/GDNF,	   SOX10/PAX3	   and	   EDN3/EDNRB	   signalling	   interact.	   	   Genetic	   linkage	  
studies	   have	   shown	   evidence	   of	   interaction	   between	   RET	   and	   EDNRB	  
mutations(Carrasquillo	  et	  al.,	  2002).	  	  There	  is	  also	  evidence	  that	  GDNF	  and	  EDN3	  
have	  synergistic	  effects.	  	  Barlow	  et	  al(Barlow	  et	  al.,	  2003)	  have	  shown	  that	  EDN3	  
enhances	  the	  proliferative	  effect	  of	  GDNF	  on	  undifferentiated	  ENSPC,	  possibly	  via	  
the	  unifying	  signalling	  system	  of	  protein	  kinase	  A.	  	  However,	  GDNF	  and	  EDN3	  also	  
have	   antagonistic	   effects,	   with	   EDN3	   inhibiting	   the	   chemotactic	   effect	   of	  
GDNF(Barlow	  et	  al.,	  2003,	  Kruger	  et	  al.,	  2003)	  and	  promoting	  ENSPC	  self-­‐renewal	  
rather	  than	  differentiation(Hearn	  et	  al.,	  1998).	  	  Evidence	  for	  interactions	  between	  
SOX10	   and	   EDN3–EDNRB	   signalling	   has	   also	   been	   uncovered,	   although	   the	  
molecular	  mechanisms	  underlying	  this	  interaction	  are	  unknown(Bondurand	  et	  al.,	  
2006).	   	   In	  addition,	  SOX10	  binding	  sites	  exist	   in	  an	  EDNRB enhancer	   region,	  and	  
are	   required	   for	   normal	   spatiotemporal	   expression	   of	   EDNRB	   in	   the	   ENS(Zhu	   et	  
al.,	  2004).	  	  
	  
These	   findings	  are	  summarised	   in	  Figure	  1.2,	  and	   it	   seems	   likely	   that	  given	  both	  
the	   synergistic	   and	  contradictory	  effects	  of	   the	  growth	  and	   transcription	   factors	  
mentioned	   to	   date,	   the	   development	   of	   the	   ENS	   must	   be	   further	   refined	   by	  
spatiotemporal	   and	   concentration	   dependent	   effects	   on	   the	   migrating	   ENSPC.	  	  
Therefore,	  although	  there	  has	  been	  considerable	  progress	  in	  the	  field	  of	  ENS	  stem	  
cell	  biology	  in	  recent	  years,	  a	  considerable	  amount	  of	  work	  still	  needs	  be	  done.	  	  In	  
particular,	   apart	   from	   a	   handful	   of	   studies,	   very	   little	   work	   has	   been	   done	   to	  
elucidate	   the	   reactions	   of	   postnatal	   ENSPC	   to	   the	   regulator	   cues	   discussed	   to	  
date.	   	   Further	   work	   in	   this	   area	   forms	   chapter	   3	   of	   this	   thesis	   and	   such	  
understanding	   is	   likely	   to	   be	   important	   to	   the	   development	   of	   a	   successful	  
postnatal	  ENSPC	  based	  transplantation	  therapy	  for	  HSCR.	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Figure	   1.2:	   	   Balance	   of	   RET	   and	   EDNRB	   signalling	   in	   the	   developing	   distal	  
embryonic	  gut	  on	  ENSC	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1.2.9	  	  Summary	  of	  bowel	  development	  and	  motility	  
	  
The	  developed	  bowel	  requires	  the	  ENS	  to	  function	  correctly,	  and	  the	  development	  
of	  the	  ENS	  is	  therefore	  key	  in	  the	  pathogenesis	  of	  Hirschsprung’s	  disease.	  	  Studies	  
have	   demonstrated	   the	   roles	   of	   growth	   factors,	   transcription	   factors	   and	  
extracellular	   proteins	   in	   the	   development	   of	   the	   ENS,	   and	  have	   shown	  how	   the	  
ENS	   interacts	  with	  the	   ICC	  pacemakers	  to	  regulate	  gut	  motility.	   	   It	   is	  still	  unclear	  
how	   colonic	  motility	   is	   generated	   and	   regulated	   in	  mice	   (and	   therefore	   human)	  
models	   in	   the	   perinatal	   period,	   which	   is	   a	   critical	   time	   in	   the	   presentation	   and	  
management	  of	  Hirschsprung’s	  disease	  in	  humans.	  	  
1.3	  	  Hirschsprung’s	  disease	  
	  
Hirschsprung’s	  disease	  is	  characterised	  by	  the	  congenital	  absence	  of	  ENS	  ganglion	  
cells	   from	  the	  distal	  bowel,	  affecting	  a	  segment	  extending	  retrogradely	   from	  the	  
distal	  internal	  anal	  sphincter,	  most	  commonly	  to	  the	  sigmoid	  colon	  but	  sometimes	  
affecting	  a	  much	  larger	  segment	  of	  bowel.	  
	  
HSCR	   can	   therefore	   be	   primarily	   classified	   on	   the	   anatomical	   extent	   of	   the	  
disease;	  the	  commonest	  form	  is	  short	  segment	  disease,	  affecting	  the	  bowel	  from	  
the	   sigmoid	   colon	   onwards	   and	   comprising	   approximately	   80%	   of	   cases.	   	   Long	  
segment	  disease	  and	  total	  colonic	  HSCR	  (where	  a	  variable	  portion	  of	  small	  bowel	  
is	  also	  affected)	  affect	  10-­‐15%	  of	  patients(Passarge,	  1967,	  Goldberg,	  1984,	  Baillie	  
et	   al.,	   1999,	   Fekete	   et	   al.,	   1986,	   Redring	   et	   al.,	   1997).	   	   Small	   numbers	   of	   cases	  
present	   as	   almost	   complete	   aganglionosis,	   up	   to	   and	   sometimes	   including	   the	  
stomach(Şenyüz	   et	   al.,	   1988)	   (but	   not	   the	   oesophagus,	   which	   as	   mentioned	   is	  
derived	  from	  	  a	  distinct	  somatic	  population	  of	  early	  ENSPC	  and	  does	  not	  seem	  to	  
be	  involved	  in	  clinical	  cases).	  	  Controversy	  exists	  over	  the	  diagnosis	  of	  “ultrashort”	  
segment	   HSCR	   and	   the	   related	   condition	   internal	   sphincter	   achalasia,	   where	  
anorectal	   manometry	   is	   abnormal	   but	   ganglion	   cells	   are	   identified	   on	   rectal	  
biopsy(Neilson	  and	  Yazbeck,	  1990).	   	   Such	  diagnoses	  are	   complicated	  by	   the	   fact	  
that	   there	   is	   a	  physiological	   aganglionic	   zone	  at	   least	  2-­‐5mm	  above	   the	  dentate	  
line	   in	   newborns,	   and	   this	   area	   increases	   in	   length	   to	   adult	   life(Aldridge	   and	  
Campbell,	  1968).	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1.3.1	  	  History	  
	  
Hirschsprung’s	   disease	   is	   eponymously	   named	   after	   the	  Danish	   paediatrician	   Dr	  
Harald	  Hirschsprung	   (1830-­‐1916),	   after	  his	  presentation	   in	  1886	  of	   two	   cases	  of	  
children	   dying	   from	   bowel	   obstruction.	   	   The	   children	   had	   a	   normal	   rectum	   and	  
markedly	   dilated	   and	   hypertrophied	   large	   bowel,	   and	   Hirschsprung	   labelled	   the	  
condition	  congenital	  megacolon(Hirschsprung,	  1887).	  	  However,	  similar	  cases	  had	  
been	  described	  previously,	  and	  the	  first	  description	  of	  the	  clinical	  entity	   labelled	  
Hirschsprung’s	   disease	   has	   been	   attributed	   to	   Frederick	   Ruysh	   in	   1861(Skaba,	  
2007).	  
	  
Despite	  such	  early	  descriptions,	  the	  pathogenesis	  of	  HSCR	  remained	  in	  doubt	  for	  
many	  years.	   	   In	  1897	  Frederick	  Treves	  described	  the	  successful	   treatment	  of	  a	  6	  
year	  old	  girl	  with	  probable	  HSCR	  by	  resecting	  the	  rectum	  and	  pulling	  through	  the	  
non-­‐dilated	  colon	  to	  create	  a	  new	  anus(Treves,	  1989).	  	  Despite	  his	  argument	  that	  
the	   cause	   of	   the	   disease	   was	   an	   abnormal	   anorectum,	   and	   the	   absence	   of	  
ganglion	   cells	   in	   the	   distal	   colon	   reported	   by	   Tittel(Tittel,	   1901)	   it	  was	   not	   until	  
much	   later	   that	   such	   a	   theory	   was	   generally	   accepted;	   until	   the	   1940s	   most	  
doctors	  were	  still	  of	  the	  opinion	  that	  it	  was	  the	  dilated	  colon	  that	  was	  abnormal	  in	  
HSCR(Skaba,	  2007).	  	  	  
	  
Major	  advances	   in	   the	  understanding	  and	  therapy	  of	  Hirschsprung	  disease	  came	  
with	   the	   understanding	   of	   the	   role	   of	   the	   myenteric	   plexus	   in	   colonic	  
motility(Robertson	  and	  Kernohan,	  1938)	  and	  the	  lack	  of	  such	  cells	  in	  the	  undilated	  
rectum	  and	  colon	  of	  children	  with	  HSCR(Tiffin	  et	  al.,	  1940).	   	  These	  findings	  were	  
confirmed	  by	  Whitehouse	   and	   Kernohan(Whitehouse	   and	   Kernohan,	   1948),	   and	  
Zuelzer	   	   and	   Wilson(Zuelzer	   and	   Wilson,	   1948),	   who	   described	   absence	   of	  
ganglion	  cells	  in	  the	  wall	  of	  the	  distal	  colon,	  with	  hypertrophic	  nerve	  trunks	  in	  the	  
same	  bowel	  segment	  and	  proximal	  to	  the	  aganglionic	  segment	  a	  transition	  zone	  of	  
variable	  length	  containing	  sporadic	  ganglion	  cells	  and	  fewer	  nerve	  trunks.	  	  It	  was	  
at	  this	  time	  that	  Swenson	  and	  Bill	  (Swenson	  and	  Bill,	  1948)	  showed	  that	  the	  distal	  
colon	  was	  continuously	  contracted	  and	   lacked	  normal	  peristalsis.	  They	  theorised	  
that	  excision	  of	  the	  distal	  aganglionic	  bowel	  with	  a	  sphincter	  preserving	  colo-­‐anal	  
anastomosis	   would	   relieve	   the	   functional	   obstruction	   whilst	   simultaneously	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preserving	  continence(Swenson	  O,	  1949).	  	  This	  understanding,	  and	  the	  success	  of	  
this	  procedure,	  still	  forms	  the	  cornerstone	  of	  treatment	  for	  Hirschsprung	  disease.	  
	  
	  
1.3.2	  	  Incidence,	  epidemiology	  and	  aetiology	  
	  
Although	   individual	   reports	   have	   varied,	   the	   commonly	   accepted	   figure	   for	   the	  
incidence	  of	  HSCR	  in	  Western	  populations	  is	  approximately	  1	  in	  5000(Sprouge	  and	  
Baird,	   1985,	   Orr	   and	   Scobie,	   1983,	   Chakravarti	   and	   Lyonnet,	   2001).	   	   There	   is	  
however	   evidence	   of	   racial	   variation,	   with	   a	   reportedly	   higher	   incidence	   in	  
African-­‐Americans	  and	  Asians	  and	   lower	   incidence	   in	  Californian	  Hispanics(Torfs,	  
1988,	  Goldberg,	  1984).	   	  These	  racial	  variations	  account	   for	  an	  approximately	  1.5	  
fold	  increase	  in	  incidence	  in	  African-­‐American	  and	  Asian	  populations.	  
	  
Interestingly,	  the	  sex	  ratio	  in	  short	  segment	  disease	  (4M:1F)	  is	  different	  to	  that	  in	  
long	   segment	   disease	   (approximate	   ratio	   1:1)(Badner	   et	   al.,	   1990).	   	   Part	   of	   this	  
variation	   has	   been	   attributed	   to	   non-­‐coding	   mutations	   in	   the	   RET	   proto-­‐
oncogene(Emison	   et	   al.,	   2005).	   	   However,	   epigenetic	   and	   environmental	   factors	  
must	  also	  be	  at	  work,	  as	  there	  at	   least	  5	  cases	  of	   identical	  twins	  where	  only	  one	  
twin	  has	  been	  affected	  with	  HSCR(Croaker,	  2006).	  
	  
As	   discussed	   in	   the	   development	   of	   the	   enteric	   nervous	   system,	   many	   factors	  
regulate	  the	  development	  of	  the	  enteric	  nervous	  system.	  	  	  It	  is	  now	  accepted	  that	  
HSCR	   is	   a	  polygenic	  genetic	  disorder	  with	  almost	  a	  100%	  heritability,	  with	   some	  
cases	  presumably	  due	  to	  sporadic	  mutations)(Amiel	  and	  Lyonnet,	  2001,	  Emison	  et	  
al.,	   2005).	   	   The	   discussion	   of	   the	   aetiology	   of	   HSCR	   is	   therefore	   part	   of	   the	  
discussion	  of	  ENS	  development	  and	  the	  genetics	  of	  clinical	  HSCR.	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1.3.3	  	  Genetics	  of	  HSCR	  
	  
Perturbations	   in	   any	   of	   the	   factors	   discussed	   in	   section	   1.2.1	   above	   could	  
potentially	  affect	  the	  development	  of	  the	  ENS,	  but	  only	  a	  few	  have	  known	  clinical	  
correlations	  with	  HSCR.	  It	  is	  likely	  that	  the	  polygenic	  nature	  of	  HSCR	  is	  responsible	  
for	  the	  lack	  of	  simple	  genetic	  correlations.	  
	  
At	   the	   grossest	   level,	   the	   sex	   distribution	   of	   short	   segment	   HSCR	   provides	  
evidence	   of	   an	   underlying	   genetic	   cause.	   	   In	   slightly	  more	   detail,	   chromosomal	  
abnormalities	  are	  also	  linked	  to	  HSCR.	  	  Trisomy	  21	  (Down	  syndrome)	  is	  by	  far	  the	  
most	   frequent,	   involving	   2-­‐10%	  of	  HSCR	   cases(Bodian	   and	  Carter,	   1963,	   Spouge	  
and	   Baird,	   1985,	   Garver	   et	   al.,	   1985).	   	   However,	   apart	   from	   one	   sequence	   that	  
seems	   to	   be	   specific	   to	   a	   particular	   kindred,	   to	   date	   a	   specific	   genetic	   locus	   on	  
chromosome	   21	   conferring	   susceptibility	   to	   HSCR	   has	   not	   been	  
identified(Puffenberger	   et	   al.,	   1994b).	   	   There	   are	   other	   chromosomal	  
abnormalities	  associated	  with	  HSCR;	  they	  are	  summarised	  in	  Table	  1.3.	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Table	  1.3	  	  Association	  of	  chromosomal	  abnormalities	  with	  HSCR.	  	  
Adapted	  from	  (Chakravarti	  and	  Lyonnet,	  2001)	  and	  (Amiel	  and	  Lyonnet,	  2001)	  
	  




Trisomy21	  	   Down	   syndrome,	   S-­‐HSCR,	   5	   to	   10	  
male:female	  sex	  ratio	  	  
2	   to	   10%	  




in	  1	  study	  
Del	  10q11	  	   Mental	  retardation,	  L-­‐HSCR	  	   2	  cases	  	   RET	  	  
Del	  13q22	  	   Mental	   retardation,	   growth	  
retardation,	   dysmorphic	   features,	   S-­‐
HSCR	  	  
7	  cases	  	   EDNRB	  	  
Del	  2q22-­‐q23	  	   Postnatal	   growth	   retardation	   and	  
microcephaly,	   mental	   retardation,	  
epilepsy,	  dysmorphic	  features,	  HSCR*	  
3	  cases	  	   SIP1	  	  
Del	  17q21	  	   	   4	  cases	  	   ?	  	  
Dup	  17q21-­‐q23	  	   Multiple	  anomalies	   4	  cases	  	   ?	  	  
Trisomy	   22pter-­‐
q11	  	  
Cat	  eye	  syndrome	  	   	   ?	  	  
	  
	  
The	   association	   of	   HSCR	   with	   various	   syndromes	   also	   provides	   insight	   into	   the	  
genetic	  causes	  of	  HSCR.	  	  These	  are	  summarised	  in	  Table	  1.4	  and	  commented	  upon	  
in	  more	  detail	  where	  relevant	  to	  specific	  gene/protein	  abnormalities.	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Table	  1.4:	  	  Syndromes	  associated	  with	  HSCR.	  	  	  
Adapted	  from	  (Chakravarti	  and	  Lyonnet,	  2001,	  Amiel	  and	  Lyonnet,	  2001)	  and	  OMIM	  
	  
	   Syndrome	   Associated	   genetic	  
anomalies	  
Features	  and	  comments	  
Neurocristopathy	  
syndromes	  
Waardenberg-­‐syndrome	   and	  
related	  syndromes	  
PAX3	   and	   MITF	   mutations	  
in	   WS1,	   endothelin	   and	  
SOX10	  mutation	  in	  WS4s	  
Pigmentary	   anomalies	   (white	   forelock,	   iris	   hypoplasia,	   patchy	  
hypopigmentation),	   deafness.	   	   Shah-­‐Waardenberg	   syndrome	   is	  
associated	  with	  HSCR	  (WS4).	  
	   Congenital	   central	  
hypoventilation	  syndrome	  
PHOX2B	  mutation	  in	  most;	  
other	   mutations	   in	   RET,	  
GDNF	  and	  EDN3	  reported	  
Haddad	  syndrome	  when	  associated	  with	  HSCR.	  	  Failure	  of	  autonomic	  
control	   of	   ventilation	   during	   sleep)	   and	   other	   autonomic	  
disturbances	  also.	  
	   Yemenite	   deaf-­‐blind-­‐	  
hypopigmentation	  
SOX	   10	   mutations	  
identified	  in	  some	  cases	  
Hearing	   loss,	   eye	   anomalies	   (microcornea,	   coloboma,	   nystagmus),	  
pigmentary	  anomalies.	  
	   BADS	   (Black	   locks-­‐albinism-­‐
deafness	  syndrome)	  
	   Hearing	   loss,	  hypopigmentation	  of	  the	  skin	  and	  retina.	   	  One	  patient	  
described	  with	  HSCR.	  	  
	   Piebaldism	   KIT	  mutations	   Patchy	  hypopigmentation	  of	  the	  skin	  
	   MEN2A	   RET	  mutations	   Medullary	   thyroid	   carcinoma,	   phaeochromocytoma,	   parathyroid	  
adenomas	  
HSCR	  always	  present	   Goldberg-­‐Shprintzen	   KIAA1279	  mutations	   Cleft	  palate,	  hypotonia,	  learning	  difficulties,	  facial	  dysmorphism	  
	   Mowat-­‐Wilson	  syndrome	   ZFHX1B	  mutation	   Clinically	   very	   similar	   to	   Goldberg-­‐Shprintzen.	   	   Microcephaly,	  
learning	  difficulties,	  epilepsy,	  facial	  dysmorphism	  
	   HSCR	   with	   limb	  
abnormalities	  
	   Various	   rare	   syndromes	   exist	   with	   other	   associated	   anomalies	  
(cardiac,	  facial	  and	  spinal).	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   BRESHEK	  syndrome	  
	  
X-­‐linked	   Brain	   anomalies,	   retardation,	   ectodermal	   dysplasia,	   skeletal	  
malformations,	   Hirschsprung	   disease,	   ear/eye	   anomalies,	   cleft	  
palate/cryptorchidism,	  and	  kidney	  dysplasia/hypoplasia	  
HSCR	   occasionally	  
present	  
Bardet-­‐Biedl	  Syndrome	   9	   genetic	   subtypes	  
identified.	  
Pigmentary	   retinopathy,	   obesity,	   hypogonadism,	   mild	   mental	  
retardation,	   postaxial	   polydactyly.	   	   Related	   to	   Kauffman-­‐McKusick	  
syndrome	  and	  shares	  a	  similar	  aetiology	  in	  some	  cases.	  
	   Kauffman-­‐McKusick	  	   Gene	   on	   c20p12	   encoding	  
a	   protein	   similar	   to	   the	  
chaperonins	  
Hydrometrocolpos,	  postaxial	  polydactyly,	  congenital	  heart	  defect	  
	   Cartilage-­‐hair	  hypoplasia	   RMRP	   gene	   mutations	  
(codes	   an	  
endoribonuclease)	  
Short	  limb	  dwarfism,	  metaphyseal	  dysplasia,	  immunodeficiency	  
	   Mesomelic	   dysplasia,Werner	  
type	  
	   Absence	  of	  tibiae	  and	  preaxial	  polysyndactyly	  of	  hands	  and	  feet.	  	  	  
	   Smith-­‐Lemli-­‐Opitz	  syndrome	   Sterol	   delta-­‐7-­‐reductase	  
gene	   mutations	   –	   related	  
to	   cholesterol	   synthesis;	  
may	  disrupt	  SHH	  signalling.	  
Growth	  retardation,	  microcephaly,	  learning	  difficulties,	  hypospadias,	  
2–3	  toes	  syndactyly,	  dysmorphic	  features	  
Rare	  associations	   Fukuyama	   congenital	  
muscular	  dystrophy	  	  
	   Muscular	  dystrophy,	  polymicrogyria,	  hydrocephalus,	  MR,	  seizures	  
	   Clayton-­‐Smith	  syndrome	   	   Dysmorphic	  features,	  hypoplastic	  toes	  and	  nails,	  ichthyosis.	  
	   Kaplan	  syndrome	   	   Agenesis	   of	   corpus	   callosum,	   adducted	   thumbs,	   ptosis,	   muscle	  
weakness	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In	   terms	   of	   specific	   genetic	   abnormalities	   associated	   with	   HSCR,	   8	   genes	   have	  
been	  identified	  with	  clinical	  manifestations	  of	  HSCR.	  	  These	  are	  the	  RET	  (RET),	  glial	  
cell	   line	   derived	   neurotrophic	   factor	   (GDNF),	   neurturin	   (NTN),	   endothelin	   B	  
receptor	   (EDNRB),	   endothelin	   3	  (EDN3),	   endothelin	   converting	   enzyme	   1	  (ECE1),	  
SOX10,	  and	  SIP1	  genes.	  	  	  
	  
Mutations	  in	  the	  RET	  gene	  are	  responsible	  for	  approximately	  50%	  of	  familial	  HSCR	  
cases(Chakravarti	   and	   Lyonnet,	   2001),	   and	   they	   can	   produce	   a	   variety	   of	  
phenotypes	   in	   the	   same	   family	   (Edery	  et	  al.,	   1994,	  Romeo	  et	  al.,	   1994).	   Linkage	  
studies	   in	   affected	   populations	   have	   also	   identified	   a	   non-­‐coding	   mutation	   in	  
intron	  1	  of	  the	  gene	  to	  be	  associated	  with	  HSCR	  (Emison	  et	  al.,	  2005),	  and	  could	  
explain	  several	   features	  of	   the	  complex	   inheritance	  pattern	  of	  HSCR.	   	  This	  study	  
concluded	   that	   RET	   mutations	   in	   coding	   and/or	   non-­‐coding	   sequences	   are	  
probably	   a	   necessary	   feature	   of	   all	   cases	   of	   HSCR.	   However,	   the	   non-­‐coding	  
mutations	  in	  isolation	  are	  not	  sufficient	  for	  HSCR	  to	  occur,	  and	  need	  to	  be	  coupled	  
with	  another	  mutation	  of	  some	  kind	  (Emison	  et	  al.,	  2005).	  	  GDNF	  mutations	  have	  
been	  identified	  in	  only	  a	  handful	  of	  HSCR	  patients	  to	  date,	  and	  can	  be	  regarded	  as	  
a	  rare	  cause	  of	  HSCR	  (<5%)(Salomon	  et	  al.,	  1996,	  Angrist	  et	  al.,	  1996,	  Ivanchuk	  et	  
al.,	  1996).	  	  Moreover,	  GDNF	  mutations	  may	  not	  be	  sufficient	  to	  lead	  to	  HSCR	  since	  
four	  out	  of	  six	  patients	  have	  additional	  contributory	  factors,	  such	  as	  RET	  mutations	  
or	   trisomy	   21.(Salomon	   et	   al.,	   1996,	   Angrist	   et	   al.,	   1996).	   	   	   Similarly,	   a	   NTN	  
mutation	   has	   been	   identified	   in	   one	   family,	   in	   conjunction	   with	   a	   RET	  
mutation(Doray	  et	  al.,	  1998).	  
	  
EDN3	  and	  EDNRB	  polymorphisms	  have	  been	  described	  in	  syndromic	  and	  isolated	  
HSCR,	   although	   the	   genetic	   background	   is	   important	   and	   penetrance	  
variable(Puffenberger	  et	  al.,	  1994a,	  Kusafuka	  and	  Puri,	  1998).	  	  Individuals	  lacking	  
EDN3	  mutations	  but	  having	  decreased	  levels	  of	  EDN3	  mRNA	  expression	  have	  also	  
been	  described(Kenny	  et	  al.,	  2000).	  	  In	  non-­‐syndromic	  HSCR,	  less	  than	  5%	  of	  cases	  
appear	   to	   be	   a	   direct	   consequence	   of	   EDN3/EDNRB	   mutations(Brooks	   et	   al.,	  
2005).	   	  More	   recent	   research	  however	   looking	  at	  196	   cases	  of	  HSCR	  has	   shown	  
that	  a	  specific	  EDN3	  haplotype	  is	  overexpressed	  in	  sporadic	  cases,	  leading	  to	  the	  
conclusion	   that	   EDN3	   alleles	   act	   as	   low	   penetrance	   susceptibility	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modifiers(SÃ¡nchez-­‐MejÃ-­‐as	  et	  al.).	  This	  may	  be	  reflected	  in	  the	  amount	  of	  EDN3	  
mRNA	   expressed	   as	   noted	   above,	   and	   indeed	   in	   mice	   a	   reduced	   expression	   of	  
ECE-­‐1	   and	   EDN3	  mRNA	   has	   been	   observed	   in	  males	   at	   a	   time	   point	   critical	   for	  
ENSC	  migration(Vohra	  et	  al.,	  2007).	  	  This	  observation	  may	  partly	  explain	  the	  male	  
preponderance	  observed	  in	  HSCR.	  	  In	  addition,	  a	  heterozygous	  ECE1	  mutation	  has	  
been	  identified	  in	  a	  patient	  with	  HSCR	  and	  craniofacial	  and	  cardiac	  defects(Hofstra	  
et	  al.,	  1999).	  
	  
The	  WS4	  variant	  of	  Waardenburg-­‐Shah	  syndrome	  (HSCR	  plus	  partial	  albinism)	  has	  
been	   shown	   to	   be	   related	   to	   mutations	   in	   SOX10(Pingault	   et	   al.,	   2000)	   with	  
patients	   showing	   defects	   in	   NC	   cells	   necessary	   for	   both	   melanocyte	   and	   ENS	  
development.	  WS4	   can	   also	   be	   caused	   by	   homozygous	  mutations	   in	   EDN3	   and	  
ENDRB(Southard-­‐Smith	   et	   al.,	   1999,	   Southard-­‐Smith	   et	   al.,	   1998,	   Hofstra	   et	   al.,	  
1996).	  Another	  syndrome	  with	  a	  direct	  genetic	   link	  between	  HSCR	  and	  NC	  stem	  
cell	  development	  is	  Haddad	  syndrome	  (central	  hypoventilation	  with	  HSCR),	  where	  
mutations	   in	  Phox2b	  have	  been	   reported	  as	   the	  underlying	  cause(Verloes	  et	  al.,	  
1993,	  Amiel	  and	  Lyonnet,	  2001).	  
	  
Overall,	   although	   studies	   with	   animal	   models	   and	   human	   genetic	   studies	   have	  
improved	  our	  understanding	  of	  HSCR,	   it	   is	   clear	   that	   this	   is	  a	  complex	  polygenic	  
disease	  with	   interacting	   genetic	   elements,	   as	   discussed	   in	   section	   1.2.8.7	   about	  
SOX10,	   RET	   and	   EDN3.	   	   The	   clinical	   implications	   of	   this	   are	   that	   HSCR	   can	   be	  
associated	   with	   other	   congenital	   anomalies	   and	   there	   is	   a	   risk	   of	   other	   family	  
members	  also	  being	  affected	  with	  HSCR.	  	  Overall,	  the	  risk	  of	  inheriting	  HSCR	  in	  an	  
affected	   family	   has	   been	   put	   at	   3%	   for	   short	   segment	   HSCR	   and	   17%	   for	   long	  
segment	   HSCR,	   although	   this	   is	   subject	   to	   considerable	   variations	   (see	   table	  
1.5)(Chakravarti	  and	  Lyonnet,	  2001).	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Table	  1.5:	  	  Percentage	  of	  risk	  of	  familial	  recurrence	  in	  HSCR	  	  




1.3.4	  	  Clinical	  presentation	  of	  HSCR	  
	  
At	   present,	   there	   are	   no	   reliable	   antenatal	   tests	   suitable	   for	   the	   diagnosis	   of	  
HSCR(Croaker,	  2006),	  despite	  early	   reports	   that	   it	  dilated	  bowel	   can	  be	   seen	  on	  
ultrasound	   in	   the	   third	   trimester	   of	   pregnancy(Vermesh	   et	   al.,	   1986).	   	   A	  
subsequent	   large	   series	   did	   not	   detect	   dilated	   bowel	   in	   3	   cases	   of	   postnatally	  
diagnosed	  HSCR(Corteville	  et	  al.,	  1996).	  
	  
The	   vast	   majority	   of	   children	   with	   HSCR	   therefore	   present	   antenatally,	   usually	  
within	   the	   neonatal	   period.	   	   Symptoms	   classically	   include	   the	   failure	   to	   pass	  
meconium	  in	  the	  first	  24	  hours	  of	   life,	  abdominal	  distension	  and	  vomiting	  which	  
becomes	   bilious,	   although	   as	  HSCR	   represents	   a	   clinical	   disease	   spectrum	   there	  
are	  children	  who	  experience	  less	  severe	  symptoms	  and	  who	  may	  present	  later	  in	  
life	  with	  symptoms	  of	  severe	  constipation	  (Holschneider	  and	  Ure,	  2000).	  
	  
Children	   with	   HSCR	   may	   present	   with	   enterocolitis	   or	   have	   episodes	   after	  
diagnosis	  and	  definitive	  treatment.	  	  Enterocolitis	  produces	  diarrhoea,	  obstructive	  
symptoms,	  sepsis	  and	  radiological	  or	  histological	  signs	  of	  mucosal	  ulceration	  and	  
	   Long	   segment	  
HSCR	  
Colonic	   segment	  
HSCR	  
Short	   segment	  
HSCR	  
	   Male	   Female	   Male	   Female	   Male	   Female	  
Sibling	   of	   affected	  
male	  
11	   8	   10	   7	   4	   1	  
Sibling	   of	   affected	  
female	  
23	   18	   13	   10	   6	   2	  
Offspring	   of	  
affected	  male	  
18	   13	   11	   9	   ~0	   ~0	  
Offspring	   of	  
affected	  female	  
28	   22	   15	   11	   ~0	   ~0	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pneumatosis(Vieten	   and	   Spicer,	   2004).	   	   The	   incidence	   of	   enterocolitis	   in	   HSCR	  
varied	   in	   incidence	  between	  approximately	   10	   and	  60%,	  depending	  on	   the	   case	  
series	  and	  diagnostic	  criteria.	  	  	  	  
	  
Whatever	   the	   mode	   of	   initial	   presentation,	   the	   definitive	   diagnosis	   of	   HSCR	   is	  
made	  using	  rectal	  biopsies	  taken	  deep	  enough	  to	  include	  the	  submucosal	  plexus:	  	  
the	  absence	  of	  ganglion	  cells	  and	  the	  presence	  of	  hypertrophies	  nerve	  trunks	  seen	  
on	  acetylcholine	  esterase	  staining	  are	  diagnostic	  of	  the	  disease.	  	  Other	  diagnostic	  
tools,	   such	   as	   lower	   GI	   contrast	   studies	   and	   anorectal	   manometry,	   are	   neither	  
sensitive	  nor	  specific	  enough	  to	  reliably	  diagnose	  HSCR.	  	  	  
	  
Once	  a	  diagnosis	  of	  HSCR	  has	  been	  made,	  initial	  treatment	  consists	  of	  treating	  any	  
concurrent	  sepsis	  and	  decompressing	  the	  affected	  bowel	  using	  regular	  rectal	  and	  
colonic	   washouts.	   	   Traditionally,	   a	   colostomy	   would	   then	   be	   performed	   before	  
definitive	   surgery	   was	   completed	   outside	   of	   the	   neonatal	   period(Holschneider	  
and	  Ure,	  2000).	   	  Unfortunately,	   this	   requires	   two	  or	   three	  operative	  procedures	  
and	  consequent	  hospital	  stays.	  	  With	  recent	  advances	  in	  surgical	  and	  anaesthetic	  
technique,	   many	   surgeons	   now	   advocate	   a	   one-­‐stage	   procedure	   that	   can	   be	  
performed	  in	  the	  neonatal	  period.	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1.3.5	  	  An	  overview	  of	  definitive	  surgical	  treatments	  for	  HSCR	  
	  
There	  are	  four	  major	  types	  of	  surgery	  currently	  performed	  for	  HSCR,	  all	  of	  which	  
can	   be	   performed	   as	   either	   single	   or	   multiple	   stage	   procedures,	   either	   by	  
conventional	  or	  laparoscopic	  surgery.	  	  That	  such	  a	  variation	  can	  exist	  suggests	  that	  
no	   one	   procedure	   has	   clearly	   demonstrated	   its	   superiority	   over	   the	   rest;	  
conversely	   it	   could	   be	   argued	   that	   significant	   problems	   can	   be	   found	   in	   all	  
procedures.	   	  A	  diagrammatic	   representation	  of	   these	  procedures	  can	  be	  seen	   in	  
Figure	   1.3	   (adapted	   from	   (Holschneider	   and	   Ure,	   2000)).	   	   In	   all	   of	   these	  
procedures,	  a	  key	  step	  is	  to	  ensure	  that	  the	  diagnosis	  of	  HSCR	  is	  correct	  and	  the	  
level	   of	   ganglionic	   bowel	   is	   ascertained;	   this	   can	   be	   accomplished	   by	   inspecting	  
the	   bowel	   (where	   a	   transition	   between	   ganglionic	   dilated	   and	   aganglionic	  
constructed	  bowel	  can	  often	  be	  seen)	  and	  by	  sending	  seromuscular	  biopsies	  from	  
the	   bowel	   for	   urgent	   intraoperative	   frozen	   section,	   where	   aganglionic	   or	  
ganglionic	  myenteric	  plexus	  can	  be	  seen.	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1.3.5.1	  	  Swenson’s	  Technique	  
	  
As	   previously	   mentioned,	   the	   first	   successful	   definitive	   surgery	   for	   HSCR	   was	  
performed	  by	  Swenson(Swenson	  and	  Bill,	  1948).	   	  The	  sigmoid	  colon	  and	   rectum	  
are	  mobilised	  and	   resected	  down	   to	   the	  anal	   canal	   via	  a	   trans-­‐abdominal	   route.	  	  
The	  anal	  canal	   is	   then	  everted	  (See	  Figure	  1.3A)	  and	  an	  anastomosis	  performed.	  	  
This	  procedure	  involves	  and	  extensive	  pelvic	  dissection	  than	  can	  severely	  damage	  
the	   autonomic	   nervous	   supply	   to	   both	   bowel	   and	   bladder,	   the	   ureters	   and	   vas	  
deferens	  in	  the	  male,	  	  unless	  the	  plane	  of	  dissection	  is	  kept	  extremely	  close	  to	  the	  
bowel	  wall.	  	  Concerns	  about	  such	  damage	  and	  the	  subsequent	  long-­‐term	  outcome	  
led	  to	  the	  development	  of	  other	  surgical	  techniques.	  
	  
1.3.5.2	  	  Duhamel	  (Duhamel-­‐Grobb)	  procedure	  
	  
Duhamel	   initially	   described	   the	   Duhamel	   procedure	   in	   1956(Duhamel,	   1956).	  	  
Theoretically	   it	   represented	   an	   advance	   in	   the	   treatment	   of	   HSCR	   because	   the	  
internal	   anal	   sphincter	   was	   left	   intact	   and	   the	   only	   pelvic	   dissection	   was	  
performed	   in	   the	   retrorectal	   space,	   preserving	   the	   innervation	   of	   the	   pelvic	  
organs.	  	  	  The	  rectum	  is	  divided	  and	  oversewn	  at	  the	  peritoneal	  reflection,	  and	  the	  
residual	  aganglionic	  bowel	  mobilised	  and	  resected.	  	  The	  retrorectal	  space	  is	  then	  
dissected	   and	   the	   ganglionic	   bowel	   pulled	   inferiorly	   as	   shown	   in	   Figure	   1.3D.	  	  
Initially	   Duhamel	   described	   an	   incision	   just	   above	   the	   dentate	   line;	   Grobb	  
modified	   this	   to	   an	   incision	   1.5-­‐2.5	   cm	   above	   the	   dentate	   line	   to	   preserve	   the	  
internal	  anal	  sphincter(Grob	  et	  al.,	  1959).	  	  	  Subsequent	  modifications	  have	  aimed	  
to	   minimise	   the	   blind-­‐ending	   rectal	   pouch	   that	   may	   form(Martin	   and	   Caudill,	  
1967)	   and	   introduced	   surgical	   stapling	   devices	   for	   the	   rectal	   anastomosis	  
(Steichen	  et	  al.,	  1987).	  
	  
1.3.5.3	  	  Rehbein’s	  anterior	  resection	  
	  
Described	   by	   Rehbein	   in	   1959(Rehbein	   and	   Zimmermann,	   1959),	   this	   technique	  
involves	   a	   low	   anterior	   rectosigmoid	   resection	   and	   primary	   anastomosis	   of	  
	   60	  
ganglionic	   bowel	   onto	   the	   residual	   aganglionic	   rectal	   stump.	   	   This	   leaves	  
approximately	   5-­‐6cm	   of	   aganglionic	   bowel	   above	   the	   dentate	   line	   and	   many	  
patients	   subsequently	   require	   repeated	   anal	   dilatations	   and	   suffer	   from	  
constipating	  symptoms(Rintala	  and	  Pakarinen,	  2006).	  	  	  
	  
1.3.5.4	  	  Soave	  endorectal	  pullthrough	  
	  
Historically,	   the	   Soave	   endorectal	   pullthrough	   was	   the	   last	   major	   surgical	  
innovation	  in	  the	  treatment	  of	  HSCR	  before	  the	  introduction	  of	  minimally	  invasive	  
techniques.	   	   In	  1964	  Soave	  described	  a	  submucosal	  dissection	  of	  the	  aganglionic	  
bowel	   in	  the	  pelvis,	  thereby	  preserving	  the	  innervations	  and	  organs	  of	  the	  pelvis	  
(Figure	  1.3B)(Soave,	   1964).	   	   This	  was	  originally	  done	   transabdominally	   and	  after	  
the	  ganglionic	  bowel	  was	  pulled	  through	  the	  aganglionic	  muscular	  sleeve,	   it	  was	  
left	  until	  a	   secondary	  anastomosis	  was	  performed	  10	  days	   later.	   	  A	  modification	  
by	   Boley	   added	   a	   primary	   anastomosis(Boley,	   1964)	   and	   recently	   the	   Soave	  
procedure	   has	   been	   modified	   to	   perform	   the	   endorectal	   dissection	   entirely	  
transanally	  	  (Saltzman	  et	  al.,	  1996,	  Rintala	  and	  Lindahl,	  1993).	  	  The	  abdominal	  part	  
of	  the	  procedure	  can	  then	  be	  performed	  laparoscopically(Georgeson	  et	  al.,	  1995)	  
or	   even	   transanally,	   resulting	   in	   a	   totally	   transanal	   procedure(de	   la	   Torres-­‐
Mondragon	  and	  Ortega-­‐Salgado,	  1998).	   	   This	   last	  procedure	  does	  however	   raise	  
the	  possibility	  that	  a	  case	  of	  long	  segment	  HSCR	  will	  not	  be	  recognised	  until	  after	  
the	  commencement	  of	   the	  Soave	  pullthrough.	   	  This	   then	  commits	  both	   surgeon	  
and	  child	  to	  an	  ileo-­‐anal	  anastomosis	  (with	  or	  without	  an	  ileal	  pouch),	  which	  may	  
not	  be	  the	  optimal	  surgical	  strategy(Langer	  et	  al.,	  2003).	  
	  
1.3.5.5	  	  Summary	  of	  surgical	  procedures	  for	  HSCR	  
	  	  
Overall	   the	   commonest	   procedures	   now	   performed	   for	   HSCR	   are	   the	   Duhamel	  
and	   Soave	   variants(Klein	   and	   Philippart,	   1993).	   	   Both	   of	   these	   operations	  mean	  
that	   residual	   aganglionic	   bowel	   is	   left	   behind,	   and	   in	   particular	   the	   aganglionic	  
internal	  anal	  sphincter	  is	  preserved.	  	  This	  is	  significant	  in	  terms	  of	  the	  outcome	  of	  
HSCR	   surgery	   and	   Swenson	   himself	   has	   long	   been	   critical	   of	   these	   aspects	   of	  
modern	  HSCR	  surgery(Swenson,	  2004).	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1.3.6	  	  Outcomes	  in	  Hirschsprung’s	  disease	  
	  
There	   are	   several	   areas	   where	   improvements	   in	   the	   outcome	   after	   surgery	   for	  
HSCR	  need	   to	  be	  made.	   	   These	  need	   to	  be	   analysed	   in	   terms	  of	   short	   and	   long	  
term	  outcomes	  and	  also	  by	  the	  type	  of	  surgery	  performed.	  
	  
1.3.6.1	  	  Short	  term	  outcomes	  after	  surgery	  for	  HSCR	  
	  
Short-­‐term	  complications	  of	  note	  after	  definitive	  surgery	   for	  HSCR	  are	  mortality,	  
enterocolitis,	   wound	   problems,	   anastomotic	   leaks	   and	   strictures	   and	   bowel	  
function.	  	  In	  terms	  of	  mortality,	  with	  advances	  in	  perioperative	  care,	  the	  mortality	  
rate	   is	   now	   very	   low	   (approximately	   1%)(Langer	   et	   al.,	   2003,	   Teitelbaum	   et	   al.,	  
2000)	  and	  in	  most	  cases	  either	  relates	  to	  associated	  congenital	  anomalies	  (such	  as	  
cardiac	   defects)or	   episodes	   of	   enterocolitis(Wang	   et	   al.,	   2004)	   rather	   than	   the	  
surgery	  per	  se.	  
	  
Enterocolitis	   is	   a	   much	   commoner	   problem,	   with	   overall	   incidences	   in	   recent	  
series	  of	  between	  20	  and	  40%(Menezes	  and	  Puri,	  2006).	  	  	  	  The	  postoperative	  risk	  
of	  enterocolitis	  has	  been	  cited	  as	  15%	   in	  a	   recent	   review(Rintala	  and	  Pakarinen,	  
2006),	   although	   this	   figure	   conceals	   considerable	   variation	   between	   the	   various	  
surgical	  procedures:	  	  the	  Duhamel	  having	  the	  lowest	  incidence	  of	  enterocolitis	  (at	  
13%),	   the	   Soave	   procedure	   26%	   and	   the	   Swenson	   procedure	   49%(Rintala	   and	  
Pakarinen,	  2006).	  	  It	  is	  possible	  that	  the	  residual	  aganglionic	  cuff	  	  of	  bowel	  that	  is	  
present	   in	   the	   Soave	   procedure	   is	   responsible	   for	   this,	   and	   some	   surgeons	  
advocate	   a	   posterior	   myotomy/myectomy	   in	   children	   with	   recurrent	  
enterocolitis(Wildhaber	  et	  al.,	  2004),	  although	  this	  does	  not	  explain	  the	  relatively	  
high	  rate	  of	  enterocolitis	  seen	  after	  the	  Swenson	  procedure.	  
	  
Other	   early	   postoperative	   complications	   such	   as	   wound	   problems	   and	  
anastomotic	   leaks	   	   are	   generally	   similar	   whatever	   the	   type	   of	   surgery	  
employed(Rintala	   and	  Pakarinen,	   2006).	   	   Stool	   frequency	   is	   initially	   very	   high	   in	  
children	  following	  a	  Soave	  pullthrough	  or	  Swenson	  procedure	  but	  is	  less	  frequent	  
after	   the	  Duhamel	  due	   to	   the	   larger	   rectal	   reservoir;	   these	  differences	  generally	  
subside	  after	  6-­‐12	  months(Shankar	  et	  al.,	  2000).	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1.3.6.2	  	  Long	  term	  outcomes	  after	  surgery	  for	  HSCR	  
	  
The	   key	   long-­‐term	   outcomes	   in	   children	   with	   HSCR	   are	   continence	   and	   bowel	  
function.	   	   Comparisons	   between	   studies	   in	   terms	   of	   functional	   results	   are	  
complicated	  by	  the	  lack	  of	  a	  standard	  assessment	  tool	  for	  bowel	  function,	  leading	  
to	   authors	   inventing	   their	   own	   scoring	   systems(Reding	   et	   al.,	   1997,	   Bai	   et	   al.,	  
2002)	  or	  adapting	  scoring	  systems	  used	  for	  anorectal	  malformations(Baillie	  et	  al.,	  
1999,	  Rintala	  and	  Lindahl,	  1995,	  Moore	  et	  al.,	  1996b).	  	  There	  are	  also	  problems	  in	  
that	  most	   reports	   of	   long	   term	   outcome	   represent	   historical	   series	   from	   either	  
institutions	   where	   a	   large	   number	   of	   surgical	   procedures	   were	   performed	  
(Fortuna	  et	  al.,	  1996,	  Foster	  et	  al.,	  1990,	  Moore	  et	  al.,	  1996b,	  Marty	  et	  al.,	  1995)	  
or	  the	  results	  of	  a	  single	  surgeon	  whose	  results	  may	  not	  be	  generalizable	  to	  the	  
general	  surgical	  population(Jung,	  1995,	  Hung,	  1991).	  	  Finally,	  there	  is	  the	  problem	  
that	  in	  older	  historical	  series	  no	  objective	  criteria	  for	  the	  assessment	  of	  outcome	  
were	  identified	  prospectively,	  and	  instead	  a	  retrospective	  classification,	  often	  into	  
relatively	  simple	  categories	  (i.e.	  clean,	  soiling)	  is	  employed(Sherman	  et	  al.,	  1989).	  	  
This	   may	   exacerbate	   the	   problem	   of	   children	   and	   parents	   consistently	  
underreporting	   the	   severity	   of	   their	   symptoms	   to	   their	   primary	   surgeon(Heij	   et	  
al.,	  1995).	   	   Finally,	  only	  a	   few	  studies	  have	  compared	   the	   functional	  outcome	   in	  
children	   with	   HSCR	   compared	   to	   normal,	   age-­‐matched	   controls(Reding	   et	   al.,	  
1997,	   Bai	   et	   al.,	   2002,	   Baillie	   et	   al.,	   1999,	   Diseth	   et	   al.,	   1997,	   Heikkinen	   et	   al.,	  
1995,	  Mills	  et	  al.,	  2008).	  
	  
Nevertheless,	  the	  despite	  the	  heterogeneity	  of	  such	  studies,	  there	  are	  some	  clear	  
messages	  that	  emerge.	   	  Firstly,	  bowel	  function,	  and	  therefore	  operative	  success,	  
improves	  with	  age(Rintala	  and	  Pakarinen,	  2006,	  Mills	  et	  al.,	  2008).	   	   Secondly,	   in	  
almost	  every	  series	  reported,	  there	  is	  a	  significant	  minority	  of	  patients	  who	  do	  not	  
achieve	   good	   results.	   	   Thirdly,	   the	   results	   in	   long	   segment	  disease	  are	   generally	  
worse	   than	   in	   short	   segment	   disease(Moore	   et	   al.,	   1996b,	   Catto-­‐Smith	   et	   al.,	  
2007,	   Choe	   et	   al.,	   2008,	   Wildhaber	   et	   al.,	   2005,	   Ludman	   et	   al.,	   2002).	   	   These	  
results	  are	  summarised	  in	  table	  1.6.	  	  As	  can	  be	  seen,	  the	  early	  optimism	  of	  studies	  
reporting	   excellent	   results	   for	   all	   the	   surgical	   procedures	   has	   not	   persisted	   in	  
more	   recent	   and	   more	   detailed	   analyses.	   	   Overall	   there	   is	   a	   high	   incidence	   of	  
faecal	   incontinence,	   reoperative	  surgery	  and	  permanent	  stoma	  formation	   (at	  up	  
to	  10%(Baillie	  et	  al.,	  1999,	  Puri	  and	  Nixon,	  1977,	  Tariq	  et	  al.,	  1991,	  Jung,	  1995)).	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Table	  1.6:	  	  Long	  term	  functional	  outcome	  in	  after	  definitive	  surgery	  for	  HSCR.	  	  	  
Adapted	  from	  (Rintala	  and	  Pakarinen,	  2006)	  with	  the	  inclusion	  of	  additional	  studies.	   	  Small	  studies	  (<20	  patients)	  and	  those	  with	  <5	  years	  follow	  up	  data	  
have	  been	  excluded.	  
	  
	  
Study	   Year	   Patient	  
number	  
Method	   Surgical	  
technique	  




%	   normal	  
bowel	  
control	  
Rehbein(Rehbein	  et	  al.,	  1966)	   	   	   	   	   	   	   	   	  
Duhamel(Duhamel,	  1964)	   1964	   202	   Case	  note	  review	   Duhamel	   not	  
specified	  
-­‐	   -­‐	   100	  
Puri(Puri	  and	  Nixon,	  1977)	   1977	   89	   Case	  note	  review	   Swenson	   18+	  years	   44	  to	  1	   32	  to	  0	   99	  
Seiber	   1978	   	   	   	   	   	   	   	  
Holschneider(Holschneider,	  
1982)	  
1982	   432	   Case	  note	  review	   Mixed	   not	  
specified	  
14	   32	   54	  
Sherman(Sherman	   et	   al.,	  
1989)	  
1989	   477	   Case	   note	   review	   and	  
interview	  
Swenson	   6-­‐40	  years	   8	  to	  2	   6	  to	  3	   94	  
	   64	  
Morikawa(Morikawa	   et	   al.,	  
1989)	  
1989	   82	   Case	   notes,	  
manometry	  
Soave	   10	  years	   -­‐	   -­‐	   90	  
Foster	  (Foster	  et	  al.,	  1990)	   1990	   63	   Case	  note	  review	   Mixed	   7	  months	  to	  
24	  years	  
12	  to	  0	   -­‐	   88	   after	   5	  
years	  
Hung(Hung,	  1991)	   1991	   202	   Case	  note	  review	   Duhamel	   10	   months-­‐
24	  years	  
not	  specified	   not	  specified	   97.5	  
Tariq(Tariq	  et	  al.,	  1991)	   1991	   30	   not	  specified	   Soave	   5-­‐10	  years	   17	   0	   68	  
Rescorla(Rescorla	  et	  al.,	  1992)	   1992	   55	   Interview	   Duhamel	   5-­‐20	   9	  to	  0	   -­‐	   91	  to	  100	  
Jung(Jung,	  1995)	   1995	   137	   Case	  note	  review	   Mainly	  
Duhamel	  
4-­‐15	  years	   0	   4	  to	  0	   99	  
Catto-­‐Smith(Catto-­‐Smith	  et	  al.,	  
1995)	  
1995	   60	   Questionnaire	   and	  
diary	  
Multiple	   6-­‐11	  years	   53	   20	   -­‐	  
Heikkinen(Heikkinen	   et	   al.,	  
1995)	  
1995	   100	   Case/control	   Mixed	   15-­‐39	  years	   9	   1	   91	  
Marty(Marty	  et	  al.,	  1995)	   1995	   135	   Case	   note	   review	   and	  
questionnaire	  
Mixed	   3	   months	   -­‐
21	  years	  
12	   7.5	   80	  
Heij(Heij	  et	  al.,	  1995)	   1995	   63	   Case	   note	   review	   and	  
questionnaire	  
Duhamel	   4	  -­‐18	  years	   35	   up	  to	  42	   20	  
	   65	  
Moore(Moore	  et	  al.,	  1996b)	   1996	   115	   Case	   note	   review	   and	  
interview	  
Multiple	   4	  years	   19	  to	  6	   35	   75	  
Reding(Reding	  et	  al.,	  1997)	   1997	   37	   Case/control	   Mixed	   1-­‐22	   -­‐	   -­‐	   66	  
Diseth(Diseth	  et	  al.,	  1997)	   1997	   19	   Case/control	   Duhamel	   10-­‐20	  years	   -­‐	   -­‐	   68	  
Yanchar(Yanchar	   and	   Soucy,	  
1999)	  
1999	   45	   Case	   note	   review	   and	  
questionnaire	  
Multiple	   5	  years	   58	  to	  8	   22	  to	  8	   -­‐	  
Baillie(Baillie	  et	  al.,	  1999)	   1999	   80	   Case/control	   Duhamel	   5-­‐16	  years	   -­‐	   -­‐	   42	  to	  79	  
Van	   der	   Zee(van	   der	   Zee	   and	  
Bax,	  2000)	  
2000	   29	   Case	   note	   review	   and	  
questionnaire	  
Duhamel	   5-­‐7	  years	   27	   21	   52	  
Shankar(Shankar	  et	  al.,	  2000)	   2000	   51	   Case	  note	  review	   Soave	   4	  years	   24	   0	   76	  
Bai(Bai	  et	  al.,	  2002)	   2002	   45	   Case/control	   Swenson	   8-­‐16	  years	   44	   7	   49	  
Minford(Minford	  et	  al.,	  2004)	   2004	   67	   Case	   note	   review,	  
interview	   and	  
questionnaire	  
Mixed	   4-­‐11	  years	   -­‐	   -­‐	   45	  
Menezes(Menezes	   et	   al.,	  
2006)	  
2006	   194	   Case	  note	  review	   Mixed	   3	   to	   20	  
years	  
10	   22	   68	  
Wester	   2006(Wester	   et	   al.,	  
2006)	  
2006	   44	   Case	   note	   review	   and	  
interview	  
Rehbein	   2-­‐10	  	  years	   27	   46	   29	  
	   66	  
Catto-­‐Smith(Catto-­‐Smith	  et	  al.,	  
2007)	  
2007	   98	   Questionnaire	   and	  
diary	  
Multiple	   3-­‐24	  years	   39	   approx	  35	   61	  
Zhang(Zhang	  et	  al.,	  2007)	   2007	   346	   Case	   note	   review,	  
questionnaire,	  
manometry	  
Swenson	   8	   to	   20	  
years	  
20	   10	   61.5	  
El-­‐Sawaf(El-­‐Sawaf	  et	  al.,	  2007)	   2007	   41	   Case	   note	   review	   and	  
interview	  
Soave	   3-­‐	  9	  years	   20	   29	   80	  
Mills(Mills	  et	  al.,	  2008)	   2008	   51	   Case	   note	   review	   and	  
questionnaires	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1.3.6.3	  	  Predicting	  outcome	  in	  HSCR	  
	  
Studies	   aiming	   to	   identify	   risk	   factors	   that	   determine	   outcome	   in	   HSCR	   have	  
identified	   several	   criteria.	   	   As	   mentioned	   above,	   the	   length	   of	   the	   affected	  
segment	  is	  important,	  along	  with	  the	  incidence	  of	  enterocolitis,	  presence	  of	  Down	  
syndrome	  and	  other	  anomalies	  and	  male	  sex(Murthi	  and	  Raine,	  2003,	  Fouquet	  et	  
al.,	   2002,	   Quinn	   et	   al.,	   1994,	   Prato	   et	   al.,	   2008).	   	   Of	   these,	   the	   length	   of	   the	  
aganglionic	  segment	  is	  the	  most	  important	  prognostic	  marker(Prato	  et	  al.,	  2008).	  	  
	  
1.3.6.4	  	  Summary	  
	  
From	   these	   results,	   it	   can	   be	   concluded	   that	   no	   type	   of	   current	   surgery	   for	   the	  
treatment	   of	   HSCR	   is	   adequate	   to	   the	   task	   of	   producing	   a	   growing	   child,	   and	  
grown	   adult	   with	   a	   normal	   functioning	   bowel.	   	   This	   has	   led	   to	   the	   research	  
presented	   within	   this	   thesis	   aiming	   to	   develop	   a	   novel	   therapeutic	   stem	   cell	  
treatment	  for	  HSCR.	  	  
	  
1.4	  	  Other	  conditions	  that	  may	  also	  benefit	  from	  stem	  cell	  
therapy	  
	  
Although	   HSCR	   is	   the	   primary	   candidate	   for	   the	   development	   of	   a	   stem	   cell	  
treatment	   that	   would	   restore	   the	   functioning	   of	   the	   ENS,	   there	   are	   other	  
pathological	   processes	   that	  may	   also	   benefit.	   	   These	   are	   briefly	   detailed	   below,	  
although	  the	  suitability	  and	  feasibility	  of	  such	  treatments	   is	  highly	  speculative	  at	  
the	  present	  time	  
	  
1.4.1	  	  Intestinal	  neuronal	  dysplasia	  (IND)	  
	  
Intestinal	   neuronal	   dysplasia	   has	   been	   described	   as	   a	   cause	   of	   altered	   bowel	  
function	  in	  children.	   	   It	  was	  initially	  described	  by	  Meier	  Rouge	  1971(Meier-­‐Ruge,	  
1971)	  (REF)	  and	  has	  been	  the	  subject	  of	  much	  controversy.	  	  There	  are	  two	  types	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of	   IND.	   	   In	   type	  A	   there	   is	  hypoplasia	  or	  aplasia	  of	   the	   sympathetic	   innervation,	  
which	   presents	   in	   the	   neonatal	   period	  with	   severe	   constipation,	   diarrhoea,	   and	  
mucosal	  ulceration	  similar	  to	  that	  seen	  with	  ulcerative	  colitis(Meier-­‐Ruge,	  1992).	  	  
IND	  A	   is	  thought	  to	  be	  rare	  and	  has	  been	  the	  subject	  of	   little	  attention,	  possible	  
because	   the	   techniques	   necessary	   to	   make	   the	   diagnosis	   are	   not	   routinely	  
employed(Kapur,	   2003).	   	   In	   the	   more	   commonly	   described	   	   but	   more	  
controversial	   Type	   B	   disease	   there	   is	   normal	   sympathetic	   innervation	   but	  
hyperganglionosis	  of	   the	  submucosal	  plexus	  and	  giant	  ganglion	  cells(Meier-­‐Ruge	  
et	  al.,	  1995),	  and	   it	   can	  occur	   in	   isolation	  or	   in	  association	  with	  HSCR	  or	  colonic	  
strictures.	  
	  
Despite	  seemingly	  well-­‐defined	  diagnostic	  criteria,	  a	  multi-­‐centre	  study	  looking	  at	  
the	  histological	  diagnosis	  of	  IND	  type	  B	  found	  almost	  no	  inter-­‐observer	  agreement	  
on	   the	   diagnosis	   (Koletzko	   et	   al.,	   1999).	   	   It	   was	   therefore	   theorised	   that	   the	  
changes	  described	  in	  IND	  were	  in	  fact	  age-­‐related	  variants	  of	  normal.	  	  There	  have	  
been	  many	  subsequent	  articles	  and	  reports	  questioning	  the	  validity	  of	  IND	  B	  as	  a	  
discrete	   pathological	   entity	   (for	   summary,	   see(Kapur,	   2003).	   	   Meier-­‐Rouge	   has	  
responded	   by	   acknowledging	   that	   many	   symptomatic	   children	   diagnosed	   with	  
IND	  B	  will	  improve	  with	  time	  and	  revising	  the	  diagnostic	  criteria(Meier-­‐Ruge	  et	  al.,	  
2004).	  	  	  
	  
The	  existence	  of	  an	  identifiable	  genetic	  cause	  for	  the	  anomalies	  reported	  in	  IND	  B	  
would	   go	   a	   long	  way	   to	   establishing	   its	   existence	   as	   a	   pathological	   entity.	   	   The	  
gene	  HOX11L1	  has	  been	  implicated	  in	  the	  development	  of	  the	  pathological	  entity	  
described	   as	   IND	   B(Shirasawa	   et	   al.,	   1997),	   on	   the	   basis	   that	   mice	   with	   an	  
inactivating	   mutation	   in	   this	   gene	   develop	   megacolon	   and	   hyperganglionosis.	  	  
However,	   subsequent	   research	  has	  not	   yet	   found	  a	   role	   for	   this	   gene	   in	  human	  
disease(Costa	  et	  al.,	  2000)	  and	  it	  has	  been	  proposed	  that	  the	  defects	  seen	  in	  this	  
model	   are	   not	   a	   result	   of	   primary	   ENS	   defects	   and	   are	   instead	   muscular	   in	  
origin(Kapur	  et	  al.,	  2005).	  	  Even	  so,	  there	  is	  still	  the	  possibility	  that	  more	  research	  
in	   this	  area	  will	  uncover	   such	  a	  genetic	   link;	  defects	   in	   the	  EDNRB	  pathway	  also	  
seem	  to	  produce	  a	  picture	  in	  mice	  similar	  to	  INDB(von	  Boyen	  et	  al.,	  2002).	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There	  are	  also	  reports	  of	   IND	  B	   features	  associated	  with	   the	  transitional	  zone	   in	  
proven	   cases	   of	   HSCR,	   lending	   credence	   to	   the	   concept	   that	   other	   forms	   of	  
disordered	   ENS	   development	   other	   than	   pure	   aganglionosis	   are	   likely	   to	   be	  
clinically	   significant(Moore	   et	   al.,	   1994),	   although	   again	   the	   relationship	  of	   such	  
abnormalities	   in	   clinical	   practice	   is	   far	   from	   clear(Schmittenbecher	   et	   al.,	   1999).	  	  
Whatever	   the	  merits	  of	   the	  actually	   classification,	   the	   IND	  debate	  highlights	   the	  
fact	  that	  there	  appears	  to	  be	  a	  subset	  of	  children	  with	  disordered	  bowel	  function	  
and	  an	  atypical	  ENS,	  and	  that	  even	  within	  the	  ganglionic	  bowel	  in	  HSCR	  there	  may	  
be	   disordered	   neuronal	   anatomy	   and	   functioning.	   	   This	   may	   be	   amenable	   to	  
correction	  with	  ENSC	  transplantation.	  
	  
1.4.2	  	  Slow	  transit	  constipation	  
	  
Although	   constipation	   in	   childhood	   is	   very	   common,	   it	   usually	   responds	  well	   to	  
treatment.	   	   There	   remains	   however	   a	   group	   of	   children	   with	   intractable	  
symptoms,	  with	  evidence	  of	  a	  global	  or	  specific	  delay	  within	  the	  colon	  and	  these	  
have	   been	   labelled	   as	   having	   slow	   transit	   constipation(Hutson	   et	   al.,	   2001).	  	  
Originally	   described	   by	  William	   Arbuthnot	   Lane	   in	   1908	   and	   1909,	   slow	   transit	  
constipation,	   or	   idiopathic	   chronic	   constipation,	   was	   originally	   thought	   to	   be	   a	  
disease	   primarily	   affecting	   young	   women(Preston	   and	   Lennard-­‐Jones,	   1986).	  	  
However,	   studies	   have	   consistently	   described	   a	   subset	   of	   children	   who	   also	  
appear	  to	  fit	  into	  this	  diagnostic	  category(Wheatley	  et	  al.,	  1999b,	  Benninga	  et	  al.,	  
1996).	  	  
	  
The	   aetiology	   of	   slow	   transit	   constipation	   in	   children	   is	   still	   under	   investigation	  
and	   is	   likely	   to	   be	   multifactorial.	   	   There	   is	   a	   genetic	   component	   to	   some	  
cases(Hutson	  et	  al.,	  2001)	  with	  evidence	  of	  abnormalities	  in	  ENS	  neurotransmitter	  
and	   the	   c-­‐Kit	   genes(Garcia-­‐Barcelo	   et	   al.,	   2007).	   	   Other	   ENS	   abnormalities	   have	  
also	   been	   identified	   in	   children;	   	   including	   reduced	   neuronal	  
density(Krishnamurthy	   et	   al.,	   1985)	   and	   reduced	   	   numbers	   of	   tachykinin	   and	  
enkephalin	  nerve	  fibres(Porter	  et	  al.,	  1998),	  as	  well	  as	  alterations	  in	  the	  levels	  of	  
other	  neurotransmitters	   including	  substance	  P(Hutson	  et	  al.,	  1997)	   (Wheatley	  et	  
al.,	  1999a)	  and	  VIP	  (Sjolund	  et	  al.,	  1997).	  	  The	  results	  with	  regard	  to	  VIP	  have	  been	  
conflicting,	   as	   some	   studies	   have	   found	   increased	   levels,	   and	   it	   has	   been	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suggested	   that	   this	  may	   reflect	   changes	  secondary	   to	   laxative	  use(Hutson	  et	  al.,	  
2001).	  	  Other	  studies	  have	  also	  found	  alterations	  in	  the	  interstitial	  cells	  of	  Cajal	  in	  
children	  with	   slow	   transit	   constipation,	   including	   a	   reduction	   in	   the	   volume	  and	  
number	  of	   ICC	   in	   the	  colon(He	  et	  al.,	  2000,	  Wedel	  et	  al.,	  2002,	  Lee	  et	  al.,	  2005)	  
and	   also	   the	   morphology	   of	   the	   ICC	   processes(Wedel	   et	   al.,	   2002).	   	   There	   is	  
however	  the	  possibility	  that	  such	  morphometric	  studies	  do	  not	  take	  into	  account	  
the	  relative	  dilation	  of	  the	  bowel	  found	  in	  such	  patients,	  which	  would	  be	  expected	  
to	   decrease	   the	   overall	   density	   of	   the	   ICC	   network	   even	   though	   the	   absolute	  
numbers	   of	   ICC	   are	   unchanged.	   	   Another	   group	   has	   also	   suggested	   that	   some	  
children	  with	   slow	   transit	   constipation	  may	  be	   suffering	   from	  a	   form	  of	   visceral	  
myopathy,	   as	   they	   have	   alterations	   in	   colonic	   smooth	   muscle	   sensitivity	   to	  
cholinergergic	  stimuli	  (Slater	  et	  al.,	  1997).	  	  There	  is	  also	  evidence	  of	  a	  small	  fibre	  
neuropathy	  in	  some	  patients	  with	  slow	  transit	  constipation(Knowles	  et	  al.,	  1999).	  
	  	  
The	   fact	   that	   so	   many	   abnormalities	   have	   been	   identified	   in	   children	   with	   STC	  
suggests	   that	   the	   term	  may	  well	   represent	   a	   collection	  of	   different	  pathological	  
entities	  with	  the	  same	  ultimate	  clinical	  features,	  but	  there	  is	  certainly	  evidence	  of	  
dysfunctional	  ENS	  activity	  and	  abnormal	  ENS	  neuronal	  density	  and	  distribution.	  	  	  
	  
	  
1.4.3	  	  Chronic	  idiopathic	  intestinal	  pseudoobstruction	  (CIIPO)	  
	  
In	   some	   cases,	   the	   distinction	   between	   slow	   transit	   constipation	   and	   CIIPO	   is	  
blurred	   and	   some	   authors	   conflate	   the	   two	   entities,	   but	   diagnostic	   criteria	   for	  
CIIPO	   specify	   that	   obstruction	   (without	   an	   intraluminal	   lesion),	   not	   simply	  
constipation,	   is	  present(Rudolph	  et	  al.,	  1997).	   	  Furthermore,	   the	  classification	  of	  
CIIPO	  itself	  includes	  pathologies	  that	  are	  both	  congenital	  and	  acquired,	  and	  reflect	  
both	  myopathies	  and	  neuropathies(Connor	  and	  Di	   Lorenzo,	  2006).	   	  Neuropathic	  
CIIPO	  again	  has	  a	  number	  of	  aetiologies:	  	  Autoimmune	  disruption	  of	  the	  ENS	  has	  
been	   recognised	   as	   a	   cause(Wood,	   2000).	   	   In	   a	   human	   familial	   form	  of	   CIIPO,	   a	  
frameshift	   mutation	   causing	   disruption	   of	   the	   cytoskeletal	   protein	   filamin	   A,	  
leading	  to	  ENS	  dysfunction,	  has	  recently	  been	  identified(Gargiulo	  et	  al.,	  2007).	  	  In	  
addition,	   a	   mouse	   model	   for	   CIPO	   has	   shown	   disordered	   protein	   kinase	   A	  
signalling,	   leading	   to	   structurally	   myenteric	   plexus	   but	   disrupted	   ENS	   motor	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neuronal	  signalling(Howe	  et	  al.,	  2006).	   	  These	  and	  other	  results	  point	  to	  the	  fact	  
that	  some	  cases	  of	  CIIPO	  are	  due	  to	  defective	  ENS	  functioning	  and	  may	  therefore	  
be	  amenable	  to	  a	  stem	  cell	  based	  treatment.	  
	  
1.4.4	  Irritable	  bowel	  syndrome	  	  
	  
Although	   this	   thesis	   is	   principally	   concerned	   with	   the	   developing	   and	   neonatal	  
ENS	   and	   treatments	   aimed	   at	   improving	   symptoms	   in	   a	   paediatric	   age	   group,	  
there	   is	   an	   important,	   and	   large,	   group	   of	   adults	  who	   also	   experience	   disabling	  
symptoms	   of	   functional	   bowel	   dysmotility.	   	   Some	   of	   them	   (with	   slow	   transit	  
constipation)	   have	   been	   alluded	   to	   above;	   another	   large	   group	   suffer	   from	  
irritable	   bowel	   syndrome	   (IBS).	   	   IBS	   is	   characterised	   by	   the	   symptom	   cluster	   of	  
recurrent	  abdominal	  pain	  or	  discomfort	  	  at	  least	  3	  days	  a	  month	  in	  past	  3	  months	  
associated	  with	   two	  or	  more	  of	   improvement	  with	  defecation,	  onset	   associated	  
with	   change	   in	   frequency	   of	   stool	   and	   onset	   associated	   with	   change	   in	   form	  
(appearance)	  of	  stool,	  according	  to	  the	  consensus	  Rome	  III	  criteria(Longstreth	  et	  
al.,	  2006).	  	  It	  has	  been	  estimated	  to	  affect	  5-­‐10%	  of	  the	  adult	  population(Saito	  et	  
al.,	  2002).	  
	  
The	   relevance	   of	   ENS	   stem	   cell	   transplantation	   to	   IBS	   is	   that	   destruction	   of	   the	  
enteric	   nervous	   system	   in	   an	   autoimmune	   process	   has	   been	   linked	   to	   the	  
pathogenesis	  of	  some	  IBS	  symptoms(Wood,	  2000),	  and	   inflammatory	  changes	   in	  
the	  myenteric	   plexus	   have	   also	   been	   noted	   in	   patients	   with	   IBS(Barbara	   et	   al.,	  
2002).	  	  Although	  it	  is	  logical	  to	  direct	  initial	  therapeutic	  strategies	  at	  inhibiting	  the	  
automimmune/inflammatory	   response,	   there	   remains	   the	   possibility	   that	   for	  
some	   patients	   with	   irreversible	   damage	   to	   the	   ENS,	   stem	   cell	   transplantation	  
would	  provide	  symptomatic	  improvement.	  	  
	  
1.4.5	  Age	  degenerative	  changes	  
	  
Similarly,	   it	  has	  been	  shown	  that	  neuronal	  and	  glial	  numbers	   in	  the	  ENS	  (in	  both	  
the	   myenteric	   and	   submucous	   plexus)	   decline	   with	   age(Phillips	   and	   Powley,	  
2007),	  which	  correlate	  with	  a	  deterioration	  in	  bowel	  function(Wade	  and	  Hornby,	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2005).	   	   There	   is	   again	   the	   possibility	   that	   ENS	   stem	   cell	   transplantation	   could	  
improve	  bowel	  function	  in	  an	  ageing	  population,	  although	  this	  would	  presumably	  
only	  be	  for	  severe	  cases,	  given	  the	  potential	  complications	  of	  such	  a	  procedure.	  
	  
1.4.6	  Chagas’	  disease	  
	  
One	   hundred	   and	   one	   years	   ago,	   Carlos	   Chagas	   described	   American	  
trypanosomiasis,	  better	  known	  as	  Chagas	  disease.	   	  Although	  rare	   in	   the	  UK,	   this	  
disease	   is	   a	   major	   	   public	   health	   problem	   with	   significant	   social	   and	   economic	  
implications	  in	  most	  Latin	  American	  countries	  -­‐	  approximately	  8	  million	  people	  in	  
Latin	  America	  are	  affected(Armaganijan	  and	  Morillo).	  	  	  
	  
5%	   of	   those	   with	   chronic	   Chagas	   disease	   will	   die	   from	   a	   megacolon	   or	  
megaoesophagus,	  which	  are	  the	  end	  results	  of	  patchy	  inflammation	  and	  neuronal	  
depopulation	  within	  both	  the	  myenteric	  and	  submucosal	  plexus	  of	  the	   intestinal	  
wall(Teixeira	  et	  al.,	  2006).	   	  The	  exact	  cause	  of	   this	  neuronal	  depopulation	   is	   still	  
not	   known,	  and	   it	  may	  be	   the	   result	  of	  direct	  parasitic	   induced	  cell	  death	  or	  an	  
autoimmune	  response(Kalil	  and	  Cunha-­‐Neto,	  1996).	  	  Interestingly,	  a	  regenerative	  
neuronal	   response	   has	   been	   seen	   in	   the	   ENS	   of	   patients	   with	   chronic	   Chagas	  
disease(da	  SILVEIRA	  et	  al.,	  2008)	  and	  it	   is	  therefore	  tempting	  to	  speculate	  that	  if	  
the	  associated	  inflammatory	  response	  seen	  in	  this	  disease	  can	  be	  controlled	  then	  
ENS	   stem	   cell	   transplantation	   may	   play	   a	   part	   in	   treating	   the	   acquired	  
megaoesophagus	  and	  megacolon	  that	  can	  result.	  
	  
1.4.4	  	  Summary	  of	  other	  conditions	  that	  may	  also	  benefit	  from	  
ENS	  stem	  cell	  therapy	  
	  
The	  study	  of	  many	  functional	  disorders	  of	  the	  bowel	  is	  still	  in	  its	  infancy,	  and	  it	  is	  
likely	  that	  many	  of	  the	  current	  syndromic	  labels	  such	  as	  slow	  transit	  constipation	  
and	  irritable	  bowel	  syndrome	  cover	  a	  wide	  range	  of	  pathological	  entities,	  not	  all	  
of	   which	   feature	   ENS	   defects	   as	   the	   primary	   problem.	   	   However,	   it	   does	   seem	  
likely	   that	   there	   is	   a	   subset	   of	   conditions	   where	   ENS	   function	   is	   impaired,	   for	  
which	  ENS	  stem	  cell	  transplantation	  may	  have	  a	  role	  in	  treatment.	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The	   above	   list	   of	   conditions	   also	   excludes	   any	   potential	   benefits	   that	  may	   arise	  
from	  a	  basic	  understanding	  of	  ENS	  development	  and	  regulation,	  and	  advances	  in	  
understanding	   neuronal	   stem/precursor	   cell	   transplantation	   and	   engraftment	   in	  
the	  bowel	  may	  have	  other	  applications,	   such	  as	   stem	  cell	   transplantation	   in	   the	  
spinal	  cord	  for	  neuronal	  injury	  and	  in	  the	  brain	  to	  treat	  Parkinson’s	  disease.	  	  
	  
1.5	  	  Development	  of	  an	  ENS	  stem	  cell	  treatment	  
	  
The	  development	  of	  a	  safe	  and	  effective	  stem	  cell	  therapy	  for	  HSCR	  requires:	  a)	  a	  
source	  of	  appropriate	  stem	  cells,	  b)	  reliable	  and	  reproducible	  methods	  of	  isolating	  
these	  cells,	  c)	  evaluation	  of	  the	  properties	  of	  these	  cells,	  d)	  effective	  methods	  of	  
stem	  cell	   transplantation,	   including	   the	  mechanism	  of	  delivery	  and	  e)	   control	  of	  
environmental	  factors	  that	  could	  affect	  the	  outcome	  of	  any	  transplantation.	  	  This	  
section	  outlines	  the	  work	  done	  in	  these	  areas	  prior	  to	  the	  commencement	  of	  this	  
MD	  and	  highlights	  the	  areas	  where	  further	  research	  is	  needed.	  
	  
	  
1.5.1	  	  Potential	  sources	  of	  ENS	  stem	  cells	  
	  
The	  obvious	  source	  for	  ENS	  stem	  cells	   is	  the	  ENS	  itself,	  given	  that	  (as	  detailed	   in	  
section	  1.2)	  there	  are	  so	  many	  ENS	  stem	  cells	  present	  within	  the	  embryonic	  gut.	  	  
There	   is	  however	  no	  guarantee	  that	  these	  cells	  will	  persist	   into	  fetal	  or	  neonatal	  
life,	   and	   no	   guarantee	   that	   they	   will	   possess	   the	   same	   degree	   of	   pluripotency.	  	  
Therefore	   other	   possible	   sources	   of	   cells	   capable	   of	   generating	   a	   new	   ENS	  may	  
need	  to	  be	  considered.	  
	  
1.5.1.1	  	  CNS	  stem	  cells	  
	  
One	   such	   source	   is	   the	   CNS.	   	   CNS	   stem	   cells	   (CNSC)	   can	   be	   identified	   in	   the	  
embryo	  and	  fetus,	  and	  remain	  multipotent,	  so	  that	  cultured	  neurosphere-­‐derived	  
cells	  from	  the	  subventricular	  zone	  of	  the	  CNS	  are	  capable	  of	  migrating	  along	  chick	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neural	   crest	   pathways	   and	   differentiating	   into	   phenotypes	   similar	   to	   NC	   cell	  
derivatives(Durbec	   and	   Rougon,	   2001).	   	   During	   the	   course	   of	   this	   thesis,	   it	   was	  
reported	  that	  CNSC	  had	  been	  successfully	  transplanted	  into	  the	  stomach	  of	  NOS-­‐
deficient	   mice	   and	   appeared	   to	   effect	   a	   functional	   change(Micci	   et	   al.,	   2005),	  
which	   although	   an	   exciting	   result,	   does	   not	   demonstrate	   that	   such	   cells	   are	  
capable	  of	  the	  full	  range	  of	  ENS	  neuronal	  differentiation.	  	  
	  
1.5.1.2	  	  Other	  stem	  cell	  sources	  
	  
A	  more	  speculative	  approach	  has	  been	  investigated	  by	  the	  use	  of	  stem	  cells	  that	  
are	  not	  direct	  neural	  progenitors.	  Thus,	  attempts	  have	  been	  made	  to	   induce	  the	  
differentiation	   of	   embryonic	   stem	   cells(Takaki	   et	   al.,	   2006)	   and	   bone	   marrow-­‐
derived	  mesenchymal	  stem	  cells	  towards	  a	  neuronal	  phenotype(Bossolasco	  et	  al.,	  
2005).	  The	  bone	  marrow	  cells	  were	  induced	  to	  differentiate	  by	  treatment	  of	  with	  
medium	   conditioned	   by	   ENSC.	   	   Although	   the	   neurons	   produced	   expressed	  
neurotransmitter	   phenotypes	   found	   in	   the	   ENS	   including	   nitric	   oxide	   synthase	  
(NOS)	   and	   vasoactive	   intestinal	   polypeptide	   (VIP),	   these	   transmitters	   are	   not	  
restricted	  to	  the	  ENS	  and	  therefore	  any	  claim	  for	  directed	  differentiation	  towards	  
a	  specific	  enteric	  neuronal	  phenotype	  requires	   further	   investigation.	   	  The	  newer	  
developments	   in	   the	   field	   of	   induced	   pluripotent	   stem	   cells	   will	   be	   covered	   in	  
Chapter	  5.	  
	  
1.5.1.3	   	   Problems	   with	   non-­‐ENS	   stem	   cells	   for	   transplantation	   and	  	  
treatment	  	  
	  
The	   feasibility	  of	  using	  stem	  cells	   that	  are	  not	   the	   immediate	  progenitors	  of	   the	  
ENS	   is	   open	   to	   question,	   as	   it	   remains	   to	   be	   seen	   if	   the	   phenotypes	   of	   cells	  
derived	   from	   them	   are	   exactly	   those	   of	   the	   neural	   cells	   required.	   Furthermore,	  
stem	  cells	  –	  particularly	  embryonic	  stem	  cells	  –	  have	  neoplastic	  potential.	  While	  
the	  extent	  of	  such	  problems	  for	  ENSC	  is	  clearly	  less	  than	  for	  stem	  cells	  from	  other	  
sources,	   clearly	   the	   use	   of	   ENSC	   derived	   from	   human	   embryos	   is	   ethically	  
problematic	   and	   such	   cells	   would	   also	   have	   the	   disadvantage	   that	   their	  
therapeutic	   use	  would	   necessitate	   an	   allograft,	   with	   consequent	   immunological	  
problems	  and	  the	  possibility	  of	  transmissible	  infections.	  These	  problems	  would	  be	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eliminated	  by	  the	  isolation	  of	  ENSC	  from	  the	  normally	  innervated	  proximal	  colon	  
of	  children	  affected	  by	  HSCR,	  after	  diagnosis.	  	  	  
	  
Therefore,	  for	  therapeutic	  techniques,	  it	  would	  appear	  that	  ENS	  derived	  stem	  cells	  
are	   preferable	   to	   non-­‐ENS	   sources,	   and	   the	   ideal	   ENS	   stem	   cells	   would	   be	  
autologous	   postnatally	   derived	   cells	   that	   maintain	   the	   capacity	   to	   generated	   a	  
neo-­‐ENS	  after	  transplantation	  but	  with	  minimal	  neoplastic	  potential.	  	  
	  
1.5.2	  	  Isolation	  of	  ENSC	  
	  
1.5.2.1	  	  Isolation	  of	  embryonic	  and	  fetal	  ENSC	  
	  
The	   existence	   of	   ENS	   stems	   cells	   originating	   in	   the	   embryonic	   neural	   crest	   and	  
migrating	  along	  the	  embryonic	  gut	  has	  been	  documented	  previously	  (see	  section	  
1.2.1).	   	   However,	   from	   this	   initial	   work	   it	   is	   not	   clear	   whether	   such	   stem	   cells	  
persist	   throughout	   embryonic	   life	   into	   the	   neonatal	   period	   or	   whether	   they	  
terminally	  differentiate	   into	  neurons	  and	  glia	  after	  migration	   is	  complete.	   	   Initial	  
reports	  demonstrated	  that	  ENS	  stem	  cells	  persisted	  in	  the	  embryonic	  mouse	  gut,	  
and	  various	  methods	  could	  be	  employed	  to	  isolate	  and	  culture	  them.	  	  	  	  
	  
These	   techniques	   are	   summarised	   in	   Table	   1.7.	   	   It	   should	   be	   noted	   that	   the	  
varying	  methods	   of	   isolation	  might	   result	   in	   differing	   types	   of	   cell	   isolated	   as	   it	  
remains	   unclear	   if	   there	   is	   topological	   or	   chronological	   heterogeneity	   in	   the	  
population	   of	   ENSC	   in	   the	   gut.	   	   They	   generally	   involve	   taking	   pieces	   of	  
embryonic/fetal	   gut	   tissue	   and	   dissociating	   it	   to	   a	   single	   cell	   suspension,	   with	  
various	  methods	  used	  to	  enhance	  the	  ENSC	  cell	  numbers	  present	  in	  the	  resulting	  
culture.	  	  The	  use	  of	  cell	  isolation	  techniques	  based	  on	  markers	  clearly	  relies	  on	  the	  
assumption	   that	   all	   NC	   stem	   cells	   express	   the	   same	   marker.	   	   To	   obviate	   this	  
potential	   problem,	   use	   can	   be	   made	   of	   the	   property	   of	   ENSC	   to	   proliferate	   as	  
neurospheres–a	  technique	  developed	  for	  the	  isolation	  and	  amplification	  of	  CNS.	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Table	  1.7:	  	  Summary	  of	  techniques	  used	  to	  isolate	  ENSC	  
Reference Species Gestation Isolation method Culture method Comments 
(Chalazonitis, Rothman et al. 1994; 
Chalazonitis, Rothman et al. 1998; Chalazonitis, 
D'Autreaux et al. 2004) 
Rat E12,14,16 Dissociation of whole gut and magnetic micro-
bead selection for p75 positive cells 
Adherent conditions on collagen and laminin 
substrate with serum supplemented medium 
initially 
Prenatal 
(Lo. 1995) Rat E14.5 Dissociation of whole gut and FACS sorting for 
Ret positive cells 
Cell colonies on Petri dish coated with poly-D-
lysine (PDL) and fibronectin (FN) 
Prenatal 
(Natarajan, Grigoriou et al. 1999) Mouse E11.5 Whole gut dissociation with FACS sorting of 
RET+ cells 
Cultured in explanted E11.5 mouse gut in 
organ bath 
Prenatal 
 (Bixby, Kruger et al. 2002) Rat E14.5 Dissociation of whole gut with FACS for 
p75+/α4 integrin+ 
Adherent conditions plates coated with PDL 
and FN with lower PaO2.  Colonies, not 
neurospheres 
Prenatal 
(Kruger, Mosher et al. 2002) Rat E14.5, P5-
110 
As per Bixby 2002 As per Bixby 2002 Pre and 
Postnatal 
(Iwashita, Kruger et al. 2003) Rat E14.5 Dissociation of whole gut with FACS sorting for 
p75+/α4 integrin positive cells 
Adherent conditions plates coated with poly-
D-lysine (PDL) and FN. Colonies, not 
neurospheres 
Prenatal 
(Schafer, Hagl et al. 2003) Mouse E12 Dissociation of whole gut Neurospheres grown in culture flask, adherent 
and mechanically loosened 
Prenatal 




(Suarez-Rodriguez and Belkind-Gerson 2004) Mouse P3-5, P168-
336 
Dissociation of whole intestine with collagenase 
/ dispase solution, trituration and differential 
sedimentation 
Adherent conditions on chamber slides at low 
density (50-100 cells per 25mm2) 
Postnatal 
 (Fu, Lui et al. 2004) Mouse E11.5 Dissociation of whole gut Adherent conditions plated coated with PDL 
and FN, recultured clusters and eventually 
neurospheres 
Prenatal 
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1.5.2.2	  	  ENSC	  Neurospheres	  
	  
Neurospheres	   are	   cellular	   aggregates	   that	   contain	   not	   only	   stem	   cells	   but	   also	  
their	   more	   differentiated	   progeny,	   including	   neurons	   and	   glia(Reynolds	   and	  
Weiss,	   1996).	   	  Neurosphere	  biology	   is	   still	   an	   area	  of	   ongoing	   research,	   but	   the	  
microenvironment	  created	  by	  the	  formation	  of	  a	  neurosphere	  appears	  to	  support	  
not	  only	  the	  persistence	  but	  the	  replication	  of	  CNS	  stem	  cells,	  and	  allows	  for	  the	  
expansion	   of	   stem	   cell	   numbers	   by	   the	   redissociation	   and	   reculture	   of	  
neurospheres(Campos,	  2004).	  	  	  
	  
1.5.2.3	  	  Postnatal	  ENSC	  
	  
A	  key	  development	  therefore	  was	  the	  discovery	  that	  ENS	  stem	  cells	  (ENSC)	  could	  
be	  isolated	  not	  only	  from	  the	  mouse	  gut	  during	  embryonic	  development	  but	  also	  
in	   the	   newborn	   period	   in	   the	   form	   of	   neurospheres	   and	   neurosphere	   like	  
bodies(Almond	  et	  al.,	  2003,	  Bondurand	  et	  al.,	  2003).	  ENSC	  have	  also	  been	  isolated	  
from	   adult	   mouse	   colon	   (Kruger	   et	   al.,	   2002,	   Suarez-­‐Rodriguez	   and	   Belkind-­‐
Gerson,	  2004)	  and	  there	  is	  evidence	  that	  the	  adult	  colon	  may	  be	  re-­‐colonized	  by	  
endogenous	   ENSC:	   ablation	   of	   a	   segment	   of	   mouse	   colonic	   ENS	   with	  
benzalkonium	   chloride	   is	   followed	   by	   restitution	   via	   hypertrophy	   of	   peripheral	  
myenteric	   ganglia	   and,	   crucially,	   neurogenesis(Hanani	   et	   al.,	   2003a).	   	   	   There	   is,	  
therefore,	   there	   is	   good	  evidence	   to	   support	   the	  possibility	   of	   postnatal	   human	  
ENS	  stem	  cells	  localised	  within	  the	  bowel.	  
	  
1.5.3	  	  Properties	  of	  ENSC	  
	  
Primary	   neurospheres	   generated	   from	   embryonic	   mouse	   bowel	   contain	   a	  
heterogeneous	  group	  of	  cells	   including	  differentiated	  neurons	  and	  glia,	   together	  
with	  a	   small	  number	  of	   stem	  cells.	   	  The	  exact	  number	  of	  ENSC	  within	  a	  primary	  
embryonic	   neurosphere	   will	   obviously	   vary	   but	   experiments	   using	   a	   green	  
fluorescent	   protein	   (GFP)	   retrovirus	   to	   transfect	   dissociated	   neurospheres	  
indicate	  that	  it	  is	  about	  1-­‐2%	  of	  all	  cells	  within	  the	  neurosphere(Bondurand	  et	  al.,	  
2006).	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Of	  interest	  is	  location	  of	  such	  stem	  cells	  within	  the	  neurosphere	  and	  whether	  they	  
maintain	  the	  capability	  to	  differentiate	  into	  the	  full	  range	  of	  ENS	  neurons	  and	  glia,	  
as	   well	   as	  migrate	   and	   form	   a	   new	   ENS	   network.	   	   There	   is	   evidence	   that	   fetal	  
mouse	  ENSC	  can	  perform	  all	  of	   these	   functions(Bondurand	  et	  al.,	  2006,	  Bixby	  et	  
al.,	   2002).	   	   However,	   there	   appear	   to	   be	   significant	   differences	   between	   ENSC	  
isolated	  in	  embryonic	  life	  and	  those	  isolated	  postnatally.	  	  	  
	  
Firstly,	  the	  mitotic	  rate	  of	  ENSC	  derived	  from	  postnatal	  mice	  is	  lower	  than	  that	  of	  
embryonic	   mice(Kruger	   et	   al.,	   2002,	   Bondurand	   et	   al.,	   2003).	   	   The	   range	   of	  
neuronal	   phenotypes	  produced	  by	   ENSC	  generated	   from	  postnatal	   tissue	  would	  
also	   appear	   to	   be	   restricted.	   Although	   NOS,	   VIP	   and	   neuropeptide	   Y	   (NPY)	  
neurogenesis	   appeared	   normal	   in	   postnatal	   mouse	   ENSC	   cultured	   in	   adherent	  
conditions,	   a	   loss	   or	   reduction	   in	   ability	   to	   form	   serotoninergic,	   tyrosine	  
hydroxylase	  (TH),	  and	  dopamine	  beta-­‐hydroxylase	  neurons,	  together	  with	  a	  shift	  
towards	  gliogenesis	  was	  observed(Kruger	  et	  al.,	  2002).	   	  There	  may	  also	  be	   inter-­‐
species	  differences	  in	  the	  properties	  of	  ENSC.	  	  These	  are	  key	  areas	  where	  further	  
research	  on	  any	  postnatal	  human	  ENSC	  will	  need	  to	  be	  directed.	  
	  
1.5.4	  Transplantation	  and	  environmental	  factors	  	  
	  
The	  environment	  that	  ENSC	  encounter	  when	  transplanted	  into	  the	  gut	  will	  play	  a	  
crucial	  role	  in	  the	  development	  and	  behaviour	  of	  their	  progeny.	  Furthermore,	  the	  
response	   of	   the	   gut	   wall	   to	   ENSC	   and	   their	   progeny	  may	  well	   differ	   in	   an	   age-­‐
dependent	   manner.	   Indeed,	   the	   environment	   into	   which	   the	   cells	   will	   be	  
transplanted	  may	  be	   abnormal	   in	  HSCR	  patients.	   This	   is	   potentially	   the	   case	   for	  
extracellular	   matrix	   components	   including	   laminin(Alpy	   et	   al.,	   2005)	   or	  
mesenchymal	  signals	  including	  EDN3(Bondurand	  et	  al.,	  2006,	  Hosoda	  et	  al.,	  1994),	  
both	  of	  which	  have	  been	  associated	  with	  HSCR.	  	  The	  use	  of	  supplemental	  growth	  
factors	  is	  one	  possible	  way	  in	  which	  these	  signals	  could	  be	  delivered,	  avoiding	  the	  
inherent	  problems	  of	  the	  abnormal	  tissue,	  and	  again	  this	  is	  an	  area	  where	  further	  
research	  is	  required.	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A	  further	  problem	  is	  that	  transplanted	  ENSC	  may	  be	  defective	  if	  derived	  from	  an	  
autologous	  source	  (e.g.	  lacking	  the	  RET	  or	  ENDRB	  receptors).	  However,	  based	  on	  
genetic	  studies	  on	  HSCR,	  any	  deficits	   in	  gene/receptor	  function	  will	  be	  small	  and	  
multifactorial,	  and	  may	  not	  be	  evident	  over	  the	  short	  distances	  transplanted	  cells	  
must	  migrate.	  Furthermore,	  while	   it	  might	  be	  expected	  that	  ENSC	   from	  patients	  
affected	  with	  RET	  mutations	  would	  be	  unable	  to	  colonise	  aganglionic	  bowel,	  it	  has	  
been	  shown	  that	  ENSC	  derived	  from	  mice	  with	  the	  miRet51	  mutation	  are	  capable	  
of	   forming	   neurospheres	   and	   differentiating	   into	   both	   neurons	   and	   glia	   in	  
culture(Bondurand	  et	  al.,	  2003).	  In	  theory	  this	  could	  allow	  auto-­‐transplantation	  of	  
an	  HSCR	  patient’s	  own	  ENSC	  into	  aganglionic	  bowel.	  
	  
The	  method	   of	   delivery,	   and	   the	   state	   of	   the	   transplanted	   cells	   (in	   a	   single	   cell	  
suspension	  or	  as	  part	  of	  a	  neurosphere)	  has	  received	  minimal	  attention	  as	  yet.	  	  	  
	  
1.5.5	  	  Strategy	  to	  develop	  human	  HSCR	  stem	  cell	  treatment	  
	  
In	   summary,	   as	   discussed	   throughout	   this	   introduction,	   advances	   in	   the	  
understanding	  of	  ENS	  stem	  cell	  biology	  and	  the	  pathogenesis	  of	  HSCR	  have	  raised	  
the	  possibility	  that	  the	  defect	  in	  the	  ENS	  in	  this	  condition	  could	  be	  treated	  using	  a	  
stem	  cell	   transplantation	   technique.	   	  As	  discussed	   in	   section	  1.3.5.5,	   one	  of	   the	  
possible	  reasons	  for	  the	  relatively	  poor	  outcome	  after	  surgery	  for	  HSCR	  is	  likely	  to	  
be	   the	   amount	   of	   aganglionic	   tissue	   left	   in	   the	   patient,	   including	   the	   anal	  
sphincter	   and	   a	   few	   centimetres	   of	   rectum.	   	   As	   shown	  above,	   re-­‐innervation	  of	  
this	   short	   segment	   of	   bowel	   with	   implanted	   autologous	   ENSC	   generated	   from	  
tissue	  removed	  during	  surgery	  is	  the	  most	  feasible	  potential	  stem	  cell	  therapy	  for	  
HSCR.	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1.6	  	  Aims	  of	  thesis	  
	  
This	  thesis	  therefore	  has	  the	  following	  aims:	  
	  
1. 	  To	   develop	   a	  method	   of	   isolating	   and	   culturing	   postnatal	   human	   ENSC	  
from	   the	   bowel	   of	   children	   undergoing	   surgery	   both	   for	   HSCR	   and	  
conditions	  in	  which	  the	  ENS	  is	  normal.	  
2. To	   characterise	   such	   postnatal	   human	   ENSC	   in	   terms	   of	   proliferation,	  
differentiative	  capacity,	   the	  ability	  to	  form	  neural	  networks	  and	  undergo	  
transplantation.	  
3. To	  investigate	  the	  response	  of	  human	  postnatal	  ENSC	  to	  relevant	  growth	  
factors.	  
4. To	  investigate	  whether	  the	  transplantation	  of	  human	  postnatal	  ENSC	  can	  
produce	  a	  genuine	  neo-­‐ENS,	  interact	  with	  host	  ICC	  and	  affect	  a	  change	  in	  
bowel	  motility.	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Chapter	  2:	  	  Culture	  of	  postnatal	  human	  ENS	  stem	  cells	  
	  
2.1	  	  Introduction	  
	  
The	   isolation	   and	   culture	   of	   ENS	   stem	   cells	   from	   embryonic	   mice	   is	   well	  
established	   and	   there	   are	   several	   different	   techniques	   available	   to	   do	   this,	  
although	  all	  of	  them	  take	  the	  dissection	  and	  dissociation	  of	  the	  embryonic	  bowel	  
into	  a	  single	  cell	  suspension	  as	  the	  first	  step.	  	  ENSC	  are	  then	  enriched	  and	  grown	  
in	  culture	  using	  either	  FACS	  or	  magnetic	  beads	  to	  select	  for	  the	  stem	  cell	  markers	  
p75(Pomeranz	   et	   al.,	   1993),	   p75	   and	   α4	   integrin(Bixby	   et	   al.,	   2002)	   and	   RET(Lo	  
and	   Anderson,	   1995),	   or	   by	   culturing	   in	   the	   form	   of	   neurospheres	   with	   no	  
immunoselection(Almond	   et	   al.,	   2003,	   Bondurand	   et	   al.,	   2003,	   Schafer	   et	   al.,	  
2003).	  
	  
These	   techniques	   have	   been	  modified	   to	   allow	   for	   the	   isolation	   and	   culture	   of	  
postnatal	   rodent	   ENSC(Kruger	   et	   al.,	   2002,	   Bondurand	   et	   al.,	   2003,	   Suarez-­‐
Rodriguez	   and	   Belkind-­‐Gerson,	   2004).	   	   Although	   there	   are	   obvious	   differences	  
between	  mouse	  and	  human	  colon,	  most	  obviously	  in	  the	  size	  of	  the	  tissue	  and	  the	  
relative	   maturity	   of	   human	   colon	   in	   respect	   to	   rat	   and	   mouse	   colon(Karen	  
Walthall,	   2005),	   it	   seems	   logical	   to	   attempt	   to	   adapt	   these	   techniques	   to	   the	  
isolation	  and	  culture	  of	  human	  postnatal	  ENSC.	  
	  
2.1.1	  	  Identification	  of	  stem	  cells	  
	  
As	  defined	   in	  Chapter	   1,	   a	   stem	  cell	   has	   the	   capacity	   to	   self-­‐renew	   (make	  more	  
stem	  cells	  by	  cell	  division)	  as	  well	  as	  to	  differentiate	  into	  mature,	  specialized	  cells.	  	  
The	  identification	  of	  ENSC	  as	  genuine	  stem	  cells	  is	  problematic.	  	  	  
	  
	   82	  
There	  are	  various	  cellular	  markers	  that	  have	  been	  used	  to	  identify	  ENSC,	  including	  
Sox10,	  RET,	  p75	  and	  nestin	  (see(Young	  and	  Newgreen,	  2001)	  for	  a	  review).	   	  RET,	  
all	  undifferentiated	  neural	  crest	  cells	  within	  the	  gut	  wall	  express	  p75	  and	  Phox2b	  
as	  they	  begin	  to	  colonise	  the	  hindgut(Young	  and	  Newgreen,	  2001).	  	  RET,	  p75	  and	  
nestin	  have	   all	   been	  used	   in	  previous	   studies	   to	   identify	   ENSC	   (Natarajan	  et	   al.,	  
1999,	  Sidebotham	  et	  al.,	  2001,	  Schafer	  et	  al.,	  2003,	  Belkind-­‐Gerson	  et	  al.,	  2006).	  	  
The	  problem	  with	  such	  markers	  is	  that	  they	  are	  not	  necessarily	  exclusive	  to	  ENSC.	  	  
RET	   and	   Phox2b	   expression	   is	   maintained	   in	   cells	   differentiating	   into	   a	   neural	  
lineage	  and	  p75	  expression	  is	  maintained	  in	  cells	  differentiating	  into	  a	  glial	  lineage	  
(Young	  et	  al.,	  1999).	  	  Nestin	  has	  been	  advocated	  a	  good	  marker	  for	  ENSC(Belkind-­‐
Gerson	  et	  al.,	  2006,	  Rauch	  et	  al.,	  2006)	  but	  although	  its	  expression	  in	  glial	  cells	  in	  
the	  CNS	  is	  very	  low,	  it	  is	  expressed	  postnatally	  in	  ENS	  glia	  and	  ICC(Vanderwinden	  
et	  al.,	  2002).	  	  It	  can	  therefore	  be	  concluded	  that	  there	  is,	  at	  the	  present	  time,	  no	  
specific	  marker	  for	  ENSC.	  
	  
Another	  method	  of	  identifying	  neural	  stem	  cells	  is	  utilising	  their	  capacity	  to	  form	  
neurospheres(Reynolds	  and	  Weiss,	  1996).	  	  This	  capacity	  has	  led	  to	  the	  concept	  of	  
the	  neurosphere	  assay	  –	  the	  assumption	  that	  under	  specific	  conditions,	  only	  such	  
stem	  cells	  will	  form	  free	  floating	  spherical	  cellular	  aggregates(Pacey	  et	  al.,	  2006).	  	  
However,	   other	   cell	   types	   will	   also	   form	   spherical	   aggregates	   in	   culture	   and	  
therefore	  this	  assay	  is	  not	  specific	  enough	  to	  positively	  identify	  ENSC.	  
	  
A	  further	  method	  of	  identifying	  ENSC	  is	  by	  their	  behaviour:	  	  a	  true	  stem	  cell	  is	  able	  
to	  undergo	  asymmetric	  division	  to	  produce	  an	  identical	  daughter	  cell	  and	  a	  more	  
differentiated	  precursor	   cell	  which	  undergoes	   subsequent	  differentiation,	   in	   this	  
case	   to	   either	   neurons	   or	   glia.	   	   ENSPC	   can	   therefore	   be	   demonstrated	   by	  
identifying	  a	  single	  cell	  that	  goes	  on	  to	  produce	  both	  neurons	  glia	  within	  the	  same	  
colony	   –	   a	   demonstration	   of	   clonality(Bondurand	   et	   al.,	   2003).	   	   Alternatively,	   it	  
could	  also	  be	  demonstrated	  that	  a	  neurosphere	  is	  capable	  of	  generating	  multiple	  
daughter	   cells	  when	  disaggregated.	   	   	   If	   these	  daughter	   cells	  have	  characteristics	  
identical	  to	  those	  of	  the	  original	  neurosphere,	  and	  can	  form	  further	  neurospheres	  
with	   the	   same	   characteristics,	   this	   is	   a	   strong	   argument	   that	   there	   must	   be	  
multipotent	  stem	  cells	  present,	  rather	  than	  a	  collection	  of	  precursor	  cells.	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Combinations	   of	   the	   above	   techniques	   are	   therefore	   employed	   in	   the	  
identification	  ENSC	  during	  the	  course	  of	  this	  thesis.	  
	  
	  
2.1.2	  Summary	  of	  work	  done	  prior	   to	   the	  commencement	  of	  
this	  thesis	  
	  
Work	  done	  by	  Almond	  on	  the	  isolation	  and	  characterisation	  of	  embryonic	  mouse	  
ENSC	  has	  been	  previously	  described(Almond	  et	  al.,	  2003)	  and	  the	  techniques	  used	  
in	   this	   thesis	   build	   on	   this	   work.	   	   In	   summary	   Almond	   developed	   a	   method	   of	  
producing	  ENSC	  from	  embryonic	  mouse	  caeca	  at	  harvested	  at	  E11.5	  and	  culturing	  
them	   in	   the	   form	  of	  neurospheres.	   	  These	  neurospheres	  were	  shown	  to	  contain	  
differentiated	   neurons	   and	   glia	   and	   contained	   single	   cells	   with	   the	   capacity	   to	  
form	  both	  neurons	  and	  glia.	   	  Furthermore	   it	  was	  possible	  to	  clonally	  expand	  the	  
neurospheres	   from	   a	   single	   cell,	   proving	   the	   existence	   of	   true	   ENSC	  within	   the	  
neurospheres.	  
2.2	  	  Aims	  
	  
The	   aim	   of	   this	   study	   was	   to	   develop	   a	   method	   of	   isolating	   postnatal	   human	  
ENSPC.	   	   Initially,	   competency	   in	   growing	   embryonic	   mouse	   neurospheres	  
previously	   shown	   to	   contain	   ENSPC	   was	   achieved.	   	   The	   method	   for	   growing	  
mouse	   ENSC	   was	   then	   adapted	   to	   produce	   human	   ENSC	   in	   the	   form	   of	  
neurospheres.	  	  ENSC	  were	  identified	  by	  immunofluorescence	  for	  the	  markers	  p75	  
and	   nestin,	   the	   ability	   to	   produce	   both	   neurons	   and	   glia	   and	   the	   ability	   to	   self-­‐
renew	  by	  the	  generation	  of	  secondary	  and	  tertiary	  neurospheres.	  	  ENSC	  were	  also	  
identified	   by	   their	   ability	   to	   produce	   neurons	   and	   glia	   once	   transplanted	   into	  
aganglionic,	  embryonic	  mouse	  hindgut.	  
	  
The	   following	   sections	   describe	   groups	   of	   experiments;	   for	   each	   group	   the	  
methods	   and	   results	   will	   be	   described,	   followed	   by	   a	   discussion	   of	   significant	  
results	   and	   issues	   related	   to	   the	   experimental	   design	   before	  moving	   on	   to	   the	  
next	  section.	  
	   84	  
2.3	   	   Generation	   of	   embryonic	   mouse	   neurospheres	  
containing	  ENSC	  
	  
As	  mentioned	  above,	  the	  initial	  work	  described	  here	  was	  repeated	  as	  part	  of	  this	  
thesis	   to	   gain	   experience	   with	   the	   techniques	   involved	   before	   developing	   a	  
method	  of	  culturing	  postnatal	  human	  ENSC.	   	  This	   is	  a	  recapitulation	  of	  the	  work	  
described	   by	   Almond	   and	   does	   not	   represent	   original	   research.	   	   The	   EMNS	  
generated	   would	   also	   provide	   controls	   for	   future	   experiments	   involving	   human	  
neurospheres.	  	  	  
	  
2.3.1	  	  Methods	  
2.3.1.1	  	  Animal	  selection,	  preparation	  and	  dissection	  
	  
Ethical	  approval	  for	  the	  use	  of	  mice	  in	  this	  research	  had	  previously	  been	  obtained	  
and	  approved	  under	  Home	  Office	  guidelines,	   study	  number	  40/2658	  “Stem	  cells	  
in	   the	   enteric	   nervous	   system”.	   	   CD-­‐1	   mice	   (Charles	   River,	   Margate,	   Kent,	   UK)	  
were	   time	   mated	   and	   pregnant	   female	   mice	   sacrificed	   by	   CO2	   asphyxiation	   or	  
cervical	   dislocation	   at	   E11.5,	   at	   which	   time	   point	   ENSC	   have	  migrated	   into	   the	  
caecum(Woodward	  et	  al.,	  2000).	  
	  
The	  female	  mice	  were	  then	  placed	  on	  a	  sterile	  field,	  the	  abdomen	  prepped	  with	  
70%	  alcohol	  and	  then	  opened	  using	  sterile	  forceps	  and	  scissors.	   	  A	  second	  set	  of	  
sterile	  instruments	  was	  used	  to	  open	  the	  peritoneal	  cavity	  and	  remove	  the	  uterus.	  	  
This	  was	  placed	  in	  a	  50ml	  sterile	  conical	  tube	  (BD	  Falcon,	  VWR	  International	  Ltd,	  
Lutterworth,	   UK)	   containing	   warmed	   solution	   of	   Dulbecco’s	   modified	   Eagle	  
medium	   containing	   4500mg/l	   glucose	   and	   25mM	   HEPES	   (DMEM-­‐HEPES,	  
Invitrogen	   Ltd,	   Paisley,	   UK).	   	   Uteri	   were	   removed	   from	   up	   to	   6	   mice	   in	   one	  
session.	   	   A	   dissecting	   plate	   was	   prepared	   by	   sterilizing	   with	   70%	   alcohol	   and	  
rinsed	   3	   times	   in	   calcium/magnesium	   free	   phosphate-­‐buffered	   saline	   (PBS,	  
Invitrogen)	  before	   the	  addition	  of	   sufficient	  DMEM-­‐HEPES	   to	  cover	   the	  plate.	   	  A	  
single	  uterus	  was	  then	  selected	  and	  opened	  to	  deliver	  the	  embryos,	  which	  were	  
placed	   on	   the	   dissecting	   plate.	   	   Dissection	   was	   performed	   with	   the	   aid	   of	   a	  
dissecting	  microscope	  using	  x16	  -­‐x40	  magnification.	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The	   mice	   embryos	   were	   dissected	   to	   remove	   the	   caecum	   and	   terminal	  
ileum/proximal	   colon.	   	   These	   were	   placed	   in	   a	   15ml	   sterile	   conical	   tube	   (BD	  
Falcon,	   VWR)	   containing	   warmed	   DMEM	   with	   1000mg/l	   glucose	   and	   sodium	  
pyruvate	  (DMEM-­‐low,	  Invitrogen)	  and	  kept	  in	  a	  water	  bath	  at	  37˚C	  until	  all	  caeca	  
had	  been	  harvested.	  
	  
2.3.1.2	  	  Generation	  of	  single	  cell	  suspension	  from	  E11.5	  mouse	  caeca	  
	  
The	  test	  tube	  containing	  mouse	  caeca	  was	  then	  centrifuged	  at	  120G	  for	  2	  minutes	  
and	  the	  supernatant	  removed	  with	  a	  3ml	  sterile	  transfer	  pipette	  (VWR).	  	  2	  mls	  of	  
PBS	  and	  100µl	  of	  0.5%	  trypsin	   (Invitrogen)	  were	  added	  to	   the	  residual	  sediment	  
and	  incubated	  at	  37˚C	  for	  45minutes.	  	  The	  reaction	  was	  quenched	  by	  centrifuging	  
at	   120G	   for	   2	   minutes,	   removing	   the	   supernatant	   and	   adding	   2ml	   of	   standard	  
neurosphere	  culture	  medium	  (see	  Appendix	  1	   for	  details).	   	  The	  caeca	  were	  then	  
triturated	  using	  a	  1ml	  sterile	  transfer	  pipette	  (VWR)	  until	  a	  single	  cell	  suspension	  
was	  generated.	  	  This	  was	  confirmed	  using	  a	  haemocytometer.	  
	  
The	  resulting	  cell	  suspension	  was	  then	  divided	  between	  among	  35mm	  Petri	  dishes	  
(Sarstedt	   Ltd,	   Leicester,	   UK),	   the	   number	   of	   dishes	   depending	   on	   the	   original	  
number	  of	  caeca	  dissected:	   	  up	  to	  10	  caeca,	  1	  dish;	  11-­‐20	  caeca	  2	  dishes,	  21-­‐30	  
caeca	  3	  dishes	  etc.	  	  The	  volume	  of	  cell	  culture	  medium	  was	  then	  made	  up	  to	  3ml	  
and	  the	  dishes	  incubated	  at	  37oC	  in	  5%	  CO2.	  	  	  
	  
2.3.1.3	  	  Cell	  culture	  and	  maintenance	  
	  
At	   3	   day	   intervals,	   mildly	   adherent	   cells	   were	   gently	   resuspended	   by	   agitation	  
using	  a	  sterile	  100µl	  pipette	  and	  the	  culture	  medium	  containing	  nonadherent	  cells	  
was	   transferred	   to	   a	   new	   dish	   and	   replenished	   with	   an	   equal	   volume	   of	   fresh	  
medium.	  
	  
At	  regular	  intervals	  of	  0,	  7,	  14,	  21	  and	  28	  days	  in	  culture,	  a	  representative	  35mm	  
petri	   dish	   containing	   EMNS	  was	   selected	   and	   the	   size	   of	   the	   neurospheres	  was	  
measured.	  	  The	  same	  dish	  was	  used	  for	  all	  measurements.	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Measurement	   was	   done	   by	   resuspending	   any	   adherent	   neurospheres	   using	   a	  
sterile	  pipette	  to	  agitate	  the	  culture	  medium	  and	  distribute	  neurospheres	  evenly	  
in	   the	   culture	   medium.	   	   The	   size	   (both	   diameters)	   of	   all	   neurospheres	   in	   the	  
35mm	  petri	  dish	  was	  measured	  done	  using	  a	  Nikon-­‐PMS	  inverted	  phase	  contrast	  
microscope	  with	  x200	  magnification.	   	  Neurosphere	  volume	  was	  calculated	  using	  
the	  formula	  for	  the	  volume	  of	  an	  ellipsoid,	  
	   ! = 43 !!!!!!!	  
	  
where	  r1=the	  long	  radius	  of	  the	  ellipse,	  r2=the	  short	  radius	  of	  the	  ellipse	  and	  r3	  is	  
assumed	  to	  equal	  to	  r2.	  
	  
	  
2.3.2	  	  Results	  
	  
By	   5	   days	   under	   non-­‐adherent	   culture	   conditions,	   some	   of	   the	   suspended	   cells	  
had	   proliferated	   to	   form	   neurosphere-­‐like	   aggregates	   (embryonic	   mouse	  
neurospheres,	   EMNS)	   that	   continued	   to	   increase	   in	   size	   up	   to	   at	   least	   30	   days.	  	  
Initial	   neurosphere	   numbers	   were	   low	   but	   these	   increased	   throughout	   the	  
duration	  of	   the	  culture.	   	  Figure	  2.1	  shows	   the	  growth	  of	  mouse	  embryo-­‐derived	  
neurospheres	   from	   a	   single	   cell	   suspension.	   	   EMNS	   that	   adhered	   to	   the	   culture	  
dish	  also	  began	  to	  show	  signs	  of	  differentiation,	  namely	  neurite	  outgrowth	  (Figure	  
2.1E).	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The	  results	  of	  measurement	  of	  EMNS	  size	  and	  number	  are	  shown	  in	  Table	  2.1	  and	  
Figure	   2.2.	   	   As	   mentioned	   above,	   neurosphere	   number	   increased	   during	   the	  
duration	  of	  culture	  with	  most	  growth	  of	  EMNS	  occurring	  between	  7	  and	  14	  days.	  	  
After	  28	  days,	  neurosphere	  size	  and	  number	  did	  not	  increase	  significantly.	  
	  
Table	  2.1:	  	  Yield	  and	  size	  of	  EMNS	  	  
	  
	   EMNS	  
Day	   Neurosphere	  number	   Neurosphere	  volume	  	  (µm3	  x103)	  
0	   0	   0	  
7	   20	   72 +/- 19 
14	   53	   702 +/- 146 
21	   66	   671 +/- 80 
28	   70	   1190 +/- 364 
	  
Data	  are	  mean	  +/-­‐	  SEM	  
	   	  
Figure 2.2  Growth of mouse neurospheres.
Figure 2.2:  Box and whisker plot (interquartile range and range respectively) showing the size of 
EMNS at 7, 14, 21 and 28 days in culture.  Neurosphere size tends to increase throughout the culture 
period before reaching a steady state at D28.
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2.3.3	  	  Discussion	  
	  
2.3.3.1	  Generation	  of	  embryonic	  mouse	  neurospheres	  
	  
These	  experiments	  demonstrate	   that	   embryonic	  mouse	  neurosphere-­‐like	  bodies	  
containing	  can	  be	  generated	  from	  e11.5	  dissociated	  caeca.	  	  	  
	  
As	  described	  in	  Chapter	  1,	  the	  generation	  of	  ENSC	  from	  embryonic	  mouse	  bowel,	  
and	  culture	  in	  the	  form	  of	  neurospheres,	  is	  well	  described	  (Table	  1.7).	  	  The	  culture	  
technique	  described	  here	  differs	   in	  that	  the	   importance	  of	  non-­‐adherent	  culture	  
conditions	   is	   emphasised	   (Almond	   et	   al.,	   2007),	   which	   is	   in	   contrast	   to	   other	  
techniques	   where	   the	   neurospheres	   are	   initially	   adherent(Bondurand	   et	   al.,	  
2003).	   	   Theoretically,	   when	   neurospheres	   adhere	   the	   cells	   within	   begin	   to	  
differentiate(Lobo	  et	  al.,	  2003)	  and	  therefore	  culturing	  in	  petri	  dishes	  in	  adhesion-­‐
free	   conditions	  may	   therefore	   promote	   ENSC	   development	   and	   inhibit	   terminal	  
differentiation.	  
	  
The	  use	  of	  selection	  methods,	  such	  as	  cell	  sorting	  for	  RET+	  or	  p75/ α4 integrin+ve	  
cells,	   has	   also	   been	   reported	   (Table	   1.7).	   	   However,	   there	   is	   no	   evidence	   that	  
these	   techniques	   enhance	   neurosphere	   yield	   or	   that	   the	   population	   of	   cells	  
selected	  is	  the	  same	  in	  both	  cases;	  therefore	  the	  use	  of	  such	  techniques	  may	  well	  
limit	  the	  available	  pool	  of	  ENSC	  or	  potential	  ENSC	  unnecessarily.	  	  Indeed,	  it	  is	  not	  
clear	   yet	   whether	   the	   neurospheres	   generated	   from	   ENS	   cells	   arise	   from	   stem	  
cells	   or	   progenitor	   cells	   that	   have	   de-­‐differentiated	   back	   into	   a	   stem	   cell	  
phenotype:	  	  there	  is	  some	  evidence	  from	  the	  structure	  of	  neurospheres	  that	  the	  
latter	   case	   may	   be	   correct(Campos,	   2004).	   	   For	   these	   reasons,	   no	   selection	  
process	  was	  employed	  in	  the	  generation	  of	  neurospheres.	  
	  
Using	   the	   culture	   technique	   employed	   in	   this	   thesis,	   it	   has	   been	   demonstrated	  
that	  the	  EMNS	  generated	  are	  capable	  of	  forming	  a	  new	  neurosphere,	  capable	  of	  
differentiating	   into	   both	   neurons	   and	   glia,	   from	   a	   single	   cell	   grown	   in	  
isolation(Almond	  et	  al.,	  2007).	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This	   result	   is	   important	   as	   it	   produces	   a	   clonal	   neurosphere.	   	   Growing	   such	   a	  
neurosphere	   from	   a	   single	   cell	   is	   difficult,	   as	   the	   efficiency	   of	   neurosphere	  
generation	   is	   proportional	   to	   initial	   cell	   density,	   for	   reasons	   as	   yet	  
unknown(Campos,	   2004).	   	   This	   finding	   has	   been	   reproduced	   by	   other	  
investigators	   (Bondurand	   et	   al.,	   2003),	   but	   other	   groups	   have	   instead	   inferred	  
clonality	  of	  secondary	  neurospheres	  by	  culturing	  at	  so-­‐called	  clonal	  density(Bixby	  
et	  al.,	  2002,	  Kruger	  et	  al.,	  2002).	  	  The	  theory	  behind	  this	  method	  of	  culture	  is	  that	  
the	   cell	   density	   is	   so	   low	   that	   cell-­‐cell	   interactions	   are	   limited	   and	   therefore	  
colonies	   and	   subsequent	   neurospheres	   will	   be	   (principally)	   clonal.	   	   Although	  
sound	  in	  theory,	  there	   is	  some	  evidence	  that	   in	  fact	   interactions	  are	  much	  more	  
common	  than	  presumed,	  and	  in	  fact	  many	  neurospheres	  grown	  in	  such	  conditions	  
will	  be	  chimeric	  in	  nature(Singec	  et	  al.,	  2006).	  
	  
Individual	   cell	   culture	   must	   therefore	   be	   regarded	   as	   the	   gold	   standard	   for	  
determining	  neurosphere	  clonality.	  	  However,	  the	  in	  practical	  terms,	  whether	  the	  
cells	   present	   are	   stem	   or	   more	   differentiated	   precursor	   cells.	   The	   key	  
characteristic	  of	  an	  ENS	  neurosphere	   is	   its	   capacity	   to	  generate	   the	  spectrum	  of	  
ENS	  neurons	  and	  glia	  on	  subsequent	  differentiation	  and	  to	  self-­‐renew	  in	  culture.	  
Previously	   this	   was	   demonstrated	   in	   both	   individual	   cell	   culture	   and	   on	  
transplantation	   on	   EMNS	   into	   aganglionic	   mouse	   hindgut	   isolated	   at	   e11.5	  
(Almond	  et	  al.,	  2007)	  
	  
2.3.3.2	  	  Identification	  of	  cells	  present	  in	  EMNS-­‐transplanted	  bowel	  
	  
In	   the	   work	   described	   above(Almond	   et	   al.,	   2007)	   it	   was	   shown	   that	   it	   was	  
possible	   to	   transplant	   EMNS	   and	   produce	   a	   neo-­‐ENS	   with	   the	   generation	   and	  
migration	  of	  both	  neurons	  and	  glia.	  
	  
Identifying	   the	   cells	   present	   in	   a	  mouse-­‐mouse	   hybrid	   presents	  more	   problems	  
than	  in	  a	  human-­‐mouse	  transplant.	   	   It	   is	  possible	  to	  overcome	  such	  problems	  by	  
labelling	   the	   cells	   prior	   to	   transplantation,	   and	   various	   techniques	   including	  
cellular	  dyes(Rauch	  et	  al.,	  2006)	  and	  green	  fluorescent	  protein(Bondurand	  et	  al.,	  
2003)	   have	   been	   used.	   	   There	   have	   however	   been	   concerns	   that	   following	   cell	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death,	  cellular	  dyes	  can	  be	  taken	  up	  by	  recipient	  cells	  and	  cause	  a	   false-­‐positive	  
identification	  of	  successful	  engraftment(Skidmore	  et	  al.,	  2005).	  	  	  
	  
No	   such	  methods	  were	   employed	   in	   these	   or	   subsequent	   experiments	   because	  
careful	  dissection	  removing	  the	  bowel	  at	  e11.5	  before	  the	  migrating	  wave	  of	  ENSC	  
had	  reached	  the	  distal	  bowel	  produced	  consistently	  aganglionic	  hindguts(Almond	  
et	   al.,	   2007),	   and	   therefore	   the	  only	  possible	   source	  of	  neuronal	  or	   glial	   cells	   in	  
EMNS	  transplanted	  specimens	  was	   from	  the	  neurosphere	   itself.	   	   	  The	  success	   in	  
producing	   extensive	   networks	   of	   neuronal	   cells	   in	   aganglionic	   transplants	  
indicated	   that	   this	   might	   be	   a	   viable	   method	   of	   testing	   the	   feasibility	   of	  
transplantation	  with	  human-­‐derived	  neurospheres.	  	  The	  next	  stage	  in	  this	  process	  
was	   therefore	   to	   develop	   the	   techniques	   used	   in	   embryonic	   mice	   to	   neonatal	  
human	  tissue	  samples.	  
	  
	  
2.4	   	   Generation	   of	   neonatal	   human	   neurospheres	  
containing	  ENSC	  
	  
2.4.1	  	  Methods	  
	  
Ethical	   approval	   for	   the	   generation	   of	   neonatal	   human	   neurospheres	   was	  
obtained	   from	   the	   Liverpool	   Research	   Ethics	   Committee	   (“Isolation	   of	   human	  
enteric	  nervous	  system	  stem	  cells”	  reference	  number	  04/Q01502/90).	  
	  
After	  prospectively	  obtaining	  written	  consent,	  a	  doughnut	  of	  bowel	  was	  removed	  
at	   the	   time	   of	   surgery	   approximately	   1cm	   long.	   	   This	   was	   wrapped	   in	   sterile,	  
saline-­‐soaked	   gauze	   and	   transferred	   to	   a	   sterile	   specimen	   pot	   before	   being	  
immediately	  transferred	  to	  the	  laboratory.	  
	  	  
	   	  
	   93	  
2.4.1.1	  	  Initial	  experiments	  to	  isolate	  human	  ENSC	  
	  
Initial	  attempts	   to	   isolate	  human	  ENSC	  were	  based	  on	   the	  method	  described	  by	  
Schafer(Schafer	  et	  al.,	  1997).	  	  The	  specimen	  was	  opened	  out,	  rinsed	  three	  times	  in	  
PBS	  and	  placed	  into	  a	  90mm	  agar	  filled	  dish	  filled	  containing	  PBS	  (Figure	  2.3A).	  	  A	  
piece	   of	   bowel	   from	   the	   initial	   specimens	   was	   also	   placed	   in	   4%	  
paraformaldehyde	   for	   4	   hours	   and	   processed	   for	   immunohistochemistry	   as	  
described	   in	   the	  next	   section.	   	  Using	  a	  dissecting	  microscope,	   the	  muscle	   layers	  
were	   removed	   from	   the	  mucosa	   and	   submucosal	   (Figure	   2.3B).	   	   The	   remaining	  
muscle	  was	  cut	  into	  strips	  approximately	  1-­‐2mm	  wide	  and	  up	  to	  5mm	  long.	  	  The	  
muscle	   strips	   were	   transferred	   to	   a	   15ml	   conical	   vial	   containing	   2ml	   1%	  
collagenase	   and	  DNAse	   at	   1mg/ml	   and	   incubated	   at	   37oC	   for	   1hr.	   	   The	   vial	  was	  
then	  vortexed	   for	  15s	  and	   the	   contents	  emptied	   into	  a	   sterile	  35mm	  petri	   dish.	  	  
Under	   a	   dissecting	   microscope	   the	   sample	   was	   screened	   and	  myenteric	   plexus	  
fragments	   were	   removed	   using	   a	   sterile	   200µl	   pipette	   (Figure	   2.3E).	   	   The	  
remaining	   tissue	  was	   resuspended	   in	  with	   fresh	   collagenase/DNAse	   solution	   for	  
30mins,	   then	   vortexed	   once	   more	   and	   myenteric	   plexus	   fragments	   were	   again	  
removed.	   	   This	   process	   was	   repeated	   3	   times	   in	   total.	   	   Myenteric	   plexus	  
fragments	  were	   then	   either	   added	   to	   standard	   neurosphere	   culture	  medium	  or	  
dissociated	  using	  2ml	  0.05%	  trypsin	  in	  Ca++/Mg++	  free	  PBS	  for	  30mins,	  followed	  by	  
gentle	   trituration.	   	   Some	   fragments	   of	   plexus	  were	   also	   fixed	   and	   processed	   by	  
placing	   in	   4%	   paraformaldehyde	   for	   30	   minutes	   and	   processing	   for	  
immunohistochemistry	   as	   described	   in	   the	   next	   section.	   	   The	   dissociated	  
myenteric	   plexus	   and	   resulting	   cell	   suspension	   was	   centrifuged	   at	   90G	   for	   10	  
minutes,	   the	   trypsin	   removed	   using	   a	   sterile	   transfer	   pipette	   and	   the	   pellet	  
resuspended	   in	   standard	   neurosphere	   culture	   medium.	   	   The	   resulting	   cultures	  
were	   placed	   in	   35mm	  petri	   dishes	  with	   3ml	   of	   culture	  medium.	   	   1ml	   of	   culture	  
medium	  was	  changed	  every	  3	  days.	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2.4.1.2	  	  Characterisation	  of	  initial	  human	  neurosphere-­‐like	  bodies	  
	  
After	   growth	   in	   culture	   of	   the	   myenteric	   plexus	   fragments,	   neurosphere	   like	  
bodies	   (NLB)	   were	   seen	   to	   form.	   	   These	   were	   characterised	   after	   28	   days	   in	  
culture.	  	  	  
	  
NLB	   were	   selected	   after	   28	   days	   culture.	   	   Specimens	   were	   fixed	   in	   4%	   (w/v)	  
paraformaldehyde	  in	  PBS	  for	  1	  h	  at	  room	  temperature	  and	  then	  rinsed	  extensively	  
with	  PBS.	  	  NLB,	  pieces	  of	  bowel	  and	  myenteric	  plexus	  fragments	  (see	  above)	  were	  
immersed	  in	  20%	  (w/v)	  sucrose	  for	  1	  h	  prior	  to	  embedding	  in	  7.5%	  (w/v)	  gelatine	  
in	  15%	  (w/v)	  sucrose.	   	  Embedded	  specimens	  were	  frozen	  at	   -­‐80ºC	   in	   isopentane	  
and	  7μm	  serial	  sections	  cut	  using	  a	  cryostat.	  
	  
For	  immunostaining,	  samples	  were	  pre-­‐treated	  for	  30	  min	  with	  PBS	  containing	  1%	  
(w/v)	   bovine	   serum	   albumin	   (Sigma-­‐Aldrich)	   and	   0.5%	   (w/v)	   Triton	   X100	   (VWR	  
International	   Ltd,	  Poole,	  UK)	  except	  prior	   to	  p75	   labelling	  when	   the	  Triton	  X100	  
was	   omitted.	   Primary	   antisera	   were	   applied	   for	   16	   h	   at	   the	   following	  
concentrations:	   rabbit	   anti-­‐p75	   nerve	   growth	   factor	   receptor	   (p75,	   Abcam	   Ltd,	  
Cambridge,	   UK)	   1:400,	   rabbit	   anti-­‐S100B	   (Dako	   Ltd,	   Ely,	   UK)	   and	   rabbit	   anti-­‐
PGP9.5	   (Biogenesis	   Ltd,	   Poole,	  UK)	   1:4000.	   	   Slides	  were	   rinsed	   three	   times	  with	  
PBS	   before	   incubating	   for	   4	   hours	   with	   fluorescein	   isothiocyanate	   (FITC)-­‐	  
conjugated	  goat	   anti-­‐rabbit	   IgG	   (1:400).	   	  After	   rinsing	   three	   times	  with	  PBS,	   the	  
samples	  were	  mounted	  using	  DAKO	  mounting	  medium.	  
	  
2.4.1.3	  	  Development	  of	  isolation/culture	  technique	  
	  
The	   following	   refinements	   of	   the	   initial	   culture	   technique	   to	   isolate	   human	   ENS	  
neurospheres	  were	  employed:	  
	  
1. 	  The	   addition	   of	   metronidazole	   to	   the	   initial	   cell	   culture	   medium	   at	   a	  
concentration	  of	  100µg/ml.	  
2. The	   use	   of	   trypsin	   on	   the	   isolated	   myenteric	   plexus	   fragments	   with	  
gentler	  trituration	  to	  achieve	  a	  single	  cell	  suspension.	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3. The	  addition	  of	   leukaemia	   inhibitory	   factor	   (LIF)	   to	  the	   initial	  cell	  culture	  
medium	  at	  a	  concentration	  of	  10ng/ml.	  	  LIF	  has	  proved	  to	  be	  important	  in	  
the	  maintenance	  and	  self-­‐renewal	  of	  embryonic	  mouse	  stem	  cells(Burdon	  
et	  al.,	  2002)	  and	  the	  expansion	  of	  human	  CNS	  neural	  stem	  cells	  has	  also	  
been	  described	  using	  LIF(Carpenter	  et	  al.,	  1999).	  	  	  
	  
2.4.1.4	  	  Final	  development	  of	  isolation/culture	  technique	  
	  
The	  final	  development	  of	  the	  isolation	  technique	  for	  human	  neurospheres	  was	  to	  
abandon	   the	   attempt	   to	   isolate	   myenteric	   plexus	   and	   culture	   all	   of	   the	   cells	  
resulting	  from	  a	  dissociation	  of	  the	  circular/longitudinal	  smooth	  muscle	  complex.	  	  
This	  initially	  resulted	  in	  several	  large	  pieces	  of	  undigested	  tissue	  and	  therefore	  the	  
sample	  was	  filtered	  before	  culture.	   	  The	  usage	  of	  metronidazole	  was	  changed	  to	  
gentamicin	  as	  bacterial	  contamination	  remained	  a	  problem.	  
	  
The	  bowel	   sample	  was	   placed	   in	   sterile	   gauze	   soaked	  with	   sterile	   normal	   saline	  
and	  placed	  in	  a	  sterile	  screw-­‐top	  container.	  	  It	  was	  transported	  to	  the	  laboratory	  
at	   room	   temperature	  and	  washed	   in	   sterile	  PBS	   x3	  using	  3	   separate	   containers.	  	  	  
The	  sample	  was	  placed	  on	  a	  sterile	  dissecting	  dish	  containing	  PBS	  and	  gentamicin	  
at	   a	   concentration	   of	   50µg/ml.	   	   The	   muscle	   layers	   were	   dissected	   free	   from	  
submucosa	  and	  mucosa	  and	  the	  serosal	  side	  cleaned	  free	  from	  blood	  vessels	  and	  
fat	  as	  much	  as	  possible.	   	  The	  bowel	  muscle	  was	  cut	   into	  small	  pieces	   (1-­‐2mm2).	  	  
The	  cut	  muscle	  was	  transferred	  into	  a	  conical	  15ml	  container	  containing	  PBS.	  	  The	  
container	  was	  gently	  centrifuged	  (120G	  1	  min)	  to	  get	  the	  muscle	  pieces	  strips	  to	  
the	  bottom	  of	  the	  tube	  if	  necessary.	  	  The	  PBS	  was	  removed	  and	  replaced	  with	  2ml	  
collagenase	   (1mg/ml)	   and	   2ml	   dispase	   then	   incubated	   in	   a	  water	   bath	   for	   1	   hr.	  	  
The	   collagenase/dispase	   solution	   was	   removed	   and	   refreshed	   with	   repeat	  
addition	  of	  2ml	  collagenase	  and	  2	  ml	  dispase.	  	  It	  was	  then	  vortexed	  for	  30s	  to	  help	  
break	  up	  tissue	  and	  incubated	  for	  a	  further	  1	  hr.	  	  The	  samples	  were	  then	  vortexed	  
further	   and	   inspected	   to	   see	   if	   it	   was	   macroscopically	   and	   microscopically	  
dissociated.	   	   If	   it	   was	   not,	   then	   the	   digestion	   with	   collagenase/dispase	   was	  
repeated	  until	  dissociation	  was	  achieved.	  	  The	  bowel	  sample	  was	  then	  centrifuged	  
at	   120G	   for	   2	   mins	   and	   the	   old	   supernatant	   removed.	   	   	   The	   residual	   cell	  
suspension	   was	   then	   filtered	   using	   a	   40micrometer	   mesh	   filter	   (Falcon®	   Cell	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Strainer,	  BD	  Biosciences,	  Oxford,	  UK)	  over	  a	   large	  50ml	   sterile	   conical	   tube.	  The	  
filtrate	  was	  centrifuged	  at	  120G	  for	  5	  mins	  and	  the	  supernatant	  removed.	  	  It	  was	  
replaced	  with	   1ml	   of	   cell	   culture	  medium	   and	   the	   cell	   density	   assessed	   using	   a	  
haemocytometer.	   	   The	  cell	   suspension	  was	   then	  divided	  between	  4	  35mm	  Petri	  
dishes	   and	   topped	   up	   with	   warm	   culture	   medium	   to	   4-­‐5	   ml	   volume	   and	  
supplemented	  with	  gentamicin	  at	  a	  concentration	  of	  50µg/ml.	   	   It	  was	   incubated	  




The	  bowel	  samples	  taken	  and	  used	   in	  experiments	  to	  generate	  human	  ENSC	  are	  
detailed	  in	  Table	  2.2.	  	  	  
	  
2.4.2.1	  	  Initial	  experiments	  to	  isolate	  human	  ENSC	  
	  
After	   dissociation	   of	   the	   bowel,	   the	   reticulated	   nature	   of	   the	   myenteric	   plexus	  
samples	   could	   be	   seen	   (Figure	   2.3E).	   	   Immunofluorescence	   of	   the	   plexus	  
fragments	  for	  PGP9.5	  revealed	  extensive	  neuronal	  networks	  as	  expected	  from	  the	  
control	  sample	  of	  intact	  human	  bowel	  (Figures	  2.3C	  and	  F).	  	  Attempted	  growth	  of	  
myenteric	  plexus	  fragments	  dissociated	  with	  trypsin	  was	  unsuccessful	  and	  no	  NLB	  
formed	  in	  these	  samples;	  instead	  there	  was	  widespread	  cell	  death	  within	  1	  week	  
of	  culture.	  
	  
However,	  when	  grown	  intact	  in	  culture	  the	  myenteric	  plexus	  rapidly	  lost	  its	  initial	  
appearance,	   the	   meshed	   network	   fragmenting	   into	   individual	   rounded	  
neurosphere-­‐like	  bodies	  (Figure	  2.4	  A-­‐C).	  	  Initially	  these	  NLB	  appeared	  to	  grow	  in	  
culture	  in	  a	  similar	  manner	  to	  other	  neurospheres	  isolated	  from	  mice,	  but	  after	  28	  
days	   in	   culture	  many	  of	   the	   cells	  within	   the	  NLB	   appeared	   to	  have	  died	   and	   an	  
apparent	  hollow	   skeleton	  of	   connective	   tissue	  was	   left	  behind	   (Figure	  2.4D).	   	   In	  
addition,	   when	   mouse	   (embryonic	   or	   neonatal)	   neurospheres	   were	   seen	   to	  
adhere	   to	   the	   petri	   dish	   during	   culture,	   extensive	   neurite	   outgrowth	   could	   be	  
seen	  to	  occur	  (see	  Chapter	  3).	  	  When	  the	  initial	  human	  NLB	  adhered,	  no	  neurites	  
were	  formed.	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Age	   of	  
patient	  
Diagnosis	   Sample	  type	   Infected?	   Successful?	  





2	   7	  days	   NEC Terminal ileum No No 




Sigmoid colon No No 
4	   2	  days	   NEC Colostomy No No 




Colostomy Yes No 




Colostomy No No 




Colostomy Yes No 














10	   27	  days	   Milk curd 
obstruction 
Ileostomy Yes No 
11	   6	  
months	  
no data Ileostomy 
(proximal ileum) 
Yes No 







13	   3	  
months	  
HSCR Ganglionic colon Yes No 








Colostomy No Yes 
16	   3	  days	   HSCR Colostomy Yes No 




Colostomy No Yes 
18	   12	  days	   HSCR Pull-through No Yes 
19	   2	  
months	  
Colonic atresia Colon and ileum No Yes 
20	   16	  
years	  
Crohns Colon   No No 
21	   20	  days	   HSCR Pull-through 
splenic flexure 
Yes No 
22	   15	  
months	  
NEC Ileostomy No No 
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23	   21	  days	   NEC Colostomy No Yes 
24	   2.5	  
months	  
HSCR Pull-through No No 
25	   3	  years	   Tethered cord Colostomy No Yes 
26	   9	  
months	  
OEIS Colostomy No Yes 




Colostomy No No 
Sample	  
number	  
Age	   of	  
patient	  
Diagnosis	   Sample	  type	   Infected?	   Successful?	  
28	   3	  
months	  
HSCR Pull-through No Yes 
29	   8 days	   HSCR Pull-through No Yes 
30	   15 
days	  
HSCR Pull-through No Yes 
31	   30 
days	  
HSCR Pull-through No Yes 
32	   12 
days	  
HSCR Pull-through No Yes 
33	   16	  
years	  
Augment Ileum Yes No 
34	   10	  
years	  
Augment Ileum No No 
35	   25	  days	   HSCR –long 
segment 
Jejunal resection No No 




Jejunostomy No No 




Colostomy No No 




Ileum No No 
39	   20	  
months	  
HSCR - short 
segment 
Ileum No No 
40	   12	  
months	  
HSCR - short 
segment 
Pull-through No Yes 
41	   13	  
months	  
HSCR - long 
segment 
Ileum No Yes 
42	   26	  days	   HSCR Pull-through No Yes 




Ileostomy No Yes 
	  
N.B.	  Gestational	  ages	  of	  premature	  babies	  were	  not	  recorded.	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2.4.2.2	  	  Characterisation	  of	  initial	  human	  neurosphere-­‐like	  bodies	  
	  
The	  surviving	  NLB	  were	  harvested	  at	  this	  time	  point	  and	  stained	  for	  p75,	  PGP9.5	  
and	   S100.	   	   There	  was	   no	   staining	   for	   p75	   and	   very	   few	   cells	  were	   identified	   as	  
either	  neurons	  or	  glia	  (Figure	  2.4	  E-­‐H).	  	  The	  lack	  of	  identifiable	  ENSC,	  poor	  growth	  
and	   lack	   of	   neurite	   outgrowth	   of	   the	   NLB	   led	   to	   further	   modifications	   of	   this	  
technique.	  
	  
2.4.2.3	  	  Development	  of	  isolation/culture	  technique	  
	  
Repeated	  attempts	  at	  growing	  NHNS	  with	  either	  of	  the	  initial	  techniques	  (intact	  or	  
dissociated	  myenteric	  plexus)	  were	  unsuccessful	  in	  samples	  2-­‐3.	  	  In	  sample	  4	  and	  
onwards	   metronidazole	   was	   added	   to	   the	   culture	   medium	   as	   infection	   of	   the	  
culture	   medium	   was	   noted	   to	   be	   a	   significant	   problem.	   	   This	   did	   not	   however	  
produce	  NHNS.	   	  Gentle	   trituration	  and	  variations	   such	  as	   the	  addition	  of	  DNAse	  
were	  also	  unsuccessful	  The	  addition	  of	  LIF	   to	   the	  culture	  medium	   in	  samples	  12	  
and	  13	  did	  lead	  to	  the	  generation	  of	  neurosphere-­‐like	  bodies	  from	  the	  single	  cell	  
suspension	  produced	  from	  myenteric	  plexus	  but	  after	  14	  days	  in	  culture	  these	  did	  
not	  look	  healthy	  (Figure	  2.5)	  and	  subsequently	  all	  neurospheres-­‐like	  bodies	  died.	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2.4.2.4	  	  Final	  development	  of	  isolation/culture	  technique	  
	  
Because	   of	   the	   failure	   to	   generate	   NHNS	   form	   myenteric	   plexus	   samples,	  
digestion	   and	   culture	   of	   the	  whole	   bowel	   sample	   after	   cleaning	   the	   serosa	   and	  
removal	  of	  mucosa/submucosal	  was	  attempted	  (bowel	  sample	  15).	  	  This	  method	  
proved	   to	  be	   successful	   in	  both	   this	   case	  and	   the	  majority	  of	   subsequent	   cases.	  	  
Whether	   neurospheres	   could	   be	   successfully	   generated	   from	   the	   sample	   is	  
detailed	   in	  Table	  2.2	  on	  page	  99.	   	  The	  definitive	   isolation	  and	  culture	   technique	  
used	  in	  all	  subsequent	  experiments	  is	  detailed	  in	  Appendix	  1.	  	  
	  
2.4.3	  	  Discussion	  
	  
2.6.3.1	  	  Location	  of	  ENSC	  in	  postnatal	  tissue	  
	  
Several	   variations	   in	   technique	   were	   necessary	   before	   the	   final	   methods	   for	  
isolating	  human	  ENS	  and	  culturing	  neurospheres	  was	  developed.	  	  Because	  of	  the	  
volume	  of	  tissue	  involved	  in	  comparison	  to	  embryonic	  and	  neonatal	  bowel	  it	  was	  
originally	   envisaged	   that	   direct	   isolation	   and	   culture	   of	  myenteric	   plexus	  would	  
prove	  effective;	  however	   this	  was	  not	   the	  case.	   	  This	  may	  be	  because	   the	   initial	  
cell	   density	  was	   too	   low,	  which	   can	  affect	   the	  neurosphere	   yield	   (as	  mentioned	  
above).	  	  	  It	  may	  also	  be	  that	  the	  neurospheres	  are	  not	  arising	  from	  the	  myenteric	  
plexus,	  as	  in	  the	  final	  method	  the	  whole	  of	  the	  gut	  wall	  was	  dissociated.	  	  The	  issue	  
of	  the	  location	  of	  ENS	  stem	  cells	  within	  the	  bowel	  wall	  has	  not	  been	  resolved	  out	  
of	   the	   embryonic	   period.	   	   Hanani	   et	   al(Hanani	   et	   al.,	   2003a)	   have	   created	   an	  
experimental	  model	  where	  postnatal	  mouse	  colon	  is	  ablated	  using	  benzalkonium	  
chloride;	   this	   effectively	   destroys	   the	   serosa,	   longitudinal	  muscle	   and	  myenteric	  
plexus.	   	   They	  were	   then	  able	   to	   study	   tissue	   regeneration	  over	   a	   60-­‐day	  period	  
and	   noticed	   that	   the	   ENS	   regenerated	   from	   the	   periphery	   of	   the	   injured	   area,	  
generating	  not	  only	  new	  nerve	  fibres	  but	  also	  new	  neurons	  and	  neuronal	  clusters	  
mimicking	   myenteric	   ganglia.	   	   This	   clearly	   implies	   the	   presence	   of	   postnatal	  
neuronal	  stem	  or	  progenitor	  cells	  capable	  of	  responding	  to	  injury,	  but	  the	  location	  
of	   these	   cells	   was	   not	   clear.	   	   Fibres	   were	   seen	   to	   originate	   from	   the	   adjacent	  
myenteric	  plexus	  but	  the	  authors	  comment	  that	  a	  submucosal	  origin	  could	  not	  be	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excluded.	  	  	   	  This	  is	  an	  area	  where	  further	  research	  would	  be	  of	  interest	  and	  may	  
help	  to	  improve	  yields	  in	  the	  future.	  
	  
2.4.3.2	  	  ENSC	  from	  postnatal	  bowl	  of	  children	  with	  HSCR	  
	  
The	  human	  postnatal	  neurospheres	  were	  successfully	  derived	   from	  gut	   tissue	  of	  
patients	  with	  various	  diagnoses	  and	  ages	  (Table	  2.2);	  of	  particular	  interest	  was	  the	  
ability	   of	   ENSPC	   obtained	   from	   the	   ganglionic	   bowel	   of	   children	   with	  
Hirschsprung’s	   disease	   to	   generate	   neurospheres.	   	   	   The	   small	   data	   sample	  
obtained	   with	   these	   experiments,	   in	   combination	   with	   a	   widely	   heterogeneous	  
group	   in	   terms	  of	  age,	   sex	  and	  diagnosis,	  mean	   that	  no	   firm	  conclusions	  can	  be	  
drawn	   about	   patient	   factors	   that	   may	   influence	   the	   generation	   of	   NHNS.	   	   It	   is	  
however	  interesting	  that	  the	  proportion	  of	  successful	  results	  is	  at	  least	  as	  high	  in	  
patients	  with	  HSCR	  as	  opposed	   to	   those	  without,	  but	   these	  patients	  were	  often	  
younger	   than	   those	   in	   the	   non-­‐HSCR	   group	   and	   therefore	   confounding	   factors	  
may	  be	  relevant.	  
	  
However,	   the	   fact	   that	  such	  neurospheres	  can	  be	  generated	  at	  all	   from	  children	  
with	  HSCR	   is	   consistent	  with	   the	   notion	   that	   the	   ability	   of	   ENSPC	   from	  patients	  
with	  Hirschsprung’s	  disease	  to	  develop	  into	  neurons	  is	  not	  intrinsically	  defective,	  
and	   that	   the	   neural	   progenitor	   cells	   remain	   throughout	   the	   bowel	   during	   early	  
postnatal	   life,	   supporting	   the	   feasibility	   of	   autologous	   transplantation.	   	   	   There	  
does	  however	   remain	   the	  possibility	   that	   there	  will	  be	  a	   subset	  of	  patients	  with	  
HSCR	  and	  an	  intrinsic	  ENSPC	  defect	  that	  will	  prohibit	  neurosphere	  formation.	  
	  
Another	  group	  has	  also	   reported	   the	  successful	  generation	  of	  NHNS	   from	  HSCR-­‐
affected	   children(Rauch	   et	   al.,	   2006),	   although	   interestingly	   they	   reported	   that	  
the	  neurospheres	  generated	  were	  consistently	  smaller	  than	  those	  generated	  from	  
non-­‐HSCR	   affected	   bowel.	   	   This	   finding	   was	   not	   replicated	   in	   the	   experiments	  
conducted	  here;	   it	  was	   impossible	   to	  differentiate	  between	  HSCR	  and	  non-­‐HSCR	  
originating	   neurospheres	   on	   morphological	   grounds,	   as	   shown	   in	   Figure	   2.6,	  
although	  a	  formal	  morphometric	  analysis	  was	  not	  undertaken.	  	  It	  should	  be	  noted	  
that	   there	  are	  some	  significant	  differences	   in	   the	  culture	   technique	  described	   in	  
this	  paper	  and	  the	  technique	  used	  in	  this	  thesis:	  	  in	  particular	  the	  use	  of	  myenteric	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plexus	  fragment	  rather	  than	  whole	  bowel,	  the	  use	  of	  adherent	  culture	  conditions	  
and	   the	   addition	   of	   CTNF,	  GDNF	   and	   neurturin.	   	   As	   discussed	   in	   Chapter	   1,	   the	  
members	  of	  the	  GDNF	  family	  promote	  neuronal	  differentiation	  of	  ENSC,	  and	  this	  
may	  cause	  a	  more	  limited	  number/pool	  of	  available	  ENSC	  to	  form	  neurospheres.	  
It	  is	  also	  worth	  commenting	  that,	  as	  discussed	  above	  and	  below,	  the	  eventual	  size	  
of	  neurospheres	  formed	  in	  this	  manner	  may	  not	  be	  dependent	  on	  the	  properties	  
of	  the	  ENSC	  generating	  them.	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2.5	   	   Characterisation	   of	   neonatal	   human	   neurospheres	  
(NHNS)	  containing	  ENSC	  
	  
Having	  produced	  neurosphere-­‐like	  bodies	   it	  was	   then	  necessary	   to	  demonstrate	  
that	  they	  contained	  ENSC,	  as	  it	  has	  already	  been	  mentioned	  that	  some	  single	  cell	  
suspensions	  are	  capable	  of	  forming	  neurosphere-­‐like	  spherical	  aggregates	  in	  non-­‐
adherent	  culture	  conditions	  despite	  the	  absence	  of	  stem	  or	  progenitor	  cells.	  
	  
2.5.1	  	  Method	  
	  
The	  following	  experiments	  were	  performed	  on	  samples	  17,	  18,	  19,	  23	  and	  28.	  
2.5.1.1	  	  Growth	  of	  NHNS	  
	  
NHNS	  were	   isolated	  and	  grown	   in	  culture	  as	  described	  above.	   	  Measurement	  of	  
human	  neurosphere	   size	  was	   performed	   in	   the	   same	  way	   as	   for	   EMNS	   (section	  
2.3.1.3).	  	  	  
	  
2.5.1.2	  	  Cell	  marker	  expression	  of	  single	  cell	  suspension	  and	  NHNS	  
	  
For	   immunohistochemistry	  of	   the	  single	  cell	   suspension	  of	  dissociated	  cells	  prior	  
to	  culture,	  a	  1ml	  aliquot	  of	  cell	  suspension	  was	  centrifuged	  at	  300G	  for	  2	  minutes.	  	  
The	   supernatant	  was	   removed	   and	   the	   resulting	   pellet	  was	   fixed	  with	   4%	   (w/v)	  
paraformaldehyde	   in	   PBS	   for	   30	  minutes	   at	   room	   temperature.	   	   The	   single	   cell	  
suspension	  was	  centrifuged	  and	  washed	  with	  PBS	  three	  times	  before	  suspension	  
in	  20%	  sucrose	  for	  1	  hour	  at	  room	  temperature.	   	   	   	  The	  cell	  suspension	  was	  then	  
embedded	   in	  a	   small	  drop	   (200µl)	  of	  7.5%	   (w/v)	  gelatine	   (Sigma-­‐Aldrich)	   in	  15%	  
(w/v)	   sucrose,	   frozen	   at	   -­‐80ºC	   in	   isopentane	   (Sigma-­‐Aldrich)	   and	   7μm	   serial	  
sections	  cut	  using	  a	  cryostat.	  
	  
Neurospheres	   were	   prepared	   for	   immunohistochemistry	   by	   pre-­‐treating	   for	   30	  
min	  with	  PBS	  containing	  1%	  (w/v)	  bovine	  serum	  albumin	  (Sigma-­‐Aldrich)	  and	  0.5%	  
(w/v)	  Triton	  X100	  (VWR	  International	  Ltd,	  Poole,	  UK)	  except	  prior	  to	  p75	  labelling	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when	  the	  Triton	  X100	  was	  omitted.	  Primary	  antisera	  were	  applied	  for	  16	  h	  at	  the	  
following	   concentrations:	   rabbit	   anti-­‐p75	   nerve	   growth	   factor	   receptor	   (p75,	  
Abcam	  Ltd,	  Cambridge,	  UK)	  1:400,	   rabbit	  anti-­‐protein	  gene-­‐product	  9.5	   (PGP9.5,	  
Biogenesis	   Ltd,	   Poole,	   UK)	   1:4000,	   rabbit	   anti-­‐S100B	   (Dako	   Ltd,	   Ely,	   UK)	   1:200,	  
mouse	   anti-­‐human	   ribonucleoprotein	   antibody	   (HRNP,	   Chemicon)	   1:50,	   rabbit	  
anti-­‐nitric	  oxide	  synthase	  (NOS,	  Biogenesis)	  1:40,	  sheep	  anti-­‐tyrosine	  hydroxylase	  
(TH,	   Abcam)	   1:1000,	   rabbit	   anti-­‐vasoactive	   intestinal	   peptide	   (VIP,	   Chemicon	  
International	   Ltd,	  Harrow,	  UK)	  1:800,	   rabbit	   anti-­‐calcitonin	   gene-­‐related	  peptide	  
(CGRP,	  Abcam)	  1:50,	   rabbit	   anti-­‐substance	  P	   (SP,	   Chemicon)	   1:500.	   	   Slides	  were	  
rinsed	  twice	  with	  PBS	  before	  incubating	  for	  4	  hour	  with	  fluorescein	  isothiocyanate	  
(FITC)-­‐conjugated	   goat	   anti-­‐rabbit	   IgG	   (Sigma-­‐Aldrich),	   FITC-­‐conjugated	   rabbit	  
anti-­‐sheep	  IgG	  (Dako)	  and	  FITC-­‐conjugated	  rabbit	  anti-­‐mouse	  IgG	  (Abcam).	  	  After	  
rinsing	  with	  PBS,	  the	  samples	  were	  mounted	  using	  DAKO	  mounting	  medium.	  	  For	  
labelling	  with	  c-­‐Kit,	  specimens	  were	  fixed	  in	  acetone	  at	  -­‐20oC	  for	  20	  minutes	  and	  
then	  rinsed	  with	  PBS	  before	  embedding	  in	  7.5%	  (w/v)	  gelatine	  (Sigma-­‐Aldrich)	   in	  
15%	  (w/v)	  sucrose	  and	  immediate	  freezing	  at	  -­‐80ºC	  in	  isopentane	  (Sigma-­‐Aldrich).	  	  
Serial	   sections	   (7μm)	  were	  cut	  using	  a	  cryostat.	   	  Sections	  were	   then	  pre-­‐treated	  
for	   30	  min	  with	  phosphate	  buffered	   saline	  PBS	   containing	  1%	   (w/v)	   goat	   serum	  
(Sigma-­‐Aldrich)	  and	  0.5%	  (w/v)	  Triton	  X100	  (VWR	  International	  Ltd,	  Lutterworth,	  
UK).	   	  Primary	  antisera	  were	  applied	  at	   the	   following	  concentrations:	   rabbit	  anti-­‐
protein	   gene-­‐product	   9.5	   (PGP9.5,	   Biogenesis	   Ltd,	   Poole,	   UK)	   1:4000,	   rat	   anti-­‐
mouse	  c-­‐Kit	  (ACK-­‐2,	  Chemicon	  International)	  1:50.	  	  For	  c-­‐Kit/PGP9.5	  dual	  labelling,	  
both	  primary	  antibodies	  were	  applied	  together	  for	  16	  hours	  at	  4oC.	   	  Slides	  were	  
rinsed	   three	   times	   with	   PBS	   before	   incubating	   for	   2	   hours	   with	   appropriate	  
secondary	  antisera:	  Texas	  Red	  conjugated	  sheep	  anti-­‐rabbit	   (Abcam,	  Cambridge,	  
UK)	   1:400	   and	   Alexa-­‐Fluor	   488	   conjugated	   goat	   anti-­‐rat	   1:500	   (Sigma-­‐Aldrich).	  	  
After	   rinsing	   with	   PBS,	   the	   samples	   were	   mounted	   using	   DAKO	   fluorescent	  
mounting	  medium	  (DAKO	  UK	  Ltd,	  Ely,	  UK).	  
	  
To	   assess	   cell	   proliferation,	   30-­‐day	   primary	   neurospheres	   were	   incubated	   with	  
10µM	   bromodeoxyuridine	   (BrdU)	   (BD	   Biosciences)	   for	   	   4	   and	   18	   hours.	   After	  
incubation,	  cells	  were	  fixed	  as	  described	  above,	  placed	  in	  4M	  HCl	  for	  15	  minutes	  
and	   then	  washed	  with	   distilled	  water	   followed	   by	   PBS.	   	   Incorporated	   BrdU	  was	  
detected	  by	  a	  2	  h	  incubation	  with	  mouse	  anti-­‐BrdU	  (Dako)	  diluted	  1:25	  followed	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by	   rinsing	   in	   PBS	   and	   a	   further	   2	   h	   incubation	   with	   FITC-­‐conjugated	   goat	   anti-­‐
mouse	   IgG	   (Sigma-­‐Aldrich)	   diluted	   1:200.	   	   Dual	   labelling	   was	   performed	   by	  
completing	   the	   first	   antibody	   incubation	   with	   the	   appropriate	   secondary	  
antibody,	  rinsing	  3	  times	  in	  PBS	  and	  then	  adding	  the	  second	  primary	  antibody.	  	  
	  
Negative	  controls	  were	  generated	  by	  omitting	  the	  primary	  antisera.	  	  A	  sample	  of	  
human	  bowel	  (as	  described	  in	  section	  2.4.1.2)	  was	  used	  as	  a	  positive	  control.	  
	  
2.5.1.3	  	  Demonstration	  of	  clonality	  of	  NHNS	  
	  
To	   demonstrate	   clonality	   of	   NHNS,	   30-­‐day	   neurospheres	   were	   collected	   and	  
dissociated	  in	  0.05%	  trypsin	  for	  30	  minutes.	  	  Two	  methods	  were	  then	  employed.	  	  	  
	  
In	   the	   first,	   the	  neurospheres	  were	   then	   centrifuged	  at	  120G	   for	  2	  minutes	   and	  
supernatant	   removed	   and	   replaced	   with	   1ml	   of	   standard	   cell	   culture	   medium.	  	  
This	  was	   followed	  by	  gentle	   trituration	  to	  achieve	  a	  single	  cell	   suspension.	   	  20µl	  
aliquots	   were	   then	   placed	   in	   a	   48	   well	   cell	   culture	   plate	   (Nunclon	   Multidish,	  
Sigma-­‐Aldrich)	   and	   the	   cells	   refreshed	   with	   standard	   neurosphere	   medium	   (as	  
defined	  in	  Appendix	  1)	  every	  2	  days.	  	  The	  plates	  were	  initially	  screened	  to	  identify	  
wells	   where	   there	   was	   only	   a	   single	   cell	   present	   and	   these	   wells	   were	   then	  
screened	  daily	  for	  evidence	  of	  neurosphere	  formation.	  	  This	  method	  was	  designed	  
to	   ensure	   that	   any	   neurospheres	   generated	  must	   have	   originated	   from	   a	   single	  
cell.	  
	  
Secondly,	   the	  single	  cell	  suspension	  was	  generated	  as	  described	  above.	   	  The	  cell	  
density	   was	   then	   measured	   using	   a	   haemocytometer	   and	   the	   cell	   suspension	  
further	   diluted	   with	   standard	   neurosphere	   culture	   medium	   to	   achieve	   a	   cell	  
density	  of	  100	  cells	  per	  ml	   (clonal	  density,	   (Morrison	  et	  al.,	   1999)).	   	   The	  diluted	  
suspension	   was	   then	   cultured	   in	   standard	   neurosphere	   culture	   medium	   in	   a	  
90mm	   tissue	   culture	   petri	   dish.	   	   This	   method	   creates	   a	   very	   low	   density	   cell	  
culture	  where	  it	   is	  unlikely	  that	  single	  cells	  will	  come	  into	  contact	  and	  adhere	  to	  
form	  a	  chimeric	  neurosphere.	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2.5.1.4	  	  Transplantation	  of	  	  NHNS	  into	  embryonic	  mouse	  distal	  hindgut	  	  
	  
Having	  demonstrated	  that	  NHNS	  contain	  p75	  positive	  cells	  and	  putative	  ENSC,	  the	  
next	   stage	   in	   the	   development	   of	   a	   stem	   cell	   transplantation	   technique	  was	   to	  
show	   that	   these	   cells	   could	   be	   transplanted	   into	   aganglionic	   distal	   hindgut	   and	  
that	   any	   new	   ENS	   neurons	   found	   in	   the	   transplant	   were	   generated	   within	   the	  
neurosphere,	   rather	   than	   being	   pre-­‐existing	   neurons	   incorporated	   into	   the	  
neurosphere	  initially.	  
	  
For	  transplantation,	  specimens	  of	  distal	  hindgut	  were	  harvested	  from	  e11.5	  CD-­‐1	  
mouse	   embryos	   as	   shown	   in	   Figure	   2.7	   and	   cultured	   on	   a	   semi-­‐permeable	  
membrane	   (Millicell,	  Millipore	   UK	   Ltd,	  Watford,	   UK).	  	   This	   was	   done	   by	   placing	  
3ml	  of	  warmed	  tissue	  culture	  medium	  in	  a	  50mm	  tissue	  culture	  dish	  and	  placing	  
the	  culture	  plate	  insert	  within	  it.	  	  The	  hindgut	  was	  dissected	  free	  in	  sterile	  PBS	  in	  
the	   same	  way	   and	   the	   caecum	  was	   removed.	   	   The	   hindgut	   was	   then	   removed	  
using	   a	   sterile	   100µm	   pipette	   and	   placed	   on	   the	   culture	   plate	   insert.	   	   A	   40µl	  
aliquot	   of	   tissue	   culture	  medium	   (containing	   DMEM-­‐high,	   see	   Appendix	   1)	   was	  
then	  placed	  on	  the	  hindgut	  sample.	  	  Tissue	  culture	  medium	  was	  changed	  every	  3	  
days	  and	  the	  aliquot	  of	  medium	  on	  top	  of	  the	  hindgut	  sample	  was	  also	  changed	  
by	  carefully	  removing	  it	  with	  a	  sterile	  40µl	  pipette	  and	  replacing	  the	  medium.	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Single	   human	   neurospheres	   that	   had	   been	   cultured	   for	   a	   minimum	   of	   28	   days	  
were	   apposed	   to	   the	   proximal	   end	   of	   the	   isolated	   hindgut	   using	   a	   100µl	   sterile	  
pipette,	  as	  shown	  in	  Figure	  2.7.	  	  As	  controls,	  gut	  explants	  were	  cultured	  without	  
neurospheres	  and	  explants	  cultured	  with	  the	  caecum	  still	  attached,	  as	  described	  
in	   Figure	   2.7A.	  	   Specimens	  were	   fixed	   and	   processed	   for	   immunohistochemistry	  
after	  8	  days	  in	  culture.	  
	  
Tissue	  culture	  specimens	  were	  fixed	  by	  removing	  the	  tissue	  culture	  medium	  and	  
gently	   washing	   three	   times	   in	   PBS.	   	   All	   specimens	   were	   fixed	   in	   4%	   (w/v)	  
paraformaldehyde	   in	   PBS	   for	   1	   h	   at	   room	   temperature	   and	   then	   rinsed	  3	   times	  
with	   PBS.	   	   They	   were	   then	   immersed	   in	   20%	   (w/v)	   sucrose	   for	   1	   h	   prior	   to	  
embedding	   in	   7.5%	   (w/v)	   gelatine	   in	   15%	   (w/v)	   sucrose.	   	   Embedded	   specimens	  
were	  frozen	  at	  -­‐80oC	  in	  isopentane	  and	  7μm	  serial	  sections	  cut	  using	  a	  cryostat.	  
	  
Immunohistochemistry	   was	   performed	   for	   PGP9.5	   and	   S100	   as	   described	  
previously.	   	   To	   identify	   human	   cells	   in	   the	   embryonic	   mouse	   gut,	   mouse	   anti-­‐
human	   ribonucleoprotein	  antibody	   (HRNP,	  Chemicon)	  1:50	  was	  used	  with	  Texas	  
Red-­‐conjugated	   goat	   anti-­‐mouse	   IgG	   1:200	   (Abcam	   Ltd,	   Cambridge,	   UK).	   	   To	  
assess	   whether	   cells	   were	   generated	   within	   the	   neurosphere,	   human	  
neurospheres	  were	  incubated	  with	  10	  mM	  BrdU	  for	  18	  h	  before	  transplantation.	  	  
Incorporated	  BrdU	  was	  detected	  by	  a	  2	  h	  incubation	  with	  mouse	  anti-­‐BrdU	  (Dako)	  
diluted	   1:25	   followed	  by	   rinsing	   in	   PBS	   and	   a	   further	   2	   h	   incubation	  with	   Texas	  
Red-­‐conjugated	   goat	   anti-­‐mouse	   IgG	   (Abcam)	   diluted	   1:200.	   	   Dual	   labelling	  was	  




2.5.2.1	  	  Growth	  of	  NHNS	  
	  
Pictures	  of	  NHNS	  growing	   in	   culture	   are	   shown	   in	   Figure	  2.8.	   	   The	  mean	   size	  of	  
NHNS	  at	   different	   time	  points	   is	   shown	   in	   Figure	   2.8F	   and	   comparison	  made	   to	  
EMNS.	   	   This	   data	   is	   also	   shown	   in	   Table	   2.3.	   	   Although	   there	   appeared	   to	   be	   a	  
trend	   for	  mouse	  neurospheres	   to	  grow	  more	  rapidly	  and	  be	   larger	   than	  human-­‐
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derived	   neurospheres,	   there	   was	   no	   statistically	   significant	   difference	   in	   size	  
between	  human	  and	  mouse	  neurospheres	  when	  the	  data	  for	  all	  time	  points	  was	  
aggregated	   (two-­‐tailed	   t=test,	   p=0.065)	   or	   when	   individual	   time	   points	   were	  
considered	  separately	  (Kruskal-­‐Wallis	  1-­‐way	  ANOVA	  with	  Dunns	  post	  test,	  p>0.05	  
for	  all	  time	  points.	  
	  
Table	  2.3:	  	  Yield	  and	  size	  of	  EMNS	  and	  NHNS	  	  	  
	  
	  
	   EMNS	   NHNS	  









0	   0	   0	   0	   0	  
7	   20	   72 +/- 19 18	   39 +/- 9 
14	   53	   702 +/- 146 21	   199 +/- 74 
21	   66	   671 +/- 80 48	   536 +/- 120 
28	   70	   1190 +/- 364 52	   783 +/- 100 
	  
	  
	   	  




Figure 2.8 Growth of NHNS
The growth of human neurospheres.  Phase contrast 
micrographs of: (A) Single cell suspension of human 
cells at D0.  (B)  Neurospheres at D7 of culture.  (C) 
Neurosphere at D14 of culture.  Note neurite 
outgrowth from the neurosphere (arrowhead).  (D)  
Neurospheres at D21 of culture.  Although neuro-
sphere size had increased, there also many smaller 
cell clusters and individual cells present.  (E)  Neuro-
spheres at D28 of culture.  Neurosphere size has 
increased to steady state and there are fewer indi-
vidual cells surviving within the culture.  (F)  Scatter 
plot (median and range) showing size of NHNS neuro-
spheres in comparison with EMNS at the same time-
point.  Human neurospheres tended to be smaller 
than their embryonic mouse counterparts, but this 
observation does not reach statistical significance 
(two-tailed t=test for aggregated data, p=0.065 and 
Kruskal-Wallis 1-way ANOVA with Dunns post test, 
p>0.05 for individual time points). 
Scale bars = 200µm
F
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2.5.2.2	  	  Cell	  marker	  expression	  of	  single	  cell	  suspension	  and	  NHNS	  
	  
Immunofluorescence	   of	   the	   single	   cell	   suspension	   derived	   from	   digesting	   the	  
circular	  and	  longitudinal	  muscle	  layers	  is	  shown	  in	  Figure	  2.9.	  	  This	  demonstrates	  
that	   within	   the	   digested	   sample	   there	   are	   cell	   positive	   for	   human	   nuclei,	   p75,	  
PGP9.5	   and	   S100.	   	   The	   majority	   of	   the	   cells	   however	   are	   positive	   for	   SMA,	   as	  
would	   be	   expected.	   	   There	  were	   few	   cells	   positive	   for	   p75	   and	   relatively	  more	  
positive	  for	  PGP9.5	  and	  S100B.	   	  This	  raises	  the	  possibility	  that	  there	  may	  be	  p75	  
positive	  ENSC	  present	  within	  the	  sample.	  
	  
After	   30	   days	   in	   culture,	   Immunohistochemistry	   confirmed	   the	   presence	   of	   the	  
neural	   crest	   cell	   marker	   p75	   (Figure	   2.10A)	   as	   well	   as	   glial	   and	   neuronal	   cell	  
markers	  within	  mature	   neurospheres	   (Figure	   2.10B	   and	   C).	   	   BrdU	   incorporation	  
demonstrated	   proliferating	   cells	   that	   tended	   to	   be	   uniformly	   distributed	  
throughout	  the	  neurospheres,	  in	  contrast	  to	  mouse	  neurospheres	  (Figure	  2.10D).	  
Dual	   labelling	   with	   PGP9.5	   and	   BrdU	   showed	   the	   presence	   of	   cells	   positive	   for	  
both	  BrdU	  and	  PGP,	  indicating	  that	  new	  neuronal	  cells	  had	  been	  generated	  from	  
actively	   dividing	   precursors	   within	   the	   neurosphere	   (Figure	   2.10D	   inset,	  
arrowhead).	  	  Immunofluorescent	  labelling	  for	  neurotransmitters	  commonly	  found	  
in	   the	  ENS	  showed	  the	  presence	  of	  NOS	   (Figure	  2.10E),	  ChAT	   (Figure	  2.10F),	  VIP	  
(Figure	   2.10G),	   SP	   (Figure	   2.10H)	   and	   CGRP	   (Figure	   2.10I)	   within	   the	  
neurospheres.	   No	   TH	   immunoreactivity	   was	   seen	   and	   the	   proportion	   of	   cells	  
staining	  for	  NOS	  and	  ChAT	  was	  greater	  than	  that	  for	  the	  other	  neurotransmitters.	  
	  
There	   appeared	   to	   be	   a	   positive	   reaction	   to	   c-­‐Kit	   in	   the	   primary	   neurospheres	  
(Figure	   2.11A	  and	  B)	   but	   a	   similar	   pattern	  of	   staining	  was	   seen	  on	   the	  negative	  
control	  (Figure	  2.11C).	   	  c-­‐kit	  and	  PGP9.5	  dual	  labelling	  of	  transplanted	  NHNS	  (for	  
transplantation	   and	   culture	   method,	   see	   section2.5.1.4)	   demonstrated	   that	  	  
defined	   c-­‐kit	   staining	   appeared	   to	   appear	   within	   the	   neurosphere	   at	   the	  
peripheries	   (Figure	   2.11D).	   	   It	   therefore	   seems	   likely	   that	   there	   are	   some	   c-­‐Kit	  
reactive	   cells	   within	   the	   neurosphere	   but	   the	   results	   presented	   here	   cannot	  
definitively	  confirm	  this.	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2.5.2.3	  	  Demonstration	  of	  clonality	  of	  NHNS	  
	  
Despite	  multiple	  attempts	  at	  demonstrating	  clonality	  of	  NHNS	  in	  a	  similar	  way	  to	  
that	   described	   for	   mouse	   neurospheres(Almond	   et	   al.,	   2007),	   no	   neurospheres	  
formed	   under	   these	   conditions.	   	   However,	  when	  NHNS	  were	   cultured	   at	   clonal	  
density,	   then	   new	   neurospheres	   began	   to	   form	   (Figure	   2.12A	   and	   B).	   	   These	  
neurospheres	  were	  very	  low	  in	  number	  (typically	  1	  or	  2	  per	  90mm	  Petri	  dish)	  but	  
displayed	   the	   typical	   morphology	   of	   NHNS	   and	   produced	   neurite	   outgrowth	  
(Figure	  2.12C	  and	  D).	  	  	  
	  
2.5.2.4	   	  NHNS	  can	  be	  transplanted	  into	  embryonic	  mouse	  distal	  hindgut	  
and	  differentiate	  to	  form	  a	  neo-­‐ENS	  containing	  both	  neurons	  and	  glia	  
	  
Human	  neurospheres	  were	  transplanted	  onto	  the	  rostral	  end	  of	  cultured	  11.5	  dpc	  
murine	   hindgut	   explants.	   Upon	   transplantation,	   fusion	   with	   the	   explant	   rapidly	  
occurred	  and	  cells	  migrated	   into	   the	  mouse	   tissue	   (Figure	  2.13A	  and	  B).	  After	  8	  
days	  in	  culture,	  staining	  for	  PGP9.5	  showed	  the	  site	  of	  neurosphere	  engraftment	  
and	   cells	  migrating	  within	   the	   bowel	  wall	   in	   a	   similar	   pattern	   to	   that	   seen	  with	  
embryonic	   mouse	   neurospheres	   (Figure	   2.13C).	   	   To	   confirm	   that	   the	   migrating	  
cells	  originated	  from	  the	  human	  neurospheres,	   they	  were	  dual-­‐labelled	  with	  the	  
marker	   of	   human	   cell	   nuclei,	   HRNP	   (Figure	   2.13D).	   	   This	   dual	   labelling	  
demonstrates	  that	  in	  some	  cases	  human	  neurosphere-­‐derived	  cells	  had	  migrated	  
a	  considerable	  distance.	  	  In	  addition,	  neurosphere	  cells	  labelled	  with	  BrdU	  before	  
transplantation	   could	   be	   seen	   to	   have	   migrated	   away	   from	   the	   neurosphere	  
(Figure	   2.13E).	   Dual	   labelling	  with	   PGP9.5	   and	   BrdU	   showed	   that	   cells	   that	   had	  
undergone	  division	  within	  the	  neurosphere	  prior	  to	  transplantation	  were	  capable	  
of	   migrating	   within	   the	   explant	   and	   differentiating	   into	   a	   neuronal	   phenotype	  
(Figure	  2.13E,	  inset).	  
	  
Dual	   labelling	   with	   PGP9.5	   or	   S100	   and	   HRNP	   confirmed	   that	   cells	   within	   the	  
neurosphere	   were	   capable	   of	   migration	   within	   the	   wall	   of	   the	   gut	   and	  
differentiation	   into	   neuronal	   and	   glial	   phenotypes	   (Figure	   2.13F,G),	   indicating	  
their	  origin	  as	  ENSPC	  born	  in	  the	  neurosphere.	  ChAT-­‐positive	  (Figure	  2.13H),	  NOS-­‐
positive	   (Figure	   2.13I)	   and	   a	   smaller	   number	   of	   VIP-­‐positive	   cells	   (Figure	   2.13J)	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had	  migrated	   into	   the	  explants	   after	   8	  days	   in	   culture,	   but	  no	  TH-­‐,	   CGRP-­‐	  or	   SP	  
positive	   cells	   were	   detected	   (not	   shown).	   A	   consistent	   finding	   in	   these	  
experiments	  was	   that	  NOS-­‐positive	   but	  HRNP-­‐negative	   staining	   cells	  were	  often	  
found	   alongside	   NOS-­‐positive,	   HRNP-­‐positive	   cells	   (Figure	   2.13I).	   	   Further	  
examples	  of	  engrafted	  NHNS	  into	  embryonic	  mouse	  distal	  hindgut	  can	  be	  seen	  in	  
Figure	  2.14.	   	  Figure	  2.14	  also	  demonstrates	  that	  aganglionic	  distal	  colon	  samples	  
removed	   at	   E11.5	   and	   cultured	   in	   the	   same	   conditions	   without	   a	   neurosphere	  
transplant	   demonstrate	   no	   reactivity	   to	   PGP9.5	   or	   S100B,	   confirming	   previous	  
findings	  by	  Almond	  (Almond	  et	  al.,	  2007)	  and	  therefore	  the	  validity	  of	  the	  model.	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Figure	  2.13	  Transplantation	  of	  NHNS.	  
	  
Migration	   and	   differentiation	   of	   human	   neurospheres	   in	   mouse	   hindgut	  
explants.	   	  The	   position	   of	   the	   grafted	   neurosphere	   is	   indicated	   by	   a	   solid	  
arrowhead.	   	   (A):	   	   Phase	   contrast	   photomicrograph	   showing	   initial	   neurosphere	  
position	   in	   relation	   to	   proximal	   hindgut,	   day	   1	   of	   culture.	   	  (B):	   Phase	   contrast	  
photomicrograph	  showing	  position	  of	  human	  neurosphere	  (arrowed)	  and	  growth	  
of	   explant	   after	   8	   days	   in	   culture.	   	  (C-­‐J):	   Immunoreactivity	   after	   8	   days	   in	  
culture.	   	  (C):	  PGP	  9.5.	   	  The	  position	  of	   the	  transplanted	  neurosphere	   is	   indicated	  
by	  the	  arrow	  and	  PGP	  9.5	  positive	  cells	  can	  be	  seen	  distributed	  within	  the	  wall	  of	  
the	   gut.	   	  L	   indicates	   the	   lumen	   of	   the	   explant.	   	  (D):	   Human	   nuclei	   on	   same	  
specimen	  as	   fig.	   5C.	   	  The	   inset	   shows	  a	  magnified	  view	  of	   the	  area	   indicated	  by	  
the	  box,	  where	  a	  migrated	  human	  cell	  nucleus	  can	  be	  seen	  away	  from	  the	  original	  
neurospheres	  graft.	  	  (E):	  	  BrdU	  immunoreactivity	  from	  the	  same	  explant	  as	  5C	  and	  
5D.	   	  Migration	   of	   cells	   with	   BrdU	   positive	   nuclei	   along	   the	   wall	   of	   the	   hindgut	  
explant	  can	  be	  seen	  (hollow	  arrowhead).	  	  The	  inset	  shows	  a	  cell	  dual	  labelled	  for	  
PGP9.5	   (green)	   and	  BrdU	   (red).	   	  (F):	  Dual	   labelling	   showing	  PGP	  9.5	   (green)	   and	  
HRNP	  (red)	  positive	  cells	  that	  have	  migrated	  away	  from	  the	  neurosphere	  (top	  left)	  
and	  along	  the	  wall	  of	  the	  bowel.	  	  Inset	  shows	  a	  detail	  of	  several	  cells	  positive	  for	  
both	   PGP9.5	   and	   HRNP.	   	  (G):	   Dual	   labelling	   for	   S100	   (green)	   and	   HRNP	   (red)	  
showing	   some,	   but	   not	   all,	   migrated	   cells	   expressing	   a	   glial	   phenotypic	  
marker.	   	  (H):	   	   Immunoreactivity	   for	   ChAT.	   	   ChAT	   (green)	   and	   HRNP	   (red)	   dual	  
labelling	   is	   shown	   in	   the	   inset.	   	   (H):	   Migrated	   cells	   away	   from	   the	   main	  
neurosphere	   body	   dual	   labelled	   for	   NOS	   (green)	   and	   HRNP	   (red).	   	  Note	   the	  
presence	   of	   NOS-­‐positive,	   HRNP-­‐negative	   cells	   within	   the	   bowel	   wall.	   	  (I):	  
Migrated	  cells	  dual	  labelled	  for	  VIP	  (green)	  and	  HRNP	  (red).	   	  Calibration	  bars:	  (A-­‐
D):	  200µm;	  	  (E):	  100	  µm;	  	  (F-­‐H):	  50µm;	  	  (I-­‐J):	  20µm	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2.5.3	  	  Discussion	  
	  
The	  findings	  in	  the	  preceding	  section	  are	  key	  in	  that	  they	  establish	  that	  as	  a	  bare	  
minimum,	  ENS	  progenitor	  cells	  capable	  of	  producing	  neurons	  and	  glia	  are	  present	  
within	  the	  neurospheres	  generated	  form	  neonatal	  human	  bowel	  samples,	  and	  in	  
fact	   it	   is	   highly	   likely,	   on	   the	   basis	   of	   secondary	   and	   neurosphere	   generation	  
(further	  detailed	  in	  Chapter	  3),	  that	  true	  ENSC	  are	  present.	  
	  	  
2.5.3.1	  	  Growth	  of	  NHNS	  
	  
The	   growth	   rate	   of	   embryonic	   mouse	   and	   neonatal	   human	   neurospheres	   was	  
broadly	  similar	  (Figure	  2.8F),	  although	  the	  apparent	  higher	  growth	  rate	  of	  EMNS	  
was	  not	  statistically	  significant.	   	  This	  finding	  would	  appear	  to	  be	  in	  contradiction	  
to	   the	  data	  on	  phosphohistone	  H3	  expression	   in	  cultured	  neurospheres	   (Figures	  
3.5	  and	  3.6),	  where	  EMNS	  appear	  to	  have	  a	  significantly	  higher	  mitotic	  rate	  than	  
NHNS.	  	  This	  discrepancy	  may	  be	  explained	  by	  the	  recent	  finding	  that	  neurosphere	  
volume	   is	  affected	  more	  by	  sphere-­‐sphere	  merging	  than	  direct	  growth(Singec	  et	  
al.,	   2006).	   	   The	  actual	   size/volume	  of	  neurospheres	  after	  7-­‐14	  days	   in	   culture	   is	  
therefore	  not	  a	  reliable	  indicator	  of	  mitotic	  rate	  and	  growth	  potential.	  
	  	  
2.5.3.2	  	  Clonality	  of	  NHNS	  
	  
In	   section	   2.3.3.1	   it	   was	   stated	   that	   the	   gold	   standard	   for	   determining	  
neurosphere	  clonality	  is	  the	  ability	  of	  a	  single	  cell	  generated	  after	  dissociation	  of	  a	  
primary	  neurosphere	  to	  generate	  a	  new	  neurosphere	  grown	  in	  isolation.	  
	  
This	   standard	   of	   proof	   has	   not	   been	   achieved	   in	   this	   thesis,	   as	   experiments	  
designed	   to	   demonstrate	   this	   were	   unsuccessful.	   	   Explanations	   for	   this	   result	  
include:	  	  (a)	  there	  are	  no	  genuine	  ENSC	  in	  the	  primary	  NHNS,	  (b)	  the	  efficiency	  of	  
neurosphere	  generation	  at	  a	  single	  cell	  density	   is	   so	   low	   in	  postnatal	   tissue	   that	  
insufficient	   attempts	   were	   made	   and	   (c)	   generation	   of	   a	   neurosphere	   from	   a	  
single	   ENSC	   in	   postnatal	   tissue	   is	   dependent	   on	   unknown	   factors	   not	   present	  
when	  a	  cell	  is	  grown	  in	  isolation.	  	  This	  final	  issue	  could	  have	  addressed	  by	  the	  use	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of	  conditioned	  medium	  taken	  from	  other	  neurosphere	  cell	  cultures,	  but	  this	  was	  
not	  done	  in	  the	  work	  presented	  in	  this	  thesis.	  
	  
The	   fact	   that	   a	   neurosphere	   could	   be	   grown	   when	   cells	   were	   plated	   at	   clonal	  
density	  is	  evidence	  for	  the	  presence	  of	  an	  ENSC	  and	  further	  evidence	  comes	  from	  
the	   fact	   that	   it	   is	   possible	   to	   generate	   secondary	   and	   tertiary	   neurospheres	   in	  
exponentially	  expanding	  numbers	  after	  the	  dissociation	  of	  NHNS.	  	  The	  data	  from	  
experiments	   2.5.1.2	   also	   show	   that	   neurons	   are	   generated	   within	   the	  
neurosphere,	  indicating	  that	  at	  the	  very	  least	  ENS	  progenitor	  cells	  are	  present.	  	  	  
	  
Nevertheless,	  it	  is	  a	  valid	  criticism	  that	  there	  is	  no	  conclusive	  proof	  within	  the	  data	  
presented	  as	  part	  of	  this	  thesis	  that	  ENSC	  are	  present	  within	  the	  NHNS.	  	  However,	  
the	  fact	  that	  such	  neurospheres	  are	  capable	  of	  generating	  neurons	  and	  glia	  that	  
can	  migrate	  into	  aganglionic	  tissue	  and	  produce	  a	  functional	  effect	  renders	  such	  a	  
question	  academic	   in	  respect	  the	  development	  of	  a	  “stem	  cell”	  based	  treatment	  
for	   HSCR,	   as	   ultimately	   it	   is	   the	   functional	   result	   that	   is	   key.	   	   Whether	   such	  
changes	  arise	  from	  a	  genuine	  stem	  cell	  or	  a	  more	  differentiated	  progenitor	  cell	  is	  
obviously	  of	  interest	  but	  pragmatically	  may	  not	  be	  of	  significance.	  
	  
2.5.3.3	  	  NHNS	  neurotransmitter	  expression	  
	  
In	   terms	   of	   neurotransmitter	   expression	   and	   neurosphere	   properties,	   cultured	  
human	   and	  mouse	   neurospheres	  were	   similar	   (Figures	   2.10	   and	   (Almond	   et	   al.,	  
2007)).	   	   	   After	   transplantation	   fewer	   neuronal	   phenotypes	   appeared	   to	   have	  
migrated	  within	  the	  gut	  tissue	  as	  no	  evidence	  of	   immunoreactivity	   for	  TH,	  CGRP	  
or	   SP	   was	   found.	   This	   observation	   is	   consistent	   with	   the	   hypothesis	   that	   the	  
differentiated	   neurons	   observed	   within	   the	   gut	   tissue	   originated	   from	  
undifferentiated	   precursors	   in	   the	   human	   neurosphere,	   rather	   than	   being	  
previously	   differentiated	   neurosphere	   cells.	   Evidence	   has	   been	   presented	  
consistent	  with	   a	   restriction	   in	   the	  developmental	   potential	   of	   postnatal	   rodent	  
ENSPC(Kruger	   et	   al.,	   2002)	   However,	   the	   presence	   of	   CGRP	   containing	   neurons	  
within	   the	   untransplanted	   neurospheres	   supports	   the	   hypothesis	   that	   the	  
progenitor	   cells	   are	   capable	   of	   producing	   cells	   from	   the	   Mash-­‐1	   independent	  
lineage(Li	   et	   al.,	   2004,	   Pham	   et	   al.,	   1991)	   and	   therefore	   have	   retained	   their	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pluripotency.	   	   Although	   there	   is	   a	   transient	  wave	   of	   TH	   expression	   during	   early	  
ENS	   development,(Gershon,	   1998b)	   within	   the	   mature	   bowel	   intrinsic	  
dopaminergic	   neurons	   (that	   also	   express	   TH)	   arise	   late	   in	   development	   from	   a	  
Mash-­‐1	   independent	   precursor(Blaugrund	   et	   al.,	   1996).	   	   The	   lack	   of	   these	  
neurotransmitters	  in	  cells	  migrating	  from	  transplanted	  human	  neurospheres	  may	  
therefore	   reflect	   the	   absence	   of	   appropriate	   signalling	   cues	   in	   the	   embryonic	  
bowel.	   The	   origin	   of	   the	   NOS-­‐positive	   HRNP-­‐negative	   neurons	   adjacent	   to	   the	  
NOS-­‐positive	  HRNP-­‐positive	  cells	   that	  had	  migrated	   into	  the	  explants	  remains	  to	  
be	  determined.	  	  Although	  it	  is	  known	  that	  not	  all	  human	  cell	  nuclei	  stain	  positive	  
for	   HRNP(Clevenger	   and	   Epstein,	   1984),	   the	   relatively	   large	   numbers	   of	   these	  
NOS-­‐positive	  cells	  may	  indicate	  that	  these	  cells	  originated	  from	  the	  sacral	  neural	  
crest(Anderson	  et	  al.,	   2006),	  but	  alone	   lack	   the	   capacity	   to	   form	  neurons	   in	   the	  
absence	  of	  vagal	  ENSPC.	  	  
	  
2.5.3.4	  	  Engraftment	  of	  NHNS	  
	  
Recently,	  concerns	  have	  been	  raised	  about	  the	  use	  of	  BrdU	  staining	  to	  track	  stem	  
cell	  engraftment(Burns	  et	  al.,	  2006).	  	  When	  injected	  into	  the	  brains	  of	  embryonic	  
mice	  or	  adult	  rats,	  labelled	  BrdU	  stem	  cells	  or	  BrdU	  containing	  medium	  could	  give	  
false	  positive	  results	  due	  to	  take	  up	  of	  BrdU	  from	  dead	  cells	  or	  directly	  from	  the	  
medium.	  However,	   in	  experiment	  2.5.2.4,	   the	  presence	  of	  HRNP	  staining	  closely	  
correlated	  with	  that	  of	  BrdU	   in	  engrafted	  specimens,	   indicating	  the	  migration	  of	  
human	  ENSPC	  generated	  within	  neurospheres	  that	  subsequently	  differentiate	  to	  
neuronal	  and	  glial	  phenotypes.	  	  
	  
The	  finding	  that	  NHNS	  transplantation	  leads	  to	  the	  formation	  of	  new	  neurons	  and	  
glia	  within	  otherwise	  aganglionic	  embryonic	  mouse	  hindgut	   is	  obviously	  of	  great	  
importance	  in	  the	  development	  of	  a	  stem	  cell	  based	  treatment	  for	  HSCR.	  	  
	  
Clearly,	  demonstration	  that	  ENSPC	  can	  also	  colonise	  postnatal	  aganglionic	  bowel	  
will	  be	  a	  necessary	  future	  step	  leading	  to	  their	  autologous	  transplantation	  in	  the	  
treatment	   of	   Hirschsprung’s	   disease.	   	   Experiments	   to	   examine	   the	   feasibility	   of	  
such	  transplantation	  are	  detailed	  in	  chapter	  4.	  	  However,	  it	  should	  be	  noted	  that	  
the	   postnatal	   bowel	   constitutes	   a	   markedly	   different	   environment	   from	   that	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found	   in	   the	   embryonic	   gut	   and	   knowledge	   of	   the	   molecular	   basis	   of	  
Hirschsprung’s	   disease,	   and	   the	   response	   of	   ENSPCs	   to	   growth	   factors	   such	   as	  
GDNF,	   may	   be	   required	   for	   autologous	   transplantation	   to	   be	   successful.	   These	  
experiments	   are	   detailed	   in	   the	   next	   chapter.	   	   Furthermore,	   before	  
transplantation	   becomes	   a	   realistic	   possibility,	   experiments	   are	   necessary	   to	  
determine	   the	   functionality	   of	   ENSPC	   derived	   neurons.	   	   These	   experiments	   are	  
also	  described	  in	  Chapter	  4.	  
	  
	   	  
	   129	  
Chapter	  3:	  	  Properties	  of	  Neonatal	  Human	  ENS	  Neurospheres	  
	  
3.1	  	  Introduction	  
	  
In	  the	  previous	  chapter	   it	  was	  demonstrated	  that	  neurospheres	  containing	  ENSC	  
capable	   of	   forming	   neurons	   and	   glia	   could	   be	   generated	   from	  postnatal	   human	  
bowel,	  including	  from	  the	  bowel	  of	  neonates	  with	  Hirschsprung’s	  disease.	  	  These	  
neurospheres	   could	   be	   successfully	   transplanted	   into	   embryonic	  mouse	  hindgut	  
and	  appeared	  to	  generate	  a	  neo-­‐ENS.	  
	  
Initial	  observations	  (detailed	  below)	  during	  the	  experiments	  detailed	  in	  Chapter	  2	  
indicated	   that	   there	   may	   be	   a	   difference	   between	   embryonic	   and	   postnatal	  
neurosphere	  responses	  to	  GDNF.	   	  Knowledge	  of	  how	  postnatal	  ENSC	  respond	  to	  
these	   growth	   factors	   may	   be	   important	   in	   successful	   transplantation	   into	  
postnatal	   tissue,	   as	   would	   be	   required	   for	   a	   successful	   stem	   cell	   treatment	   for	  
HSCR.	  	  Such	  a	  treatment	  would	  also	  almost	  certainly	  require	  more	  neurospheres	  
to	  be	  generated	  than	  just	  the	  initial	  yield	  obtained	  using	  the	  methods	  detailed	  in	  
Chapter	  2.	   	   It	   is	   therefore	   important	   that	  NHNS	  numbers	   could	  be	  expanded	  by	  
forming	  secondary	  and	  tertiary	  neurospheres.	  
	  
3.2	  	  Aims	  
	  
This	   chapter	   therefore	   details	   further	   characterisation	   of	   the	   primary	  
neurospheres	   in	   terms	   of	   response	   to	   the	   growth	   factors	   GDNF	   and	   EDN3,	   in	  
particular	  looking	  at	  neurite	  outgrowth	  and	  mitotic	  rate.	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The	  second	  part	  of	  this	  chapter	  then	  goes	  on	  to	  detail	  the	  work	  done	  to	  generate	  
secondary	   and	   tertiary	  neurospheres	   from	  primary	  human	  neurospheres	   and	   to	  
characterise	  them	  in	  terms	  of	  numbers	  and	  cell	  marker	  expression.	  	  	  
3.3	  	  Response	  of	  neurospheres	  to	  ENS	  growth	  factors	  	  
	  
3.3.1	  	  Methods	  
	  
It	   was	   observed	   that	   EMNS	   produced	   a	   florid	   neurite	   outgrowth	   when	   the	  
neurosphere	   adhered	   to	   the	   bottom	   of	   the	   Petri	   dish	   (Figure	   3.1A	   and	   B).	   	   In	  
contrast,	  NHNS	  never	  produced	  this	   reaction	  and	  only	  very	   rarely	  demonstrated	  
neurite	   outgrowth	   (Figure	   3.1C	   and	   D).	   	   GDNF	   is	   known	   to	   influence	   neurite	  
outgrowth(H.	  Yan,	  2003b),	  and	  therefore	   it	  was	  proposed	  that	  this	  maymight	  be	  
due	   to	   a	   lack	  of	   	  GDNF.	   	   In	   a	  pilot	   experiment,	   addition	  of	  GDNF	  at	   10ng/ml	   to	  
NHNS	  grown	  on	  an	  8	  well	  chamber	  slide	  coated	  with	  poly-­‐D	  lysine	  and	  laminin	  (for	  
protocol,	   see	   below)	   produced	   neurite	   outgrowth,	   which	   was	   confirmed	   by	  
staining	  for	  PGP9.5	  (Figure	  3.1E	  and	  F).	  
	  
To	  investigate	  this	  further,	  EMNS,	  NMNS	  and	  NHNS	  were	  generated	  and	  cultured	  
as	  described	   in	  Chapter	  2	  and	  Appendix	  2.	   	  NHNS	  were	  generated	  from	  samples	  
28-­‐32	   (all	   HSCR	   patients).	   	   Neurospheres	   were	   selected	   for	   subsequent	   culture	  
once	  their	  rate	  of	  growth	  had	  fallen	  to	  steady	  state:	  	  3	  weeks	  for	  EMNS,	  4	  weeks	  
for	  NMNS	  and	  4-­‐6	  weeks	  for	  NHNS.	  	  	  
	  
To	   study	   the	   effect	   of	   various	   growth	   factors,	   8	  well	   chamber	   slides	   (BD	   Falcon	  
Chamber	   Slide,	   VWR	   International,	   Lutterworth,	   UK)	   were	   first	   sequentially	  
coated	  with	  150μg/	  cm2	  poly-­‐D-­‐lysine	  (Sigma-­‐Aldrich)	  for	  8h	  and	  then	  1.5µg/cm2	  
laminin	   (Sigma-­‐Aldrich)	   for	   8	   hours,	   with	   3	   rinses	   of	   phosphate	   buffered	   saline	  
(PBS)	  after	  each	  coating.	  	  After	  the	  final	  rinse,	  0.75ml	  of	  standard	  culture	  medium	  
and	   1-­‐2	   neurospheres	  were	   added	   to	   each	   chamber.	   	   Growth	   factors	   and	   their	  
inhibitors	  (all	  Sigma-­‐Aldrich)	  were	  used	  as	  follows:	  	  GDNF	  (10ng/ml),	  neutralising	  
anti	   GDNF	   antibody	   (10µg/ml),	   EDN3	   (100nM)	   and	   the	   endothelin	   3	   inhibitor	  
BQ788	  (5µM/l).	  	  These	  doses	  were	  chosen	  as	  they	  have	  previously	  been	  shown	  to	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influence	  the	  behaviour	  of	  ENS	  precursors	  in	  a	  tissue	  culture	  system(Sidebotham	  
et	   al.,	   2002a,	   Barlow	   et	   al.,	   2003).	   	   Evaporative	   losses	   of	   culture	  medium	  were	  
replaced	  every	  2	  days	  and	  cultures	  maintained	  for	  5	  days.	  
	  
For	  statistical	  analysis,	  data	  were	  plotted	  and	  analysed	  using	  GraphPad	  Prism	  4.03	  
(GraphPad	   Software,	   San	   Diego,	   CA,	   USA).	   	   Data	   were	   assumed	   to	   be	   sampled	  
from	   Gaussian	   distributions	   unless	   obviously	   skewed.	   	   A	   1-­‐way	   analysis	   of	  
variance	   (ANOVA)	   with	   Tukey’s	   multiple	   comparison	   test	   was	   employed	   for	  
parametric	  data	  and	  the	  Kruskal-­‐Wallis	  ANOVA	  with	  Dunn’s	  multiple	  comparison	  
test	   for	   non-­‐parametric	   data.	   	   A	   p	   value	   of	   less	   than	   0.05	   was	   considered	  
statistically	  significant.	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3.3.1.1	  Measurement	  of	  neurite	  number,	  circumference	  and	  area	  	  
	  
The	  measurement	  of	  neurite	  outgrowth	  in	  dorsal	  root	  ganglia	  is	  a	  common	  assay	  
for	  GDNF	  activity(H.	  Yan,	  2003a).	  	  After	  5	  days	  in	  culture,	  the	  number	  of	  neurites	  
growing	  from	  the	  neurosphere	  was	  counted	  using	  a	  Nikon	  TMS-­‐F	  inverted	  phase	  
contrast	   microscope	   by	   a	   single	   observer.	   	   Neurosphere	   radius	   and	   area	   were	  
measured	  on	  digital	  photographs	  of	  the	  neurosphere	  taken	  at	  this	  time	  point	  and	  
imported	   into	   Adobe	   Photoshop	   CS2	   (Adobe	   Systems	   Incorporated	  
345	   Park	   Avenue,	   San	   Jose,	   CA	   95110-­‐2704)	   after	   calibration	   with	   a	   standard	  
graticule.	  	  	  
	  
Neurosphere	  circumference	  was	  calculated	  using	  the	  formula	  C=2πr.	  	  	  
	  
Neurite	   numbers	   were	   expressed	   in	   terms	   of	   neurites/µm	   of	   circumference	   to	  
account	  for	  possible	  differences	  in	  neurosphere	  size	  between	  groups.	  
	  
3.3.1.2	  	  Measurement	  of	  mitotic	  rate	  
	  
After	   5	   days	   in	   culture,	   the	   culture	   medium	   was	   carefully	   removed	   and	   the	  
neurospheres	   were	   gently	   washed	   three	   times	   with	   PBS	   using	   a	   1ml	   transfer	  
pipette.	  	  Neurospheres	  were	  then	  fixed	  using	  4%	  (w/v)	  paraformaldehyde	  in	  15%	  
(w/v)	  sucrose	  solution	  (both	  Sigma-­‐Aldrich)	  for	  30	  minutes.	  
	  	  	  
Samples	   were	   washed	   in	   three	   times	   in	   PBS	   and	   mitoses	   detected	   using	   the	  
marker	   phosphohistone	   H3(Hendzel	   et	   al.,	   1997).	   	   Anti-­‐phosphohistone	   H3	  
antibody	   (Upstate,	   Lake	   Placid,	   USA)	   in	   0.2%	   (v/v)	   triton	   (Sigma-­‐Aldrich)	   was	  
applied	  at	  a	  dilution	  of	  1:100	  overnight	  at	  4oC.	   	  After	  rinsing	  three	  times	   in	  PBS,	  
anti-­‐rabbit-­‐FITC	   (1:200)	   was	   applied	   for	   2	   hours.	   	   The	   chambers	   were	   then	  
removed	   after	   a	   further	   three	   rinses	   in	   PBS	   before	   mounting	   with	   Dako	  
fluorescent	  mounting	  medium	   (DAKO	  UK	   Ltd,	   Ely,	   UK).	   	  Mitotic	   cells	  were	   then	  
counted	   by	   a	   single	   observer	   using	   fluorescent	  microscopy.	   	   	  Mitotic	   cells	  were	  
expressed	   in	   terms	   of	  mitoses/µm2	   of	   neurosphere	   area	   (as	   photographed	   and	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measured	   as	   above)	   to	   account	   for	   possible	   differences	   in	   neurosphere	   area	  
between	  groups.	  	  Negative	  controls	  omitted	  the	  addition	  of	  the	  primary	  antibody.	  
	  
3.3.1.3	  Assessment	  of	  inter-­‐	  and	  intra-­‐	  observer	  reliability	  
	  
Intra-­‐observer	   variability	   was	   assessed	   by	   repeated	   (10)	   measurements	   of	  
neurosphere	  area,	  neurite	  and	  mitotic	  cell	  numbers	  of	  the	  same	  neurosphere	  and	  
the	   coefficient	   of	   variation	   (COV)	   calculated.	   	   The	   coefficient	   of	   variation	   is	  
defined	   as	   the	   standard	   deviation	   of	   the	   sample	   divided	   by	   the	   mean	   of	   the	  
sample.	   	   	   Inter-­‐observer	  variability	  was	  assessed	  by	  a	  second	  observer	  repeating	  
measurements	   of	   neurosphere	   area,	   neurite	   and	   mitotic	   cell	   numbers	   on	   10	  
different	  neurospheres	  and	  the	   intraclass	  correlation	  coefficient	  calculated	  using	  
SPSS	  for	  Windows.	  
	  
3.3.2	  	  Results	  
	  
3.3.2.1	  	  Response	  of	  neurospheres	  to	  ENS	  growth	  factors	  
	  
After	   5	   days	   in	   culture,	   all	   neurospheres	   had	   adhered	   to	   the	   laminin	   matrix.	  	  
Although	  the	  growth	  rate	  of	  NHNS	  was	  slower	  than	  that	  of	  EMNS	  and	  NMNS,	  the	  
eventual	   size	   they	   achieved	   was	   significantly	   higher	   (Figure	   3.2,	   1	   way	   ANOVA	  
with	   Tukey’s	   multiple	   comparison	   test,	   p<0.05	   for	   comparison	   with	   EMNS	   and	  
p<0.005	   for	   comparison	   with	   NMNS).	   	   Neurospheres	   produced	   radial	   neurite	  
outgrowths	  once	  adhered	  and	  subsequently	  small	  satellite	  clusters	  of	  cells	  could	  
be	   seen	   to	   form,	   mimicking	   ganglia	   of	   the	   ENS	   and	   connected	   by	   neurite	  
processes.	   	   This	   phenomenon	  was	  most	  pronounced	   in	   EMNS	   (Figure	  3.1A)	   and	  
rarely	  occurred	  in	  NHNS.	  
	  
Inter	   and	   intra	   observer	   reliability	   scores	   are	   shown	   in	   Table	   3.1.	   	   These	  
demonstrate	   that	   the	   methods	   for	   counting	   neurites,	   measuring	   neurosphere	  
area	  and	  counting	  PHH3	  positive	  mitotic	  cells	  were	  reliable	  and	  reproducible	  (see	  
section	  3.3.1.3).	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Table	  3.1	   	   Intra-­‐	  and	   inter-­‐	  variability	   for	  measurements	   	  of	  neurosphere	  area,	  
neurite	   outgrowth	   and	   mitoses	   identified	   by	   phosphohistone	   H3	  
immunolabelling.	  
	  





Intraobserver	   Coefficient	   of	  
variation(%)	  
2.5	   4.3	   6	  
	   	   	   	   	  
Interobserver	   Intraclass	   correlation	  
coefficient	   	  
0.940	   0.860	   0.996	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3.3.2.2	  Measurement	  of	  neurite	  number	  ,	  circumference	  and	  area	  	  
	  
EMNS	   neurite	   outgrowth	   occurred	   spontaneously	   in	   high	   numbers	   when	   the	  
neurospheres	   adhered	   to	   the	   laminin	   matrix	   (Figures	   3.3A-­‐D).	   	   There	   was	   no	  
discernable	   difference	   between	   neurite	   length	   and	   branching,	   or	   ganglion	  
formation,	  between	   the	  different	  growth	   factor	   conditions	   (Figures	  3.3	  A-­‐D).	   	   In	  
addition,	  there	  was	  no	  significant	  difference	  in	  neurite	  number	  when	  GDNF,	  EDN3	  
and	  their	  inhibitors	  were	  added	  separately	  (Figure	  3.3A-­‐C,	  Figure	  3.4A).	  	  However,	  
when	  GDNF	  and	  EDN3	  were	  added	  in	  combination,	  there	  were	  significantly	  fewer	  
neurites	  (Figures	  3.3D	  and	  3.4A,	  1	  way	  ANOVA	  with	  Tukey’s	  multiple	  comparison	  
test,	  p<0.05).	  
	  
NMNS	  neurospheres	  again	  produced	  spontaneous	  neurite	  outgrowth,	  albeit	  to	  a	  
lesser	  extent	  than	  EMNS	  (Figures	  3.3E-­‐3H	  and	  Figure	  3.4B).	   	  Neurite	  growth	  was	  
significantly	   higher	   than	   in	   control	   conditions	   in	   the	   presence	   of	   anti-­‐GDNF	  
antibodies	   (Figures	   3.3G	   and	   Figure	   3.4B,	   1	   way	   ANOVA	   with	   Tukey’s	   multiple	  
comparison	   test,	   p<0.05).	   	   The	   apparent	   trend	   towards	   an	   increase	   in	   neurite	  
number	  with	  the	  addition	  of	  GDNF	  was	  not	  statistically	  significant	  (Figure	  3.4B).	  
	  
Neonatal	   human	   neurospheres	   tended	   to	   form	   far	   fewer	   neurites,	   and	   in	  many	  
cases	  produced	  no	  neurite	  outgrowth,	  as	  previously	  noted	  (Figures	  3.3I-­‐3.3L	  and	  
Figure	   3.4C).	   	   Only	   after	   the	   addition	   of	   GDNF	   were	   neurites	   produced	   in	  
substantial	   numbers,	   and	   even	   then	   to	   a	   lesser	   extent	   than	   NMNS	   and	   EMNS	  
(Figure	  3.3J).	  	  The	  effect	  of	  GDNF	  of	  neurite	  production	  was	  statistically	  significant	  
(Figure	  3.4C,	  1	  way	  ANOVA	  with	  Tukey’s	  multiple	  comparison	  test,	  p<0.05).	  	  There	  
was	  a	  complete	  lack	  of	  neurite	  production	  in	  the	  presence	  of	  anti	  GDNF	  antibody,	  
EDN3	  and	  the	  EDN3	  antagonist	  BQ788.	  	  However,	  where	  neurite	  production	  was	  
less	   pronounced,	   there	   was	   an	   increase	   in	   the	   number	   of	   myofibroblast-­‐like	  	  
spindle-­‐shaped	  cells	  surrounding	  the	  neurosphere	  (Figures	  3.3I,	  K	  and	  L).	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3.3.2.3	  	  Measurement	  of	  mitotic	  rate	  
	  
In	  general,	   the	  mitotic	   rate	  of	  EMNS	  was	  significantly	  higher	   than	   that	  of	  NMNS	  
and	   NHNS	   (Figures	   3.5	   and	   Figure	   3.6,	   1	   way	   ANOVA	   with	   Tukey’s	   multiple	  
comparison	  test).	  	  The	  mitotic	  rates	  of	  NMNS	  and	  NHNS	  were	  similar	  and	  did	  not	  
significantly	   differ	   (p>0.05),	   indicating	   the	   developmental	   difference	   between	  
embryonic	  and	  neonatal	  cell	  proliferation	  rates.	  
	  
EMNS	   showed	   an	   increase	   in	   mitotic	   rate	   in	   response	   to	   GDNF	   but	   not	   EDN3	  
(Figures	   3.5	   A-­‐F,	   Figure	   3.6A).	   	   Proliferating	   cells	   tended	   to	   be	   located	   on	   the	  
periphery	  of	  the	  neurosphere	  (Figures	  3.5A	  and	  3.5C),	  although	  where	  the	  rate	  of	  
proliferation	  was	   very	  high,	  mitotic	   cells	  were	   found	  distributed	   throughout	   the	  
neurosphere	  (Figure	  3.5B).	  
	  
In	  contrast,	  NMNS	  and	  NHNS	  both	  showed	  no	  significant	   increase	  in	  mitotic	  rate	  
in	  the	  presence	  of	  GDNF	  (Figures	  3.5G-­‐R,	  Figures	  3.6B	  and	  5C)	  but	  both	  displayed	  
an	   increase	   to	   EDN3.	   	   Again,	   proliferating	   cells	   tended	   to	   be	   located	   in	   the	  
periphery	  of	  the	  neurosphere	  (Figures	  3.5G-­‐R).	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3.3.2.4	  	  Assessment	  of	  intra-­‐	  and	  inter-­‐	  observer	  reliability	  
	  
Results	   for	   intra-­‐	   and	   inter-­‐	   observer	   variability	   are	   shown	   in	   Table	   3.1.	   	   The	  
coefficient	  of	   variation	   for	   repeated	  measures	  by	  one	  observer	   is	   generally	   low,	  
representing	  good	  agreement	  and	  little	  variation.	  	  There	  is	  no	  accepted	  figure	  for	  
the	   appropriate	   value	   of	   the	   COV	   but	   up	   to	   6%	   variation	   in	   this	   sample	   seems	  
acceptable.	  	  For	  interobserver	  variation,	  intraclass	  correlation	  coefficients	  of	  0.86	  
and	  above	  represent	  substantial	  to	  almost	  perfect	  agreement(Shrout,	  1998).	  
	  
3.3.3	  	  Discussion	  
	  
3.3.3.1	  	  Response	  of	  ENS	  neurospheres	  to	  growth	  factors	  
	   	  
As	  mentioned	  above,	  the	  response	  of	  NHNS	  to	  ENSC	  affecting	  growth	  factors	  may	  
be	   important	   in	   the	   development	   of	   a	   stem	   cell	   based	   treatment	   for	   HSCR.	  	  
Therefore	  these	  experiments	  aimed	  to	  measure	  the	  response	  of	  neurospheres	  to	  
the	   growth	   factors	   GDNF	   and	   EDN3	   in	   terms	   of	   neurite	   formation,	  mitotic	   rate	  
and	   neurosphere	   growth.	   	   The	   effects	   of	  GDNF	   and	   EDN3	  on	   ENSPC	   have	   been	  
widely	  studied	  in	  embryonic	  bowel	  in	  vivo	  and	  in	  vitro,	  but	  not	  on	  such	  cells	  in	  the	  
form	   of	   neurospheres.	   	   As	   previously	   stated	   in	   Chapter	   1,	   GDNF	   increases	   the	  
proliferation	   of	   such	   cells,	   stimulates	   differentiation	   and	   migration.	   	   EDN3	  
maintains	   ENSPC	   in	   an	   undifferentiated	   state	   and	   also	   appears	   to	   affect	   ENSPC	  
migration.	  	  	  
	  
In	   section	   1.2.8.4.1	   it	   was	   mentioned	   that	   although	   there	   has	   been	   extensive	  
study	  of	   the	  effect	  of	  growth	   factors	  on	  embryonic	  ENSPC,	   there	  has	  been	   little	  
work	   on	   postnatally	   derived	   ENSPC	   and	   ENS	   neurospheres.	   	   To	   summarise,	  
Bondurand	   et	   al(Bondurand	   et	   al.,	   2003)	   demonstrated	   that	   individual	   ENSPC	  
isolated	  from	  embryonic	  and	  neonatal	  mice	  showed	  an	  increase	  in	  mitotic	  rate	  in	  
response	   to	   GDNF	   and	   qualitatively	   found	   the	   presence	   of	   GDNF	   appeared	   to	  
increase	  neurite	  branching	  and	  length.	   	  Barlow	  et	  al(Barlow	  et	  al.,	  2003)	  showed	  
that	   in	   embryonic	   isolated	   ENSPC	   this	   effect	   of	   GDNF	   on	   mitotic	   rate	   was	  
enhanced	  by	  the	  action	  of	  EDN3.	  	  Kruger	  et	  al(Kruger	  et	  al.,	  2002),	  also	  looking	  at	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individual	   ENSPC	   responses,	   demonstrated	   that	   postnatal	   rat	   ENSPCs	   have	   a	  
reduced	  response	  to	  bone	  morphogenic	  protein	  4	  (BMP4).	  	  The	  responses	  of	  cells	  
in	   a	   neurosphere	   microenvironment	   may	   well	   differ	   from	   these	   descriptions	  
however.	  
	  
In	   Chapter	   2	   it	   was	   noted	   that	   there	   was	   no	   statistically	   significant	   different	  
difference	   in	  neurosphere	   size	  between	  EMNS	  and	  NHNS,	   although	   there	  was	  a	  
trend	   for	  EMNS	  to	  be	   larger.	   	  This	  data	  conflicts	  with	   the	   results	   seen	  here	   that	  
NHNS	   are	   significantly	   larger	   after	   5	   days	   in	   culture	   on	   a	   laminin	   matrix.	   	   This	  
result	  is	  also	  surprising	  given	  the	  higher	  mitotic	  rate	  seen	  in	  EMNS.	  	  It	  may	  be	  that	  
as	  EMNS	  show	  much	  more	  neurite	  production	  and	  cell	  migration	  then	  NHNS	  (see	  
Figures	  3.1A	  and	  C)	  more	  cells	  are	  leaving	  the	  neurosphere,	  resulting	  in	  a	  smaller	  
size.	  	  It	  may	  also	  be	  a	  property	  of	  the	  neurosphere	  microenvironment	  and	  laminin	  
adhesion	  that	  allows	  the	  human	  neurospheres	  to	  grow	  to	  a	   larger	  size.	   	  Because	  
of	  these	  size	  differences,	  neurosphere	  outgrowth	  and	  mitotic	  rate	  were	  expressed	  
in	  terms	  of	  originating	  neurosphere	  area	  at	  5	  days.	  
	  
3.3.3.2	  	  Reliability	  of	  measurements	  
	  
As	  demonstrated	  by	  the	  high	  inter-­‐	  and	  intra-­‐	  observer	  correlations,	  our	  methods	  
of	  assessing	  neurosphere	  area,	  and	  counts	  of	  neurite	  numbers	  and	  mitotic	  cells,	  
were	  reliable	  and	  reproducible.	  	  One	  criticism	  of	  these	  results	  is	  that	  the	  principal	  
assessor	  was	  not	  blinded	  to	  the	  results.	  	  It	  would	  not	  be	  possible	  to	  blind	  for	  some	  
differences,	  as	  the	  embryonic	  and	  postnatal	  neurospheres	  are	  physically	  different.	  	  
Although	   a	   possibility	   for	   bias	   therefore	   exists	   in	   these	   samples,	   it	   should	   be	  
noted	  that	  similar	  studies	  in	  the	  literature	  have	  not	  only	  had	  similar	  problems	  in	  
terms	   of	   blinding,	   but	   have	   also	   had	   no	   assessment	   of	   reliability(Barlow	   et	   al.,	  
2003,	  Bondurand	  et	  al.,	  2003,	  Kruger	  et	  al.,	  2002).	  
	  
3.3.3.3	  	  Response	  of	  neurosphere	  neurite	  outgrowth	  to	  growth	  factors	  
	  
EMNS	   produce	   extensive	   numbers	   of	   neurite	   outgrowths,	   although	   the	   number	  
produced	   is	   significantly	   less	   following	   the	  addition	  of	  both	  GDNF	  and	  EDN3.	   	   In	  
ENSC	  isolated	  from	  E11.5	  embryos	  and	  cultured	  for	  3	  days	  in	  vitro,	  Barlow(Barlow	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et	  al.,	  2003)	  found	  that	  the	  addition	  of	  GDNF	  and	  EDN3	  significantly	  increased	  the	  
proportion	   of	  mitotically	   active	   undifferentiated	   ENSC,	   to	   a	   greater	   extent	   than	  
the	   increase	   in	  more	   differentiated	   cells	   produced	   by	   the	   effect	   of	   GDNF.	   	   The	  
effect	  on	  neurite	  outgrowth,	  as	  a	  surrogate	  marker	  for	  the	  number	  of	  neuronally	  
differentiated	  cells,	  would	  therefore	  agree	  with	  this	  result.	  
	  
No	   such	   synergistic	   reactions	   to	   GDNF	   and	   EDN3	   addition	  were	   found	   in	   either	  
NMNS	  or	  NHNS,	  although	  the	  effect	  of	  the	  addition	  of	  GDNF	  to	  NHNS	  was	  striking.	  	  
It	   is	   not	   clear	   why	   inhibiting	   GDNF	   function	   in	   NMNS	   should	   increase	   neurite	  
production;	   this	  may	   indicate	   a	   developmental	   or	   species-­‐specific	   difference,	   as	  
neonatal	  mice	  are	  not	  as	  developmentally	  mature	  as	  human	  neonates.	  	  	  
	  
Another	   possibility	   is	   that	   because	   the	  NHNS	   used	   in	   these	   sets	   of	   experiments	  
were	  all	  derived	  from	  patients	  with	  HSCR,	  there	  is	  a	  GDNF	  dependence	  on	  neurite	  
production	  because	  of	  some	  RET	  pathway	  abnormality	  that	  has	  contributed	  to	  the	  
development	  of	  HSCR.	  	  Against	  this	  argument	  is	  that	  the	  original	  observations	  on	  
neurite	  outgrowth	  (Figure	  3.1)	  and	  pilot	  study	  about	  neurite	  outgrowth	  in	  human	  
neonatal	   neurospheres	   were	   made	   in	   samples	   15,	   17	   and	   26:	   	   in	   other	   words	  
there	  was	  no	  observed	  difference	  between	   the	  behaviour	  of	   the	   two	  subsets	  of	  
neurospheres	   (from	   non-­‐HSCR	   and	  HSCR	   bowel	   samples)	   as	   they	   both	   required	  
GDNF	  to	  produce	  significant	  numbers	  of	  neurospheres.	   	  This	   is	  however	  an	  area	  
that	   would	   require	   a	   confirmatory	   study	   to	   prove	   this	   hypothesis,	   but	   even	   if	  
there	   is	   no	   such	   dependence	   in	   other	   non-­‐HSCR	   samples	   this	   finding	   is	   still	  
important	   for	   the	   development	   of	   an	   autologous	   stem	   cell	   based	   therapy	   for	  
HSCR.	  
	  
3.3.3.4	  	  Response	  of	  neurosphere	  mitotic	  rate	  to	  growth	  factors	  
	  
Due	  to	  the	  high	  cell	  density	  found	  within	  the	  neurosphere,	  it	  was	  not	  possible	  to	  
employ	   a	   dual	   labelling	   technique	   to	   allow	   analysis	   of	   individual	   cell	   type	   and	  
number.	  	  Therefore	  it	  is	  not	  possible	  to	  say	  whether	  the	  mitotic	  cells	  seen	  within	  
the	   neurosphere	   were	   ENSPC	   or	   more	   differentiated	   neurons	   and	   glia.	   	   Using	  
confocal	  microscopy	   and	   fluorescent	   labelling	   for	   RET,	   PHH3,	   TUJ-­‐1	   (a	   neuronal	  
marker)	   and	   a	   nuclear	   dye,	   Barlow	   et	   al(Barlow	   et	   al.,	   2003)	   identified	   ENSC	   as	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RET+	  /	   	  TUJ-­‐1	   -­‐	  and	  neuroblasts	  as	  RET	  +	  /	  TUJ-­‐1	  +;	  as	  discussed	   in	  section	  2.1.1	  
RET	  reactivity	   is	  a	  useful	  early	  marker	  of	  ENSC	   lineage	  but	   is	  not	  appropriate	  for	  
later	   identification	  due	   to	   the	  potential	   reactivity	  of	  differentiated	  neurons,	  and	  
again	   this	   classification	   is	   essentially	   presumptive.	   	   The	   later	   identification	   of	  
mitotic	  nestin	  +	  cells	  in	  NHNS	  in	  the	  absence	  of	  glial	  cells	  (section	  3.4.2.3)	  would	  
imply	  that	  the	  majority	  of	  mitotic	  cells	  at	  least	  in	  the	  NHNS	  are	  ENSC	  in	  origin.	  	  It	  
is	  also	  not	  possible	   to	  comment	  on	  the	  ratio	  of	  neurons	   to	  glia	  produced	  within	  
the	  neurosphere	  using	  these	  methods.	  	  	  
	  
The	  effect	  of	  GDNF	  of	  stimulating	  mitosis	   in	  EMNS	  but	  not	   in	  neonatally	  derived	  
neurospheres	  would	  appear	  to	  be	  a	  developmental	  difference	  as	  is	  it	  consistent	  in	  
NMNS	   and	   NHNS.	   	   Likewise,	   the	   effect	   of	   EDN3	   in	   stimulating	   mitotic	   rate	   in	  
neonatal	  neurospheres	   is	   consistent.	   	   This	  EMNS	  data	  appears	   to	   contradict	   the	  
findings	  discussed	  above,	  where	  GDNF	  and	  EDN3	  produce	  a	  synergistic	  increase	  in	  
the	  mitotic	  rate	  of	  ENSC(Barlow	  et	  al.,	  2003).	  	  However,	  these	  experiments	  were	  
not	  performed	  in	  neurospheres	  and	  it	   is	  quite	  possible	  that	  although	  the	  mitotic	  
rate	   of	   undifferentiated	   cells	   has	   increased,	   the	   rate	   of	   more	   differentiated	  
neuroblasts	  (which	  respond	  to	  GDNF)	  is	  decreased.	  	  The	  dependence	  of	  neonatal	  
neurosphere	  mitosis	  on	  EDN3	  is	  an	  interesting	  and	  new	  finding.	  	  This	  may	  reflect	  a	  
relative	   lack	   of	   EDN3	   in	   neonatal	   neurospheres	   as	   opposed	   to	   embryonic	  
neurospheres,	   perhaps	   due	   to	   a	   lack	   of	   other	   cell	   types	   secreting	   this	   growth	  
factor.	   	   It	   may	   also	   be	   that	   in	   neonatal	   ENSC,	   EDN3	   is	   crucial	   in	   promoting	   or	  
maintaining	  an	  undifferentiated	  state.	  
	  
This	   finding	   will	   clearly	   be	   of	   interest	   in	   the	   development	   of	   ENSC-­‐based	  
treatments	  for	  HSCR	  and	  other	  ENS	  disorders.	  
	  
3.3.3.5	  	  Conclusion	  
	  
The	   results	   of	   experiments	   3.2.1	   demonstrate	   both	   developmental	   and	   species-­‐
specific	   differences	   in	   the	   response	   of	   neurospheres	   to	   growth	   factors	   found	   in	  
the	   developing	   gut	   wall	   environment.	   	   They	   provide	   further	   evidence	   for	   an	  
interaction	   between	   GDNF	   and	   EDN3	   signalling	   in	   embryonic	   mouse	   ENSPC,	  
demonstrate	   that	   NHNS	   require	   GDNF	   production	   for	   significant	   neurite	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outgrowth	   and	   that	   the	   regulation	   of	   mitotic	   rate	   in	   neonatally-­‐derived	  
neurospheres	  is	  under	  the	  control	  of	  EDN3	  rather	  than	  GDNF.	  
	  
3.4	  	  Generation	  and	  properties	  of	  secondary	  and	  tertiary	  
neurospheres	  
	  
As	  previously	  described	  in	  chapter	  2,	  it	  was	  possible	  to	  generate	  a	  low	  number	  of	  
secondary	   neurospheres	   when	   a	   primary	   neurosphere	   was	   dissociated	   and	   the	  
cells	  grown	  at	  clonal	  density.	  	  There	  is	  evidence	  within	  the	  literature	  that	  the	  yield	  
of	  neurosphere	  number	  is	  proportional	  to	  the	  original	  cell	  density(Campos,	  2004),	  
and	   that	   increasing	   the	   cell	   density	   therefore	   increased	   the	   numbers	   of	  
neurospheres	   generated.	   	   The	   reasons	   for	   this	   are	   not	   clear.	   	   In	   this	   series	   of	  
experiments,	   secondary	   and	   tertiary	   neurospheres	  were	   generated	   using	   higher	  
cell	  densities.	  	  
	  
3.4.1	  	  Method	  
	  
3.4.1.1	  	  Generation	  of	  secondary	  neurospheres	  
	  
The	  following	  experiments	  used	  neurospheres	  generated	  from	  bowel	  samples	  40	  
and	  41.	   	  10	  primary	  neurospheres	  were	  selected	  after	  30	  days	  growth	   in	  culture	  
and	  collected	  using	  a	  sterile	  100µl	  pipette.	  	  They	  were	  rinsed	  in	  PBS	  and	  placed	  in	  
2mls	   0.05%	   trypsin	   in	   PBS	   for	   20minutes.	   	   The	   sample	  was	   then	   centrifuged	   at	  
120G	   for	   2	  mins,	   the	   trypsin	   removed	   and	   replaced	  with	   2mls	   standard	   culture	  
medium.	   	   The	   sample	   was	   triturated	   using	   a	   1ml	   transfer	   pipette	   until	   the	  
neurospheres	  were	   dissociated.	   	   The	   suspension	  was	   then	   cultured	   in	   standard	  
neurosphere	   culture	   medium	   in	   a	   35mm	   petri	   dish.	   	   The	   number	   of	   new	  
neurospheres	  present	  was	  assessed	  at	  0,	  7,	  14,	  21	  and	  28	  days.	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3.4.1.2	  	  Generation	  of	  tertiary	  neurospheres	  
	  
Tertiary	   neurospheres	   were	   generated	   by	   selecting	   10	   secondary	   neurospheres	  
and	  subjecting	  them	  to	  the	  same	  dissociation	  and	  reculture	  as	  for	  the	  generation	  
of	  secondary	  neurospheres.	  	  Neurospheres	  were	  again	  counted	  at	  the	  time	  points	  
described	   above.	   	   Secondary	   and	   tertiary	   neurospheres	  were	   generated	   from	   3	  
separate	  samples.	  
	  
3.4.1.3	  	  Expression	  of	  p75,	  PGP9.5	  and	  S100	  
	  
Primary,	  secondary	  and	  tertiary	  neurospheres	  were	  selected	  after	  28	  days	  growth,	  
fixed	  and	  cut	  into	  7µm	  frozen	  sections	  as	  described	  in	  section	  2.4.1.2.	  	  They	  were	  
stained	  for	  p75,	  PGP9.5	  andS100	  as	  described	  in	  this	  section.	  
	  
To	   quantify	   differences	   in	   expression	   of	   these	   markers	   between	   neurospheres,	  
the	   ImageJ	   (Rasband,	   W.S.,	   U.	   S.	   National	   Institutes	   of	   Health,	   Bethesda,	  
Maryland,	   USA,	   http://rsb.info.nih.gov/ij/)	   program	   was	   employed.	   	   This	   is	   an	  
open	   source	   image	   processing	   software	   package	   that	   allows	   the	   area	   of	  
fluorescent	  staining	  to	  be	  measured	  using	  imported	  image	  files.	  
	  
To	   standardise	   measurements,	   all	   images	   of	   neurospheres	   were	   taken	  
immediately	  after	  staining	  using	  the	  same	  camera	  settings.	  	  The	  ImageJ	  automatic	  
thresholding	  routine	  was	  used	  to	  avoid	  bias	   introduced	  by	  an	  observer	  manually	  
setting	   the	   image	   threshold,	  as	   this	  alters	   the	  proportion	  of	   staining	  counted	  by	  
the	   program.	   	   At	   least	   5	   neurospheres	   were	   assessed	   for	   each	   category.	   	   The	  
proportion	   of	   positive	   staining	   for	   each	   neurosphere	   was	   expressed	   as	   a	  
percentage	  of	  total	  neurosphere	  area.	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3.4.1.4	  	  Expression	  of	  nestin	  and	  phosphohistone	  H3	  
	  
Secondary	  human	  neonatal	  neurospheres	  were	  assessed	  for	  co-­‐expression	  of	  the	  
ENSC	   stem	   cell	   marker	   nestin	   and	   the	   mitotic	   marker	   phosphohistone	   H3.	  	  
Neurospheres	   were	   prepared	   and	   sectioned	   as	   previously	   described.	   	   A	   dual	  
immunofluorescence	   technique	   was	   performed.	   	   	   Anti-­‐phosphohistone	   H3	  
antibody	   (Upstate,	   Lake	   Placid,	   USA)	   in	   0.2%	   (v/v)	   triton	   (Sigma-­‐Aldrich)	   was	  
applied	  at	  a	  dilution	  of	  1:100	  overnight	  at	  4oC.	   	  After	  rinsing	  three	  times	   in	  PBS,	  
anti-­‐rabbit-­‐FITC	   (1:200)	   was	   applied	   for	   2	   hours.	   	   After	   rinsing	   in	   PBS,	   mouse	  
monoclonal	  anti-­‐nestin	  antibody	  (Abcam)	  was	  then	  applied	  at	  a	  dilution	  of	  1:200	  
and	   again	   incubated	   overnight.	   	   Following	   rinsing	   in	   PBS,	   secondary	   anti-­‐mouse	  
Texas	  Red	  (Abcam,	  Cambridge,	  UK)	  was	  applied	  at	  1:400	  for	  2	  hours).	  	  The	  slides	  
were	   rinsed	   and	   mounted	   with	   Dako	   fluorescent	   mounting	   medium	   (DAKO	   UK	  
Ltd,	  Ely,	  UK).	  	  	  Negative	  controls	  omitted	  both	  primary	  antibodies.	  
	  
3.4.1.5	   	   Transplantation	   of	   secondary	   and	   tertiary	   neurospheres	   into	  
embryonic	  mouse	  colon	  
	  
These	   experiments	   used	   samples	   40,	   42	   and	   43.	   	   Tertiary	   neonatal	   human	  
neurospheres	  were	   transplanted	   into	  murine	  aganglionic	  embryonic	  distal	   colon	  
as	   previously	   described	   (section	   2.5.1.4).	   	   In	   summary,	   neurospheres	   were	  
collected	   after	   28	   days	   in	   culture	   and	   transplanted	   into	   distal	   hindgut	   removed	  
from	  CD-­‐1	  mouse	  embryos	  at	  11.5	  days	  of	  gestation.	  	  The	  transplanted	  bowel	  was	  
then	  cultured	  for	  10	  days	  following	  which	  the	  transplanted	  bowel	  was	  processed	  
for	   immunofluorescence	   as	   described	   above.	   Ungrafted	   distal	   hindgut	   was	   also	  
cultured	  as	   a	   control	   and	  assessed	  as	   above	   to	  ensure	   that	   all	   neurons	   and	  glia	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3.4.2	  	  Results	  
	  
3.4.2.1	  	  Generation	  of	  secondary	  neurospheres	  
	  
After	  dissociation	  and	  culture	  of	  primary	  neurospheres	  at	  a	  much	  higher	  density	  
(0.5x106	  cells/ml)	  than	  clonal	  density,	  neurospheres	  appeared	  to	  form.	  	  These	  are	  
shown	   in	   Figure	   3.7A-­‐E.	   	   Adhesion	   of	   cells	   to	   the	   petri	   dish	   appeared	   to	   be	   an	  
important	   step	   (Figure	   3.7B)	   and	   after	   14	   days	   neurospheres	   like	   bodies	   were	  
apparent	  (Figure	  3.7C).	  	  Neurosphere	  number	  and	  size	  continued	  to	  expand	  until	  
day	  28.	  	  Neurosphere	  numbers	  per	  35mm	  petri	  dish	  at	  day	  28	  are	  shown	  in	  Figure	  
3.8.	   	   The	   number	   of	   neurospheres	   produced	   by	   this	   method	   expands	  
exponentially.	  	  	  	  
	  
3.4.2.2	  	  Generation	  of	  tertiary	  neurospheres	  
	  
Tertiary	   neurospheres	   formed	   from	   secondary	   neurospheres	   in	   an	   identical	  
fashion.	   	   Pictures	  of	  neurospheres	   at	  day	  28	  are	   shown	   in	   Figure	  3.7F.	   	   Tertiary	  
neurospheres	   could	   also	   be	   seen	   to	   form	   neurites,	   indicating	   preservation	   of	  
neurogenic	   potential	   despite	   two	   cycles	   of	   dissociation	   and	   regrowth	   (Figures	  
3.7G	  and	  H).	  	  	  
	  
	   	  

Figure 3.8 Neurosphere number expansion
Figure 3.8:  Graph showing neurosphere number following dissociation of 10 
primary neurospheres and subsequent numbers of secondary and tertiary neuro-
spheres produced.  Growth is exponential with the dotted line representing the 
exponential function y=e(2x) where x=1 for primary neurospheres, 2 for secondary 
neurospheres and 3 for tertiary neurospheres.
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3.4.2.3	  	  Expression	  of	  p75,	  PGP9.5	  and	  S100	  
	  
Representative	   images	  of	  primary,	   secondary	  and	  tertiary	  neurospheres	   for	  p75,	  
PGP9.5	   and	   S100	   are	   shown	   in	   Figure	   3.9.	   	   It	   is	   appears	   that	   p75	   expression	   is	  
increased	   in	   secondary	   and	   tertiary	   neurospheres	   but	   that	   S100	   expression	   is	  
absent.	   	   These	   impressions	   are	   confirmed	   by	   quantitative	   analysis	   using	   the	  
ImageJ	   software:	   	   the	   results	   are	   shown	   in	   Figure	   3.10.	   	   Tertiary	   neurospheres	  
showed	  a	  significant	   increase	   in	  the	  proportion	  of	  p75	  staining	   (61%	  vs.	  24%	  for	  
primary	  neurospheres	  p<0.05)	  but	  a	  significant	  decrease	  in	  the	  proportion	  of	  S100	  
staining	  (0%	  vs.	  0.5%	  for	  primary	  neurospheres,	  p<0.05).	  
	  
3.4.2.4	  	  Expression	  of	  nestin	  and	  phosphohistone	  H3	  
	  
The	   results	   of	   the	   dual	   labelling	   for	   nestin	   and	   PHH3	   are	   shown	   in	   Figure	   3.11.	  	  
These	   demonstrate	   extensive	   nestin	   staining	   in	   secondary	   neurospheres	   with	  
occasional	   mitotically	   active	   cells.	   	   Many	   of	   the	   mitotic	   cells	   are	   also	   nestin	  
positive	  (Figures	  3.11C	  and	  D)	  but	  mitotic	  cells	  seemed	  more	  generally	  distributed	  
through	   the	   neurosphere,	   in	   comparison	   to	   the	   peripheral	   location	   in	   EMNS	  
(Figure	  3.11A	  and	  B).	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3.4.2.5	   	   Transplantation	   of	   secondary	   and	   tertiary	   neurospheres	   into	  
embryonic	  mouse	  colon	  
	  
Secondary	   and	   tertiary	   neurospheres	   could	   be	   successfully	   grafted	   into	   murine	  
aganglionic	  distal	  hindgut	  and	  grown	  in	  culture	  for	  10	  days.	  Immunofluorescence	  
for	  PGP9.5	  revealed	  extensive	  reactivity	  within	  the	  neurosphere	  but	  also	   in	  cells	  
migrating	  away	  from	  the	  neurosphere	  (Fig	  3.12A).	  	  Immunofluorescence	  for	  S100	  
demonstrated	   a	   lack	   of	   reactivity	   within	   the	   neurosphere	   but	   reactivity	   in	   cells	  
migrating	   from	   the	   site	   of	   transplanted	   neurosphere	   (Fig	   3.12B).	   Aganglionic	  
controls	  were	  PGP9.5	  and	  S100-­‐negative	  (data	  as	  previously	  shown).	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3.4.3	  	  Discussion	  
	  
3.4.3.1	   	   Expansion	   of	   neurosphere	   numbers	   as	   secondary	   and	   tertiary	  
neurospheres	  
	  
The	  fact	  that	  secondary	  and	  tertiary	  neurospheres	  could	  be	  formed	  from	  primary	  
NHNS	   in	   exponentially	   expanding	   numbers	   is	   (albeit	   inconclusive)	   evidence	   that	  
true	  ENSC	  are	  present	  within	  the	  original	  neurospheres.	  	  It	  is	  however	  interesting	  
that	  attempts	  to	  generate	  neurospheres	  at	  clonal	  density	   failed.	   	  This	  raises	  two	  
possibilities.	   	   Firstly,	   the	   “neurosphere”	   expansion	   apparently	   seen	   is	   due	   to	  
aggregation	   of	   dispersed	   cells	   rather	   than	   clonal	   expansion	   of	   stem/progenitor	  
cells.	   	   Such	   limitations	   of	   the	   neurosphere	   assay	   are	   discussed	  by	  Reynolds	   and	  
Rietze(Reynolds	   and	   Rietze,	   2005).	   	   It	   seems	   logical	   that	   at	   high	   densities,	   such	  
aggregation	  must	   take	   pace,	   but	   it	   does	   not	   explain	   the	   exponential	   growth	   of	  
neurosphere	  number,	  nor	  the	  increase	  in	  p75	  staining	  seen	  between	  primary	  and	  
tertiary	  neurospheres.	   	  An	  alternative	  explanation	   is	   that	  postnatal	  human	  ENSC	  
are	   limited	   in	   their	   capacity	   for	   self-­‐renewal	   and	   require	   supporting	  
cells/messages	   to	   divide	   and	   grow.	   	   It	   is	   apparent	   that	   more	   work	   in	   this	   area	  
would	  be	  needed	  to	  develop	  the	  expansion	  of	  such	  neurospheres	  for	  therapeutic	  
use.	  
	  
3.4.3.2	  	  Changes	  in	  expression	  of	  p75,	  PGP9.5	  and	  S100	  
	  
3.4.3.2.1	  	  Validity	  of	  quantitative	  analysis	  using	  the	  imageJ	  program	  
	  
The	   imagej	   program	   is	   widely	   used	   in	   the	   quantitative	   analysis	   of	  
immunofluorescence	   (e.g.	   (Kim	   et	   al.,	   2008)).	   	   Important	   sources	   of	   error	  when	  
using	  this	  technique	  are	  differing	  camera	  settings	  and	  the	  thresholding	  technique	  
used	   to	   identify	   a	   cut-­‐off	   between	   stained	   and	   unstained	   areas(Inman	   et	   al.,	  
2005).	   	  To	  minimise	  these	  errors,	  all	  settings	  were	  identical	  when	  photographing	  
the	  neurospheres	  and	   the	  same	  automated	   thresholding	   routine	  was	  employed.	  	  
The	   final	   check	  of	   consistency	  must	   be	  done	  manually	   and	   the	   results	   obtained	  
using	  imageJ	  agree	  with	  the	  qualitative	  results	  shown	  in	  Figure	  3.9.	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3.4.3.2.2	  	  Differences	  in	  cell	  marker	  expression	  
	  
The	   fact	   that	   p75	   expression	   increases	   in	   secondary	   and	   tertiary	   neurospheres	  
without	   a	   corresponding	   increase	   in	   glial	   cell	  markers	   is	   strong	   evidence	   that	   a	  
population	  of	   ENS	  progenitors	   or	   stem	   cells	   is	   increasing.	   	   The	   results	   shown	   in	  
Figure	   3.11,	   of	   a	   nestin-­‐positive	   cell	   undergoing	   mitosis	   in	   secondary	  
neurospheres,	  also	  support	  this	  hypothesis.	  	  	  
	  
It	  is	  interesting	  however	  that	  the	  proportion	  of	  S100	  positive	  cells	  decreases.	  	  This	  
may	  mean	   that	   there	   are	   not	   true	   ENSC	   present	   within	   the	   neurospheres,	   and	  
that	  only	  neuroblasts	  can	  be	  generated	  in	  subsequent	  generations.	  	  However,	  the	  
fact	  that	  S100	  positive	  cells	  are	  generated	  when	  the	  neurosphere	  is	  transplanted	  
suggests	  that	  there	  is	  in	  fact	  no	  loss	  of	  differentiative	  potential.	  	  It	  may	  therefore	  
be	   that	   the	   neurosphere	   microenvironment	   is	   simply	   not	   appropriate	   for	   the	  
differentiation	  of	  glial	  cells,	  and	  this	  is	  rectified	  on	  transplantation	  into	  embryonic	  
bowel.	   	   The	  bulk	   of	   research	   into	   ENS	  development	   has	   concentrated	  on	  which	  
factors	  are	  neurogenic;	  the	  assumption	  being	  that	  in	  the	  absence	  of	  these	  factors	  
glial	   differentiation	   occurs.	   	   There	   is	   little	   evidence	   to	   support	   this	   hypothesis.	  	  
The	   area	   of	   glial	   differentiation	   is	   therefore	   one	   which	   will	   require	   further	  
research	   if	   the	   generation	   of	   glial	   cells	   is	   impaired	   after	   transplantation	   into	   a	  
more	   mature	   gut	   environment,	   as	   it	   is	   known	   that	   glial	   cells	   have	   a	   role	   in	  
maintaining	  the	  neurotransmitter	  balance	  of	  mature	  and	  developing	  bowel(Aube	  
et	  al.,	  2006).	  
	  
The	   lack	  of	   glial	  marker	  expression	   is	   important	  when	  considering	   the	   results	  of	  
nestin	  expression.	  	  As	  mentioned	  in	  Chapter	  2,	  the	  confounding	  cell	  types	  within	  
the	  gut	   that	  express	  nestin	   in	  addition	  to	  ENSC	  are	  glia	  and	   ICC.	   	  As	  NHNS	  were	  
also	   found	   to	   have	   low	   levels	   of	   c-­‐Kit	   expression	   (see	   Chapter	   2.5.2.2),	   it	   can	  
therefore	  be	  concluded	  that	  the	  nestin	  reactivity	  seen	  here	  is	  due	  to	  the	  presence	  
of	   ENSC,	   and	   that	   these	   cells	   are	   mitotically	   active	   within	   the	   neurosphere,	   in	  
agreement	  with	  the	  BrdU	  reactivity	  seen	  in	  Chapter	  2.	  	  	  
	  
	   161	  
A	   criticism	   of	   the	   technique	   employed	   in	   experiment	   3.4.1.5	   is	   that	   no	   dual	  
labelling	   of	   PGP9.5/	   S100B	   and	   a	   marker	   for	   human	   cells	   (such	   HRNP)	   was	  
performed,	   raising	   the	   possibility	   that	   the	   reactivity	   seen	   is	   due	   to	   presence	   of	  
cells	  within	   the	   aganglionic	   hindgut	   sample	   rather	   than	   those	  deriving	   from	   the	  
engrafted	   neurosphere.	   	   Although	   this	   possible,	   the	   locality	   of	   reactivity	   to	   the	  
region	   of	   the	   neurosphere,	   and	   the	   previously	   documented	   lack	   of	   reactivity	   in	  
ungrafted	  aganglionic	  samples	  both	  make	  this	  unlikely.	  	  A	  definitive	  answer	  would	  
require	   the	   repetition	   of	   these	   experiments	  with	   further	   dual	   labelling	   or	   some	  
other	  marking	  technique.	  
	  
Nevertheless,	  whether	  NHNS	  contain	  ENSC	  or	  more	  differentiated	  precursors,	  and	  
whether	   they	   are	   capable	   of	   producing	   glial	   cells	   in	   secondary	   and	   tertiary	  
neurospheres,	   is	   pragmatically	   not	   as	   relevant	   as	   whether	   they	   are	   capable	   of	  
inducing	  a	  functional	  change	  in	  the	  bowel	  they	  are	  transplanted	  into.	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  Chapter	  4:	  	  Effects	  of	  human	  neurosphere	  transplantation	  
	  
4.1	  	  Introduction	  
	  
In	   Chapter	   2,	   it	   was	   demonstrated	   that	   neonatally	   derived	   human	   ENS	  
neurospheres	  would	  engraft	   into	   aganglionic	   embryonic	  mouse	  hindgut	   isolated	  
at	   E11.5	   and	   grown	   in	   tissue	   culture.	   	   In	   Chapter	   3	   it	   was	   shown	   that	   such	  
neurospheres	  respond	  to	  GDNF	  and	  END3,	  which	  are	  growth	  factors	  found	  in	  the	  
developing	   ENS	   environment,	   and	   the	   capacity	   of	   these	   neurospheres	   to	   grow	  
exponentially	   when	   dissociated	   into	   secondary	   and	   tertiary	   neurospheres	  
provides	  further	  evidence	  of	  their	  ENSC	  content.	  	  	  	  However,	  when	  considering	  a	  
potential	   stem	   cell	   treatment	   for	   Hirschsprung’s	   disease,	   the	   key	   ability	   of	  
neurosphere-­‐derived	  cells	  would	  be	  to	  integrate	  with	  the	  existing	  smooth	  muscle	  
and	  ICC	  of	  the	  recipient	  bowel	  and	  produce	  a	  functional	  change	  in	  the	  aganglionic	  
bowel	  they	  are	  grafted	  into.	  	  This	  chapter	  begins	  this	  assessment.	  
	  
4.1.1	  	  A	  note	  on	  the	  attribution	  of	  work	  in	  this	  chapter	  
	  
The	  work	  described	  in	  this	  chapter	  arose	  out	  of	  close	  collaboration	  with	  another	  
investigator,	   Dr	   D	   Hawcutt.	   	   The	   initial	   design	   of	   the	   experiments	   to	   measure	  
bowel	   contractility	   was	   done	   myself,	   and	   generated	   the	   human	   neurospheres	  
used	  in	  the	  transplantation	  experiments.	   	  Dr	  Hawcutt	  and	  I	  were	  jointly	  involved	  
in	   the	   generation	   of	   embryonic	   mouse	   and	   neurospheres	   and	   the	   their	  
transplantation.	  	  We	  also	  conducted	  measurement	  of	  bowel	  contractility	  and	  data	  
analysis	  jointly.	  	  I	  performed	  all	  work	  in	  section	  4.3	  alone.	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4.2	  	  Aims	  
	  
The	   aim	   of	   the	   research	   described	   in	   this	   chapter	   was	   therefore	   to	   assess	   the	  
effect	  of	  neurosphere	  transplantation,	  by	  investigating	  the	  structural	  relationship	  
of	   the	   engrafted	   cells	   with	   endogenous	   ICC,	   signal	   transduction	   mechanisms	  
between	   engrafted	   neurons	   and	   endogenous	   cells	   and	   the	   functional	   effect	   of	  
transplantation	  by	  measuring	  any	  change	   in	  the	  frequency	  of	  bowel	  contraction.	  	  	  
As	  these	  experiments	  are	  closely	  related	  and	  results	  from	  the	  structural	  data	  are	  
key	  to	  validating	  the	  model	  used	  for	  analysing	  functional	  outcome,	  the	  discussion	  
for	  all	  experiments	  is	  to	  be	  found	  at	  the	  end	  of	  this	  chapter	  after	  the	  descriptions	  
of	  methods	  and	  results.	  	  
	  
4.3	  	  Structural	  integration	  of	  transplanted	  NHNS	  neurons	  
	  
4.3.1	  	  Method	  
	  
Bowel	  explant	  cultures	  
	  
Time	   mated	   CD-­‐1	   mice	   (Charles	   River	   Laboratories	   UK	   Ltd,	   Kent,	   UK)	   were	  
sacrificed	  by	  cervical	  dislocation	  at	  embryonic	  day	  (E)	  11.5	  in	  accordance	  with	  UK	  
Home	   Office	   regulations.	   	   As	   described	   in	   Chapter	   2.5.1.4	   and	   Figure	   2.7,	  
ganglionic	  and	  aganglionic	  bowel	  explants	  were	  generated	  from	  the	  distal	  colon.	  	  
A	   maximum	   of	   4	   explants	   were	   transferred	   onto	   0.4	   μm	   semi-­‐permeable	  
membrane	   culture	   plate	   inserts	   (Millipore	   UK	   Ltd,	  Watford,	   UK)	   in	   50mm	   Petri	  
dishes	  (Sarstedt	  Ltd,	  Leicester,	  UK).	  	  Dishes	  contained	  3ml	  standard	  tissue	  culture	  
medium	  comprising	  HEPES-­‐buffered	  Dulbecco’s	  modified	  Eagle	  medium	  (DMEM)	  
with	   4500	   mg/l	   glucose,	   1%	   (v/v)	   fetal	   bovine	   serum,	   100	   U/ml	   penicillin,	   100	  
µg/ml	  streptomycin,	  2mM	  glutamine	  and	  0.05	  mM	  2-­‐mercaptoethanol,	   (all	   from	  
Gibco	   Invitrogen,	   Paisley,	   UK),	   and	   were	   incubated	   at	   37ºC	   in	   a	   humidified	   5%	  
(v/v)	  CO2atmosphere.	  	  The	  medium	  was	  changed	  every	  2	  days	  and	  also	  one	  hour	  
before	  measurement	  of	  contractility.	  	  	  
	  
	   164	  
Neurosphere	  generation	  and	  transplantation	  	  
	  
Embryonic	   mouse	   neurospheres	   (EMNS)	   and	   neonatal	   human	   neurospheres	  
(NHNS)	   were	   generated	   as	   previously	   described	   in	   Chapters	   2.3	   and	   2.4.	  	  
Mechanical	   dissection	   and	   enzymatic	   dissociation	  were	   used	   to	   generate	   single	  
cell	   suspensions	  containing	  ENSPC	   from	  embryonic	  mouse	  and	  postnatal	  human	  
bowel	   samples	   from	   five	   patients:	   3	   with	   HSCR	   (samples	   28,	   41	   and	   42)(tissue	  
from	  ganglionic	   bowel	   including	   either	   sigmoid	   colon	   or	   terminal	   ileum),	   1	  with	  
imperforate	  anus	  (sample	  17)	  and	  1	  with	  colonic	  atresia	  (sample	  19).	  	  The	  human	  
ENSPC	  were	  cultured	   in	  standard	  neurosphere	  culture	  medium.	   	  Single	  EMNS	  or	  
NHNS	  that	  had	  been	  cultured	   for	  a	  minimum	  of	  21	  days(for	  EMNS)	  and	  28	  days	  
(NHNS)	   were	   apposed	   to	   the	   proximal	   end	   of	   the	   E11.5	   mouse	   isolated	   distal	  




Specimens	  were	  fixed	  in	  acetone	  at	  -­‐20oC	  for	  20	  minutes	  and	  then	  rinsed	  with	  PBS	  
before	  embedding	  in	  7.5%	  (w/v)	  gelatine	  (Sigma-­‐Aldrich)	  in	  15%	  (w/v)	  sucrose	  and	  
immediate	  freezing	  at	  -­‐80oC	  in	  isopentane	  (Sigma-­‐Aldrich).	   	  Serial	  sections	  (7μm)	  
were	  cut	  using	  a	  cryostat.	  	  For	  immunostaining,	  samples	  were	  pre-­‐treated	  for	  30	  
min	  with	  phosphate	  buffered	  saline	  PBS	  containing	  1%	  (w/v)	  goat	  serum	  (Sigma-­‐
Aldrich)	   and	   0.5%	   (w/v)	   Triton	   X100	   (VWR	   International	   Ltd,	   Lutterworth,	   UK).	  	  
Primary	  antisera	  were	  applied	  at	  the	  following	  concentrations:	  rabbit	  anti-­‐protein	  
gene-­‐product	  9.5	  (PGP9.5,	  Biogenesis	  Ltd,	  Poole,	  UK)	  1:4000,	  mouse	  anti-­‐smooth	  
muscle	  actin	  conjugated	  with	  Cy3	  (SMA,	  Sigma-­‐Aldrich)	  1:1200	  and	  rat	  anti-­‐mouse	  
c-­‐Kit	   (ACK-­‐2,	  Chemicon	   International)	  1:50.	   	  For	  c-­‐Kit/PGP9.5	  dual	   labelling,	  both	  
primary	  antibodies	  were	  applied	  together	  for	  16	  hours	  at	  4oC.	  	  For	  c-­‐Kit/SMA	  dual	  
labelling,	   the	   c-­‐Kit	   primary	   antibody	  was	   applied	   for	   16	   hours	   at	   4oC,	   incubated	  
with	  the	  appropriate	  secondary	  antibody	  and	  rinsed	  three	  times	  with	  PBS,	  before	  
the	  SMA	  primary	  antibody	  was	  applied	   for	  1	  hour	  at	   room	   temperature.	   	   Slides	  
were	  rinsed	  three	  times	  with	  PBS	  before	  incubating	  for	  2	  hours	  with	  appropriate	  
secondary	  antisera:	  Texas	  Red	  conjugated	  sheep	  anti-­‐rabbit	   (Abcam,	  Cambridge,	  
UK)	   1:400	   and	   Alexa-­‐Fluor	   488	   conjugated	   goat	   anti-­‐rat	   1:500	   (Sigma-­‐Aldrich).	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After	   rinsing	   with	   PBS,	   the	   samples	   were	   mounted	   using	   DAKO	   fluorescent	  
mounting	  medium	  (DAKO	  UK	  Ltd,	  Ely,	  UK).	  
	  
4.3.1.1	  	  Relationship	  to	  endogenous	  ICC	  and	  smooth	  muscle	  cells	  
	  
As	  detailed	   in	  Chapter	   1,	   there	   are	  3	   key	   functional	   elements	   in	   generating	   and	  
regulating	   contractility	   in	   the	   gut:	   	   the	   smooth	   muscle,	   the	   ICC	   and	   the	   ENS.	  	  
These	   experiments	   therefore	   looked	   at	   the	   interaction	   between	   endogenous	  
smooth	  muscle,	  endogenous	  ICC	  and	  grafted	  neurons.	  
	  
4.3.1.1.1	   	   Development	   of	   ICC	   and	   smooth	   muscle	   	   in	   embryonic	   mouse	  
colon	  
	  
To	  validate	  the	  tissue	  culture	  model	  as	  a	  viable	  one	  for	  the	  study	  of	  neurosphere	  
engraftment,	   it	   was	   necessary	   to	   know	   the	   normal	   development	   of	   ICC	   and	  
smooth	   muscle	   within	   embryonic	   mouse	   distal	   colon.	   	   This	   data	   has	   been	  
described	   previously(Wu	   et	   al.,	   2000)	   but	   was	   repeated	   here	   to	   develop	   and	  
optimise	  the	  staining	  protocol	  before	  looking	  at	  transplanted	  specimens.	  
	  
Time-­‐mated	  CD-­‐1	  pregnant	  mice	  were	  sacrificed	  at	  E10.5,	  E11.5,	  E13.5,	  E15.5,	  and	  
E17.5.	   	   Embryos	   were	   placed	   in	   PBS	   and	   the	   distal	   colon	   dissected	   free	   as	  
described	   in	   Chapter	   2.3.1.1.	   	   At	   E13.5	   onwards	   embryos	   were	   cervically	  
transected	  using	  sharp	  forceps	  before	  further	  dissection.	  	  	  Distal	  colon	  specimens	  
were	  fixed	  in	  acetone	  and	  stained	  as	  described	  above.	  
	  
To	   act	   as	   a	   positive	   control,	   neonatal	   distal	   colon	   was	   removed	   from	   day	   0	  
newborn	   CD-­‐1	   mice	   (E19.5	   equivalent)	   after	   they	   were	   sacrificed	   by	   cervical	  
dislocation.	   	   The	   bowel	   was	   opened	   and	   cleared	   of	   stool	   before	   rinsing	   three	  
times	   in	  PBS	  and	   fixing	   in	  acetone	  at	   -­‐20oC	   for	  30minutes.	   	  The	  bowel	  specimen	  
was	  then	  embedded	  in	  gelatine,	  sectioned	  and	  stained	  as	  detailed	  above.	  
	  
After	  sectioning,	   the	  bowel	  was	  pre-­‐treated	  for	  30	  min	  with	  phosphate	  buffered	  
saline	  PBS	  containing	  1%	  (w/v)	  goat	  serum	  (Sigma-­‐Aldrich)	  and	  then	  stained	  for	  c-­‐
kit	  using	  rat	  anti-­‐mouse	  monoclonal	  antibody	  ACK-­‐2	  (Chemicon,	  1:50,	  overnight	  at	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4oC)	   with	   goat	   anti-­‐rat	   conjugated	   FITC	   antibody	   (Abcam,	   2	   hours,	   room	  
temperature)	   as	   a	   secondary	   antibody	   and	   3	  washes	   for	   PBS	   after	   the	   required	  
duration	   of	   antibody	   incubation.	   	   Slides	   were	   mounted	   and	   examined	   as	  
described	  previously.	   	  Smooth	  muscle	  staining	  was	  performed	  using	  mouse	  anti-­‐
smooth	  muscle	  actin	  conjugated	  with	  Cy3	  (SMA,	  Sigma-­‐Aldrich	  1:1200)	  incubated	  
overnight	  at	  4oC	  before	  washing	  three	  times	  with	  PBS	  and	  mounting.	  
	  
Dual	  labeling	  was	  performed	  as	  follows:	  	  initially	  the	  c-­‐kit	  antibody	  was	  applied	  as	  
described	   above	   and	   incubated	   with	   the	   FITC-­‐conjugated	   secondary	   antibody.	  	  
After	  washing	  with	  PBS,	  the	  second	  primary	  antibody	  (PGP9.5,	  Biogenesis,	  1:4000,	  
or	   SMA,	   Sigma-­‐Aldrich,	   1:1200)	  was	   applied	   overnight	   at	   4oC	   before	  washing	   in	  
PBS.	  	  For	  PGP9.5,	  the	  secondary	  antibody	  anti-­‐rabbit	  Texas	  Red	  1:400	  was	  applied	  
for	  2	  hours	  at	  room	  temperature.	  	  Slides	  were	  washed	  and	  mounted	  as	  usual.	  
	  
Negative	   controls	   consisted	   of	   slides	   where	   both	   primary	   antibodies	   were	  
omitted.	  
	  
4.3.1.1.2	   	   Development	   of	   ICC	   and	   smooth	   muscle	   in	   embryonic	   mouse	  
hindgut	  grown	  in	  tissue	  culture,	  and	  with	  EMNS	  and	  NHNS	  transplantation	  
	  
The	   previous	   experiments	   characterised	   the	   normal	   relationship	   between	  
developing	   embryonic	   mouse	   colon	   and	   both	   ICC,	   smooth	   muscle	   and	   enteric	  
neurons.	  	  The	  following	  experiments	  demonstrate	  the	  relationship	  between	  these	  
structures	  in	  explanted	  hindgut	  grown	  in	  tissue	  culture,	  before	  going	  on	  to	  show	  
how	   transplantation	   of	   neurospheres	   containing	   ENSPC	   affects	   these	  
relationships.	  	  
	  
Distal	   neonatal	   colon	   (E19.5	   equivalent)	   was	   therefore	   compared	   to	   ganglionic	  
distal	   colon,	   aganglionic	   distal	   colon,	   and	   aganglionic	   distal	   colon	   transplanted	  
with	  EMNS	  and	  NHNS	  after	  8	  days	  in	  culture.	  
	  
Slides	   were	   cut	   and	   prepared	   for	   immunofluorescence	   as	   described	   above.	  	  
Labelling	  for	  c-­‐kit/PGP	  and	  c-­‐kit/SMA	  were	  performed	  as	  described	  above.	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4.3.2	  	  Results	  
	  
Explants	  of	   E11.5	   colon	  were	  maintained	   for	  up	   to	  12	  days	   in	   culture,	   8	  days	   in	  
culture	  corresponding	  to	  term	  equivalence	  (E19.5).	  	  During	  this	  time	  the	  explants	  
attached	  loosely	  to	  the	  substrate,	  remained	  viable	  and	  grew.	  	  Most	  of	  the	  culture	  
explants	   curled	   upon	   themselves	   rather	   than	   remaining	   linear,	   but	   we	   did	   not	  
identify	   any	   differences	   in	   sizes	   of	   ganglionic,	   aganglionic	   or	   transplanted	   distal	  
colons	   after	   culture.	   	   Spontaneous	   contractions	   developed	   in	   all	   ganglionic	   and	  
aganglionic	  bowel	  explants	  (Table	  4.1	  and	  see	  below).	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Table	  4.1:	  	  Number	  of	  explants	  exhibiting	  contraction	  after	  8	  days	  culture	  in	  the	  




















control	  Ab	  (%)	  
Ganglionic	  
distal	  colon	  
12/12	  (100)*	   3/4	  (75)	   0/4	  (0)*	   3/4	  (75)	  
Aganglionic	  
distal	  colon	  
12/12	  (100)*	   3/4	  (75)	   0/4	  (0)*	   4/4	  (100)	  
	  
*Significance	   for	   difference	   between	   number	   of	   explants	   contracting	   with	   and	  
without	  addition	  of	  10μg/ml	  anti	  c-­‐Kit	  antibody	  after	  8	  days	  in	  culture:	  	  p<0.05	  for	  
all	  regions,	  Kruskal-­‐Wallis	  test	  with	  Dunn’s	  post-­‐test.	  
	  
4.3.2.1	  	  Relationship	  to	  endogenous	  ICC	  
	  
4.3.2.1.1	   	  Development	  of	  ICC	  and	  smooth	  muscle	   	   in	  muscle	  in	  embryonic	  	  
mouse	  embryonic	  mouse	  colon	  
	  
Figures	   4.1	   and	   4.2	   demonstrate	   the	   evolution	   of	   C-­‐kit	   staining	   in	   the	   mouse	  
embryonic	  hindgut	  in	  addition	  to	  the	  development	  of	  SMA	  reactivity	  (Figure	  4.1)	  
and	   PGP	   (Figure	   4.1).	   	   c-­‐kit	   reactivity	   is	   present	   at	   e11.5	   but	   appears	   diffusely	  
distributed	  within	  the	  bowel	  wall	  (Figures	  4.1A	  and	  4.2A).	  	  At	  e13.5	  c-­‐kit	  reactivity	  
has	   localised	  to	  the	  outer	   layer	  of	   the	  gut	  wall	   (Figures	  4.1D	  and	  4.2D	   .4.2D.	   	  At	  
e11.5,	   SMA	   reactivity	   co-­‐localises	   with	   c-­‐kit	   (Figures	   4.1B	   and	   C),	   and	   at	   e13.5	  
there	   is	   an	   inner	   band	   of	   c-­‐kit	   cells,	   which	   are	   reactive	   for	   both	   SMA	   and	   c-­‐kit	  
(Figure	   4.1F).	   	   With	   further	   development,	   the	   SMA	   and	   c-­‐kit	   staining	   are	  
completely	  independent,	  demonstrating	  the	  common	  smooth	  muscle	  origin	  of	  the	  
ICC	   but	   subsequent	   differentiation	   (Figures	   4.1G-­‐I).	   	   In	   these	   figures	   the	   c-­‐kit	  
population	   continues	   to	  apparently	   reduce	   in	  density	  while	   the	  SMA	  population	  
develops	   into	   two	   distinct	   visible	   bands	   of	   inner	   circular	   and	   outer	   longitudinal	  
muscle.	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At	   e19.5/P0,	   the	   mouse	   distal	   colon	   can	   be	   seen	   to	   have	   a	   very	   narrow	   c-­‐kit	  
population,	  and	   in	  addition	  the	  cells	  develop	  a	  classical	  stellate	  appearance	  with	  
delicate	  processes	  extending	  from	  the	  cells	  (Figures	  4.1G	  and	  4.2G).	  	  Background	  
reactivity	  from	  the	  gut	  mucosa	  becomes	  more	  prominent	  at	  this	  stage	  however.	  	  	  
	  
The	  relationship	  of	  the	  ICC	  to	  PGP	  9.5	  reactive	  ganglia	  can	  be	  seen	  in	  Figure	  4.2.	  	  
Neuronal	   cells	   can	  be	   seen	   to	   fill	   the	  apparent	  voids	   left	  by	   c-­‐kit	   staining	  at	   the	  
level	  of	  the	  myenteric	  plexus	  and	  these	  maintain	  a	  close	  relationship	  to	  the	  ICC	  as	  
the	  number	  of	  c-­‐kit	  reactive	  cells	  decrease	  in	  number	  from	  E11.5	  to	  E19.5.	  
	  
4.3.2.1.2	   	   Development	   of	   ICC	   and	   smooth	   muscle	   in	   embryonic	   mouse	  
colon	  grown	  in	  tissue	  culture,	  and	  with	  EMNS	  and	  NHNS	  transplantation	  
	  
The	   results	   of	   these	   experiments	   are	   shown	   in	   Figures	   4.3,	   4.4	   and	   4.5.	   	   The	  
staining	   pattern	   for	   PGP	   9.5	   and	   c-­‐kit	   in	   ganglionic	   samples	   cultured	   for	   8	   days	  
was	   comparable	   to	   that	   seen	   in	   P0	  neonatal	  mouse	  bowel,	  with	   the	   exceptions	  
that	  the	  cultured	  samples	  lacked	  a	  longitudinal	  muscle	  layer,	  and	  c-­‐Kit	  reactivity	  in	  
cultured	  samples	  was	  confined	  to	  a	  layer	  corresponding	  with	  the	  ICC-­‐MY	  (Figures	  
4.3A-­‐F).	  	  	  
	  
As	  described	  in	  detail	  previously(Almond	  et	  al.,	  2007),	  the	  transplanted	  bowel	  was	  
colonized	  with	  neurosphere	  derived	  cells	  by	  day	  8	  in	  culture	  (Figure	  4.5),	  while	  in	  
the	  control	  aganglionic	  untransplanted	  distal	  colon	  lacked	  neurons	  (Figures	  4.3G).	  	  
The	  distribution	  of	  the	  ICC	  marker	  c-­‐Kit	  was	  also	  similar	  in	  these	  samples,	  with	  c-­‐
Kit	  immunoreactivity	  present	  in	  both	  transplanted	  and	  untransplanted	  aganglionic	  
bowel	   (Figures	  4.3H,	  and	  4.4,	  4.5).	   	   In	  aganglionic	  distal	   colon,	   the	  band	  of	   c-­‐Kit	  
staining	   appeared	   thinner	   than	   in	   ganglionic	   or	   transplanted	   bowel,	   possibly	  
resulting	   from	   the	   lack	  of	   the	  myenteric	  plexus	  around	  which	  c-­‐kit	  positive	   cells	  
usually	  lie	  (Figure	  4.3	  H).	  
	  
	  
	   	  
Figure 4.3 Development of ICC, smooth muscle and neurons  in 





Figure 4.3:  c-kit/PGP 9.5 staining in neonatal mouse bowel and explanted hindgut.  Immunofluo-
resence for c-kit (green) and SMA/PGP 9.5 (red).  (A-C)  Neonatal mouse colon at e19.5.  (A) c-kit 
activity is restricted principally to the myenyteric plexus layer showing the close relationship of 
ICC-MY to ENS ganglia within the myenteric plexus.  (B)  SMA activity demonstrates the two layers 
of the inner circular (hollow arrowhead) and outer longitudinal (arrowhead) muscle.  (C)  Dual label 
negative control shows no reactivity.  (D-F)  Tissue culture of ganglionic distal colon after 8 days in 
culture.  All three tissue types (ICC, smooth muscle and neurons) are present, with ICC in close 
proximity to the myenteric ganglia (D), and a few PGP9.5 positive cells can be seen penetrating 
deeper into the explant (arrowhead).   (E)  The smooth muscle layer is thinner than in term distal 
colon and constitutes a circular layer only; c-Kit positive cells are still present in large numbers and 
there is no overlap of staining with smooth muscle cells.  (F)  Negative control.  (G-I)  Cultured agan-
glionic distal colon after 8 days in tissue culture.  (G)  This lacks PGP9.5 positive ganglia and the 
layer of c-Kit positive cells appears attenuated as a result, although cell numbers are comparable 
and the spatial  relationship with the smooth muscle layer is preserved (H).  (I)  Negative control 
again shows no reactivity.  Scale bars = 100μm
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Figure	  4.5:	  	  Development	  of	  ICC	  and	  neurons	  in	  transplanted	  embryonic	  mouse	  
colon	  tissue	  culture	  
	  
Immunofluorescence	  for	  c-­‐kit	  (green)	  and	  SMA/PGP	  9.5	  (red),	  with	  merged	  figures	  
in	  (C,	  F,	  I,	  L	  and	  O).	  	  (A-­‐F)	  	  Aganglionic	  distal	  colon	  sample	  transplanted	  with	  EMNS	  
at	  day	  1	  and	  cultured	  for	  8	  days.	  	  Migration	  of	  PGP9.5	  positive	  cells	  into	  the	  bowel	  
wall	   has	   occurred,	   with	   the	   relationship	   between	   PGP9.5	   positive	   cells,	   c-­‐Kit	  
positive	   cells	   and	   SMA	   reactivity	   similar	   to	   that	   of	   ganglionic	   distal	   colon	   and	  
neonatal	  mouse	  distal	  colon	  (Figure	  4.3).	  	  The	  band	  of	  c-­‐Kit	  reactivity	  (A)	  and	  (D)	  
appears	   thicker	   than	   in	   Figure	   4.3	   (G)	   and	   (H)	   due	   to	   the	   presence	   of	   PGP9.5	  
positive	   cells	   within	   it	   (B,	   C,	   E	   and	   F);	   it	   can	   be	   seen	   that	   the	   “spaces”	   seen	   in	  
Figure	  4.4	  between	  c-­‐kit	  and	  SMA	  are	  composed	  of	  PGP	  reactive	  cells	   that	  have	  
migrated	  from	  the	  neurosphere.	  The	  arrowhead	  in	  (B)	  and	  (C)	  represents	  the	  site	  
of	  neurosphere	  engraftment	  and	  the	  hollow	  arrowhead	  PGP9.5	  reactive	  cells	  that	  
have	  migrated	  from	  the	  neurosphere.	  	  (D-­‐F)	  show	  a	  section	  of	  bowel	  wall	  remote	  
from	  the	  transplant	  site.	  	  (G-­‐L)	  	  Aganglionic	  distal	  colon	  sample	  transplanted	  with	  
NHNS	  at	  day	  1	  and	  cultured	  for	  8	  days.	   	  A	  similar	  pattern	  of	   immunoreactivity	   is	  
also	   found	   in	   aganglionic	   bowel	   following	   NHNS	   transplantation,	   with	   neurons	  
forming	  ganglia	  within	  the	  bowel	  wall	  and	  occasional	  PGP9.5	  positive	  cells	  deeper	  
within	   the	  smooth	  muscle.	   	   (G-­‐I)	   show	  the	  site	  of	  neurosphere	  engraftment	  and	  
(J-­‐L)	  a	  section	  of	  bowel	  wall	  remote	  from	  the	  neurosphere.	  	  The	  inset	  in	  (L)	  shows	  
in	   more	   detail	   how	   a	   PGP9.5	   reactive	   cell	   has	   become	   integrated	   within	   a	  
surrounding	  band	  of	   c-­‐kit	   reactive	   cells.	   	   (M-­‐O)	  Negative	   controls	   of	   aganglionic	  
distal	   colon	   sample	   transplanted	   with	   EMNS	   at	   day	   1	   and	   cultured	   for	   8	   days.	  	  
Scale	  bars	  =	  100μm.	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4.4	  Functional	  effects	  of	  NHNS	  transplantation	  
	  
As	   noted	   in	   section	   4.3.2,	   embryonic	   mouse	   bowel	   explants	   grown	   in	   tissue	  
culture	   began	   to	   contract	   spontaneously.	   	   Although	   the	   effects	   of	   the	   ENS	   are	  
numerous,	   the	   rate	   (frequency)	   of	   bowel	   contraction	   was	   chosen	   as	   being	   the	  
easiest	  potential	  marker	  of	  neuronal	  regulation	  to	  study.	  
	  
Initial	  observations	  suggested	  that	  aganglionic	  bowel	  tissue	  culture	  specimens	  had	  
a	   higher	   frequency	   of	   contraction	   than	   both	   ganglionic	   bowel	   and	   EMNS	  
transplanted	  bowel	  grown	  under	  the	  same	  conditions.	  
	  
The	  following	  experiments	  were	  designed	  and	  performed	  in	  collaboration	  with	  Dr	  
D.	   Hawcutt,	   Research	   Fellow,	   Department	   of	   Human	  Anatomy	   and	   Cell	   Biology,	  
University	  of	  Liverpool,	  Liverpool,	  UK.	  	  
	  
4.4.1	  	  Method	  
	  
4.4.1.1	  	  Development	  of	  technique	  
	  
Due	   to	   the	   small	   size	   and	   fragility	   of	   the	   samples,	   it	   was	   decided	   that	   optical	  
recording	  of	  contraction	  frequency	  would	  be	  required.	  
	  
Initial	  studies	  looked	  into	  the	  possibility	  of	  recording	  the	  bowel	  movement	  using	  a	  
digital	   camera	   attached	   to	   a	   phase	   contrast	  microscope,	   but	   problems	  with	   the	  
definition	  of	  a	  contraction	  and	  observer	  reliability	   indicated	  the	  need	  for	  a	  more	  
objective	  measurement.	  
	  
The	  Diamtrak	  program	  (Prof.	  T.	  Nield,	  Flinders	  University,	  Adelaide,	  Australia)	  was	  
originally	   developed	   to	   record	   changes	   in	   blood	   vessel	   diameter,	   but	   it	   was	  
proposed	  that	  it	  would	  also	  be	  suitable	  for	  changes	  in	  bowel	  diameter.	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4.4.1.2	  	  Study	  design	  
	  
Pilot	  data	  indicated	  that	  approximate	  values	  for	  the	  mean	  contraction	  frequency	  
of	   ganglionic	   distal	   colon	   was	   40Hz	   and	   for	   aganglionic	   distal	   colon	   60Hz,	   with	  
standard	  deviations	  of	  15Hz.	  
	  
Using	   the	   program	   G*Power	   3.05	   (Franz	   Faul,	   Universitat	   Kiel,	   Germany,	  
http://www.psycho.uni-­‐duesseldorf.de/abteilungen/aap/gpower3/)	   sample	   size	  
was	  calculated	  using	  values	  of	  0.05	  for	  α	  (risk	  of	  a	  type	  1	  statistical	  error)	  and	  0.2	  
for	  β	  (risk	  of	  type	  2	  statistical	  error).	  	  
	  
This	   gave	   an	   estimated	   sample	   size	   of	   10	   per	   group	   per	   experimental	  
manipulation,	   although	   some	   groups	   had	   higher	   numbers	   due	   to	   repetition	   of	  
experiments.	  
	  
4.4.1.3	  	  	  General	  method	  for	  analysis	  of	  bowel	  contraction	  data	  
	  
Measurements	   were	   made	   using	   a	   Nikon	   TMS-­‐F	   inverted	   phase	   contrast	  
microscope	   with	   a	   radiant	   heater/thermocouple	   (Air	   Therm,	   World	   Precision	  
Instruments,	  Stevenage,	  UK)	  to	  maintain	  the	  microscope	  stage	  at	  37ºC.	  	  Images	  of	  
contracting	  bowel	  were	   acquired	  using	   a	  Hitachi	   KP-­‐143	   video	   camera,	   digitized	  
using	   a	   Picolo	   video	   card	   (Euresys,	   Angleur,	   Belgium)	   and	   the	   frequency	   and	  
amplitude	  measured	  using	  Diamtrak	  software	  (Prof.	  T.	  Nield,	  Flinders	  University,	  
Adelaide,	   Australia).	   	   After	   standard	   preparation	   and	   tissue	   culture	   on	   semi-­‐
permeable	   membranes	   (as	   described	   in	   section	   2.5.1.4),	   samples	   could	   be	  
immediately	  transferred	  to	  the	  microscope	  for	  measurement.	  
	  
A	   contraction	   in	   both	   embryonic	   and	   neonatal	   bowel	  was	   defined	   as	   any	   radial	  
displacement	   of	   the	   bowel	   wall	   ≥	   5%	   of	   its	   thickness,	   and	   contractions	   were	  
measured	  at	  the	  point	  of	  maximum	  displacement	  in	  each	  specimen.	  	  	  
	  
Where	   samples	   were	   curved	   sufficiently	   to	   cause	   serosal-­‐serosal	   contact,	  
measurements	  of	  contractility	  were	  made	  on	  the	  greater	  (free)	  curve.	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As	   cooling	   of	   the	   specimen	   was	   noted	   to	   cause	   a	   decrease	   in	   the	   contraction	  
frequency,	   contractions	  were	   recorded	   for	   5	  minutes	   per	   explant,	   and	   explants	  
were	   kept	  out	  of	   the	   incubator	   for	   a	  maximum	  of	  30	  minutes,	   after	  which	   they	  
were	   returned	   to	   the	   incubator	   for	   at	   least	   30	  minutes	   before	   any	   subsequent	  
measurements.	  	  
	  
All	  statistical	  analysis	  and	  graphing	  was	  performed	  using	  GraphPad	  Prism	  5.0	  and	  
GraphPad	   Instat	   3.05.	   	   For	   comparison	   between	   groups,	   a	   parametric	   one-­‐way	  
ANOVA	  was	  employed	  with	  Tukey’s	  post	  test.	  	  A	  p	  value	  of	  <0.05	  was	  considered	  
statistically	  significant.	  
	  
4.4.1.4	  	  	  Control	  data	  
	  
Control	   data	  was	   acquired	   from	   three	   sources.	   	   The	   first	   was	   from	   distal	   colon	  
removed	   from	   P0	   mice.	   	   The	   mice	   were	   sacrificed	   by	   cervical	   dislocation	   and	  
placed	  on	  ice.	  	  After	  disinfection	  with	  70%	  alcohol,	  the	  large	  bowel	  was	  removed	  
using	  sterile	  scissors	  and	  forceps	  and	  placed	  in	  sterile	  PBS.	  	  The	  bowel	  was	  opened	  
longitudinally	   and	   5mm	   longitudinal	   segments	   of	   full-­‐thickness	   bowel	  wall	   from	  
the	   distal	   ganglionic	   colon	  were	   dissected	   free.	   	   These	  were	   placed	   on	   a	   tissue	  
culture	   membrane	   (Millicell,	   Millipore	   UK	   Ltd,	   Watford,	   UK)	   and	   placed	   in	  
standard	   tissue	   culture	   medium	   in	   the	   same	   manner	   as	   other	   tissue	   culture	  
samples.	  	  A	  small	  (10µl)	  aliquot	  of	  medium	  was	  also	  placed	  on	  top	  of	  the	  sample.	  	  	  
The	  bowel	  was	  placed	  in	  an	  incubator	  with	  4%CO2	  at	  37oC	  for	  1	  hour	  to	  equilibrate	  
and	   then	  measurements	  of	   the	  bowel	  wall	   contraction	  were	   taken	  as	  described	  
above.	  	  
	  
The	   second	   source	   of	   control	   data	  was	   from	   bowel	   removed	   at	   E11.5	  with	   the	  
caecum	  attached	   to	   the	   remaining	   colon	  and	   cultured	   for	   8-­‐10	  days	   to	  produce	  
ganglionic	  distal	  colon.	  	  This	  was	  also	  measured	  as	  described	  above.	  
	  
As	   a	   negative	   control,	   aganglionic	   distal	   colon	   was	   produced	   by	   removing	   the	  
caecum	  and	  proximal	  colon	  at	  E11.5	  and	  culturing	  for	  8-­‐10	  days.	  
	  
	   179	  
4.4.1.4.1	  	  Contraction	  data	  
	  
Contraction	   data	   for	   neonatal,	   ganglionic	   and	   aganglionic	   distal	   colon	   was	  
produced	   as	   described	   using	   the	   Diamtrak	   system.	   	   In	   all	   contraction	  
measurements,	  results	  were	  graphed	  and	  analysed	  using	  GraphPad	  Prism	  5.	  
	  
4.4.1.4.2	  	  Inhibition	  of	  ENS	  function	  
	  
	  
To	   determine	   whether	   the	   contractions	   were	   affected	   by	   ENS	   activity,	   the	   fast	  
sodium	  channel	  blocker	  tetrodotoxin	  (TTX)	  was	  used,	  as	  this	   inhibits	  all	  neuronal	  
activity(Narahashi	  et	  al.,	  1964).	  	  Other	  reports	  in	  the	  literature	  indicated	  that	  the	  
onset	  of	  effect	   should	  be	   rapid	   (Alberti	  et	  al.,	  2005)	  but	  when	   tetrodotoxin	  was	  
added	  to	  ganglionic	  distal	  colon	  tissue	  culture	  samples	  the	  rate	  of	  contraction	  did	  
not	  appear	  to	  change	  immediately.	  	  
	  
Therefore,	  in	  a	  pilot	  study,	  tetrodotoxin	  (Sigma-­‐Aldrich)	  was	  added	  to	  the	  culture	  
medium	   of	   8	   ganglionic	   distal	   colon	   samples	   after	   8	   days	   in	   culture	   to	   give	   a	  
concentration	  of	  1µM	  (with	  10µl	  aliquot	  of	  medium	  placed	  directly	  on	  the	  bowel)	  
and	  the	  rate	  of	  contraction	  recorded	  at	  0	  minutes,	  5	  minutes,	  1	  hour	  and	  12	  hours	  
(overnight).	  	  Between	  recordings	  the	  sample	  was	  kept	  in	  an	  incubator	  in	  standard	  
tissue	  culture	  conditions.	  
	  
The	  effect	  of	  TTX	  on	  neonatal	  bowel,	  ganglionic	  distal	  colon	  and	  aganglionic	  distal	  
colon	  control	  specimens	  was	  then	  measured	  by	  applying	  TTX	  to	  the	  tissue	  culture	  
medium	  to	  give	  a	  concentration	  of	  1µM	  and	  covering	  the	  specimen	  with	  medium	  
as	   described	   above	   before	   12	   hours	   incubation	   overnight.	   	   Contractions	   were	  
then	   measured	   and	   recorded.	   	   For	   neonatal	   distal	   colon,	   due	   to	   the	   limited	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To	  ganglionic	  distal	  colon	  samples,	  ACK2	  anti	  c-­‐Kit	  antibody	  (rat	  anti-­‐mouse	  CD117	  
monoclonal	   antibody,	   Chemicon	   Europe,	   Chandlers	   Ford,	   UK)	  was	   added	   at	   the	  
start	  of	  explant	  culture	  and	  refreshed	  with	  each	  medium	  change	  to	  maintain	  final	  
concentrations	  of	  5	  µg/ml	  and	  10	  µg/ml.	   	  Controls	  used	  a	  non-­‐relevant	  antibody	  
(mouse	   anti-­‐actin	  monoclonal	   antibody,	   clone	  AC40,	   Sigma	  Aldrich)	   at	   10µg/ml.	  	  
Contractions	  were	  measured	  as	  described	  above.	   	  4	  samples	  were	  measured	  for	  
each	  antibody/control.	  
	  
4.4.1.5	  	  Functional	  effect	  of	  neurosphere	  transplantation	  
	  
To	  assess	  the	  functional	  effect	  of	  EMNS	  and	  NHNS	  transplantation,	  neurospheres	  
were	  transplanted	  into	  cultured	  embryonic	  colon	  explants	  as	  described	  in	  section	  
2.5.1.4.	   	   	   They	   were	   cultured	   for	   8-­‐10days.	   	   Measurements	   of	   contractility	   on	  
samples	   with	   and	   without	   the	   addition	   of	   TTX	   (at	   a	   concentration	   of	   1µM,	   as	  
described	  above)	  were	  also	  performed.	  	  
	  
	  
4.4.2	  	  Results	  
	  
Examples	  of	   the	   images	  produced	  by	  the	  Diamtrak	  program	  are	  shown	   in	  Figure	  
4.6.	  	  Examples	  of	  the	  tracings	  produced	  by	  the	  output	  from	  Diamtrak	  are	  shown	  in	  
Figures	   4.7	   and	   4.8.	   	   In	   general,	   spontaneous	   contractions	   developed	   in	   all	  
samples	   except	   where	   described	   below.	   	   Contractions	   propagated	   in	   both	  
directions	  (proximally	  and	  distally).	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4.4.2.1.1	  	  Contraction	  data	  
	  
In	   term	  neonatal	  colon	  removed	  and	  placed	   in	  tissue	  culture,	  contractions	  could	  
be	   seen	   to	   occur	   spontaneously	   (Figure	   4.7A).	   	   These	   were	   regular	   and	  
comparable	   in	   terms	   of	   frequency	   with	   ganglionic	   distal	   colon	   samples	   after	   8	  
days	   in	   culture	   (Figures	   4.7B	   and	   E).	   	   There	   was	   no	   statistically	   significant	  
difference	  in	  the	  rate	  of	  contraction	  between	  term	  neonatal	  colon	  and	  ganglionic	  
distal	  colon	  in	  similar	  conditions	  (p.0.01,	  one	  way	  ANOVA	  with	  Tukey’s	  post	  test).	  	  	  
	  
Aganglionic	  distal	   colon	  had	  a	  higher	   inherent	   rate	  of	   contraction	   (Figures	  4.7	  D	  
and	   F)	   and	   the	   contractions	   appeared	   irregular	   in	   terms	   of	   amplitude	   and	  
rhythmicity.	  	  In	  addition,	  in	  aganglionic	  bowel	  the	  contractions	  did	  not	  appear	  to	  
propagate	   along	   the	   length	   of	   the	   specimen.	   	   The	   contraction	   frequency	   of	  
aganglionic	   distal	   colon	   was	   significantly	   faster	   than	   ganglionic	   distal	   colon	  
(p<0.01,	  one	  way	  ANOVA	  with	  Tukey’s	  post	  test).	  
	  
	   	  

A BTerm colon Term colon + TTX
C DGanglionic distal colon Aganglionic distal colon
7 29n= 7
***
E Contraction frequency in termcolon and ganglionic distal colon
Figure 4.7  Contraction frequency in control distal colon
F Contraction frequency in ganglionic and aganglionic distal colon
7 29n= 36 20
**
*
Figure 4.7:  Contraction frequency in control distal colon.  (A) Example of the displacement/time graph 
for term distal colon.  The frequency of the displacement is regular and low frequency.  (B) Term distal 
colon after the addition of TTX.  The frequency of contraction is higher and irregular.  (C,D) Cultured 
ganglionic distal colon before (C) and after (D) the addition of TTX.  The contractions in ganglionic distal 
colon are initially regular in terms of both frequency and amplitude but after the addition of TTX the 
frequency of contraction increases and the contractions are irregular.   (E) There is no significant differ-
ence in the contraction frequency between P0 neonatal mouse distal colon and cultured ganglionic 
distal colon (GDC) (p>0.05).  After the addition of TTX for 2 hours, the rate of contraction in P0 neonatal 
mouse distal colon is significantly increased when compared to GDC and P0 neonatal distal colon with-
out TTX (p<0.001).  (F)  Aganglionic distal colon contracts significantly faster than ganglionic distal 
colon (p<0.01).  There is no significant difference in the contraction frequency of aganglionic distal 
colon and ganglionic distal colon +TTX (p>0.05).   Key:  GDC – ganglionic distal colon; ADC – agangli-
onic distal colon;  +TTX – following addition of tetrodotoxin at a final concentration of 1µM.   All p values 
relate to a one-way parametric ANOVA with Tukey’s multiple comparison test.  * indicates p<0.05, ** 
p<0.01, *** p<0.001.  Numbers of explants per group are shown as n= in Figures E and F.  Scatter plots 
show mean and individual data points.
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Results	   of	   the	   pilot	   study	   of	   the	   speed	   of	   onset	   of	   TTX	   inhibition	   are	   shown	   in	  
Figure	  4.8.	   	  Sample	  tracings	  (Figures	  4.8	  A-­‐D)	  and	  Figure	  4.8	  G	  demonstrate	  that	  
over	  12	  hours	   there	   is	  an	   increase	   in	   the	   rate	  of	   contraction	  of	  ganglionic	  distal	  
colon	   to	   that	   seen	   in	  aganglionic	  distal	   colon.	   	  Although	   there	  appears	   to	  be	  an	  
immediate	  effect	  after	  5	  minutes	  of	   incubation,	  this	  difference	  is	  not	  statistically	  
significant,	   whereas	   it	   is	   after	   1	   and	   12	   hours	   (Figure	   4.8	   G,	   p<0.01,	   one	   way	  
ANOVA	   with	   Tukey’s	   post	   test).	   	   The	   fact	   that	   the	   rate	   of	   contraction	   still	  
increased	   between	   1	   and	   12	   hours	   indicated	   that	   the	   effect	   of	   TTX	   may	   be	  
diffusion	  limited	  and	  therefore	  overnight	  incubations	  for	  12hs	  were	  performed	  for	  
subsequent	  tests.	  
	  
Addition	  of	  TTX	  to	  neonatal	  distal	  colon	  produced	  a	   large	   increase	   in	  the	  rate	  of	  
contraction	  (Figure	  4.7	  B	  and	  E,	  p<0.001,	  one	  way	  ANOVA	  with	  Tukey’s	  post	  test).	  	  
The	   contractions	   can	   again	   be	   seen	   to	   become	   irregular	   and	   appear	  
uncoordinated.	   	   A	   similar	   rise	   was	   seen	   in	   cultured	   ganglionic	   distal	   colon,	  
although	  the	  rise	  in	  the	  rate	  of	  contraction	  was	  not	  as	  pronounced	  (Figure	  4.7	  F).	  
The	   rate	   of	   contraction	   does	   however	   appear	   to	   equal	   the	   rate	   of	   aganglionic	  
distal	  colon	  (Figure	  4.7	  F).	  	  	  
	  
Taken	  together,	  these	  results	  indicate	  that	  in	  isolated	  term	  neonatal	  distal	  colon,	  
the	   ENS	   exerts	   an	   inhibitory	   effect	   on	   the	   rate	   of	   contraction	   of	   the	   bowel.	  	  
Furthermore,	  ganglionic	  distal	  colon	  samples	  cultured	  using	  this	  technique	  have	  a	  
similar	   rate	   of	   contraction	   and	   exhibit	   the	   same	   TTX-­‐sensitive	   regulation,	   with	  
inhibition	  of	  ENS	  function	  producing	  a	  rate	  of	  contraction	  similar	  to	  that	  seen	   in	  
cultured	  aganglionic	  distal	  colon,	  as	  shown	  in	  Figure	  4.7F.	  







n=      8
F
D
Ganglionic distal colon Ganglionic distal colon + TTX 5mins
Ganglionic distal colon + TTX 1 hour Ganglionic distal colon + TTX 12 hours
NHNS Transplanted distal colon NHNS Transplanted distal colon + TTX 1 hour
Effect of TTX incubation on contraction 
frequency in ganglionic distal colon
8 88
Figure 4.8 Effect and timing of onset of TTX on embryonic tissue cultures of distal colon
Figure 4.8  Pilot study of the speed of onset of TTX 
inhibition in embryonic tissue culture.   (A-F)  Repre-
sentative displacement/time traces of ganglionic 
distal colon contractions before and after the addi-
tion of TTX.  (A)  Prior to the addition of TTX, the 
contractions are regular and of low frequency.  (B) 
After the addition of TTX, at 5 minutes the rate of 
contraction is increased.  (C)  The same sample 
after 1 hour.  The contraction frequency is again 
higher.  (D) The same sample after 12 hours.    (E-F)  
Aganglionic distal colon explant 8 days after NHNS 
transplantation shown before (E) and 1 hour after 
(F) the addition of TTX.  After 1 hour of incubation 
with TTX, the frequency of contraction is higher but 
there appear to be low frequency, high amplitude 
contractions (solid arrowheads) and superimposed 
on these higher frequency, low amplitude contrac-
tions (hollow arrowheads).  This illustrates the devel-
oping loss of inhibition that is seen at 1 hour but not 
fully realized until after 2 hours.  (G)  Scatter plot 
showing data for the contraction frequency in gangli-
onic distal colon after 8 days in culture, before and 
after the addition of TTX.  The time points recorded 
are 5 minutes, 1 hour and 12 hours.  The contraction 
frequency is increased after the addition of TTX.  
This increase is not statistically significant after 5 
minutes but is significant at 1 hour and 12 hours (1 
way ANOVA with Tukey’s correction, p<0.01).  * 
indicates p<0.05, ** p<0.01, *** p<0.001.  Bars show 
mean and individual data points are plotted.
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Long	   term	   exposure	   to	   the	   anti	   c-­‐Kit	   blocking	   antibody,	   ACK-­‐2	   inhibited	   the	  
contraction	   of	   ganglionic	   and	   aganglionic	   distal	   colon	   explants	   in	   a	   dose-­‐
dependent	  manner	  (Table	  4.1	  and	  Figure	  4.9),	  indicating	  an	  essential	  requirement	  
for	  ICC	  in	  the	  generation	  of	  contractions.	  	  
	  
4.4.2.2	  Functional	  effect	  of	  neurosphere	  transplantation	  
	  
Initially	  neurosphere	  transplants	  were	  analysed	  after	  8	  days	  in	  culture	  (Figure	  4.10	  
A-­‐C).	   	   The	   effect	   of	   neurosphere	   transplantation	   was	   to	   produce	   regular	  
contractions	  at	  a	  lower	  rate	  of	  contraction	  than	  that	  seen	  in	  otherwise	  aganglionic	  
distal	   colon.	   	   The	  addition	  of	  TTX,	   to	   inhibit	  neuronal	   function	  derived	   from	   the	  
transplanted	   neurosphere,	   produced	   an	   increase	   in	   the	   contraction	   frequency	  
(Figure	  4.10	  B	  and	  C).	   	  However,	  although	  at	  day	  8	  although	  this	  difference	  was	  
statistically	   significant	   in	   EMNS	   transplants,	   it	   was	   not	   in	   NHNS	   transplants	  
(p<0.05	  and	  p>0.05	  respectively,	  one	  way	  ANOVA	  with	  Tukey’s	  post	  test).	  	  	  
	  
It	  was	  hypothesised	  that	  as	  the	  NHNS	  had	  a	  lower	  rate	  of	  growth	  in	  culture,	  they	  
may	  also	  have	  a	  lower	  rate	  of	  migration	  and/or	  differentiation	  when	  transplanted.	  	  
To	  determine	  whether	   this	  was	  due	   to	  a	   lower	  growth/migration/differentiation	  
rate	   in	   NHNS,	   samples	   were	   then	   cultured	   and	   measured	   for	   10	   days.	   	   These	  
results	  are	  shown	  in	  Figure	  4.10D	  and	  show	  that	  although	  the	  rate	  of	  contraction	  
in	   EMNS	   is	   unchanged	   after	   prolonged	   culture,	   it	   becomes	   even	   lower	   in	  NHNS	  
samples	  and	  the	  subsequent	  increase	  in	  contraction	  rate	  after	  the	  addition	  of	  TTX	  
is	  statistically	  significant	  (p<0.01	  ,0.01,	  one	  way	  ANOVA	  with	  Tukey’s	  post	  test).	  	  
	  
Finally,	   the	   data	   for	   all	   time	   points	   between	   8	   and	   10	   days	   in	   culture	   were	  
aggregated	  to	  ensure	   that	  no	  bias	  due	  to	  selection	  of	   time	  points	  had	  occurred.	  	  
These	   results	   are	   shown	   in	   Figure	   4.10E	   and	   demonstrate	   that	   the	   contraction	  
frequency	  of	  aganglionic	  colon	  after	  8-­‐10	  days	   in	  culture	  was	  significantly	  higher	  
than	   those	   of	   ganglionic	   distal	   colon	   and	   aganglionic	   distal	   colon	   transplanted	  
with	  either	  EMNS	  or	  NHNS.	   	   In	  both	  EMNS	  and	  NHNS	   transplanted	  distal	   colon,	  
the	  addition	  of	   TTX	   significantly	   increased	   the	   contraction	   frequency.	   	   Thus,	   the	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TTX	   blockade	   of	   neural	   signalling	   produces	   a	   rate	   of	   contraction	   in	   all	   samples	  
equivalent	  to	  that	  of	  the	  aganglionic	  phenotype,	  demonstrating	  that	  the	  effects	  of	  
the	   neurosphere	   transplants	   on	   gut	   contractility	   are	   due	   to	   the	   presence	   of	  
functioning	  neurons.	  	  	  	  	   	  
Figure 4.10  Effect of neurosphere transplantation on frequency of contraction
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Figure 4.10  Effect of neurosphere transplantation on contrac-
tion frequency of aganglionic distal colon.   (A, B)  Examples of 
the displacement/time graph for NHNS transplanted agangli-
onic distal colon -/+ TTX.  (A) The frequency of contraction is 
slower and more regular than aganglionic distal colon (Figure 
4.7D), but following the addition of TTX (B) the contractions are 
higher in frequency and become less regular.  (C)  At D8 in 
culture, EMNS and NHNS transplanted bowel have comparable 
contraction frequencies to ganglionic distal colon, and the addi-
tion of TTX causes a rise in the frequency of contractions.   
However, the rate of contraction in NHNS transplanted bowel is 
higher than that of EMNS and the increase in contraction 
frequency after TTX addition  is statistically significant only for 
EMNS transplants (p<0.05).  (D)  At D10 in culture, the 
frequency of contractions in EMNS is unchanged but it is lower 
in NHNS and now the rise in the rate of contractions after the 
additon of TTX is statistically significant (p<0.01).  (E)  Graph 
showing all data aggregated for 8-10 days in culture.  Agangli-
onic distal colon contracts significantly faster than ganglionic 
distal colon (p<0.01).  There is no significant difference in the 
contraction frequency of aganglionic distal colon and ganglionic 
distal colon +TTX (p>0.05).  EMNS and NHNS transplanted 
bowel have comparable contraction frequencies to ganglionic 
distal colon (p>0.05) but have significantly lower contraction 
frequencies than aganglionic distal colon (p<0.001 for EMNS 
and p<0.05 for NHNS), demonstrating a functional effect of 
neurosphere transplantation.  The contraction frequency in both 
EMNS and NHNS transplanted bowel is significantly higher 
following the addition of TTX (p<0.01 for EMNS and p<0.001 for 
NHNS), indicating that the functional effect of neurosphere 
transplantation is neural in origin.  Key:  GDC – ganglionic distal 
colon; ADC – aganglionic distal colon; EMNS – aganglionic 
distal colon transplanted with embryonic mouse neurosphere; 
NHNS - aganglionic distal colon transplanted with neonatal 
human neurosphere; +TTX – following addition of tetrodotoxin.   
All p values relate to a one-way parametric ANOVA with Tukey’s 
multiple comparison test.  * indicates p<0.05, ** p<0.01, *** 
p<0.001.  Numbers of explants per group are shown as n= in 
Figures C-E.  Scatter plots show mean and data points.  
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4.5	  	  Discussion	  
	  
This	  chapter	  demonstrates	  that	  the	  development	  of	  ICC	  and	  smooth	  muscle	  in	  the	  
isolated	   E11.5	   aganglionic	   embryonic	   bowel	   explants	   is	   similar	   to	   that	   shown	   in	  
normal	   gut	  development,	   and	   therefore	   confirmed	   that	   this	  was	  an	  appropriate	  
model	   to	   use	   for	   the	   future	   assessment	   of	   contractility	   and	   its	   response	   to	  
neurosphere	  transplantation,	  as	  discussed	  below.	  
	  
It	   also	   shows	   that	   EMNS	   and	   NHNS	   cells	   migrate	   into	   close	   relationship	   with	  
endogenous	   ICC	   and	   that	   the	   relationship	   between	   the	   two	   appears	   similar	   to	  
that	   found	   in	   normal,	   ganglionic	   bowel.	   	   This	   finding	   has	   been	   confirmed	   by	  
electron	   microscopy,	   which	   has	   also	   demonstrated	   the	   formation	   of	   synapses	  
between	  the	  engrafted	  neurons(Lindley	  et	  al.,	  2008).	  	  
	  
This	   chapter	   also	   demonstrates	   that	   grafted	   mouse	   and	   human	   ENSPC	  
neurospheres	   can	   regulate	   the	   function	   of	   aganglionic	   colon:	   	   the	   transplants	  
restore	   the	   higher	   contraction	   frequency	   of	   aganglionic	   bowel	   to	   the	   slower	  
frequency	  of	  ganglionic	  bowel	  by	  a	  neurally	  mediated	  mechanism.	  
	  
	  
4.5.1	  	  Model	  validity	  
	  
The	  validity	  of	  the	  embryonic	  tissue	  culture	  model	  employed	   in	  this	  thesis	   is	  key	  
when	   considering	   the	   functional	   effect	   of	   neurosphere	   transplantation.	   	   	  While	  
the	  growth	  of	   the	   cultured	  explants	   is	   less	   than	   that	   in	  vivo,	   it	   should	  be	  noted	  
that	  the	  distal	  colon	  also	  undergoes	  much	  less	  growth	  when	  compared	  to	  the	  rest	  
of	  the	  bowel,	  and	  similar	  culture	  systems	  have	  proven	  to	  be	  a	  useful	  method	  to	  
study	  development	  of	  the	  mouse	  bowel	  and	  ENS(Hearn	  et	  al.,	  1999).	  	  	  
	  
Although	  the	  explants	  did	  not	  develop	  longitudinal	  smooth	  muscle	  in	  culture,	  the	  
relevance	   of	   the	   culture	   model	   to	   normal	   ENS/gut	   functional	   development	   is	  
substantiated	   by	   the	   similar	   structural	   development	   of	   ENS	   ganglia	   and	   c-­‐Kit	   -­‐
positive	   ICC-­‐MY,	   and	   the	   similar	   characteristics	   of	   neuronally	   mediated	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contraction	   in	   the	  cultured	  explants	  and	   those	  of	  normal	  perinatal	  colon	   (Figure	  
4.7).	   	   The	   development	   of	   spontaneous	   contractility	   in	   the	   bowel	   appears	  
consistent	  with	  in	  vivo	  findings	  on	  embryonic	  mouse	  gut(Anderson	  et	  al.,	  2004).	  
	  
The	   fact	   that	   incubation	   with	   the	   c-­‐Kit	   neutralising	   antibody	   ACK-­‐2	   inhibits	  
contractions	   in	   the	   ganglionic	   tissue	   culture	   model	   is	   consistent	   with	   previous	  
work	   (Ward	   et	   al.,	   1994)and	   again	   illustrates	   that	   the	   essential	   components	  
(smooth	   muscle,	   ICC	   and	   neurons	   in	   the	   ganglionic	   specimens)	   necessary	   for	  
rhythmic	  contractions	  are	  all	  present.	  
	  
The	  effect	  of	   TTX	  on	   the	   samples	   and	   the	   time	  of	  onset	  of	   TTX	   is	   important	   for	  
demonstrating	   a	   neurally	   mediated	   effect.	   	   As	   mentioned	   in	   Chapter	   4.4.1.4.2,	  
initial	  experiments	  indicated	  that	  1	  μmol/L	  TTX	  had	  an	  effect	  on	  ganglionic	  bowel	  
explant	   contractility	   within	   5	  minutes,	   the	   increased	   rate	   becoming	   statistically	  
significant	   after	   2	   hours	   of	   incubation	   and	   remaining	   significant	   for	   at	   least	   12	  
hours	  of	  culture,	  suggesting	  a	  diffusion-­‐limited	  onset.	   	  There	  are	  other	  studies	  in	  
the	  literature	  using	  this	  timescale	  for	  TTX	  addition(Reddy	  et	  al.,	  1995).	  	  While	  the	  
effects	  of	  TTX	  on	  aganglionic	  and	  transplanted	  embryonic	  explants	  were	  routinely	  
measured	   after	   12	   hours	   of	   incubation,	   its	   effects	   on	   neonatal	   colon	   were	  
determined	  after	  2	  hours	  because	  tissue	  viability	   in	  these	  explants	  was	   lost	  with	  
an	  overnight	  incubation.	  	  	  Although	  it	  is	  not	  possible	  to	  formally	  rule	  out	  that	  TTX	  
treatment	  exerts	  a	  trophic	  influence	  on	  the	  ICC,	  it	  seems	  unlikely	  both	  because	  of	  
the	   rapid	   onset	   of	   its	   effects	   in	   vitro	   and	   also	   because	   it	   has	   been	   shown	   that	  
GDNF−/−	  mice	   lacking	   an	   ENS	  have	   apparently	   normal	   ICC	   function(Ward	  et	   al.,	  
1999).	  
	  
	  Therefore	   the	   explant	   culture	   model	   appears	   suitable	   for	   an	   initial	   functional	  
assessment	   of	   ENSPC	   transplantation	   on	   the	   spontaneous	   contractions	   of	  
aganglionic	  bowel.	   	  There	  are	  however	  more	  recent	  studies	  on	  the	  development	  
of	  motility	  in	  fetal	  mouse	  bowel	  that	  are	  in	  conflict	  with	  our	  results.	  	  	  Although	  ICC	  
electrical	  slow	  wave	  activity	  in	  the	  prenatal	  developing	  mouse	  jejunum	  has	  been	  
shown	  to	  develop	  between	  E17	  and	  E18(Ward	  et	  al.,	  1997),(Beckett	  et	  al.,	  2007),	  
no	   slow	   wave	   activity	   typical	   of	   ICC	   could	   be	   found	   in	   the	   distal	   colon	   of	  
embryonic	   and	   term	  mice(Ward	   et	   al.,	   1997),(Roberts	   et	   al.,	   2007),(Ward	   et	   al.,	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2002).	   	   This	   has	   already	   led	   to	   speculation	   that	   the	   mechanism	   generating	  
contractions	  in	  term	  neonatal	  mouse	  distal	  colon	  is	  independent	  of	  electrical	  slow	  
waves	  and	  may	  be	  due	  to	  another	  form	  of	   ICC	  activity(Roberts	  et	  al.,	  2007),	  and	  
there	   is	   also	   evidence	   that	   TTX	   insensitive	   contractions	   are	   present	   within	  
developing	   zebrafish(Holmberg	  et	  al.,	   2007).	   	   	   This	   theory	   is	   consistent	  with	  our	  
data	  but	  the	  mechanism	  remains	  uncertain.	  	  	  
	  
Roberts(Roberts	   et	   al.,	   2008)	   used	   spatiotemporal	   mapping	   to	   study	   the	  
development	   of	   motility	   in	   the	   aganglionic	   colon	   of	   ET3	   -­‐/-­‐	   mice.	   	   They	  
characterised	   the	   contractions	   visible	   as	   “ripples”	   similar	   to	   those	   observed	   in	  
embryonic	   and	   early	   postnatal	   mice	   and	   theorised	   that	   these	   contractions	   are	  
also	   independent	   of	   ICC	   activity.	   	   A	   subsequent	   study(Roberts	   et	   al.,	   2010)	   also	  
demonstrated	   no	   effect	   of	   ICC	   on	   these	   contractions.	   	   It	   should	   be	   pointed	   out	  
however	   that	   the	   “ripples”	   demonstrated	   by	   the	   spatiotemporal	   mapping	  
techniques	  employed	  in	  these	  studies	  occur	  at	  different	  frequencies	  (1	  per	  minute	  
as	   opposed	   to	   3-­‐4	   per	   minute)	   and	   due	   to	   the	   methodological	   differences	  
employed	   the	  area	  of	   bowel	   studies	  here	   is	  much	   smaller,	   and	  our	   studies	  may	  
therefore	  be	  picking	  up	  finer	  details	  that	  are	  not	  apparent	  when	  the	  whole	  colon	  




4.5.2	   	   Structural	   integration	   of	   grafted	  neurosphere-­‐derived	  
cells	  
	  
The	   structural	   integration	   of	   engrafted	   cells	   is	   important	   as	   any	   mechanism	   of	  
functional	   neuronal	   coupling	   is	   likely	   to	   be	   due	   to	   the	   close	   spatial	   relationship	  
between	  neurons	  and	  ICC	  or	  smooth	  muscle	  cells.	   	  While	  synapses	  were	  formed	  
between	   the	   transplanted	   neurosphere-­‐derived	   neurons,	   no	   neuromuscular	   or	  
neuronal-­‐ICC	  synapses	  were	  seen	  on	  electron	  microscopy(Lindley	  et	  al.,	  2008).	  	  It	  
should	   be	   noted	   that	   in	   normal	   term	   neonatal	   mouse	   colon,	   no	   such	   synapses	  
have	   been	   observed	   (Faussone-­‐Pellegrini,	   1987),(Daniel,	   2004a).	   	   This	   may	  
indicate	   that	   the	   neurogenic	   regulation	   of	   contractility	   in	   the	   term	   neonate	   is	  
mediated	   by	   a	   neuromodulator,	   rather	   than	   by	   a	   classical	   synaptic	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neurotransmitter,	   and	   fits	   a	   current	   model	   of	   neuronal/ICC/smooth	   muscle	  
interaction	   (Ward,	   2000),	   in	   which	   the	   close	   spatial	   relationship	   between	  
neuronal	   vesicles/nerve	   endings	   and	   ICC	   as	   shown	   here	   allows	   the	   diffusion	   of	  
neuromodulators.	   	   This	   hypothesis,	   and	   the	   results	   presented	   here,	   are	   also	   in	  
keeping	  with	   the	   finding	   in	   P0	  mice	   that	  NOS	  positive	   cells	   are	  more	  numerous	  
than	  cholinergic	  neurons	  in	  the	  circular	  muscle	  of	  the	  colon(Roberts	  et	  al.,	  2007).	  
	  
4.5.3	  	  Functional	  effect	  of	  NHNS	  transplantation	  
	  
The	  results	  in	  Chapter	  4.4.2	  show	  that	  transplanted	  EMNS	  and	  NHNS	  restore	  the	  
higher	   frequency	   of	   contraction	   seen	   in	   aganglionic	   bowel	   to	   the	   lower	   rate	   of	  
contraction	   found	   in	   ganglionic	   bowel	   via	   a	   neurally	   mediated	   effect.	   	   Further	  
work	  arising	  from	  this	  thesis	  has	  also	  demonstrated	  that	  the	  regulation	  of	  calcium	  
movements	  within	  the	  cultured	  bowel	  sample	  is	  also	  coordinated	  by	  neurosphere	  
transplantation(Lindley	  et	  al.,	  2008).	  	  
	  
The	   ability	   of	   neurosphere-­‐derived	   neurons	   to	   reduce	   the	   frequency	   of	  
contraction	   and	   coordinate	   Ca++	   movements	   may	   have	   been	   either	   by	   a	   direct	  
effect	  on	  smooth	  muscle,	  or	  via	  an	   indirect	  effect	  mediated	  by	  endogenous	   ICC.	  	  
Clearly	  ICC	  are	  necessary	  for	  contractility	  in	  our	  experiments	  as	  contractions	  were	  
abolished	   when	   ICC	   development	   was	   inhibited	   after	   treatment	   with	   the	   c-­‐Kit	  
blocking	   ACK-­‐2	   antibody.	   	   The	   available	   evidence	   supports	   the	   notion	   that	   the	  
actions	  of	  the	  ENS	  on	  bowel	  contractility	  are	  mediated	  via	  the	  ICC(Sanders	  et	  al.,	  
2006a)	  and	  the	  observation	  that	  TTX	  -­‐insensitive	  contractions	  are	  also	  abolished	  
by	  the	  blocking	  antibody	  is	  consistent	  with	  this	  hypothesis,	  but	  the	  caveats	  on	  the	  
role	  of	  ICC	  as	  evidenced	  by	  later	  studies	  (discussed	  in	  section	  4.5.1)	  must	  be	  born	  
in	  mind.	  	  Despite	  the	  lack	  of	  fully	  differentiated	  ICC	  seen	  on	  transmission	  electron	  
microscopy	  there	  is	  evidence	  that	  immature	  ICC	  can	  still	  act	   in	  a	  pacemaker	  role	  
in	  the	  developing	  bowel(Beckett	  et	  al.,	  2007),(Liu	  et	  al.,	  1998),(Ward	  et	  al.,	  1997).	  	  
The	  absence	  of	  gap	  junctions	  between	  ICC	  and	  smooth	  muscle	  as	  shown	  here	  is	  in	  
keeping	  with	  previous	   findings	   in	   the	  mouse	   intestine(Daniel,	  2004b)	  and	   is	  also	  
consistent	  with	  recent	  work	  that	  has	  demonstrated	  that	  gap	  junctions	  may	  not	  be	  
necessary	  for	  pacing	  and	  neuronal	  coupling(Daniel	  et	  al.,	  2007a),(Thuneberg	  and	  
Peters,	  2001).	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Despite	   a	   lack	  of	   clarity	   in	   the	   role	   of	   ICC	   in	  mediating	   the	   contractions	   seen	   in	  
neurosphere-­‐grafted	  bowel,	   the	   functional	   response	   to	   grafting	   is	   clear	   in	   these	  
studies.	  	  	  
	  
	  
4.5.4	  	  Conclusions	  
	  
In	   conclusion,	   it	   has	   been	   shown	   that	   neonatal	   human	   bowel	   can	   be	   used	   as	   a	  
source	  of	  ENSPC	  capable	  of	  restoring	  the	  contractile	  properties	  of	  the	  developing	  
gut.	   	   The	   production	   of	   coordinated	   contraction	   and	   relaxation	   in	   ENSPC	   -­‐
transplanted	  bowel	  would	  be	  important	  in	  the	  treatment	  of	  HSCR	  as	  defecation	  is	  
a	   complex	   process	   that	   requires	   multiple	   steps	   to	   succeed,	   including	   rectal	  
contraction	  and	  relaxation	  of	  the	  internal	  and	  external	  anal	  sphincters(Rao	  et	  al.,	  
1998).	   	   Recently,	   the	   successful	   engraftment	   of	   embryonic	   neural	   crest-­‐derived	  
cells	   in	   aganglionic	   adult	   mouse	   colon	   has	   been	   described,	   but	   these	   allogenic	  
transplants	  generated	  a	  strong	  inflammatory	  response(Martucciello	  et	  al.,	  2007).	  	  
Neural	  tube	  derived	  stem	  cells	   from	  E11.5	  rats	  have	  also	  been	  shown	  to	  engraft	  
into	  12	  week	  old	  rats	  and	  apparently	  rescue	  function	  in	  denervated	  bowel(Liu	  et	  
al.,	   2007),	   although	   the	   model	   used	   (generating	   aganglionic	   bowel	   by	   the	  
application	  of	  benzalkonium	  chloride)	  differs	  from	  previous	  reports(Hanani	  et	  al.,	  
2003b)	  in	  that	  no	  spontaneous	  regeneration	  of	  ENS	  ganglia	  were	  seen,	  and	  these	  
results	  are	  therefore	  difficult	  to	  interpret.	  
	  
While	  it	  remains	  to	  be	  seen	  whether	  ENSPC	  can	  be	  successfully	  transplanted	  into	  
the	   relatively	   mature	   neonatal	   gut	   environment,	   the	   work	   presented	   here	   to	  
characterize	   the	   restoration	   of	   normal	   function	   after	   transplantation	   is	   a	   step	  
towards	  development	  of	  an	  autologous	  stem	  cell	  treatment	  for	  babies	  with	  HSCR.	  	  	  
	  
Interestingly,	   functional	   changes	   in	   the	   stomach	   of	   NOS	   deficient	   mice	   have	  
recently	   been	   demonstrated	   using	   progenitor	   cells	   isolated	   from	   the	  
subventricular	  zone	  of	  embryonic	  mouse	  forebrain(Micci	  et	  al.,	  2005).	   	  Although	  
this	   technique	  does	   not	   allow	  autologous	   grafting,	   the	  demonstration	  of	   similar	  
functional	   changes	   using	   human-­‐derived	   postnatal	   ENSPC	   will	   be	   an	   important	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step.	  Moreover,	  full	  characterisation	  of	  the	  behaviour	  of	  ENSPC	  and	  their	  progeny	  
in	  the	  environment	  of	  the	  gut	  wall	  will	  be	  required	  in	  order	  to	  assess	  the	  safety	  of	  
their	  transplantation	  in	  terms	  of	  absence	  of	  neoplastic	  or	  otherwise	  uncontrolled	  
growth.	   Despite	   these	   reservations	   that	   can	   only	   be	   answered	   by	   future	  
experimental	  work,	  the	  experiments	  described	  in	  this	  thesis	  clearly	  show	  that	  not	  
only	   is	   it	   possible	   to	   isolate	   and	   amplify	   human	   ENSPC,	   but	   that	   when	  
transplanted	   into	   the	   embryonic	   gut	   wall	   these	   cells	   migrate,	   differentiate	   and	  
effect	  a	  functional	  response.	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Chapter	  5:	  	  Conclusions	  
	  
5.1	  	  Summary	  of	  work	  presented	  in	  this	  thesis	  
	  
5.1.1	  	  Chapter	  1	  
	  
This	   introductory	  chapter	  details	  the	  tremendous	  advances	   in	  our	  understanding	  
of	   the	   pathogenesis	   of	   Hirschsprung’s	   disease,	   including	   the	   genetic	   and	  
molecular	  mechanisms	   affecting	   the	   development	   of	   the	   ENS.	   	   However,	   it	   also	  
shows	   that	   despite	   these	   advances,	   this	   greater	   understanding	   has	   not	   yet	  
translated	   into	   improved	   outcomes	   for	   children	   with	   Hirschsprung’s.	   	   	   It	   was	  
hypothesised	  that	  as	  ENS	  stem	  cells	  are	  capable	  of	  migrating	  the	  length	  of	  the	  gut	  
and	  populating	  it	  with	  neurons	  and	  glia,	  it	  may	  be	  possible	  to	  generate	  a	  neo-­‐ENS	  
using	  such	  cells	  and	  therefore	  create	  a	  novel	  therapy	  for	  Hirschsprung’s.	  	  	  	  
	  
	  
5.1.2	  	  Chapter	  2	  
	  
In	  chapter	  2	  of	  this	  thesis,	  existing	  techniques	  used	  to	  generate	  ENS	  neurospheres	  
from	   embryonic	   mice	   were	   adapted	   to	   generate	   neurospheres	   from	   postnatal	  
bowel	   samples	   of	   mice	   and	   humans.	   	   Significantly,	   the	   method	   resulted	   in	  
neurosphere	  generation	  from	  samples	  of	  neonatal	  colon	  and	  ileum,	  and	  from	  the	  
bowel	  of	  older	  children	  also.	  	  It	  was	  also	  possible	  to	  generate	  neurospheres	  from	  
the	  ganglionic	  bowel	  of	  children	  with	  Hirschsprung’s	  disease.	  
	  
These	   neurospheres	   were	   then	   characterised	   and	   shown	   to	   contain	   cells	  
expressing	  markers	   for	   ENS	   stem	  cells,	   neurons	   and	   glia,	   and	   it	  was	   shown	   that	  
new	  cells	   expressing	  neuronal	  markers	  were	   generated	  within	   the	  neurosphere.	  	  
Although	   no	   definitive	   proof	   of	   clonality	   of	   the	   neurospheres	   was	   established,	  
they	  still	  exhibited	  the	  ability	  to	  engraft	   into	  embryonic	  aganglionic	  mouse	  colon	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and	  produce	  both	  neurons	  and	  glia	  in	  the	  wall	  of	  the	  bowel	  that	  would	  otherwise	  
have	  contained	  no	  such	  cells.	  	  BrdU	  labelling	  confirmed	  that	  these	  neural	  cells	  had	  
indeed	  originated	  from	  the	  neurosphere.	  	  	  
	  
These	  results	  demonstrate	  that	  initial	  concept	  of	  a	  stem	  cell	  based	  treatment	  for	  
Hirschsprung’s	  disease	  was	  a	  possibility,.	  
	  
5.1.3	  	  Chapter	  3	  
	  
This	   chapter	   describes	   optimisation	   of	   growth	   conditions	   and	   further	  
characterisation	   of	   these	   neurospheres.	   	   It	   was	   shown	   that	   postnatal	   human	  
neurospheres	   require	   the	   addition	   of	   GDNF	   to	   the	   standard	   culture	   medium	  
employed	   in	  order	  to	  produce	  significant	  neurite	  outgrowth	   in	  vitro,	   	   in	  contrast	  
to	  embryonic	  mouse	  neurospheres.	  	  The	  fact	  that	  postnatal	  human	  neurospheres	  
did	  not	  require	  the	  addition	  of	  GDNF	  to	  produce	  neuronal	  migration	  when	  grafted	  
into	  embryonic	  mouse	  colon	  is	  consistent	  with	  the	  presence	  of	  endogenous	  GDNF	  
in	   the	   recipient	   tissue,.	   	   The	   number	   of	   human	   neurospheres	  was	   increased	   by	  
dissociating	   them	   to	   form	   secondary	   and	   tertiary	   neurospheres.	   	   Interestingly,	  
although	  the	  tertiary	  neurospheres	  expressed	  a	  reduction	   in	  the	  number	  of	  cells	  
displaying	  a	  glial	  cell	  marker,	  nevertheless	  such	  neurospheres	  retained	  the	  ability	  
to	  produce	  cells	  expressing	  glial	  cell	  markers	  when	  grafted	  into	  embryonic	  mouse	  
colon,	  again	  indicating	  that	  recipient	  microenvironment	  is	  a	  key	  regulator	  of	  ENS	  
progenitor	   cell	   fate	  and	  hence	  will	  be	  critical	   to	   the	   success	  or	   failure	  of	  a	   stem	  
cell	  based	  treatment.	  
	  
5.1.4	  	  Chapter	  4	  
	  
Whether	   neurosphere	   transplantation	   would	   effect	   a	   functional	   change	   in	   the	  
recipient	  bowel	  was	  investigated	  in	  chapter	  4.	  	  It	  was	  established	  that	  grafted	  cells	  
expressing	  neuronal	  markers	  migrated	  in	  explants	  of	  embryonic	  mouse	  bowel	  and	  
developed	   a	   close	   relationship	  with	   the	   interstitial	   cells	   of	   Cajal.	   	   Using	   a	   tissue	  
culture	   model	   of	   aganglionic	   embryonic	   colon	   it	   was	   established	   that	   in	   the	  
absence	  of	   ENS	   ganglia,	   the	   resting	   rate	   of	   spontaneous	   contraction	  was	   higher	  
than	   in	   that	   of	   ganglionic	   bowel.	   	   It	   was	   then	   shown	   that	   transplantation	   of	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embryonic	   mouse	   and	   neonatal	   human	   neurospheres	   restored	   the	   	   	   rate	   of	  
contraction	  to	  that	  of	  ganglionic	  bowel.	  	  
	  
In	  summary,	   therefore,	   this	   thesis	  has	  demonstrated	  that	   is	   it	  possible	  to	   isolate	  
cells	   from	   samples	   of	   postnatal	   human	   bowel	   that	   have	   the	   properties	   of	   ENS	  
progenitor	  cells	  and	  may	  well	  be	  true	  stem	  cells.	  	  It	  has	  also	  shown	  that	  such	  cells	  
can	  be	  grown	   in	   the	   form	  of	  neurospheres	  and	   transplanted	   into	  an	  aganglionic	  
embryonic	   tissue	   culture	  model	   where	   they	   engraft,	   generate	   neurons	   and	   glia	  
within	   the	   embryonic	   bowel	   and	   subsequently	   restore	   the	   frequency	   of	  
contraction	  to	   that	   found	   in	  normal	  ganglionic	  bowel.	   	  This	  work	   is	   therefore	  an	  
important	   step	   along	   the	   path	   to	   developing	   an	   autologous	   stem	   cell-­‐based	  
treatment	  for	  Hirschsprung’s	  disease.	  
	  
	  5.2	  	  Publications	  arising	  from	  this	  thesis	  
	  
Work	  from	  this	  thesis	  has	  been	  published	  in	  3	  papers	  (shown	  in	  Appendix	  3).	  
	  5.3	  	  Research	  relating	  to	  this	  thesis	  following	  publication	  
	  
Following	  the	  publication	  of	  work	  arising	  from	  this	  thesis,	  there	  have	  been	  many	  
papers	  related	  to	  the	  topics	  covered.	  	  One	  paper	  specifically	  replicated	  the	  initial	  
methods	  cited	  here	  to	  generate	  neurospheres	  from	  human	  adult	  bowel,	  although	  
the	   authors	   subsequently	   cultured	   the	   dissociated	   cells	   in	   adherent	   conditions	  
using	  fetally-­‐conditioned	  medium,	  fetal	  murine	  neurospheres	  had	  been	  grown	  in	  
the	  medium	  previously	  medium	  (Metzger	  et	  al.,	  2009a).	   	  GDNF	  supplementation	  
was	  also	  used	  in	  this	  paper	  to	  promote	  neurite	  outgrowth	  from	  postnatal	  human	  
neurospheres.	   	   Other	   papers	   selected	   for	   comment	   relate	   to	   the	   possibility	   of	  
developing	   a	   stem	   cell	   based	   treatment	   for	   Hirschsprung’s	   disease	   in	   more	  
general	  terms.	  
	  
5.3.1	  	  Neural	  crest	  cell	  transplantation	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Martuciello	  et	  al(Martucciello	  et	  al.,	  2007)	   injected	  embryonic	  vagal	  neural	  crest	  
cells	  into	  adult	  Dom	  -­‐/-­‐	  mice	  	  peritoneum	  or	  bowel	  directly,	  and	  showed	  apparent	  
integration	  of	   injected	  cells	   into	  the	  aganglionic	  gut,	  principally	  between	  circular	  
and	   longitudinal	   muscle.	   	   However,	   	   it	   has	   been	   shown	   that	   neural	   crest	   cells	  
express	   a	   positional	   identity(Zhang	   et	   al.,	   2010)	   but	   the	   phenotypes	   and	   /or	  
functional	   consequences	   of	   the	   injected	   cells	   was	   not	   established,	   leaving	   the	  
significance	   of	   this	   source	   of	   embryonic	   cells	   open	   to	   question.	   	   It	   should	   be	  
pointed	  out	   that	   given	  heterogeneity	  of	  NC	  populations	   along	   the	  neuraxis,	   any	  
NC	  based	  therapy	   is	   likely	  to	  be	  critically	  dependent	  on	  the	  selection	  of	  cells	   for	  
transplantation;	  this	  is	  not	  a	  problem	  using	  cells	  derived	  from	  the	  bowel	  itself.	  	  
	  
Recovery	  of	  anal	  sphincter	  function	  in	  an	  animal	  model	  of	  HSCR	  caused	  by	  topical	  
application	   of	   benzalkonium	   chloride	   has	   also	   been	   shown	   using	   transplanted	  
fetal	   CNS-­‐derived	   neurospheres(Dong	   et	   al.,	   2008).	   	   Neural	   tube-­‐derived	   cells	  
have	   also	   been	   transplanted	   by	   the	   same	   group	   into	   colon	   stripped	   of	   the	   ENS	  
using	   benzalkonium	   chloride(Liu	   et	   al.,	   2007).	   	   In	   this	   study	   no	   spontaneous	  
regeneration	  of	  the	  endogenous	  ENS	  was	  seen;	  this	  contrasts	  with	  the	  findings	  of	  
Hanani(Hanani	  et	  al.,	  2003a)	  as	  mentioned	   in	  Chapter	  1.	   	  There	  also	   remain	   the	  
ethical	  and	   immunological	  problems	  of	  using	  fetal	  or	  embryonic	  human	  material	  
when	   looking	  at	   therapies	   for	  HSCR,	   and	   in	  addition	   there	   is	   the	  possibility	   that	  
such	   CNS-­‐derived	   neurones	   may	   not	   replicate	   ENS	   function	   correctly.	   	   Other	  
investigators	   including	   us	   have	   therefore	   focused	   on	   ENS-­‐derived	   stem	   or	  
progenitor	  cells.	  
	  
5.3.2	  	  ENS-­‐derived	  cell	  transplantation	  
	  
Two	  important	  papers	  have	  been	  published	  subsequently	  looking	  at	  the	  possibility	  
of	   using	   ENSC	   as	   a	  method	   of	   treating	   HSCR.	   In	   an	   animal-­‐based	   study,	   Tsai	   et	  
al(Tsai	  et	  al.,	  2010)	  described	  work	  where	  embryonic	  rat	  ENSC	  were	  injected	  into	  
the	   peritoneal	   cavity	   of	   neonatal	   Ednrb	   sl/sl	   rats.	   	   This	   demonstrated	   that	  
although	  the	   injected	  cells	  engrafted	   into	  small	  bowel,	   they	  did	  not	  do	  so	   in	  the	  
aganglionic	   region	   of	   the	   colon.	   	   This	   is	   in	   contrast	   to	   the	   paper	   by	  
Martucciello(Martucciello	   et	   al.,	   2007)	   	  mentioned	   above	  where	   intraperitoneal	  
injection	   of	   neural	   crest	   cells	   did	   achieve	   integration.	   	   It	  was	   hypothesised	   that	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changes	  in	  the	  gut	  microenvironment	  may	  account	  for	  this	  difference,	  which	  is	  in	  
keeping	  with	  the	  work	  presented	  in	  this	  thesis,	  although	  no	  research	  was	  done	  to	  
investigate	  whether	  differing	  GDNF	  expression	  may	  account	  for	  it.	  	  	  Indeed,	  there	  
is	  some	  evidence	  from	  more	  recent	  work	  that	  in	  this	  instance	  EDN3	  expression	  or	  
receptor	  function	  may	  be	  a	  factor:	  	  Druckenbrod(Druckenbrod	  and	  Epstein,	  2009)	  	  
found	   that	   in	   a	   mouse	   knockout	   Ednrb	   model,	   changes	   in	   the	   postnatal	   colon	  
prevent	   ENSC	   colonisation,	   and	   Hotta	   has	   shown	   that	   E11.5	   ENSC	   can	   colonise	  
postnatal	  gut	  in	  an	  endothelin-­‐3	  deficient	  model	  of	  HSCR	  but	  that	  they	  do	  so	  at	  a	  
slower	  rate	  than	  in	  wild-­‐type	  recipient	  colon(Hotta	  et	  al.,	  2010).	  	  	  
	  
The	  other	  significant	  paper	  published	  after	  the	  work	  described	   in	  this	  thesis	  was	  
by	  Metzger	   et	   al(Metzger	   et	   al.,	   2009b).	   	   They	   used	   postnatal	   human	  mucosal	  
biopsy	  specimens	  to	  generate	  neurospheres	  that	  contain	  ENSC	  or	  ENS	  precursor	  
cells.	  	  They	  demonstrated	  that	  cells	  within	  the	  biopsy	  specimens	  were	  positive	  for	  
p75	  and	  not	  GFAP,	  indicating	  an	  ENSC	  lineage.	  	  The	  neurospheres	  generated	  from	  
these	   samples	  were	   shown	   to	   be	   able	   to	   colonise	   aganglionic	   embryonic	   bowel	  
and	  also	  grow	  upon,	  and	  occasionally	  invade,	  postnatal	  human	  aganglionic	  colon	  
maintained	  in	  tissue	  culture.	  	  In	  contrast	  to	  the	  work	  presented	  in	  this	  thesis,	  no	  
functional	   effect	   was	   investigated,	   and	   it	   should	   be	   noted	   that	   the	   method	  
presented	  in	  this	  thesis	  specifically	  excludes	  the	  mucosa	  that	  was	  biopsied	  in	  this	  
paper.	   	   It	   has	   been	   suggested	   that	   mucosal	   biopsies	   are	   more	   suitable	   for	   the	  
treatment	  of	  children	  with	  HSCR	  as	  it	  would	  not	  be	  practical	  or	  ethical	  to	  extract	  
full	   thickness	   gut	   tissue	   from	   surgical	   resections(Hotta	   et	   al.,	   2009),	   given	   that	  
repeated	   harvesting	   would	   be	   necessary	   to	   generate	   the	   required	   numbers	   of	  
cells	   for	   transplantation.	   	   But	   this	   argument	   ignores	   the	   fact	   that	   children	  
routinely	   undergo	   resection	   of	   bowel	   for	   treatment	   of	   their	   Hirschsprung’s	  
disease	   and	   that	   it	   has	   been	   demonstrated	   that	   exponential	   expansion	   of	  
neurosphere	   numbers	   can	   occur	   be	   generating	   secondary	   and	   tertiary	  
populations.	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5.3.3	   	   Generation	   of	   induced	   pluripotent	   stem	   cells	   by	   cellular	  
reprogramming	  	  
	  
One	   of	   the	  most	   exciting	   developments	   in	   stem	   cell	   technology	   in	   recent	   years	  
came	  to	  light	  towards	  the	  conclusion	  of	  the	  work	  presented	  in	  this	  thesis.	  	  Several	  
groups	  demonstrated	  that	  is	  was	  possible	  to	  reprogram	  differentiated	  fibroblasts	  
into	   pluripotent	   stem	   (iPS)	   cells,	   avoiding	   the	   need	   to	   harvest	   embryonic	   stem	  
cells	   and	   creating	   the	   possibility	   of	   generating	   stem	   cell	   treatments	   from	   skin	  
biopsies(Wernig	   et	   al.,	   2007,	   Takahashi	   and	  Yamanaka,	   2006,	  Okita	   et	   al.,	   2007,	  
Meissner	   et	   al.,	   2007).	   	   However,	   no	   specific	  work	   has	   yet	   been	  undertaken	  on	  
whether	   such	   induced	   pluripotent	   cells	   are	   suitable	   for	   differentiation	   into	   an	  
ENSC	  phenotype	  and	  subsequent	  transplantation	  in	  HSCR	  animal	  models,	  and	  this	  
therefore	  remains	  a	  promising	  but	  as	  yet	  unexplored	  line	  of	  treatment.	  
	  
5.4	   Implications	   of	   work	   presented	   in	   this	   thesis	   and	  
anticipated	  future	  work	  
	  
The	  work	  presented	  in	  this	  thesis	  shows	  that	  postnatally-­‐derived,	  autologous	  stem	  
(or	   precursor)	   cell	   transplantation	   is	   a	   possible	   treatment	   for	   Hirschsprung’s	  
disease.	  	  	  However,	  much	  more	  work	  is	  needed	  for	  this	  to	  become	  a	  reality.	  
	  
Areas	  for	  further	  work	  can	  be	  broken	  down	  in	  to	  the	  following	  main	  categories:	  
	  
Further	  characterisation	  of	  the	  cells	  within	  the	  neurospheres	  
	  
The	  cells	  within	   the	  human-­‐derived	  neurospheres	  described	   in	   chapters	  2	  and	  3	  
have	  been	  partly	  characterised	  in	  this	  thesis	  but	  more	  work	  is	  needed	  in	  this	  area.	  	  
The	   first	   question	   to	   answer	   is	  whether	   these	   cells	   are	   true	   stem	   cells	   or	  more	  
differentiated	   progenitor	   cells,	   which	   would	   require	   a	   true	   clonal	   culture.	   	   The	  
origin	  of	  these	  cells	  has	  also	  not	  been	  established	  –	  are	  they	  stem	  cells	  that	  reside	  
within	  the	  gut	  wall	  or	  are	  they	  more	  differentiated	  cells	  that	  are	  transformed	  back	  
to	  a	  stem	  or	  progenitor	  phenotype	  by	  the	  processes	  involved	  in	  their	  isolation	  and	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culture?	  	  A	  very	  recent	  paper	  has	  identified	  a	  population	  of	  cells	  within	  the	  enteric	  
ganglia	   of	   human	   adult	   jejunum	   that	   express	   nestin	   and	   PGP	   9.5	   but	   not	  
S100(Azan	  et	  al.,	  2011),	  but	  whether	   these	  cells	  are	  ENS	  precursor	  or	  stem	  cells	  
remains	  to	  be	  demonstrated.	  	  Sox2	  has	  also	  been	  identified	  as	  a	  potential	  marker	  
of	  ENSC	  persisting	   in	  postnatal	  bowel	  but	   like	  all	  other	  previously	  discussed	  ENS	  
stem	  cell	  markers,	  its	  expression	  is	  not	  unique(Heanue	  and	  Pachnis,	  2011).	  	  This	  is	  
an	  area	  of	  active	  research	  and	  it	  is	  apparent	  that	  much	  is	  still	  to	  be	  learned.	  
	  
1. Optimisation	   of	   neurosphere	   culture	   conditions	   and	   expansion	   of	  
neurosphere	  numbers	  
	  
For	  a	  realistic	  stem	  cell	  therapy	  for	  Hirschsprung’s	  and	  other	  disorders,	  it	  
would	   be	   necessary	   to	   reliably	   culture	   and	   expand	   the	   stem	   cell	  
population.	   	   Good	   manufacturing	   practice	   for	   clinical	   grade	   use	   would	  
require	  the	  absence	  of	  animal-­‐derived	  serum	  and	  culture	  factors(Unger	  et	  
al.,	  2008),	  which	  would	  require	  modification	  of	  the	  protocols	  employed	  in	  
this	   thesis.	   	   It	   would	   also	   be	   necessary	   to	   investigate	   whether	   further	  
neurosphere	  expansion	  beyond	  tertiary	  spheres	  would	  result	   in	  a	   loss	  of	  
the	  capability	  to	  generate	  particular	  cell	  phenotypes,	  such	  as	  glial	  cells.	  
	  
2. Understanding	   factors	   involved	   in	   successful	   cell	   transplantation,	  
migration	  and	  integration	  with	  the	  recipient	  ENS.	  
	  
A	  recent	  paper	  (Rodrigues	  et	  al.,	  2011)	  has	  shown	  that	  GDNF	  is	  expressed	  
by	   intestinal	   smooth	   muscle	   in	   postnatal	   gut	   and	   has	   an	   effect	   on	  
myenteric	   neuronal	   outgrowth	   and	   remodelling.	   	   This	   is	   consistent	  with	  
the	   finding	   that	   human	   postnatal	   neurospheres	   require	   the	  
supplementation	  of	  GDNF	  for	  neurite	  production	  and	  is	  also	  encouraging	  
in	  that	  it	  indicates	  that	  GDNF	  will	  be	  present	  in	  the	  bowel	  of	  children	  with	  
HSCR	   where	   stem	   cell	   transplantation	   is	   potentially	   needed.	   	   It	   seems	  
likely	   that	   there	   will	   be	   other	   factors	   that	   are	   also	   important,	   as	   (for	  
instance)	  extracellular	  matrix	  and	  adhesive	  molecules	  are	  also	  key	  to	  the	  
development	  of	  the	  ENS,	  as	  mentioned	  in	  Chapter	  1.	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3. Development	   of	   a	   successful	   technique	   to	   transplant	   neurospheres	   or	  
neurosphere-­‐derived	  cells	  into	  an	  animal	  model	  of	  HSCR	  
	  
Published	   techniques	   transplanting	   ENS	   stem	   cells	   into	   the	   gut	   have	  
involved	  intraperitoneal	  injection	  and	  seromuscular	  injection(Martucciello	  
et	  al.,	  2007).	  	  It	  has	  also	  been	  proposed	  that	  injection	  into	  the	  mesenteric	  
artery	  may	  be	  feasible(Hotta	  et	  al.,	  2009).	  	  These	  approaches	  assume	  that	  
it	  would	  be	  necessary	   to	   reinnervate	   a	   long	   segment	  of	   aganglionic	   gut,	  
but	   the	   assumption	   underlying	   the	  work	   presented	   in	   this	   thesis	   is	   that	  
surgical	  correction	  of	  Hirschsprung’s	  disease,	  removing	  a	  large	  part	  of	  the	  
affected	   gut,	   would	   be	   followed	   by	   stem	   cell	   transplantation	   into	   the	  
residual	   aganglionic	   internal	   anal	   sphincter.	   	   Direct	   transanal	   injection	  
would	   therefore	   be	   the	   favoured	   delivery	   mechanism,	   but	   again	   this	  
would	  require	  further	  work.	  
	  
4. Demonstration	   that	   such	   a	   transplantation	   technique	   produces	   a	  
functional	  improvement	  in	  the	  recipient	  animals	  
	  
Section	  5.3	  details	  recent	  work	  on	  transplantation	  of	  neural	  crest	  and	  ENS	  
stem	  cells.	  	  A	  key	  development	  of	  the	  work	  presented	  in	  this	  thesis	  would	  
be	  to	  show	  that	  embryonic	  and	  postnatally-­‐derived	  neurospheres	  from	  an	  
inbred	   HSCR	  model	  mouse	   colony	   (such	   as	   lethal	   spotting	   or	  miRET(51)	  
mice)	  can	  rescue	  bowel	  function	  and	  improve	  survival	  when	  injected	  into	  
the	  bowel	  wall	  of	  affected	  animals.	  	  With	  the	  work	  presented	  in	  this	  thesis	  
and	  subsequent	  publications,	  this	  is	  now	  a	  viable	  avenue	  of	  research.	  
	  
5. Demonstration	   that	   there	   is	   no	   associated	   tumour	   risk	   in	   such	   a	  
treatment,	  and	  development	  of	  strategies	  to	  handle	  malignant	  potential	  
	  
In	   2009	   the	   first	   recorded	   tumour	   arising	   as	   a	   result	   of	   stem	   cell	  
transplantation	   was	   described(Amariglio	   et	   al.,	   2009).	   	   In	   addition,	   a	  
clinical	  trial	  evaluating	  human	  ES	  cell-­‐derived	  oligodendrocyte	  progenitor	  
cell	   transplants	   in	  patients	  with	  a	  spinal	  cord	   injury	  has	  been	  delayed	  by	  
the	   concern	   over	   lesions	   arising	   in	   animal	   recipients(Sahni	   and	   Kessler,	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2010).	   	   These	   examples	   highlight	   the	   potential	   risks	   of	   such	   treatments,	  
especially	   when	   considering	   a	   “benign”	   functional	   disease	   such	   as	  
Hirschsprung’s.	   	   It	   is	   hoped	   that	   transplantation	   of	   more	   differentiated	  
ENS	  stem	  cells	  rather	  than	  embryonic	  or	  neural	  crest	  cells	  would	  minimise	  
this	   risk,	   but	   long	   term	   studies	   on	   the	   malignant	   potential	   of	   such	  
treatments	   need	   to	   be	   conducted	   before	   progression	   to	   human	   trials	  
could	  be	  considered.	  
	  
5.5	  	  Concluding	  comment	  
	  
"If	   the	   potential	   of	   stem	   cell	   research	   is	   realized,	   it	   would	  mean	   an	   end	   to	   the	  
suffering	   of	   millions	   of	   people	   –	   a	   rescue,	   a	   cure...stem	   cells	   could	   lead	   to	  
breakthroughs	   in	   developing	   treatments	   and	   cures	   for	   almost	   any	   terminal	   or	  
catastrophic	  disease	  you	  can	  think	  of.	  This	   is	  one	  of	  the	  reasons	  that	  support	   for	  
this	  work	   has	   galvanized	   a	   coalition	   of	   advocates	   from	   just	   about	   every	   patient	  
community	  in	  the	  nation.	  If	  stem	  cell	  research	  succeeds,	  there	  isn't	  a	  person	  in	  the	  
country	  who	  won't	  benefit,	  or	  know	  somebody	  who	  will."	  
Michael	   J.	   Fox,	   Founder,	   Michael	   J.	   Fox	   Foundation	   for	   Parkinson's	   Research.	  	  
Excerpt	  from	  his	  book,	  Lucky	  Man	  (2002)	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  Appendix	  1:	   	   Standard	   isolation	  and	  culture	  techniques	  
	  
Standard	  neurosphere	  culture	  medium	  
	  
100ml	  DMEM-­‐low	  (1mg/ml	  glucose)	  (Gibco)	  
1ml	   penicillin/streptomycin	   (100	   U/ml	   penicillin	   and	   100	   µg/ml	  
streptomycin)	  (Gibco)	  
1ml	  glutamine	  (to	  make	  2mM)	  (Gibco)	  
1ml	  fetal	  calf	  serum	  (Sigma-­‐Aldrich)	  
100µl	  mercaptoethanol	  (to	  make	  0.05mM)	  (Sigma-­‐Aldrich)	  
1ml	  N1	  supplement	  (Sigma-­‐Aldrich)	  
100µl	  bFGF	  (to	  make	  20ng/ml)(Sigma-­‐Aldrich)	  
20µl	  EGF	  (to	  make	  20ng/ml)	  (Sigma-­‐Aldrich)	  
2ml	  chick	  embryo	  extract	  (Sera	  laboratories)	  
(+100	  mg/ml	  metronidazole	  for	  human	  neurospheres	  (Sigma-­‐Aldrich))	  
Standard	  tissue	  culture	  medium	  
	  
100ml	  DMEM-­‐high	  (4500mg/L	  glucose)	  
1ml	   penicillin/streptomycin	   (100	   U/ml	   penicillin	   and	   100	   µg/ml	  
streptomycin)	  
1ml	  glutamine	  (to	  make	  2mM)	  
1ml	  fetal	  calf	  serum	  
100µl	  mercaptoethanol	  (to	  make	  0.05mM)	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Standard	   human	   neurosphere	   isolation	   and	   culture	  
technique	  
	  
The	  bowel	   sample	  was	   placed	   in	   sterile	   gauze	   soaked	  with	   sterile	   normal	   saline	  
and	  placed	  in	  a	  sterile	  screw-­‐top	  container.	  	  It	  was	  transported	  to	  the	  laboratory	  
at	  room	  temperature	  and	  washed	  in	  sterile	  PBS	  x3	  using	  3	  separate	  containers.	  	  	  	  
	  
The	  sample	  was	  placed	  on	  a	  sterile	  dissecting	  dish	  containing	  PBS	  and	  gentamicin	  
at	   a	   concentration	   of	   50µg/ml.	   	   The	   muscle	   layers	   were	   dissected	   free	   from	  
submucosa	  and	  mucosa	  and	  the	  serosal	  side	  cleaned	  free	  from	  blood	  vessels	  and	  
fat	  as	  much	  as	  possible.	  	  The	  bowel	  muscle	  was	  cut	  into	  small	  pieces	  (1-­‐2mm2).	  	  	  
	  
The	  cut	  muscle	  was	  transferred	  into	  a	  conical	  15ml	  container	  containing	  PBS.	  	  The	  
container	  was	  gently	  centrifuged	  (120G	  1	  min)	  to	  get	  the	  muscle	  pieces	  strips	  to	  
the	  bottom	  of	  the	  tube	  if	  necessary.	  	  The	  PBS	  was	  removed	  and	  replaced	  with	  2ml	  
collagenase	  (1mg/ml)	  and	  2ml	  dispase	  then	  incubated	  in	  a	  water	  bath	  for	  1	  hr.	  	  	  
	  
The	   collagenase/dispase	   solution	   was	   removed	   and	   refreshed	   with	   repeat	  
addition	  of	   	   	  2ml	  collagenase	  and	  2	  ml	  dispase.	   	   It	  was	   then	  vortexed	   for	  30s	   to	  
help	  break	  up	  tissue	  and	  incubated	  for	  a	  further	  1	  hr.	  	  	  
	  
The	   sample	   was	   then	   vortexed	   further	   and	   inspected	   to	   see	   if	   it	   was	  
macroscopically	  and	  microscopically	  dissociated.	  	  If	  it	  was	  not,	  then	  the	  digestion	  
with	  collagenase/dispase	  was	  repeated	  until	  dissociation	  was	  achieved.	  	  	  
	  
The	   bowel	   sample	   was	   then	   centrifuged	   at	   120G	   for	   2	   mins	   and	   the	   old	  
supernatant	   removed.	   	   	   The	   residual	   cell	   suspension	   was	   then	   filtered	   using	   a	  
40micrometer	  mesh	  filter	  (Falcon®	  Cell	  Strainer,	  BD	  Biosciences,	  Oxford,	  UK)	  over	  
a	   large	  50ml	  sterile	  conical	  tube.	  The	  filtrate	  was	  centrifuged	  at	  120G	  for	  5	  mins	  
and	  the	  supernatant	  removed.	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It	   was	   replaced	   with	   1ml	   of	   cell	   culture	   medium	   and	   the	   cell	   density	   assessed	  
using	  a	  haemocytometer.	  	  The	  cell	  suspension	  was	  then	  divided	  between	  4	  35mm	  
Petri	   dishes	   and	   topped	   up	   with	   warm	   culture	   medium	   to	   4-­‐5	   ml	   volume	   and	  
supplemented	  with	  gentamicin	  at	  a	  concentration	  of	  50µg/ml.	  
	  
The	   resulting	   cultures	   were	   placed	   in	   35mm	   petri	   dishes	   with	   3ml	   of	   standard	  
culture	  medium	  and	  placed	  in	  an	  incubator	  at	  37oC.	  	  1ml	  of	  culture	  medium	  was	  
changed	   every	   3	   days	   and	   any	   adherent	   neurospheres	   were	   disturbed	   using	  
gentle	  trituration.	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Appendix	   2:	   	   Generation	   of	  neonatal	  mouse	  neurospheres	  
	  
Generation	   of	   neonatal	  mouse	   neurospheres	   containing	  
ENSC	  
	  
	  Techniques	   used	   for	   the	   generation	   NMNS	   were	   present	   within	   the	   literature	  
(Kruger	  et	  al.,	  2002,	  Bondurand	  et	  al.,	  2003).	  	  These	  were	  amended	  principally	  by	  
omitting	  flow	  cytometric	  call	  selection	  and	  the	  use	  of	  culture	  medium	  containing	  
bFGF	  and	  EGF	  but	  not	  forskolin	  and	  BMP4	  or	  GDNF.	  	  This	  was	  done	  because	  this	  




Generation	  of	  neonatal	  mouse	  neurospheres	  
	  
Day	   0-­‐1	   neonatal	   CD-­‐1	  mice	  were	   sacrificed	   by	   cervical	   transaction.	   	   They	  were	  
placed	   in	  PBS	  chilled	   to	  4oC	  and	  kept	  on	   ice.	   	   Individual	  mice	  were	  selected	  and	  
the	  abdominal	  cavity	  opened.	  	  The	  colon	  (from	  caecum	  to	  rectum)	  was	  removed	  
and	   cleaned	   free	   of	   the	  mesentery.	   	   Colon	   samples	  were	   placed	   in	  DMEM-­‐high	  
supplemented	   with	   gentamicin	   (Sigma-­‐Aldrich)	   at	   a	   concentration	   of	   50µg/ml.	  	  
Once	   sufficient	   colons	   were	   harvested,	   the	   submucosa	   was	   peeled	   from	   the	  
longitudinal	  and	  circular	  muscle	  layers	  using	  dissecting	  forceps.	  	  This	  was	  easier	  at	  
the	   distal	   end	   of	   the	   colon	   and	   therefore	   the	   proximal	   colon	   and	   caecum	  were	  
discarded.	   	  The	  remaining	  colonic	  samples	  were	  then	  cut	   into	  small	  pieces	  using	  
dissecting	  scissors	  (approximately	  2mm	  square).	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Initially	   the	  mucosa	   and	   submucosa	  were	   left	   on	   the	   samples	   of	   colon,	   but	   this	  
increased	   the	   number	   of	   bacterial	   infections	   in	   cell	   culture	   and	   the	   yield	   of	  
neurospheres	   was	   very	   low	   and	   variable.	   	   Gentamicin	   was	   used	   to	   further	  
decrease	  the	  number	  of	  infections.	  
	  
The	  small	  pieces	  of	  colon	  were	  then	  digested,	  placing	  the	  colon	  in	  a	  15ml	  sterile	  
conical	  tube	  filed	  with	  PBS.	   	  This	  was	  centrifuged	  at	  120G	  for	  5	  minutes	  and	  the	  
supernatant	   removed.	   	   4mls	   of	   collagenase/dispase	   solution	   (0.5%	   (w/v)	  
collagenase	   /	   0.5%	   (w/v)	   dispase	   (Gibco	   Invitrogen)	   supplemented	   with	   2.5mM	  
Ca++	   )	  was	  added	  and	  vortexed	  to	  resuspend	  the	  colon.	   	   It	  was	   left	   for	  1	  hour	  at	  
37ºC.	   	   After	   1	   hour,	   the	   tube	   was	   recentrifuged	   and	   the	   collagenase/dispase	  
solution	   removed	   and	   replaced	   with	   fresh	   solution.	   	   The	   bowel	   was	   then	  
triturated	   again	   and	   recentrifuged.	   	   The	   supernatant	   was	   removed	   and	   the	  
deposit	  suspended	  in	  4ml	  of	  standard	  cell	  culture	  medium.	  
	  
The	  resulting	  suspension	  was	  filtered	  using	  a	  40µm	  filter	  (Falcon®	  Cell	  Strainer,	  BD	  
Biosciences,	   Oxford,	   UK)	   and	   plated	   onto	   35mm	   bacteriological	   plates	   as	  
described	   for	   EMNS	   culture.	   	   The	   medium	   was	   initially	   supplemented	   with	  
100µg/ml	   metronidazole	   (Sigma)	   but	   gentamicin	   at	   50µg/ml	   proved	   more	  
effective	  at	  preventing	  bacterial	  contamination.	  	  	  	  	  
	  
Characterisation	  of	  neonatal	  mouse	  neurospheres	  
	  
Neurospheres	  were	  selected	  after	  28	  days	  culture.	   	   	  All	   specimens	  were	   fixed	   in	  
4%	  (w/v)	  paraformaldehyde	  in	  PBS	  for	  1	  h	  at	  room	  temperature	  and	  then	  rinsed	  
extensively	  with	  PBS.	  Neurospheres	  were	  immersed	  in	  20%	  (w/v)	  sucrose	  for	  1	  h	  
prior	   to	   embedding	   in	   7.5%	   (w/v)	   gelatine	   in	   15%	   (w/v)	   sucrose.	   	   Embedded	  
specimens	  were	  frozen	  at	  -­‐80ºC	  in	  isopentane	  and	  7μm	  serial	  sections	  cut	  using	  a	  
cryostat.	  
	  
For	  immunostaining,	  samples	  were	  pre-­‐treated	  for	  30	  min	  with	  PBS	  containing	  1%	  
(w/v)	   bovine	   serum	   albumin	   (Sigma-­‐Aldrich)	   and	   0.5%	   (w/v)	   Triton	   X100	   (VWR	  
International	   Ltd,	  Poole,	  UK)	  except	  prior	   to	  p75	   labelling	  when	   the	  Triton	  X100	  
was	   omitted.	   Primary	   antisera	   were	   applied	   for	   16	   h	   at	   the	   following	  
	   241	  
concentrations:	   rabbit	   anti-­‐p75	   nerve	   growth	   factor	   receptor	   (p75,	   Abcam	   Ltd,	  
Cambridge,	   UK)	   1:400,	   rabbit	   anti-­‐protein	   gene-­‐product	   9.5	   (PGP9.5,	   Biogenesis	  
Ltd,	   Poole,	   UK)	   1:4000	   and	   rabbit	   anti-­‐S100B	   (Dako	   Ltd,	   Ely,	   UK).	   	   Slides	   were	  
rinsed	  twice	  with	  PBS	  before	  incubating	  for	  4	  hour	  with	  fluorescein	  isothiocyanate	  
(FITC)-­‐conjugated	  goat	  anti-­‐rabbit	  IgG	  (Sigma-­‐Aldrich).	  	  After	  rinsing	  with	  PBS,	  the	  
samples	  were	  mounted	  using	  DAKO	  mounting	  medium.	  





Neonatal	   mouse	   neurospheres	   can	   be	   generated	   from	   the	   colon	   of	   P0	  
mice	  
	  
Although	   the	   initial	   cell	   suspension	  contained	  numerous	  cells,	  within	  a	   few	  days	  
the	   majority	   of	   these	   had	   died	   and	   only	   a	   few	   viable	   putative	   neurospheres	  
remained	   (Appendix	   2	   Figures	   1A	   and	   B).	   	   Neonatal	   mouse	   neurospheres	   then	  
grew	   in	   a	   similar	   fashion	   to	   embryonic	   mouse	   neurospheres,	   with	   similar	  
morphology	   and	   neurite	   outgrowth	   when	   allowed	   to	   adhere	   to	   the	   petri	   dish	  
(Appendix	  2	  Figures	  1C-­‐E).	  
	  
Characterisation	  of	  neonatal	  mouse	  neurospheres	  
	  
The	  distribution	  of	  staining	   for	  p75,	  PGP9.5	  and	  S100B	  are	  shown	   in	  Appendix	  2	  
Figure	   2.	   	   There	   is	   a	   high	   degree	   of	   p75	   reactivity	   within	   the	   neurosphere	  
(Appendix	   2	   Figure	   2A)	   and	   reactivity	   to	   both	   PGP9.5	   and	   S100B	   (Appendix	   2	  
Figures	   2C	   and	   E).	   	   The	   reactivity	   and	   distribution	   of	   these	   markers	   appeared	  
consistent	  with	  those	  found	  in	  EMNS	  (for	  comparison	  see	  Almond(Almond	  et	  al.,	  
2007)).	   	   Importantly,	   there	   was	   much	   more	   reactivity	   for	   p75	   than	   S100B,	  
indicating	   that	  at	   least	  some	  of	   the	  cells	   labelled	  with	  p75	  are	  not	  of	  glial	  origin	  
and	   therefore	   may	   well	   represent	   stem	   or	   progenitor	   cells	   within	   the	  
neurosphere.	  
	  




The	   results	   of	   these	   experiments	   with	   neonatal	   mouse	   colon	   indicate	   that	   it	   is	  
possible	   to	   generate	  neurospheres	   containing	   cells	   showing	   labels	   for	   ENS	   stem	  
cells,	   neurons	   and	   glia.	   	   Other	   investigators	   using	   similar	   techniques	   have	  
demonstrated	   that	   these	   neurospheres	   contain	   ENSPC(Bondurand	   et	   al.,	   2003,	  
Kruger	   et	   al.,	   2002)	   capable	   of	   differentiating	   into	   a	   wide	   range	   of	   ENS	   neural	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